,Unnamed: 0.1,Unnamed: 0,title,date,stock,Text_Cleaned,Score,label,score
988132,988132,1000270.0,"Shares of several healthcare companies are trading lower in sympathy with the overall market following an increase in coronavirus cases in some US states that have reopened, leading to concerns of a second wave of the virus.",2020-06-11 10:22:00-04:00,PFE,shares of several healthcare companies are trading lower in sympathy with the overall market following an increase in coronavirus cases in some us states that have reopened leading to concerns of a second wave of the virus,"{'neg': 0.052, 'neu': 0.782, 'pos': 0.166, 'compound': 0.5859}",negative,0.9986187219619751
988133,988133,1000271.0,Pfizer Reports FDA Approval Of Co.'s NYVEPRIA,2020-06-11 08:04:00-04:00,PFE,pfizer reports fda approval of co s nyvepria,"{'neg': 0.0, 'neu': 0.693, 'pos': 0.307, 'compound': 0.4767}",positive,0.9959858059883118
988134,988134,1000272.0,Johnson & Johnson To Start Coronavirus Vaccine Human Trials Ahead Of Schedule In July,2020-06-11 00:16:00-04:00,PFE,johnson and johnson to start coronavirus vaccine human trials ahead of schedule in july,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998063445091248
988135,988135,1000273.0,"The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset",2020-06-10 07:30:00-04:00,PFE,the daily biotech pulse keytruda setback for merck denali pulls the plug on neurological asset,"{'neg': 0.0, 'neu': 0.848, 'pos': 0.152, 'compound': 0.3612}",negative,0.9967449903488159
988136,988136,1000274.0,"Pfizer Announces Top-Line Results From JADE TEEN Trial Of Abrocitinib In Adolescents With Moderate-To-Severe Atopic Dermatitis; Observed Improvements In Skin Clearance, Disease Extent, And Severity Among Patients 12 To <18",2020-06-10 06:46:00-04:00,PFE,pfizer announces top line results from jade teen trial of abrocitinib in adolescents with moderate to severe atopic dermatitis observed improvements in skin clearance disease extent and severity among patients 12 to less than 18,"{'neg': 0.067, 'neu': 0.827, 'pos': 0.106, 'compound': 0.128}",positive,0.9996445178985596
988137,988137,1000275.0,Valneva Announces HSR Clearance For Lyme Vaccine Collaboration With Pfizer,2020-06-08 12:04:00-04:00,PFE,valneva announces hsr clearance for lyme vaccine collaboration with pfizer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9989533424377441
988138,988138,1000276.0,AstraZeneca Approached Gilead With A Deal That Could Be The Biggest On Record: Report,2020-06-08 03:56:00-04:00,PFE,astrazeneca approached gilead with a deal that could be the biggest on record report,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9969960451126099
988139,988139,1000277.0,Ex-FDA Chief On White House's Coronavirus Vaccine Shortlist: 'They Chose Very Novel Platforms',2020-06-04 11:02:00-04:00,PFE,ex fda chief on white houses coronavirus vaccine shortlist they chose very novel platforms,"{'neg': 0.0, 'neu': 0.834, 'pos': 0.166, 'compound': 0.3804}",neutral,0.9998428821563721
988140,988140,1000278.0,Revisiting The Coronavirus Vaccine Race: Updates On The 10 Candidates In Clinics,2020-06-03 17:53:00-04:00,PFE,revisiting the coronavirus vaccine race updates on the 10 candidates in clinics,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999884843826294
988141,988141,1000279.0,"UPDATE: Five Companies Chosen For 'Vaccine Finalist' Are Moderna, Johnson & Johnson, Merck, Pfizer And AstraZeneca",2020-06-03 13:09:00-04:00,PFE,update five companies chosen for vaccine finalist are moderna johnson and johnson merck pfizer and astrazeneca,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998862743377686
988142,988142,1000280.0,"Fauci Reiterates Moderna Vaccine Data Is 'Cautiously Optimistic,' Expects Pfizer's Results To Be The Same",2020-06-02 08:56:00-04:00,PFE,fauci reiterates moderna vaccine data is cautiously optimistic expects pfizers results to be the same,"{'neg': 0.0, 'neu': 0.859, 'pos': 0.141, 'compound': 0.3182}",positive,0.9994264841079712
988143,988143,1000281.0,"The Daily Biotech Pulse: FDA Nod For Roche's Combo Therapy In Liver Cancer, Allena Rips Higher, Pfizer To Invest Up To $500M In Biotechs",2020-06-02 07:45:00-04:00,PFE,the daily biotech pulse fda nod for roches combo therapy in liver cancer allena rips higher pfizer to invest up to dollars 00 million in biotechs,"{'neg': 0.15, 'neu': 0.85, 'pos': 0.0, 'compound': -0.6597}",positive,0.9992891550064087
988144,988144,1000282.0,71 Biggest Movers From Yesterday,2020-06-02 04:39:00-04:00,PFE,71 biggest movers from yesterday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998496770858765
988145,988145,1000283.0,"Pfizer Analyst Takes Stock Of Negative Breast Cancer Data, Pharma Giant's 2025 Goals",2020-06-01 14:25:00-04:00,PFE,pfizer analyst takes stock of negative breast cancer data pharma giants 2025 goals,"{'neg': 0.424, 'neu': 0.576, 'pos': 0.0, 'compound': -0.8442}",negative,0.8833996057510376
988146,988146,1000284.0,48 Stocks Moving In Monday's Mid-Day Session,2020-06-01 12:34:00-04:00,PFE,48 stocks moving in mondays mid day session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998738765716553
988147,988147,1000285.0,"JP Morgan Maintains Neutral on Pfizer, Lowers Price Target to $36",2020-06-01 11:31:00-04:00,PFE,jp morgan maintains neutral on pfizer lowers price target to dollars 6,"{'neg': 0.113, 'neu': 0.752, 'pos': 0.135, 'compound': 0.0772}",positive,0.9987892508506775
988148,988148,1000286.0,Pfizer shares are trading lower after the company's data monitoring committee said its breast cancer treatment trial is unlikely to show statistically significant improvement.,2020-06-01 08:40:00-04:00,PFE,pfizer shares are trading lower after the companys data monitoring committee said its breast cancer treatment trial is unlikely to show statistically significant improvement,"{'neg': 0.202, 'neu': 0.583, 'pos': 0.215, 'compound': -0.1531}",negative,0.9986671209335327
988149,988149,1000287.0,26 Stocks Moving in Monday's Pre-Market Session,2020-06-01 07:02:00-04:00,PFE,26 stocks moving in mondays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998683929443359
988150,988150,1000288.0,A Peek Into The Markets: US Stock Futures Edge Lower Following Weekend of Violent Protests; Manufacturing Data In Focus,2020-06-01 06:02:00-04:00,PFE,a peek into the markets us stock futures edge lower following weekend of violent protests manufacturing data in focus,"{'neg': 0.333, 'neu': 0.667, 'pos': 0.0, 'compound': -0.7906}",negative,0.9980307221412659
988151,988151,1000289.0,"5 Stocks To Watch For June 1, 2020",2020-06-01 04:31:00-04:00,PFE,5 stocks to watch for june 1 2020,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998422861099243
988152,988152,1000290.0,Pfizer Falls On Disappointing Breast Cancer PALLAS Study,2020-05-29 16:55:00-04:00,PFE,pfizer falls on disappointing breast cancer pallas study,"{'neg': 0.559, 'neu': 0.441, 'pos': 0.0, 'compound': -0.8225}",negative,0.9983620047569275
988153,988153,1000291.0,"Pfizer Says Data Monitoring Committe Determined Phase 3 Trial Of IBRANCE Plus Endocrine Therapy in HR+, HER2- Early Breast Cancer Is Unlikely To Show Statistically Significant Improvement In Primary Endpoint",2020-05-29 16:16:00-04:00,PFE,pfizer says data monitoring committe determined phase 3 trial of ibrance plus endocrine therapy in hr her2 early breast cancer is unlikely to show statistically significant improvement in primary endpoint,"{'neg': 0.117, 'neu': 0.691, 'pos': 0.191, 'compound': 0.2023}",positive,0.9996028542518616
988154,988154,1000292.0,Pfizer Reports Final PROSPER Results Show XTANDI Significantly Extends Overall Survival In Men With Non-Metastatic Castration-Resistant Prostate Cancer,2020-05-29 08:18:00-04:00,PFE,pfizer reports final prosper results show xtandi significantly extends overall survival in men with non metastatic castration resistant prostate cancer,"{'neg': 0.184, 'neu': 0.753, 'pos': 0.063, 'compound': -0.5994}",positive,0.9997019171714783
988155,988155,1000293.0,"The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant",2020-05-29 07:22:00-04:00,PFE,the daily biotech pulse asco presentations begin altimmune pops on insider buying immutep gets r and d grant,"{'neg': 0.0, 'neu': 0.872, 'pos': 0.128, 'compound': 0.3612}",neutral,0.9998040795326233
988156,988156,1000294.0,"Cramer Shares His Thoughts On Teva, Oxford Industries And More",2020-05-29 06:40:00-04:00,PFE,cramer shares his thoughts on teva oxford industries and more,"{'neg': 0.0, 'neu': 0.804, 'pos': 0.196, 'compound': 0.296}",neutral,0.9998862743377686
988157,988157,1000295.0,Corning And Pfizer Announce Supply Agreement For Corning Valor Glass Packaging,2020-05-28 08:31:00-04:00,PFE,corning and pfizer announce supply agreement for corning valor glass packaging,"{'neg': 0.0, 'neu': 0.758, 'pos': 0.242, 'compound': 0.4939}",positive,0.9992460012435913
988158,988158,1000296.0,ContraFect Corporation Announces Private Placement Of Common Stock And Warrants To Pfizer Inc.,2020-05-26 07:32:00-04:00,PFE,contrafect corporation announces private placement of common stock and warrants to pfizer inc,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998844861984253
988159,988159,1000297.0,Novavax Begins Phase 1 Clinical Trial Of Its Coronavirus Vaccine,2020-05-26 02:48:00-04:00,PFE,novavax begins phase 1 clinical trial of its coronavirus vaccine,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998865127563477
988160,988160,1000298.0,The Week Ahead In Biotech: ASCO Presentations In The Spotlight,2020-05-24 14:40:00-04:00,PFE,the week ahead in biotech asco presentations in the spotlight,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998801946640015
988161,988161,1000299.0,"In The Midst Of Pandemic, Traders Pin Their Hopes On These Healthcare ETFs",2020-05-19 09:38:00-04:00,PFE,in the midst of pandemic traders pin their hopes on these healthcare etfs,"{'neg': 0.0, 'neu': 0.811, 'pos': 0.189, 'compound': 0.4215}",neutral,0.9998432397842407
988162,988162,1000300.0,Moncef Slaoui To Divest Moderna Stake As He Joins White House Vaccine Accelerator,2020-05-19 09:00:00-04:00,PFE,moncef slaoui to divest moderna stake as he joins white house vaccine accelerator,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997367262840271
988163,988163,1000301.0,"The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering",2020-05-19 08:24:00-04:00,PFE,the daily biotech pulse fda nod for roche arbutus releases positive readout for hbv therapy moderna announces dollars .34 billion common stock offering,"{'neg': 0.0, 'neu': 0.859, 'pos': 0.141, 'compound': 0.5574}",positive,0.9986166954040527
988164,988164,1000302.0,"These 6 Coronavirus Vaccine Candidates Are The Likeliest To Succeed, Says Morgan Stanley",2020-05-18 12:07:00-04:00,PFE,these 6 coronavirus vaccine candidates are the likeliest to succeed says morgan stanley,"{'neg': 0.0, 'neu': 0.789, 'pos': 0.211, 'compound': 0.4939}",neutral,0.9576868414878845
988165,988165,1000303.0,"GSK, Pfizer Owned ViiV Healthcare Announces Long-acting Injectable Formulation of Cabotegravir Dosed Every Two Months Shows Higher Efficacy Than Daily Oral PrEP",2020-05-18 06:25:00-04:00,PFE,gsk pfizer owned viiv healthcare announces long acting injectable formulation of cabotegravir dosed every two months shows higher efficacy than daily oral prep,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992139339447021
988166,988166,1000304.0,Pfizer Highlights Updated Phase 1b Data On PF-06939926 To Treat Duchenne Muscular Dystrophy,2020-05-15 08:03:00-04:00,PFE,pfizer highlights updated phase 1 billion data on pf 06939926 to treat duchenne muscular dystrophy,"{'neg': 0.0, 'neu': 0.838, 'pos': 0.162, 'compound': 0.4019}",neutral,0.9998667240142822
988167,988167,1000305.0,"The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO",2020-05-15 07:49:00-04:00,PFE,the daily biotech pulse co diagnostics earnings nantkwest plans pancreatic cancer study adc therapeutics ipo,"{'neg': 0.239, 'neu': 0.761, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9998635053634644
988168,988168,1000306.0,Pfizer Reports Top-Line Results From Phase 3 Lot Consistency Study Of 20-Valent Pneumococcal Conjugate Vaccine In Pneumococcal Vaccine-Naive Adults 18-49,2020-05-14 10:00:00-04:00,PFE,pfizer reports top line results from phase 3 lot consistency study of 20 valent pneumococcal conjugate vaccine in pneumococcal vaccine naive adults 18 to 49,"{'neg': 0.078, 'neu': 0.855, 'pos': 0.067, 'compound': -0.0772}",neutral,0.9998769760131836
988169,988169,1000307.0,"AbbVie's Potential Is 'Underappreciated,' Says Morgan Stanley Analyst",2020-05-13 12:03:00-04:00,PFE,abbvies potential is underappreciated says morgan stanley analyst,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9983924031257629
988170,988170,1000308.0,"Benzinga Pro's Top 5 Stocks To Watch For Wed., May 13, 2020: CSCO, PFE, NCLH, ALLK, SDC",2020-05-13 07:58:00-04:00,PFE,benzinga pros top 5 stocks to watch for wed may 13 2020 csco pfe nclh allk sdc,"{'neg': 0.0, 'neu': 0.899, 'pos': 0.101, 'compound': 0.2023}",neutral,0.9998351335525513
988171,988171,1000309.0,A Peek Into The Markets: US Stock Futures Up Ahead Of Fed's Powell Speech,2020-05-13 05:45:00-04:00,PFE,a peek into the markets us stock futures up ahead of feds powell speech,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999862790107727
988172,988172,1000310.0,Moderna CEO Says Company's Vaccine Alone Can't Meet Global Supply,2020-05-13 05:03:00-04:00,PFE,moderna ceo says companys vaccine alone cant meet global supply,"{'neg': 0.182, 'neu': 0.818, 'pos': 0.0, 'compound': -0.25}",neutral,0.9941275119781494
988173,988173,1000311.0,Pfizer Plans To Test Coronavirus Vaccine On Thousands Of Patients By September,2020-05-13 02:18:00-04:00,PFE,pfizer plans to test coronavirus vaccine on thousands of patients by september,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998770952224731
988174,988174,1000312.0,"Pfizer Highlights New Data From Trials Of 18 Approved, Investigational Medicines Will Be Presented At ASCO 20 Virtual Program May 29-31",2020-05-12 12:04:00-04:00,PFE,pfizer highlights new data from trials of 18 approved investigational medicines will be presented at asco 20 virtual program may 29 to 31,"{'neg': 0.0, 'neu': 0.887, 'pos': 0.113, 'compound': 0.4215}",neutral,0.9998787641525269
988175,988175,1000313.0,Cruise Line Earnings Later This Week Could Provide Insight On Brutal Quarter For Industry,2020-05-11 11:27:00-04:00,PFE,cruise line earnings later this week could provide insight on brutal quarter for industry,"{'neg': 0.24, 'neu': 0.76, 'pos': 0.0, 'compound': -0.6249}",positive,0.9809561371803284
988176,988176,1000314.0,Senator Schumer Called on Veterans Affairs Administration to Come Clean on Whether It's Using Veterans to Test Hydroxychloroquine,2020-05-10 17:11:00-04:00,PFE,senator schumer called on veterans affairs administration to come clean on whether its using veterans to test hydroxychloroquine,"{'neg': 0.0, 'neu': 0.863, 'pos': 0.137, 'compound': 0.4019}",neutral,0.999765932559967
988177,988177,1000315.0,"The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight",2020-05-10 15:40:00-04:00,PFE,the week ahead in biotech virtual conference presentations clovis pdufa date in the spotlight,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998880624771118
988178,988178,1000316.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,PFE,the daily biotech pulse fda approves novartis lung cancer drug 2 way contest emerging for tetraphase pharma dexcom to join SP500 500,"{'neg': 0.155, 'neu': 0.671, 'pos': 0.173, 'compound': -0.128}",neutral,0.9881570935249329
988179,988179,1000317.0,"Pfizer Begins Human Testing Of Coronavirus Vaccine In US, Michigan Among Manufacturing Centers",2020-05-05 14:58:00-04:00,PFE,pfizer begins human testing of coronavirus vaccine in us michigan among manufacturing centers,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998894929885864
988180,988180,1000318.0,'Pfizer begins coronavirus vaccine testing in US; Mich. lab could mass produce it' -Detroit Free Press,2020-05-05 13:16:00-04:00,PFE,pfizer begins coronavirus vaccine testing in us mich lab could mass produce it detroit free press,"{'neg': 0.0, 'neu': 0.82, 'pos': 0.18, 'compound': 0.5106}",neutral,0.9998853206634521
988181,988181,1000319.0,"U.S. Immigration And Customs Working With 3M, Amazon, Pfizer & Others To Curtail Imports Of Counterfeit Masks, Coronavirus Tests, Other Gear",2020-05-05 12:34:00-04:00,PFE,u s immigration and customs working with 3 million amazon pfizer and others to curtail imports of counterfeit masks coronavirus tests other gear,"{'neg': 0.0, 'neu': 0.928, 'pos': 0.072, 'compound': 0.1779}",neutral,0.9405035376548767
988182,988182,1000320.0,What You Should Know About Alexion's $1.4B Proposed Buyout Of Portola Pharma,2020-05-05 09:10:00-04:00,PFE,what you should know about alexions dollars .4 billion proposed buyout of portola pharma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998747110366821
988183,988183,1000321.0,Pfizer and BioNTech shares are trading higher after the companies announced they have dosed their first participants in the US as part of the coronavirus mRNA vaccine development program.,2020-05-05 07:12:00-04:00,PFE,pfizer and biontech shares are trading higher after the companies announced they have dosed their first participants in the us as part of the coronavirus mrna vaccine development program,"{'neg': 0.0, 'neu': 0.927, 'pos': 0.073, 'compound': 0.296}",positive,0.9996370077133179
988184,988184,1000322.0,Pfizer And BioNTech Dose First Participants In US As Part Of Global COVID-19 (Coronavirus) mRNA Vaccine Development Program,2020-05-05 06:45:00-04:00,PFE,pfizer and biontech dose first participants in us as part of global covid 19 coronavirus mrna vaccine development program,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998955726623535
988185,988185,1000324.0,Pfizer Highlights Results Of New Data For Group B Streptococcus Infection Published In Journal Of Infectious Diseases,2020-05-04 09:01:00-04:00,PFE,pfizer highlights results of new data for group b streptococcus infection published in journal of infectious diseases,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9989621639251709
988186,988186,1000325.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,PFE,the week ahead in biotech smid cap earnings news flow picks up pace,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996610879898071
988187,988187,1000326.0,From Earlier: Pfizer Aims For 10-20M Virus Vaccine Doses By End Of 2020,2020-04-30 13:07:00-04:00,PFE,from earlier pfizer aims for 10 to 20 million virus vaccine doses by end of 2020,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998723268508911
988188,988188,1000327.0,"Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15",2020-04-30 05:43:00-04:00,PFE,valneva and pfizer announce collaboration to co develop and commercialize lyme disease vaccine vla15,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9008324146270752
988189,988189,1000328.0,"Barclays Maintains Equal-Weight on Pfizer, Raises Price Target to $37",2020-04-29 11:59:00-04:00,PFE,barclays maintains equal weight on pfizer raises price target to dollars 7,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993575215339661
988190,988190,1000329.0,"The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda",2020-04-29 08:40:00-04:00,PFE,the daily biotech pulse inovios mers vaccine data fast track designation for erytech fda approves higher dose of mercks keytruda,"{'neg': 0.0, 'neu': 0.876, 'pos': 0.124, 'compound': 0.4019}",positive,0.9935001730918884
988191,988191,1000330.0,"Pfizer Says Coronavirus Vaccine Could Be Available By Fall, US Clinical Trials To Begin Next Week",2020-04-29 00:09:00-04:00,PFE,pfizer says coronavirus vaccine could be available by fall us clinical trials to begin next week,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998799562454224
988192,988192,1000331.0,A CURE For The Common Earnings Play,2020-04-28 14:48:00-04:00,PFE,a cure for the common earnings play,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.34}",neutral,0.9950436353683472
988193,988193,1000332.0,Pfizer Says Coronavirus Vaccine Could Be Ready For Emergency Use By Fall If Passes Testing; Could Begin Testing As Soon As Next Week,2020-04-28 13:14:00-04:00,PFE,pfizer says coronavirus vaccine could be ready for emergency use by fall if passes testing could begin testing as soon as next week,"{'neg': 0.1, 'neu': 0.805, 'pos': 0.096, 'compound': -0.0258}",neutral,0.9993795156478882
988194,988194,1000333.0,From Pfizer Earnings Conference Call: Net Impact Of Coronavirus Pandemic On FY20 Sales Should Be 'Negligible',2020-04-28 10:34:00-04:00,PFE,from pfizer earnings conference call net impact of coronavirus pandemic on fy20 sales should be negligible,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9974513649940491
988195,988195,1000334.0,Morning Market Stats in 5 Minutes,2020-04-28 10:32:00-04:00,PFE,morning market stats in 5 minutes,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998799562454224
988196,988196,1000335.0,Pfizer CEO Says No Change In Commitment To Merger Of Upjohn Unit With Mylan,2020-04-28 10:21:00-04:00,PFE,pfizer ceo says no change in commitment to merger of upjohn unit with mylan,"{'neg': 0.131, 'neu': 0.714, 'pos': 0.155, 'compound': 0.1027}",neutral,0.9998069405555725
988197,988197,1000336.0,"Earnings Feast: Bring a Plate With Healthcare and Caterpillar in Morning, GOOGL And AMD Later",2020-04-28 10:06:00-04:00,PFE,earnings feast bring a plate with healthcare and caterpillar in morning googl and amd later,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998534917831421
988198,988198,1000337.0,"The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update",2020-04-28 07:36:00-04:00,PFE,the daily biotech pulse pfizer earnings roches spinal muscular dystrophy treatment moderna covid 19 vaccine update,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9995588660240173
988199,988199,1000338.0,Pfizer shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.,2020-04-28 07:20:00-04:00,PFE,pfizer shares are trading higher after the company reported better than expected first quarter eps and sales results,"{'neg': 0.0, 'neu': 0.758, 'pos': 0.242, 'compound': 0.6249}",positive,0.9997077584266663
988200,988200,1000339.0,"Pfizer Sees FY20 Adj. EPS $2.82-$2.92 vs $2.86 Est., Sales $48.5B-$50.5B vs $49.33B Est.",2020-04-28 06:46:00-04:00,PFE,pfizer sees fy20 adj eps dollars .82 dollars .92 vs dollars .86 est sales dollars 8.5 billion dollars 0.5 billion vs dollars 9.33 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998810291290283
988201,988201,1000340.0,"Pfizer Q1 Adj. EPS $0.800 Beats $0.730 Estimate, Sales $12.028B Beat $11.870B Estimate",2020-04-28 06:45:00-04:00,PFE,pfizer first quarter adj eps dollars .800 beats dollars .730 estimate sales dollars 2.028 billion beat dollars 1.870 billion estimate,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999785840511322
988202,988202,1000341.0,"A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings, Economic Reports",2020-04-28 05:48:00-04:00,PFE,a peek into the markets us stock futures up ahead of earnings economic reports,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997807145118713
988203,988203,1000342.0,"Earnings Scheduled For April 28, 2020",2020-04-28 04:55:00-04:00,PFE,earnings scheduled for april 28 2020,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998875856399536
988204,988204,1000343.0,"10 Stocks To Watch For April 28, 2020",2020-04-28 04:04:00-04:00,PFE,10 stocks to watch for april 28 2020,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998575448989868
988205,988205,1000344.0,"Apple And Amazon Earnings, Fed Meeting Among Highlights In Busy Week Ahead",2020-04-27 09:44:00-04:00,PFE,apple and amazon earnings fed meeting among highlights in busy week ahead,"{'neg': 0.0, 'neu': 0.866, 'pos': 0.134, 'compound': 0.1779}",neutral,0.9997021555900574
988206,988206,1000345.0,"The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight",2020-04-26 16:37:00-04:00,PFE,the week ahead in biotech april 26 may 2 cancer conference earnings news flow in the spotlight,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9998701810836792
988207,988207,1000346.0,Inovio CEO Says 'It's Possible' For Coronavirus Vaccine To Be Ready In 12 To 18 Months,2020-04-23 22:19:00-04:00,PFE,inovio ceo says its possible for coronavirus vaccine to be ready in 12 to 18 months,"{'neg': 0.0, 'neu': 0.857, 'pos': 0.143, 'compound': 0.3612}",neutral,0.9998762607574463
988208,988208,1000347.0,Shares of several healthcare companies are trading higher. Movement appears market-related as equities gain amid a rebound in oil prices.,2020-04-23 11:27:00-04:00,PFE,shares of several healthcare companies are trading higher movement appears market related as equities gain amid a rebound in oil prices,"{'neg': 0.0, 'neu': 0.772, 'pos': 0.228, 'compound': 0.6808}",positive,0.999249279499054
988209,988209,1000348.0,"Mylan Shares Tick Higher, Still Down 0.9% For Session, But Off Intraday Low; Hearing EU Conditional Approval Was Given For Off-Patent Deal With Pfizer",2020-04-22 12:38:00-04:00,PFE,mylan shares tick higher still down 0.9 percent for session but off intraday low hearing eu conditional approval was given for off patent deal with pfizer,"{'neg': 0.084, 'neu': 0.732, 'pos': 0.183, 'compound': 0.4767}",negative,0.9980506896972656
988210,988210,1000349.0,"BioNTech, Immunic Soar On COVID-19 Developmental Updates",2020-04-22 11:02:00-04:00,PFE,biontech immunic soar on covid 19 developmental updates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997571110725403
988211,988211,1000350.0,"The Daily Biotech Pulse: Immunic To Develop COVID Treatment, Gilead Strikes IO Partnership",2020-04-22 07:51:00-04:00,PFE,the daily biotech pulse immunic to develop covid treatment gilead strikes io partnership,"{'neg': 0.172, 'neu': 0.828, 'pos': 0.0, 'compound': -0.3612}",neutral,0.9278668761253357
988212,988212,1000351.0,Pfizer shares are trading higher after the company and BioNTech received German regulatory approval to begin the first clinical trial of their coronavirus vaccine candidate.,2020-04-22 06:10:00-04:00,PFE,pfizer shares are trading higher after the company and biontech received german regulatory approval to begin the first clinical trial of their coronavirus vaccine candidate,"{'neg': 0.0, 'neu': 0.813, 'pos': 0.187, 'compound': 0.6486}",positive,0.9996707439422607
988213,988213,1000352.0,BioNTech and Pfizer Announce Regulatory Approval from German Authority Paul-Ehrlich-Institut to Commence First Clinical Trial of COVID-19 Vaccine Candidates,2020-04-22 05:34:00-04:00,PFE,biontech and pfizer announce regulatory approval from german authority paul ehrlich institut to commence first clinical trial of covid 19 vaccine candidates,"{'neg': 0.0, 'neu': 0.82, 'pos': 0.18, 'compound': 0.5267}",positive,0.9850416779518127
988214,988214,1000353.0,How The COVID-19 Pandemic Could End,2020-04-20 16:33:00-04:00,PFE,how the covid 19 pandemic could end,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998041987419128
988215,988215,1000354.0,S&P 500 Futures Up 3.2% After Hours; Many Other Stocks Moving Higher With Futures; Investors Reacting Favorably To White Phase Guidelines On Reopening Economy,2020-04-16 18:11:00-04:00,PFE,SP500 500 futures up 3.2 percent after hours many other stocks moving higher with futures investors reacting favorably to white phase guidelines on reopening economy,"{'neg': 0.0, 'neu': 0.902, 'pos': 0.098, 'compound': 0.3818}",positive,0.9996968507766724
988216,988216,1000355.0,3 Frontrunners In COVID-19 Vaccine Development: What You Need To Know,2020-04-15 15:45:00-04:00,PFE,3 frontrunners in covid 19 vaccine development what you need to know,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998724460601807
988217,988217,1000356.0,Every Member Of Trump's 'Great American Economic Revival' Industry Groups,2020-04-15 13:09:00-04:00,PFE,every member of trumps great american economic revival industry groups,"{'neg': 0.0, 'neu': 0.687, 'pos': 0.313, 'compound': 0.6249}",neutral,0.9998745918273926
988218,988218,1000357.0,WHO Spokesperson Says Not Expecting to See the Vaccine for 12 Months or Longer,2020-04-14 05:43:00-04:00,PFE,who spokesperson says not expecting to see the vaccine for 12 months or longer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998447895050049
988219,988219,1000358.0,"Pfizer, BioNTech, Arcturus Share Timelines For Human Testing As COVID-19 Vaccine Development Intensifies",2020-04-09 13:43:00-04:00,PFE,pfizer biontech arcturus share timelines for human testing as covid 19 vaccine development intensifies,"{'neg': 0.0, 'neu': 0.855, 'pos': 0.145, 'compound': 0.296}",neutral,0.9675009846687317
988220,988220,1000359.0,Why BioNTech's Stock Is Trading Higher Today,2020-04-09 10:25:00-04:00,PFE,why biontechs stock is trading higher today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994505047798157
988221,988221,1000360.0,Pfizer Says Anti-Viral Compounds Show Activity Against Sars-cov-2 In Preclinical Screening,2020-04-09 07:54:00-04:00,PFE,pfizer says anti viral compounds show activity against sars cov 2 in preclinical screening,"{'neg': 0.15, 'neu': 0.85, 'pos': 0.0, 'compound': -0.3182}",neutral,0.8657202124595642
988222,988222,1000361.0,"The Daily Biotech Pulse: FDA Nod For Pfizer, Vanda Forges Partnership For COVID-19 Drug Research, Neuronetics Pre-Announces Revenue Shortfall",2020-04-09 07:52:00-04:00,PFE,the daily biotech pulse fda nod for pfizer vanda forges partnership for covid 19 drug research neuronetics pre announces revenue shortfall,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9985625147819519
988223,988223,1000362.0,Pfizer And BioNTech Intend To Initiate First Clinical Trials Of Coronavirus Vaccine As Early As Apr. 2020; BioNTech To Receive $185M Upfront And Is Eligible For Up To $563M In Milestones,2020-04-09 07:39:00-04:00,PFE,pfizer and biontech intend to initiate first clinical trials of coronavirus vaccine as early as apr 2020 biontech to receive dollars 85 million upfront and is eligible for up to dollars 63 million in milestones,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998118281364441
988224,988224,1000363.0,"EMD Serono, Pfizer Report Completion Of Submission Of Supplemental Biologics License Application To FDA For BAVENCIO For Treatment Of Urothelial Carcinoma; FDA Grants Breakthrough Therapy Designation",2020-04-09 06:01:00-04:00,PFE,emd serono pfizer report completion of submission of supplemental biologics license application to fda for bavencio for treatment of urothelial carcinoma fda grants breakthrough therapy designation,"{'neg': 0.0, 'neu': 0.929, 'pos': 0.071, 'compound': 0.2263}",positive,0.9959239959716797
988225,988225,1000364.0,"What's The Difference Between Coronavirus, SARS-CoV-2 and COVID-19?",2020-04-03 16:22:00-04:00,PFE,whats the difference between coronavirus sars cov 2 and covid 19,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998908042907715
988226,988226,1000365.0,Cannabis Opportunity In The Time Of The Coronavirus,2020-04-02 17:59:00-04:00,PFE,cannabis opportunity in the time of the coronavirus,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.4215}",neutral,0.9998606443405151
988227,988227,1000366.0,Pfizer Reports European Approval For RUXIENCE,2020-04-02 14:05:00-04:00,PFE,pfizer reports european approval for ruxience,"{'neg': 0.0, 'neu': 0.617, 'pos': 0.383, 'compound': 0.4767}",positive,0.9978036284446716
988228,988228,1000368.0,"Morgan Stanley Maintains Equal-Weight on Pfizer, Lowers Price Target to $36",2020-04-02 09:25:00-04:00,PFE,morgan stanley maintains equal weight on pfizer lowers price target to dollars 6,"{'neg': 0.111, 'neu': 0.889, 'pos': 0.0, 'compound': -0.128}",positive,0.9992465972900391
988229,988229,1000369.0,Shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the US weigh on equities.,2020-04-01 09:20:00-04:00,PFE,shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the us weigh on equities,"{'neg': 0.193, 'neu': 0.656, 'pos': 0.151, 'compound': -0.2732}",negative,0.9986056685447693
988230,988230,1000370.0,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,2020-03-31 17:15:00-04:00,PFE,attention biotech investors mark your calendar for these april pdufa dates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998810291290283
988231,988231,1000371.0,Portfolio Manager Offers Buying Tips: Focus On What You Own,2020-03-30 16:03:00-04:00,PFE,portfolio manager offers buying tips focus on what you own,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998461008071899
988232,988232,1000372.0,"Barron's Picks And Pans: Tech Picks, SoftBank, REITs, Tesla And More",2020-03-29 10:29:00-04:00,PFE,barrons picks and pans tech picks softbank reits tesla and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998571872711182
988233,988233,1000373.0,"Cramer Reveals Stock Favorites, Says Intuitive Surgical A 'Winner'",2020-03-27 10:10:00-04:00,PFE,cramer reveals stock favorites says intuitive surgical a winner,"{'neg': 0.0, 'neu': 0.515, 'pos': 0.485, 'compound': 0.765}",positive,0.9940661191940308
988234,988234,1000374.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus legislation has boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 09:22:00-04:00,PFE,shares of several healthcare companies are trading lower selling off from this weeks strength while the us stimulus legislation has boosted economic optimism demand concerns still exist amid the coronavirus outbreak,"{'neg': 0.092, 'neu': 0.623, 'pos': 0.284, 'compound': 0.8271}",negative,0.9929678440093994
988235,988235,1000375.0,"RBC Capital Maintains Outperform on Pfizer, Lowers Price Target to $44",2020-03-27 07:29:00-04:00,PFE,rbc capital maintains outperform on pfizer lowers price target to dollars 4,"{'neg': 0.12, 'neu': 0.88, 'pos': 0.0, 'compound': -0.128}",positive,0.9996397495269775
988236,988236,1000376.0,"Shares of several healthcare companies are trading higher following Senate passage of a $2 trillion economic stimulus package, which has lifted stocks across sectors.",2020-03-26 11:49:00-04:00,PFE,shares of several healthcare companies are trading higher following senate passage of a dollars trillion economic stimulus package which has lifted stocks across sectors,"{'neg': 0.0, 'neu': 0.913, 'pos': 0.087, 'compound': 0.296}",positive,0.9996453523635864
988237,988237,1000377.0,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Xencor Licenses Tech To Vir For COVID-19 Treatment, Delay In Pfizer's Upjohn-Mylan Merger",2020-03-26 08:23:00-04:00,PFE,the daily biotech pulse fda nod for bristol myers squibb xencor licenses tech to vir for covid 19 treatment delay in pfizers upjohn mylan merger,"{'neg': 0.087, 'neu': 0.913, 'pos': 0.0, 'compound': -0.3182}",positive,0.9961131811141968
988238,988238,1000378.0,"Mylan, Pfizer Report Delay Of Deal Closing For Mylan, Upjohn Deal, Closing Now Expected H2'20",2020-03-26 07:05:00-04:00,PFE,mylan pfizer report delay of deal closing for mylan upjohn deal closing now expected h220,"{'neg': 0.141, 'neu': 0.859, 'pos': 0.0, 'compound': -0.3182}",neutral,0.6598762273788452
988239,988239,1000379.0,"Pfizer To Pause Participant Recruitment For New, Ongoing Trials For 3 Weeks",2020-03-25 12:54:00-04:00,PFE,pfizer to pause participant recruitment for new ongoing trials for 3 weeks,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.7364727258682251
988240,988240,1000380.0,FDA Says In A Letter To Pfizer And Mylan Detailed How Epipen Devices May Activate Prematurely If Blue Safety Release Is Removed Using A Sideways Force,2020-03-24 13:49:00-04:00,PFE,fda says in a letter to pfizer and mylan detailed how epipen devices may activate prematurely if blue safety release is removed using a sideways force,"{'neg': 0.0, 'neu': 0.899, 'pos': 0.101, 'compound': 0.4215}",neutral,0.980068027973175
988241,988241,1000381.0,"Shares of several healthcare companies are trading higher as equities gain amid hopes of a US stimulus agreement. Additionally, the coronavirus outbreak has increased demand for certain medical supplies.",2020-03-24 12:20:00-04:00,PFE,shares of several healthcare companies are trading higher as equities gain amid hopes of a us stimulus agreement additionally the coronavirus outbreak has increased demand for certain medical supplies,"{'neg': 0.038, 'neu': 0.56, 'pos': 0.402, 'compound': 0.9231}",positive,0.9996757507324219
988242,988242,1000382.0,26 Stocks Moving in Tuesday's Pre-Market Session,2020-03-24 07:12:00-04:00,PFE,26 stocks moving in tuesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998726844787598
988243,988243,1000383.0,Pfizer Announces FDA Approval Of Supplemental New Drug Application For Expanded Indication Of EUCRISA Ointment 2% In Children With Mild-To-Moderate Atopic Dermatitis,2020-03-24 06:46:00-04:00,PFE,pfizer announces fda approval of supplemental new drug application for expanded indication of eucrisa ointment 2 percent in children with mild to moderate atopic dermatitis,"{'neg': 0.0, 'neu': 0.886, 'pos': 0.114, 'compound': 0.4767}",positive,0.9972266554832458
988244,988244,1000384.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,PFE,stocks that hit 52 week lows on monday,"{'neg': 0.205, 'neu': 0.795, 'pos': 0.0, 'compound': -0.2023}",negative,0.9978522062301636
988245,988245,1000385.0,Stocks That Hit 52-Week Lows On Friday,2020-03-20 14:26:00-04:00,PFE,stocks that hit 52 week lows on friday,"{'neg': 0.205, 'neu': 0.795, 'pos': 0.0, 'compound': -0.2023}",negative,0.9983282685279846
988246,988246,1000386.0,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",2020-03-19 07:37:00-04:00,PFE,the daily biotech pulse pfizers eczema drug aces latestage study orphan drug designation for dicerna dyadics covid 19 connection,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998396635055542
988247,988247,1000387.0,Pfizer Announces JADE COMPARE Trial Met All Co-Primary Endpoints,2020-03-18 16:16:00-04:00,PFE,pfizer announces jade compare trial met all co primary endpoints,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998016953468323
988248,988248,1000388.0,PreMarket Prep Stock Of The Day: BioNTech,2020-03-18 14:42:00-04:00,PFE,premarket prep stock of the day biontech,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998931884765625
988249,988249,1000389.0,IDEAYA and Pfizer Enter Clinical Trial Collaboration And Supply Agreement To Evaluate Clinical Combination Of IDE196 And Binimetinib In Solid Tumors Harboring GNAQ Or GNA11 Hotspot Mutations,2020-03-18 06:04:00-04:00,PFE,ideaya and pfizer enter clinical trial collaboration and supply agreement to evaluate clinical combination of ide196 and binimetinib in solid tumors harboring gnaq or gna11 hotspot mutations,"{'neg': 0.0, 'neu': 0.839, 'pos': 0.161, 'compound': 0.5859}",positive,0.9992114305496216
988250,988250,1000390.0,"Shares of several healthcare companies are trading higher, rebounding from Monday's crash. Stocks may also potentially be getting a boost from expectations of further stimulus proposals.",2020-03-17 09:10:00-04:00,PFE,shares of several healthcare companies are trading higher rebounding from mondays crash stocks may also potentially be getting a boost from expectations of further stimulus proposals,"{'neg': 0.088, 'neu': 0.752, 'pos': 0.16, 'compound': 0.296}",positive,0.9996803998947144
988251,988251,1000391.0,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment",2020-03-17 08:48:00-04:00,PFE,the daily biotech pulse setback for dbv in peanut allergy patch review roche starts coronavirus test shipment regeneron aims for cocktail covid 19 treatment,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9570956230163574
988252,988252,1000392.0,Phizer & BioNTech shares are trading higher after the companies announced they are working to co-develop a potential coronavirus vaccine.,2020-03-17 08:28:00-04:00,PFE,phizer and biontech shares are trading higher after the companies announced they are working to co develop a potential coronavirus vaccine,"{'neg': 0.0, 'neu': 0.901, 'pos': 0.099, 'compound': 0.296}",positive,0.9995966553688049
988253,988253,1000393.0,"Pfizer, BioNTech to Co-develop Potential COVID-19 Vaccine",2020-03-17 05:18:00-04:00,PFE,pfizer biontech to co develop potential covid 19 vaccine,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999858021736145
988254,988254,1000394.0,8 Biotechs With Coronavirus Vaccines In Development,2020-03-16 10:42:00-04:00,PFE,8 biotechs with coronavirus vaccines in development,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998934268951416
988255,988255,1000395.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 09:40:00-04:00,PFE,shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus the virus has had a negative impact on the global economy,"{'neg': 0.149, 'neu': 0.732, 'pos': 0.119, 'compound': -0.296}",negative,0.9988462924957275
988256,988256,1000396.0,BioNTech Says Coronavirus Vaccine Testing Begins Next Month In 'Project Lightspeed',2020-03-16 09:14:00-04:00,PFE,biontech says coronavirus vaccine testing begins next month in project lightspeed,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998830556869507
988257,988257,1000397.0,Pfizer Issues Press Release Highlighting 5-Point Plan To Battle Coronavirus,2020-03-13 15:25:00-04:00,PFE,pfizer issues press release highlighting 5 point plan to battle coronavirus,"{'neg': 0.206, 'neu': 0.794, 'pos': 0.0, 'compound': -0.3818}",neutral,0.9998579025268555
988258,988258,1000398.0,Shares of several healthcare companies are trading higher as the market rebounds following Thursday's selloff. NOTE: Since the coronavirus outbreak the healthcare sector has been extremely volatile.,2020-03-13 09:29:00-04:00,PFE,shares of several healthcare companies are trading higher as the market rebounds following thursdays selloff note since the coronavirus outbreak the healthcare sector has been extremely volatile,"{'neg': 0.0, 'neu': 0.922, 'pos': 0.078, 'compound': 0.296}",positive,0.9947782754898071
988259,988259,1000399.0,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",2020-03-13 07:52:00-04:00,PFE,the daily biotech pulse roche obtains fda emergency use authorization for covid 19 test chembio appoints new ceo inovio slumps on earnings,"{'neg': 0.11, 'neu': 0.89, 'pos': 0.0, 'compound': -0.3818}",negative,0.998197615146637
988260,988260,1000400.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,PFE,stocks that hit 52 week lows on thursday,"{'neg': 0.205, 'neu': 0.795, 'pos': 0.0, 'compound': -0.2023}",negative,0.998155415058136
988261,988261,1000401.0,Shares of several healthcare companies are trading lower as equities sell off amid continued global coronavirus concerns. The virus has caused global economic disruption and negatively impacted stocks across sectors.,2020-03-12 09:26:00-04:00,PFE,shares of several healthcare companies are trading lower as equities sell off amid continued global coronavirus concerns the virus has caused global economic disruption and negatively impacted stocks across sectors,"{'neg': 0.139, 'neu': 0.796, 'pos': 0.065, 'compound': -0.3612}",negative,0.9984208345413208
988262,988262,1000402.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,PFE,the daily biotech pulse astrazeneca faces setback in ovarian cancer study mallinckrodt to explore covid 19 treatment imara ipo,"{'neg': 0.196, 'neu': 0.804, 'pos': 0.0, 'compound': -0.6597}",negative,0.9962843656539917
988263,988263,1000403.0,Shares of several healthcare companies are trading lower. Movement appears market related amid selloff in equities. The global coronavirus outbreak has caused volatility in global markets and impacted stocks across sectors.,2020-03-11 07:15:00-04:00,PFE,shares of several healthcare companies are trading lower movement appears market related amid selloff in equities the global coronavirus outbreak has caused volatility in global markets and impacted stocks across sectors,"{'neg': 0.066, 'neu': 0.868, 'pos': 0.066, 'compound': 0.0}",negative,0.9983373880386353
988264,988264,1000404.0,How Close Are Biotechs To Bringing A COVID-19 Treatment To Market?,2020-03-10 17:24:00-04:00,PFE,how close are biotechs to bringing a covid 19 treatment to market,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998617172241211
988265,988265,1000405.0,Shares of several healthcare companies are trading higher as markets rebound following Monday's selloff. US President Trump on Monday indicated the US may implement payroll tax cuts and other measures to support the economy amid the coronavirus outbreak.,2020-03-10 07:54:00-04:00,PFE,shares of several healthcare companies are trading higher as markets rebound following mondays selloff us president trump on monday indicated the us may implement payroll tax cuts and other measures to support the economy amid the coronavirus outbreak,"{'neg': 0.052, 'neu': 0.831, 'pos': 0.116, 'compound': 0.4019}",positive,0.999333918094635
988266,988266,1000406.0,'CMA welcomes Court of Appeal judgment in Phenytoin case' - GOV.UK,2020-03-10 06:46:00-04:00,PFE,cma welcomes court of appeal judgment in phenytoin case to gov uk,"{'neg': 0.0, 'neu': 0.803, 'pos': 0.197, 'compound': 0.4019}",neutral,0.9996609687805176
988267,988267,1000407.0,Shares of several healthcare  companies are trading lower. Movement appears market-related as markets continue to dip amid the global coronavirus outbreak and OPEC failing to reach production agreement.,2020-03-09 10:55:00-04:00,PFE,shares of several healthcare companies are trading lower movement appears market related as markets continue to dip amid the global coronavirus outbreak and opec failing to reach production agreement,"{'neg': 0.153, 'neu': 0.667, 'pos': 0.181, 'compound': 0.0}",negative,0.9981518387794495
988268,988268,1000408.0,"GlaxoSmithKline's ViiV Healthcare Reports 5-Year, $20M Renewal Of Partnership With Pfizer, Shionogi, University Of North Carolina For HIV Cure",2020-03-09 10:01:00-04:00,PFE,glaxosmithklines viiv healthcare reports 5 year dollars 0 million renewal of partnership with pfizer shionogi university of north carolina for hiv cure,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9991932511329651
988269,988269,1000409.0,52 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-09 08:04:00-04:00,PFE,52 healthcare stocks moving in mondays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999866247177124
988270,988270,1000410.0,Shares of several healthcare companies are trading lower. Movement appears market related as markets continue to dip amid the global coronavirus outbreak.,2020-03-06 09:11:00-05:00,PFE,shares of several healthcare companies are trading lower movement appears market related as markets continue to dip amid the global coronavirus outbreak,"{'neg': 0.09, 'neu': 0.82, 'pos': 0.09, 'compound': 0.0}",negative,0.9978622794151306
988271,988271,1000411.0,Lipper Award Winners Pick Healthcare and Technology Stocks Amidst Coronavirus Downturn,2020-03-06 08:33:00-05:00,PFE,lipper award winners pick healthcare and technology stocks amidst coronavirus downturn,"{'neg': 0.0, 'neu': 0.577, 'pos': 0.423, 'compound': 0.765}",neutral,0.9987382292747498
988272,988272,1000412.0,Shares of several drugmakers and healthcare companies are trading higher following US Super Tuesday results in which Joe Biden won the highest number of delegates. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.,2020-03-04 07:48:00-05:00,PFE,shares of several drugmakers and healthcare companies are trading higher following us super tuesday results in which joe biden won the highest number of delegates bidens more moderate healthcare policies have been seen as more favorable for the sector,"{'neg': 0.0, 'neu': 0.701, 'pos': 0.299, 'compound': 0.9259}",positive,0.9997041821479797
988273,988273,1000413.0,Pfizer Works On Compounds That May Help Stop Coronaviruses,2020-03-03 06:53:00-05:00,PFE,pfizer works on compounds that may help stop coronaviruses,"{'neg': 0.185, 'neu': 0.588, 'pos': 0.227, 'compound': 0.128}",neutral,0.9995220899581909
988274,988274,1000414.0,Pfizer Says Recently Completed A Preliminary Assessment Of Certain Antiviral Compounds That Were Previously In Development And That Inhibited The Replication Of Coronaviruses; Expects To Have Results Regarding Possible Coronavirus Treatment Back By The En,2020-03-02 17:24:00-05:00,PFE,pfizer says recently completed a preliminary assessment of certain antiviral compounds that were previously in development and that inhibited the replication of coronaviruses expects to have results regarding possible coronavirus treatment back by the en,"{'neg': 0.038, 'neu': 0.904, 'pos': 0.058, 'compound': 0.1779}",neutral,0.8576344847679138
988275,988275,1000415.0,Pfizer's Biologics License Application for Tanezumab Accepted for Review by the FDA,2020-03-02 06:49:00-05:00,PFE,pfizers biologics license application for tanezumab accepted for review by the fda,"{'neg': 0.0, 'neu': 0.84, 'pos': 0.16, 'compound': 0.2732}",neutral,0.9998488426208496
988276,988276,1000416.0,Stocks That Hit 52-Week Lows On Friday,2020-02-28 10:16:00-05:00,PFE,stocks that hit 52 week lows on friday,"{'neg': 0.205, 'neu': 0.795, 'pos': 0.0, 'compound': -0.2023}",negative,0.9983282685279846
988277,988277,1000417.0,Shares of several healthcare companies are trading lower as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.,2020-02-28 09:06:00-05:00,PFE,shares of several healthcare companies are trading lower as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook,"{'neg': 0.168, 'neu': 0.759, 'pos': 0.073, 'compound': -0.4404}",negative,0.9985425472259521
988278,988278,1000418.0,"Pfizer Says Continued Spread Of Coronavirus Globally Could Adversely Impact Operations, Including Manufacturing, Supply Chain, Clinical Trial Operations",2020-02-27 14:29:00-05:00,PFE,pfizer says continued spread of coronavirus globally could adversely impact operations including manufacturing supply chain clinical trial operations,"{'neg': 0.096, 'neu': 0.904, 'pos': 0.0, 'compound': -0.2023}",negative,0.9977607727050781
988279,988279,1000419.0,"Benzinga's Top Upgrades, Downgrades For February 27, 2020",2020-02-27 09:37:00-05:00,PFE,benzingas top upgrades downgrades for february 27 2020,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",positive,0.8035784959793091
988280,988280,1000420.0,"Barclays Initiates Coverage On Pfizer with Equal-Weight Rating, Announces $36 Price Target",2020-02-27 07:59:00-05:00,PFE,barclays initiates coverage on pfizer with equal weight rating announces dollars 6 price target,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994816184043884
988281,988281,1000421.0,Basilea Reports Launch of Cresemba in Australia Triggering Milestone Payment from Pfizer,2020-02-27 05:23:00-05:00,PFE,basilea reports launch of cresemba in australia triggering milestone payment from pfizer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9746032357215881
988282,988282,1000422.0,Shares of several healthcare and biotech companies are trading higher. Not seeing any news to justify the price action.,2020-02-26 14:28:00-05:00,PFE,shares of several healthcare and biotech companies are trading higher not seeing any news to justify the price action,"{'neg': 0.0, 'neu': 0.891, 'pos': 0.109, 'compound': 0.296}",negative,0.7368831038475037
988283,988283,1000423.0,Shares of several healthcare and biotech companies are trading higher. Movement appears market related as equities have rebounded this session following recent selloffs.,2020-02-26 11:19:00-05:00,PFE,shares of several healthcare and biotech companies are trading higher movement appears market related as equities have rebounded this session following recent selloffs,"{'neg': 0.0, 'neu': 0.909, 'pos': 0.091, 'compound': 0.296}",positive,0.9989867806434631
988284,988284,1000424.0,"The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates",2020-02-26 09:36:00-05:00,PFE,the daily biotech pulse menlo flunks midstage trial gw pharmas earnings covid 19 updates,"{'neg': 0.177, 'neu': 0.823, 'pos': 0.0, 'compound': -0.4215}",neutral,0.9998332262039185
988285,988285,1000425.0,Pfizer Announces European Commission Approval Of VYNDAQEL For Transthyretin Amyloid Cardiomyopathy,2020-02-18 06:47:00-05:00,PFE,pfizer announces european commission approval of vyndaqel for transthyretin amyloid cardiomyopathy,"{'neg': 0.0, 'neu': 0.763, 'pos': 0.237, 'compound': 0.4767}",positive,0.8148521780967712
988286,988286,1000426.0,"Astellas Pharma, Pfizer Reports Results Of Final Overall Survival Analysis From Phase 3 PROSPER Trial Which Evaluated XTANDI",2020-02-11 08:08:00-05:00,PFE,astellas pharma pfizer reports results of final overall survival analysis from phase 3 prosper trial which evaluated xtandi,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998214840888977
988287,988287,1000427.0,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",2020-02-11 07:23:00-05:00,PFE,the daily biotech pulse logicbio slapped with clinical hold agile inks debt deal ahead of twirla approval gilead builds stake in sierra oncology,"{'neg': 0.094, 'neu': 0.789, 'pos': 0.117, 'compound': 0.1531}",positive,0.994504988193512
988288,988288,1000428.0,Here's How Much Investing $100 In Allergan Stock Back In 2010 Would Be Worth Today,2020-02-10 11:48:00-05:00,PFE,heres how much investing dollars 00 in allergan stock back in 2010 would be worth today,"{'neg': 0.0, 'neu': 0.888, 'pos': 0.112, 'compound': 0.2263}",neutral,0.9995415210723877
988289,988289,1000429.0,3 Leveraged Healthcare ETFs Soaring This Month,2020-02-10 09:39:00-05:00,PFE,3 leveraged healthcare etfs soaring this month,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995782971382141
988290,988290,1000430.0,"UPDATE: Mizuho Initiates Coverage On Pfizer with Buy Rating, Announces $42 Price Target As Firm Sees 'products such as Eliquis, Xtandi, and Xeljanz helping ""New Pfizer"" drive 7%+ sales and 9%+ income CAGR from 2020-2025.'",2020-02-06 11:11:00-05:00,PFE,update mizuho initiates coverage on pfizer with buy rating announces dollars 2 price target as firm sees products such as eliquis xtandi and xeljanz helping new pfizer drive 7 percent and sales and 9 percent and income cagr from 2020 to 2025,"{'neg': 0.0, 'neu': 0.949, 'pos': 0.051, 'compound': 0.296}",positive,0.9922188520431519
988291,988291,1000431.0,"Mizuho Initiates Coverage On Pfizer with Buy Rating, Announces $42 Price Target",2020-02-06 05:12:00-05:00,PFE,mizuho initiates coverage on pfizer with buy rating announces dollars 2 price target,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9397119283676147
988292,988292,1000432.0,"Mizuho Initiates Coverage On Pfizer, Evolus, Karuna Therapeutics With Buy Ratings, Neurocrine Biosciences, Sage Therapeutics With Neutrals",2020-02-05 16:48:00-05:00,PFE,mizuho initiates coverage on pfizer evolus karuna therapeutics with buy ratings neurocrine biosciences sage therapeutics with neutrals,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998289346694946
988293,988293,1000433.0,13 Key NASH Drug Candidates To Watch For In A Potential $30-Billion Market,2020-02-05 16:11:00-05:00,PFE,13 key nash drug candidates to watch for in a potential dollars 0 billion market,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998785257339478
988294,988294,1000434.0,"The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus",2020-02-02 13:04:00-05:00,PFE,the week ahead in biotech merck bristol myers earnings conference presentations in focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998323917388916
988295,988295,1000435.0,"Pfizer Receives Positive CHMP Opinion For Oncology Biosimilar, RUXIENCE",2020-01-31 09:01:00-05:00,PFE,pfizer receives positive chmp opinion for oncology biosimilar ruxience,"{'neg': 0.0, 'neu': 0.69, 'pos': 0.31, 'compound': 0.5574}",positive,0.9994365572929382
988296,988296,1000436.0,EMA's CHMP Adopts Positive Opinion For Pfizer's Staquis For Treatment Of Atropic Dermatitis,2020-01-31 06:15:00-05:00,PFE,emas chmp adopts positive opinion for pfizers staquis for treatment of atropic dermatitis,"{'neg': 0.0, 'neu': 0.675, 'pos': 0.325, 'compound': 0.6486}",positive,0.9993948936462402
988297,988297,1000437.0,Mid-Afternoon Market Update: Dow Surges 250 Points; Delphi Technologies Shares Gain On Acquisition News,2020-01-28 15:00:00-05:00,PFE,mid afternoon market update dow surges 250 points delphi technologies shares gain on acquisition news,"{'neg': 0.0, 'neu': 0.699, 'pos': 0.301, 'compound': 0.6808}",positive,0.9996874332427979
988298,988298,1000438.0,Mid-Day Market Update: Crude Oil Rises Over 1%; Acceleron Pharma Shares Spike Higher,2020-01-28 12:08:00-05:00,PFE,mid day market update crude oil rises over 1 percent acceleron pharma shares spike higher,"{'neg': 0.196, 'neu': 0.688, 'pos': 0.116, 'compound': -0.3612}",positive,0.9994487166404724
988299,988299,1000439.0,PreMarket Prep Recap: Fear Of Missing Out Greater Than Fear Of Coronavirus,2020-01-28 11:40:00-05:00,PFE,premarket prep recap fear of missing out greater than fear of coronavirus,"{'neg': 0.45, 'neu': 0.419, 'pos': 0.131, 'compound': -0.7269}",neutral,0.7838231921195984
988300,988300,1000440.0,"From Pfizer's Earnings Conference Call: 'Exec Says Expects To Bring One New Gene Therapy Into Clinic ""Every Year Or So""'",2020-01-28 11:14:00-05:00,PFE,from pfizers earnings conference call exec says expects to bring one new gene therapy into clinic every year or so,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9891195297241211
988301,988301,1000441.0,From Pfizer's Earnings Conference Call: Executive Says Co Not iNterested In Big M&A,2020-01-28 10:57:00-05:00,PFE,from pfizers earnings conference call executive says co not interested in big m and a,"{'neg': 0.139, 'neu': 0.861, 'pos': 0.0, 'compound': -0.3089}",negative,0.8298367261886597
988302,988302,1000442.0,Mid-Morning Market Update: Markets Open Higher; Pfizer Earnings Miss Views,2020-01-28 10:22:00-05:00,PFE,mid morning market update markets open higher pfizer earnings miss views,"{'neg': 0.138, 'neu': 0.862, 'pos': 0.0, 'compound': -0.1531}",negative,0.9971139430999756
988303,988303,1000443.0,Turnaround Tuesday? Stocks Look To Bounce Back As Apple Earnings Loom Later,2020-01-28 09:39:00-05:00,PFE,turnaround tuesday stocks look to bounce back as apple earnings loom later,"{'neg': 0.147, 'neu': 0.853, 'pos': 0.0, 'compound': -0.2263}",positive,0.9995429515838623
988304,988304,1000444.0,Tuesday's Market Minute: Earnings Snapshot,2020-01-28 09:26:00-05:00,PFE,tuesdays market minute earnings snapshot,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998828172683716
988305,988305,1000445.0,Pfizer shares are trading lower after the company reported worse-than-expected Q4 EPS results.,2020-01-28 08:10:00-05:00,PFE,pfizer shares are trading lower after the company reported worse than expected fourth quarter eps results,"{'neg': 0.259, 'neu': 0.634, 'pos': 0.107, 'compound': -0.4767}",negative,0.9986440539360046
988306,988306,1000446.0,Pfizer Reports Mixed Q4 Earnings,2020-01-28 07:37:00-05:00,PFE,pfizer reports mixed fourth quarter earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9981253743171692
988307,988307,1000447.0,"Pfizer Sees FY20 Adj. EPS $2.82-$2.92 vs $2.90 Est., Sales $48.5B-$50.5B vs $49.52B Est.",2020-01-28 06:46:00-05:00,PFE,pfizer sees fy20 adj eps dollars .82 dollars .92 vs dollars .90 est sales dollars 8.5 billion dollars 0.5 billion vs dollars 9.52 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998798370361328
988308,988308,1000448.0,"Pfizer Q4 Adj. EPS $0.55 Misses $0.57 Estimate, Sales $12.7B Beat $12.61B Estimate",2020-01-28 06:45:00-05:00,PFE,pfizer fourth quarter adj eps dollars .55 misses dollars .57 estimate sales dollars 2.7 billion beat dollars 2.61 billion estimate,"{'neg': 0.091, 'neu': 0.909, 'pos': 0.0, 'compound': -0.2263}",neutral,0.9993859529495239
988309,988309,1000449.0,"A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings, Fed Meeting",2020-01-28 06:19:00-05:00,PFE,a peek into the markets us stock futures up ahead of earnings fed meeting,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998583793640137
988310,988310,1000450.0,"10 Stocks To Watch For January 28, 2020",2020-01-28 04:45:00-05:00,PFE,10 stocks to watch for january 28 2020,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998632669448853
988311,988311,1000451.0,"Earnings Scheduled For January 28, 2020",2020-01-28 04:00:00-05:00,PFE,earnings scheduled for january 28 2020,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999885082244873
988312,988312,1000452.0,A Preview Of Pfizer's Q4 Earnings,2020-01-27 13:15:00-05:00,PFE,a preview of pfizers fourth quarter earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999869704246521
988313,988313,1000453.0,"Going Viral: Stocks On Their Back As Virus Spreads Heading Into Key Earnings, Fed Week",2020-01-27 09:58:00-05:00,PFE,going viral stocks on their back as virus spreads heading into key earnings fed week,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9988123178482056
988314,988314,1000454.0,"The Week Ahead In Biotech: Amgen, Eli Lilly, Pfizer In Earnings Mix, IPO Flow Resumes",2020-01-26 10:23:00-05:00,PFE,the week ahead in biotech amgen eli lilly pfizer in earnings mix ipo flow resumes,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9910987019538879
988315,988315,1000455.0,"Barron's Picks And Pans: Apple, Boeing, Disney, Tesla And More",2020-01-18 15:42:00-05:00,PFE,barrons picks and pans apple boeing disney tesla and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998681545257568
988316,988316,1000456.0,"Cannabis Media Company The Fresh Toast Expands Again, Announces It's Now Cash Positive",2020-01-17 13:48:00-05:00,PFE,cannabis media company the fresh toast expands again announces its now cash positive,"{'neg': 0.0, 'neu': 0.578, 'pos': 0.422, 'compound': 0.743}",positive,0.9996240139007568
988317,988317,1000457.0,"Benzinga Pro's Top 5 Stocks To Watch For Mon., Jan. 13, 2020: WCC, LULU, XLF, TEAM, BIIB",2020-01-13 08:46:00-05:00,PFE,benzinga pros top 5 stocks to watch for mon jan 13 2020 wcc lulu xlf team biib,"{'neg': 0.0, 'neu': 0.899, 'pos': 0.101, 'compound': 0.2023}",neutral,0.9998212456703186
988318,988318,1000458.0,"Biogen To Acquire PF-05251749, A Novel Clinical Stage Asset With Application in Alzheimer's And Parkinson's From Pfizer; Pfizer To Receive $75M Upfront And Up To $635M In Milestones",2020-01-13 07:32:00-05:00,PFE,biogen to acquire pf 05251749 a novel clinical stage asset with application in alzheimers and parkinsons from pfizer pfizer to receive dollars 5 million upfront and up to dollars 35 million in milestones,"{'neg': 0.0, 'neu': 0.866, 'pos': 0.134, 'compound': 0.5859}",neutral,0.7252642512321472
988319,988319,1000459.0,Zymeworks Announces Agreement with Pfizer; Initiation of New Phase 2 Trial Evaluating ZW25 in Combination with Ibrance,2020-01-12 10:09:00-05:00,PFE,zymeworks announces agreement with pfizer initiation of new phase 2 trial evaluating zw25 in combination with ibrance,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.4939}",positive,0.9991760849952698
988320,988320,1000460.0,"Barron's Picks And Pans: Apple, Bank of America, Lockheed Martin And More",2020-01-11 11:57:00-05:00,PFE,barrons picks and pans apple bank of america lockheed martin and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998775720596313
988321,988321,1000461.0,"'California Gov. Gavin Newsom wants the state to become the first to create its own generic drug label, an attempt to create more competition and bring down prices.' -Axios, From Earlier",2020-01-10 12:55:00-05:00,PFE,california gov gavin newsom wants the state to become the first to create its own generic drug label an attempt to create more competition and bring down prices axios from earlier,"{'neg': 0.0, 'neu': 0.873, 'pos': 0.127, 'compound': 0.4939}",positive,0.9983933568000793
988322,988322,1000462.0,Concerto HealthAI Announces Expanded Collaboration With Pfizer To Accelerate Real-World Evidence And AI Technologies For Additional Disease Areas,2020-01-10 09:33:00-05:00,PFE,concerto healthai announces expanded collaboration with pfizer to accelerate real world evidence and ai technologies for additional disease areas,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995563626289368
988323,988323,1000463.0,ViiV Healthcare Says EMA's Committee For Medicinal Products For Human Use Has Granted An Accelerated Assessment For Fostemsavir Marketing Authorization Application,2020-01-10 08:20:00-05:00,PFE,viiv healthcare says emas committee for medicinal products for human use has granted an accelerated assessment for fostemsavir marketing authorization application,"{'neg': 0.0, 'neu': 0.909, 'pos': 0.091, 'compound': 0.25}",positive,0.999552309513092
988324,988324,1000464.0,"ViiV Healthcare Submits Regulatory Application To The European Medicines Agency For Fostemsavir, An Investigational, First-in-class Attachment Inhibitor For The Treatment Of HIV In Adults With Few Treatment Options Available",2020-01-10 08:18:00-05:00,PFE,viiv healthcare submits regulatory application to the european medicines agency for fostemsavir an investigational first in class attachment inhibitor for the treatment of hiv in adults with few treatment options available,"{'neg': 0.04, 'neu': 0.892, 'pos': 0.068, 'compound': 0.2263}",neutral,0.9998229146003723
988325,988325,1000465.0,"RBC Capital Yesterday Initiated Coverage On Pfizer with Outperform Rating, Announced $46 Price Target",2020-01-07 12:41:00-05:00,PFE,rbc capital yesterday initiated coverage on pfizer with outperform rating announced dollars 6 price target,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995373487472534
988326,988326,1000466.0,"Pfizer Shares Quiet After Hours As Hearing RBC Initiates Coverage On Stock With Outperform Rating, $46 Price Target",2020-01-06 16:28:00-05:00,PFE,pfizer shares quiet after hours as hearing rbc initiates coverage on stock with outperform rating dollars 6 price target,"{'neg': 0.0, 'neu': 0.891, 'pos': 0.109, 'compound': 0.296}",positive,0.995071291923523
988327,988327,1000467.0,Pfizer's Phase 3 JAVELIN Bladder 100 Study Met its Primary Endpoint,2020-01-06 07:06:00-05:00,PFE,pfizers phase 3 javelin bladder 100 study met its primary endpoint,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998437166213989
988328,988328,1000468.0,Drugmakers Kick Off 2020 With Margin-Expanding Price Hikes,2020-01-02 10:41:00-05:00,PFE,drugmakers kick off 2020 with margin expanding price hikes,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.998437225818634
988329,988329,1000469.0,Pfizer Says To Increase List Prices On Around 27% Of Its U.S. Portfolio By Average Of 5.6% On Jan 1,2019-12-31 15:57:00-05:00,PFE,pfizer says to increase list prices on around 27 percent of its u s portfolio by average of 5.6 percent on jan 1,"{'neg': 0.0, 'neu': 0.905, 'pos': 0.095, 'compound': 0.3182}",positive,0.9887588024139404
988330,988330,1000470.0,"Drugmakers Including Pfizer, GlaxoSmithKline, Sanofi, To Hike US Prices On More Than 200 Drugs In January; Median US Drug Price Increase For Jan. 1 2020 Is Around 5%, According To Healthcare Research Firm",2019-12-31 15:56:00-05:00,PFE,drugmakers including pfizer glaxosmithkline sanofi to hike us prices on more than 200 drugs in january median us drug price increase for jan 1 2020 is around 5 percent according to healthcare research firm,"{'neg': 0.0, 'neu': 0.935, 'pos': 0.065, 'compound': 0.3182}",negative,0.9791895151138306
988331,988331,1000471.0,"Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus",2019-12-29 18:38:00-05:00,PFE,week ahead in biotech pdufa date ahead for astra zeneca mercks lynparza pending clinical readouts in focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.997225821018219
988332,988332,1000472.0,FDA Approves Applications For First Generics Of Eliquis,2019-12-23 15:35:00-05:00,PFE,fda approves applications for first generics of eliquis,"{'neg': 0.0, 'neu': 0.722, 'pos': 0.278, 'compound': 0.4019}",neutral,0.6681165099143982
988333,988333,1000473.0,"Theravance Biopharma And Pfizer Inc. Enter Global License Agreement For Skin-Targeted, Locally-Acting Pan-Janus Kinase Inhibitor Program; Theravance To Receive Upfront Cash Payment Of $10M And Up To $240M In Milestones",2019-12-23 08:18:00-05:00,PFE,theravance biopharma and pfizer inc enter global license agreement for skin targeted locally acting pan janus kinase inhibitor program theravance to receive upfront cash payment of dollars 0 million and up to dollars 40 million in milestones,"{'neg': 0.033, 'neu': 0.886, 'pos': 0.081, 'compound': 0.4404}",positive,0.9984369874000549
988334,988334,1000474.0,Sangamo Announces Early Completion of Transfer to Pfizer of SB-525 Hemophilia A Gene Therapy IND and an Earned $25 Million Milestone Payment,2019-12-23 06:51:00-05:00,PFE,sangamo announces early completion of transfer to pfizer of sb 525 hemophilia a gene therapy ind and an earned dollars 5 million milestone payment,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.6453177332878113
988335,988335,1000475.0,How The Dow Jones Industrial Average Changed Over The Past Decade,2019-12-22 10:00:00-05:00,PFE,how the dow jones industrial average changed over the past decade,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9989330172538757
988336,988336,1000476.0,"FDA Issues Warning On Serious Breathing Problems With Gabapentin, Pregabalin",2019-12-19 15:01:00-05:00,PFE,fda issues warning on serious breathing problems with gabapentin pregabalin,"{'neg': 0.478, 'neu': 0.522, 'pos': 0.0, 'compound': -0.6597}",negative,0.5113064646720886
988337,988337,1000477.0,"Pfizer Reports FDA Accepted, Granted Priority Review Of Supplemental New Drug Application For BRAFTOVI In Combo With ERBITUX For Treatment Of BRAFV600E-Mutant Metastatic Colorectal Cancer After Prior Therapy",2019-12-18 10:33:00-05:00,PFE,pfizer reports fda accepted granted priority review of supplemental new drug application for braftovi in combo with erbitux for treatment of brafv600 e mutant metastatic colorectal cancer after prior therapy,"{'neg': 0.124, 'neu': 0.761, 'pos': 0.115, 'compound': -0.3182}",positive,0.9994838237762451
988338,988338,1000478.0,19 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-12-17 07:57:00-05:00,PFE,19 healthcare stocks moving in tuesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998674392700195
988339,988339,1000479.0,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",2019-12-17 07:56:00-05:00,PFE,the daily biotech pulse roche gets us antitrust clearance for spark purchase an orphan drug designation for prevail dynavax names ceo,"{'neg': 0.0, 'neu': 0.913, 'pos': 0.087, 'compound': 0.2263}",positive,0.9956621527671814
988340,988340,1000480.0,Pfizer Receives FDA Approval For XTANDI For The Treatment Of Metastatic Castration-Sensitive Prostate Cancer,2019-12-16 18:00:00-05:00,PFE,pfizer receives fda approval for xtandi for the treatment of metastatic castration sensitive prostate cancer,"{'neg': 0.215, 'neu': 0.634, 'pos': 0.151, 'compound': -0.3182}",positive,0.9990491271018982
988341,988341,1000481.0,"iRhythm Announces Participation In GUARD-AF Study Focused On Undiagnosed Atrial Fibrillation, Sponsored By Bristol-Myers Squibb-Pfizer Alliance",2019-12-16 16:09:00-05:00,PFE,irhythm announces participation in guard af study focused on undiagnosed atrial fibrillation sponsored by bristol myers squibb pfizer alliance,"{'neg': 0.0, 'neu': 0.874, 'pos': 0.126, 'compound': 0.3818}",neutral,0.9998717308044434
988342,988342,1000482.0,Pfizer shares are trading higher after the company raised its quarterly dividend from $0.36 to $0.38 per share.,2019-12-16 10:19:00-05:00,PFE,pfizer shares are trading higher after the company raised its quarterly dividend from dollars .36 to dollars .38 per share,"{'neg': 0.0, 'neu': 0.804, 'pos': 0.196, 'compound': 0.5267}",positive,0.999660849571228
988343,988343,1000483.0,Pfizer Raises Qtr Dividend From $0.36 to $0.38/Share,2019-12-16 08:32:00-05:00,PFE,pfizer raises qtr dividend from dollars .36 to dollars,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.998932421207428
988344,988344,1000484.0,"Barron's Picks And Pans: Charles Schwab, Disney, Sprint, Netflix And More",2019-12-14 13:36:00-05:00,PFE,barrons picks and pans charles schwab disney sprint netflix and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998445510864258
988345,988345,1000485.0,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer",2019-12-13 08:10:00-05:00,PFE,the daily biotech pulse second times the charm for sarepta pfizers xeljanz snags third approval newlink genetics rejects competing offer,"{'neg': 0.123, 'neu': 0.654, 'pos': 0.223, 'compound': 0.3818}",negative,0.9916378855705261
988346,988346,1000486.0,"EMA Reports Pfizer's Amsparity Received Positive Opinion From CHMP For Treatment OF Certain 
Inflammatory, Autoimmune Disorders",2019-12-13 06:17:00-05:00,PFE,ema reports pfizers amsparity received positive opinion from chmp for treatment of certain inflammatory autoimmune disorders,"{'neg': 0.0, 'neu': 0.711, 'pos': 0.289, 'compound': 0.6908}",positive,0.9992485642433167
988347,988347,1000487.0,"The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares",2019-12-10 07:56:00-05:00,PFE,the daily biotech pulse ash meeting wraps fast track designation for equillium pfizer to buy dollars m in contrafect shares,"{'neg': 0.0, 'neu': 0.896, 'pos': 0.104, 'compound': 0.296}",neutral,0.9997302889823914
988348,988348,1000488.0,"Trevena And Pfizer Entered Into Amendment To Development & Supply Agreement, Dated Dec. 15, 2016",2019-12-09 08:29:00-05:00,PFE,trevena and pfizer entered into amendment to development and supply agreement dated dec 15 2016,"{'neg': 0.0, 'neu': 0.814, 'pos': 0.186, 'compound': 0.4939}",neutral,0.9992959499359131
988349,988349,1000489.0,"Glaxo, Pfizer's ViiV Healthcare Reports Submission Of New Drug Application To FDA For Fostemsavir For Treatment Of HIV",2019-12-05 07:44:00-05:00,PFE,glaxo pfizers viiv healthcare reports submission of new drug application to fda for fostemsavir for treatment of hiv,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.6027354598045349
988350,988350,1000490.0,"The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial",2019-12-03 07:59:00-05:00,PFE,the daily biotech pulse astellas to buy audentes for dollars b applied genetics chief medical officer quits axsome aces midstage trial,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9877682328224182
988351,988351,1000491.0,Shares of several healthcare stocks are trading lower as US equities dip following escalating US-China tensions over Hong Kong. US Stocks further fell on worse-than-expected manufacturing data.,2019-12-02 11:31:00-05:00,PFE,shares of several healthcare stocks are trading lower as us equities dip following escalating us china tensions over hong kong us stocks further fell on worse than expected manufacturing data,"{'neg': 0.221, 'neu': 0.718, 'pos': 0.061, 'compound': -0.7003}",negative,0.9985547661781311
988352,988352,1000492.0,Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates,2019-11-29 08:13:00-05:00,PFE,attention biotech investors mark your calendar for these december pdufa dates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998856782913208
988353,988353,1000493.0,"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug",2019-11-26 08:06:00-05:00,PFE,the daily biotech pulse chemocentryx triples on data readout global blood given fda nod positive safety review for genfits nash drug,"{'neg': 0.0, 'neu': 0.748, 'pos': 0.252, 'compound': 0.7506}",positive,0.9990770816802979
988354,988354,1000494.0,"UPDATE: Piper Jaffray Initiates OPKO Health With Overweight, $2.50 Target Notes 'Partner Pfizer recently reported positive Phase III data on once-weekly somatrogon in pediatric Growth Hormone Deficiency'; Pfizer Anticipates Filing 'BLA 2H:20'",2019-11-25 09:09:00-05:00,PFE,update piper jaffray initiates opko health with overweight dollars .50 target notes partner pfizer recently reported positive phase iii data on once weekly somatrogon in pediatric growth hormone deficiency pfizer anticipates filing bla 2 hour 20,"{'neg': 0.06, 'neu': 0.791, 'pos': 0.149, 'compound': 0.5719}",positive,0.9994895458221436
988355,988355,1000495.0,3 Health Care ETFs Hitting New Highs,2019-11-25 07:08:00-05:00,PFE,3 health care etfs hitting new highs,"{'neg': 0.0, 'neu': 0.652, 'pos': 0.348, 'compound': 0.4939}",positive,0.9992406368255615
988356,988356,1000496.0,"Barron's Picks And Pans: Pfizer's New Identity, Electric Vehicles, Hong Kong Exodus — And Is The Bull Market About To End?",2019-11-23 15:42:00-05:00,PFE,barrons picks and pans pfizers new identity electric vehicles hong kong exodus — and is the bull market about to end,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9993638396263123
988357,988357,1000497.0,"Trump Says he Will Release a Plan to Let States Import Prescription Drugs Which are ""MUCH CHEAPER""",2019-11-22 14:08:00-05:00,PFE,trump says he will release a plan to let states import prescription drugs which are much cheaper,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.7531196475028992
988358,988358,1000498.0,"Cantor Believes Alnylam Is In 'Breakout Mode,' Sees Recent Strength From 2 Factors: 1. Greater Confidence That RNAi Is A Real New Class Of Commercial Medicines, 2. Less Concern Pfizer's Tafamidis Will Take Meaningful Share From Onpattro Launch",2019-11-21 09:48:00-05:00,PFE,cantor believes alnylam is in breakout mode sees recent strength from 2 factors 1 greater confidence that rnai is a real new class of commercial medicines 2 less concern pfizers tafamidis will take meaningful share from onpattro launch,"{'neg': 0.0, 'neu': 0.71, 'pos': 0.29, 'compound': 0.91}",positive,0.9997139573097229
988359,988359,1000499.0,"GSK's ViiV Healthcare Announces Exclusive Licensing Agreement With The National Institutes of Health For Investigational ""bNAb"" With Potential For Long-acting HIV Treatment And Prevention",2019-11-21 09:10:00-05:00,PFE,gsks viiv healthcare announces exclusive licensing agreement with the national institutes of health for investigational bnab with potential for long acting hiv treatment and prevention,"{'neg': 0.0, 'neu': 0.83, 'pos': 0.17, 'compound': 0.5719}",positive,0.9993870258331299
988360,988360,1000500.0,This Dividend ETF Is Having Its Day,2019-11-21 08:00:00-05:00,PFE,this dividend etf is having its day,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998683929443359
988361,988361,1000501.0,"The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data",2019-11-20 07:25:00-05:00,PFE,the daily biotech pulse endos cellulite treatment accepted for review diffusion pharma reports positive glioblastoma data,"{'neg': 0.0, 'neu': 0.711, 'pos': 0.289, 'compound': 0.6908}",positive,0.9883741140365601
988362,988362,1000502.0,Pfizer's ABRILADA Approved by the FDA as a Biosimilar to Humira for the Treatment of Certain Patients with Rheumatoid Arthritis,2019-11-18 06:48:00-05:00,PFE,pfizers abrilada approved by the fda as a biosimilar to humira for the treatment of certain patients with rheumatoid arthritis,"{'neg': 0.0, 'neu': 0.786, 'pos': 0.214, 'compound': 0.5994}",neutral,0.9998844861984253
988363,988363,1000503.0,"Bristol-Myers, Pfizer Report Randomized, Controlled Trial To Evaluate Effect Of Atrial Fibrillation Screening",2019-11-15 09:03:00-05:00,PFE,bristol myers pfizer report randomized controlled trial to evaluate effect of atrial fibrillation screening,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998769760131836
988364,988364,1000504.0,12 Dow Stocks With At Least 2% Dividend Yields,2019-11-13 15:45:00-05:00,PFE,12 dow stocks with at least 2 percent dividend yields,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999884843826294
988365,988365,1000505.0,Abbott CEO Miles White Steps Down,2019-11-13 11:23:00-05:00,PFE,abbott ceo miles white steps down,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997631907463074
988366,988366,1000506.0,"Mylan, Pfizer Report New Of Co. To Be Formed By Planned Combo Of Mylan, Upjohn 'Viatris",2019-11-12 12:16:00-05:00,PFE,mylan pfizer report new of co to be formed by planned combo of mylan upjohn viatris,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999882698059082
988367,988367,1000507.0,Pfizer Announces Phase 3 Study Of XELJANZ In Juvenile Idiopathic Arthritis Met Primary Endpoint,2019-11-12 06:47:00-05:00,PFE,pfizer announces phase 3 study of xeljanz in juvenile idiopathic arthritis met primary endpoint,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998353719711304
988368,988368,1000508.0,Seattle Children's Hospital Closes Five Rooms After Detecting Aspergillus,2019-11-11 12:55:00-05:00,PFE,seattle childrens hospital closes five rooms after detecting aspergillus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9893196821212769
988369,988369,1000509.0,EMD Serono and Pfizer Announce Topline Results Of the Phase III JAVELIN Gastric 100 Trial,2019-11-08 08:09:00-05:00,PFE,emd serono and pfizer announce topline results of the phase iii javelin gastric 100 trial,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998719692230225
988370,988370,1000510.0,AstraZeneca Named The Most Innovative Global Pharma Company,2019-11-06 11:20:00-05:00,PFE,astrazeneca named the most innovative global pharma company,"{'neg': 0.0, 'neu': 0.687, 'pos': 0.313, 'compound': 0.4927}",positive,0.8699854016304016
988371,988371,1000511.0,Mylan Q3 Non-GAAP EPS Beats Street Estimate; Drugmaker Narrows Guidance Range,2019-11-05 10:59:00-05:00,PFE,mylan third quarter non gaap eps beats street estimate drugmaker narrows guidance range,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9447464942932129
988372,988372,1000512.0,WeTrader Competition: Round Four Wrap-up,2019-11-01 17:15:00-04:00,PFE,wetrader competition round four wrap up,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998538494110107
988373,988373,1000513.0,"EMA Safety Committee Review Showed Pfizer's Xeljanz Could Increase Risk Of Blood Clots In Lungs, Deep Veins In Patients Already At High Risk",2019-10-31 10:43:00-04:00,PFE,ema safety committee review showed pfizers xeljanz could increase risk of blood clots in lungs deep veins in patients already at high risk,"{'neg': 0.148, 'neu': 0.671, 'pos': 0.18, 'compound': 0.2263}",negative,0.9941508173942566
988374,988374,1000514.0,"Fitbit, Pfizer, And More 'Fast Money' Picks For October 30",2019-10-30 12:15:00-04:00,PFE,fitbit pfizer and more fast money picks for october 30,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997159838676453
988375,988375,1000515.0,"Decision Day: Fed On Tap Later, Followed by Apple, Facebook After Close",2019-10-30 09:52:00-04:00,PFE,decision day fed on tap later followed by apple facebook after close,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998611211776733
988376,988376,1000516.0,"Alphabet Misses On Earnings, But Drugmakers, Mastercard Beat Expectations",2019-10-29 10:45:00-04:00,PFE,alphabet misses on earnings but drugmakers mastercard beat expectations,"{'neg': 0.153, 'neu': 0.847, 'pos': 0.0, 'compound': -0.1154}",negative,0.9956865906715393
988377,988377,1000517.0,From Pfizer Earnings Conference Call: Co. Not Looking for Larger M&A At This Time,2019-10-29 10:42:00-04:00,PFE,from pfizer earnings conference call co not looking for larger m and a at this time,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998440742492676
988378,988378,1000518.0,From Pfizer Q3 Earnings Conference Call: Sees FY19 Upjohn Sales In China Growing By Mid To High Single Digits,2019-10-29 10:26:00-04:00,PFE,from pfizer third quarter earnings conference call sees fy19 upjohn sales in china growing by mid to high single digits,"{'neg': 0.0, 'neu': 0.918, 'pos': 0.082, 'compound': 0.1779}",positive,0.9997157454490662
988379,988379,1000519.0,Pfizer Says Efforts To Improve Diagnosis Rates Of Rare Heart Disease Has Helped Drive Sales Of Recently Approved Drug VYNDAQEL,2019-10-29 10:14:00-04:00,PFE,pfizer says efforts to improve diagnosis rates of rare heart disease has helped drive sales of recently approved drug vyndaqel,"{'neg': 0.0, 'neu': 0.632, 'pos': 0.368, 'compound': 0.872}",positive,0.9996819496154785
988380,988380,1000520.0,28 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-10-29 08:33:00-04:00,PFE,28 healthcare stocks moving in tuesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998713731765747
988381,988381,1000521.0,"Pharma Earnings: Merck, Pfizer Trade Higher On Q3 Beats",2019-10-29 07:57:00-04:00,PFE,pharma earnings merck pfizer trade higher on third quarter beats,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996762275695801
988382,988382,1000522.0,"The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study",2019-10-29 07:32:00-04:00,PFE,the daily biotech pulse mirati tastes success with kras inhibitor roche spark deal delayed further morphosys halts study,"{'neg': 0.14, 'neu': 0.614, 'pos': 0.246, 'compound': 0.5267}",negative,0.9961220622062683
988383,988383,1000523.0,Pfizer shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also raised its FY19 EPS and sales guidance above analyst estimates.,2019-10-29 07:24:00-04:00,PFE,pfizer shares are trading higher after the company reported better than expected third quarter eps and sales results the company also raised its fy19 eps and sales guidance above analyst estimates,"{'neg': 0.0, 'neu': 0.85, 'pos': 0.15, 'compound': 0.6249}",positive,0.999718964099884
988384,988384,1000524.0,"Pfizer Raises FY19 Adj. EPS Guidance From $2.76-$2.86 To $2.94-$3.00 vs $2.82 Est., Raises Sales Guidance From $50.5B-$52.5B To $51.2B-$52.2B vs $51.32B Est.",2019-10-29 06:48:00-04:00,PFE,pfizer raises fy19 adj eps guidance from dollars .76 dollars .86 to dollars .94 dollars .00 vs dollars .82 est raises sales guidance from dollars 0.5 billion dollars 2.5 billion to dollars 1.2 billion dollars 2.2 billion vs dollars 1.32 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992032647132874
988385,988385,1000525.0,"Pfizer Q3 Adj. EPS $0.75 Beats $0.62 Estimate, Sales $12.68B Beat $12.26B Estimate",2019-10-29 06:47:00-04:00,PFE,pfizer third quarter adj eps dollars .75 beats dollars .62 estimate sales dollars 2.68 billion beat dollars 2.26 billion estimate,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9989792704582214
988386,988386,1000526.0,"12 Stocks To Watch For October 29, 2019",2019-10-29 05:23:00-04:00,PFE,12 stocks to watch for october 29 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999876856803894
988387,988387,1000527.0,"Earnings Scheduled For October 29, 2019",2019-10-29 04:57:00-04:00,PFE,earnings scheduled for october 29 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998824596405029
988388,988388,1000528.0,Pfizer's Q3 Earnings Preview,2019-10-28 15:06:00-04:00,PFE,pfizers third quarter earnings preview,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998409748077393
988389,988389,1000529.0,Pfizer Reports EC Has Approved BAVENCIO Plus Axitinib Combo For First-Line Treatment Of Patients With Advanced Renal Cell Carcinoma,2019-10-28 14:01:00-04:00,PFE,pfizer reports ec has approved bavencio plus axitinib combo for first line treatment of patients with advanced renal cell carcinoma,"{'neg': 0.0, 'neu': 0.789, 'pos': 0.211, 'compound': 0.5859}",positive,0.9995760321617126
988390,988390,1000530.0,More Earnings And A Fed Decision In Week Four Of The WeTrader Competition,2019-10-28 11:56:00-04:00,PFE,more earnings and a fed decision in week four of the wetrader competition,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9945381283760071
988391,988391,1000531.0,"The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings",2019-10-27 12:56:00-04:00,PFE,the week ahead in biotech adcom test for agile pfizer merck lead earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.5368040800094604
988392,988392,1000532.0,"'Fast Money Halftime Report' Traders Weigh In On Salesforce, Pfizer And More",2019-10-23 17:04:00-04:00,PFE,fast money halftime report traders weigh in on salesforce pfizer and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996300935745239
988393,988393,1000533.0,Biotech Stock On The Radar: Immunomedics' Long Wait For Redemption,2019-10-23 16:27:00-04:00,PFE,biotech stock on the radar immunomedics long wait for redemption,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.7970922589302063
988394,988394,1000534.0,OPKO and Pfizer's Phase 3 Study of Somatrogon Met its Primary Endpoint,2019-10-21 08:05:00-04:00,PFE,opko and pfizers phase 3 study of somatrogon met its primary endpoint,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996349811553955
988395,988395,1000535.0,Bristol-Myers Squibb-Pfizer Alliance Announces They Are Collaborating With Fitbit To Develop Educational Content Around Atrial Fibrillation,2019-10-17 09:06:00-04:00,PFE,bristol myers squibb pfizer alliance announces they are collaborating with fitbit to develop educational content around atrial fibrillation,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9969586133956909
988396,988396,1000536.0,"Bank of America Reinstates Neutral on Pfizer, Announces $37 Price Target",2019-10-17 07:22:00-04:00,PFE,bank of america reinstates neutral on pfizer announces dollars 7 price target,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.514809787273407
988397,988397,1000537.0,"ImaginAb Signs Multi-party Collaboration Agreement With Pfizer, AstraZeneca, Takeda to Help Further Develop Company's Cd8 Immunopet Technology",2019-10-14 04:25:00-04:00,PFE,imaginab signs multi party collaboration agreement with pfizer astrazeneca takeda to help further develop companys cd8 immunopet technology,"{'neg': 0.0, 'neu': 0.636, 'pos': 0.364, 'compound': 0.8225}",positive,0.9995788931846619
988398,988398,1000538.0,Pfizer Presents Positive Phase 3 Data for Abrocitinib in Moderate to Severe Atopic Dermatitis at EADV 2019,2019-10-12 15:51:00-04:00,PFE,pfizer presents positive phase 3 data for abrocitinib in moderate to severe atopic dermatitis at eadv 2019,"{'neg': 0.123, 'neu': 0.708, 'pos': 0.17, 'compound': 0.25}",positive,0.9994373917579651
988399,988399,1000539.0,Trader Toolkit: Cash Flow,2019-10-11 09:18:00-04:00,PFE,trader toolkit cash flow,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998539686203003
988400,988400,1000540.0,BioNTech IPO: What You Need To Know,2019-10-08 07:55:00-04:00,PFE,biontech ipo what you need to know,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998778104782104
988401,988401,1000541.0,Akcea and Ionis Each to Receive a $125M Upfront Payment From Pfizer for the Exclusive Licensing of AKCEA-ANGPTL3-L,2019-10-07 06:54:00-04:00,PFE,akcea and ionis each to receive a dollars 25 million upfront payment from pfizer for the exclusive licensing of akcea angptl3 l,"{'neg': 0.0, 'neu': 0.816, 'pos': 0.184, 'compound': 0.5423}",neutral,0.9997021555900574
988402,988402,1000542.0,"Movers And Shakers At ESMO 2019: Immunomedics, G1 Therapeutics, Seattle Genetics And More",2019-09-30 13:13:00-04:00,PFE,movers and shakers at esmo 2019 immunomedics g1 therapeutics seattle genetics and more,"{'neg': 0.0, 'neu': 0.748, 'pos': 0.252, 'compound': 0.4019}",neutral,0.9998786449432373
988403,988403,1000543.0,"Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer",2019-09-30 10:53:00-04:00,PFE,pfizer presents interim analysis results from phase 3 beacon crc trial of braftovi® encorafenib mektovi® binimetinib and cetuximab for the treatment of brafv600 e mutant metastatic colorectal cancer,"{'neg': 0.132, 'neu': 0.868, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9998739957809448
988404,988404,1000544.0,Pfizer Reports Chair Ian Read To Retire; CEO Albert Bourla Named Replacement,2019-09-27 08:03:00-04:00,PFE,pfizer reports chair ian read to retire ceo albert bourla named replacement,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998655319213867
988405,988405,1000545.0,"The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave",2019-09-27 07:56:00-04:00,PFE,the daily biotech pulse esmo conference gets underway j and js darzalex snags another approval kaleido biosciences cfo to leave,"{'neg': 0.054, 'neu': 0.807, 'pos': 0.139, 'compound': 0.4404}",negative,0.9963968396186829
988406,988406,1000546.0,"Pfizer Reports Top-Line Results From Second Pivotal Phase 3 Study Of Abrocitinib In Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis: Achieved Co-Primary, Key Secondary Endpoints",2019-09-27 06:45:00-04:00,PFE,pfizer reports top line results from second pivotal phase 3 study of abrocitinib in patients aged 12 and older with moderate to severe atopic dermatitis achieved co primary key secondary endpoints,"{'neg': 0.078, 'neu': 0.868, 'pos': 0.054, 'compound': -0.2023}",positive,0.9813665151596069
988407,988407,1000547.0,"Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company",2019-09-25 17:32:00-04:00,PFE,biotech stock on the radar anavex a neurology focused precision medicine company,"{'neg': 0.0, 'neu': 0.809, 'pos': 0.191, 'compound': 0.3818}",neutral,0.9998767375946045
988408,988408,1000548.0,"Pfizer Presents New Evidence Of Ibrance Effectiveness In HR+, HER2- Metastatic Breast Cancer Patients In Four Real-world Studies At ESMO Congress 2019",2019-09-24 08:01:00-04:00,PFE,pfizer presents new evidence of ibrance effectiveness in hr her2 metastatic breast cancer patients in four real world studies at esmo congress 2019,"{'neg': 0.167, 'neu': 0.833, 'pos': 0.0, 'compound': -0.6597}",positive,0.9764442443847656
988409,988409,1000549.0,The Week Ahead In Biotech: Spotlight On ESMO Conference,2019-09-22 16:22:00-04:00,PFE,the week ahead in biotech spotlight on esmo conference,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998661279678345
988410,988410,1000550.0,Pfizer Reports CHMP Adopts Positive Opinion For BAVENCIO Plus Axitinib For First-Line Treatment Of Patients With Advanced Renal Cell Carcinoma,2019-09-20 08:10:00-04:00,PFE,pfizer reports chmp adopts positive opinion for bavencio plus axitinib for first line treatment of patients with advanced renal cell carcinoma,"{'neg': 0.0, 'neu': 0.711, 'pos': 0.289, 'compound': 0.743}",positive,0.9995648264884949
988411,988411,1000551.0,Teva Dips Into Medical Marijuana Market With Canndoc Distribution Deal,2019-09-13 08:14:00-04:00,PFE,teva dips into medical marijuana market with canndoc distribution deal,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.918768584728241
988412,988412,1000552.0,Springworks Therapeutics IPO: What You Need To Know,2019-09-12 17:22:00-04:00,PFE,springworks therapeutics ipo what you need to know,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998738765716553
988413,988413,1000553.0,Shares of several drugmakers are trading lower on news of a drug pricing bill being developed by House Democrats. The proposed bill would set US drug prices based on prices in other wealthy countries.,2019-09-10 10:30:00-04:00,PFE,shares of several drugmakers are trading lower on news of a drug pricing bill being developed by house democrats the proposed bill would set us drug prices based on prices in other wealthy countries,"{'neg': 0.058, 'neu': 0.818, 'pos': 0.124, 'compound': 0.3612}",negative,0.9968260526657104
988414,988414,1000554.0,Pfizer Says Preliminary Results From its Phase 2 Study of 20-Valent Pneumococcal Conjugate Vaccine are Positive,2019-09-09 08:01:00-04:00,PFE,pfizer says preliminary results from its phase 2 study of 20 valent pneumococcal conjugate vaccine are positive,"{'neg': 0.0, 'neu': 0.816, 'pos': 0.184, 'compound': 0.5574}",neutral,0.9937825798988342
988415,988415,1000555.0,Pfizer Option Alert: Sep 20 $37 Calls Sweep (30) near the Ask: 1254 @ $0.303 vs 4708 OI; Earnings 10/29 Before Open [est] Ref=$36.04,2019-09-03 09:48:00-04:00,PFE,pfizer option alert sep 20 dollars 7 calls sweep 30 near the ask 1254 dollars .303 vs 4708 oi earnings before open est ref equals dollars 6.04,"{'neg': 0.0, 'neu': 0.922, 'pos': 0.078, 'compound': 0.296}",neutral,0.9997735619544983
988416,988416,1000556.0,Citi: Solid Biosciences Rally Unsupported By Fundamentals,2019-08-29 11:38:00-04:00,PFE,citi solid biosciences rally unsupported by fundamentals,"{'neg': 0.29, 'neu': 0.538, 'pos': 0.172, 'compound': -0.2732}",positive,0.9992932081222534
988417,988417,1000557.0,"Benzinga's Top Upgrades, Downgrades For August 28, 2019",2019-08-28 09:45:00-04:00,PFE,benzingas top upgrades downgrades for august 28 2019,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",neutral,0.7976285815238953
988418,988418,1000558.0,"DZ Bank Upgrades Pfizer to Hold, Announces $36 Price Target",2019-08-28 06:18:00-04:00,PFE,dz bank upgrades pfizer to hold announces dollars 6 price target,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.998812198638916
988419,988419,1000559.0,"Morgan Stanley Maintains Equal-Weight On Pfizer, Maintains $38 Target As Firm Notes 'Prevnar 20-valent (20vPnC) infant Phase 2 readout for prevention of pneumococcal disease is expected soon; we and consensus assume it moves into Phase 3'",2019-08-27 11:30:00-04:00,PFE,morgan stanley maintains equal weight on pfizer maintains dollars 8 target as firm notes prevnar 20 valent 20 vpnc infant phase 2 readout for prevention of pneumococcal disease is expected soon we and consensus assume it moves into phase 3,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9572861790657043
988420,988420,1000560.0,"Morgan Stanley Maintains Equal-Weight on Pfizer, Lowers Price Target to $38",2019-08-27 07:56:00-04:00,PFE,morgan stanley maintains equal weight on pfizer lowers price target to dollars 8,"{'neg': 0.111, 'neu': 0.889, 'pos': 0.0, 'compound': -0.128}",positive,0.9992153644561768
988421,988421,1000561.0,10 Biopharmaceutical Companies Trying To Cure Cancer,2019-08-24 13:46:00-04:00,PFE,10 biopharmaceutical companies trying to cure cancer,"{'neg': 0.423, 'neu': 0.577, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9998656511306763
988422,988422,1000562.0,"Jim Cramer Weighs In On Pfizer, Teva And More",2019-08-22 11:08:00-04:00,PFE,jim cramer weighs in on pfizer teva and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998218417167664
988423,988423,1000563.0,"The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study",2019-08-22 07:18:00-04:00,PFE,the daily biotech pulse viivs long acting hiv drug meets study goal chinese cheer for fibrogen retrophin flunks late stage study,"{'neg': 0.112, 'neu': 0.757, 'pos': 0.131, 'compound': 0.128}",positive,0.9988027811050415
988424,988424,1000564.0,"ViiV Healthcare Reports Atlas-2M Study Met Its Primary Endpoint, Showing Similar Efficacy of Cabotegravir and Rilpivirine Administered Every Eight Weeks Compared to Four-week Administration",2019-08-22 04:00:00-04:00,PFE,viiv healthcare reports atlas 2 million study met its primary endpoint showing similar efficacy of cabotegravir and rilpivirine administered every eight weeks compared to four week administration,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9866452813148499
988425,988425,1000565.0,Pfizer And Astellas Announce FDA Grants Xtandi (Enzalutamide) Application Priority Review For The Treatment Of Men With Metastatic Hormone-Sensitive Prostate Cancer,2019-08-21 14:02:00-04:00,PFE,pfizer and astellas announce fda grants xtandi enzalutamide application priority review for the treatment of men with metastatic hormone sensitive prostate cancer,"{'neg': 0.167, 'neu': 0.76, 'pos': 0.072, 'compound': -0.5423}",positive,0.9990202188491821
988426,988426,1000566.0,Shares of several healthcare companies are trading higher as optimism increased for a resolution to the US-China trade war.,2019-08-19 12:31:00-04:00,PFE,shares of several healthcare companies are trading higher as optimism increased for a resolution to the us china trade war,"{'neg': 0.141, 'neu': 0.578, 'pos': 0.282, 'compound': 0.4404}",positive,0.9996916055679321
988427,988427,1000567.0,"Shares of healthcare companies are trading higher as US markets rebound from recent weakness following a yield curve inversion, which caused recession fears. Trump also recently announced the US would delay China tariffs, renewing hopes of a trade deal.",2019-08-16 13:27:00-04:00,PFE,shares of healthcare companies are trading higher as us markets rebound from recent weakness following a yield curve inversion which caused recession fears trump also recently announced the us would delay china tariffs renewing hopes of a trade deal,"{'neg': 0.22, 'neu': 0.678, 'pos': 0.103, 'compound': -0.6908}",positive,0.999546229839325
988428,988428,1000568.0,Pfizer Option Alert: Dec 20 $38 Calls Sweep (8) near the Ask: 649 @ $0.479 vs 9234 OI; Ref=$34.1212,2019-08-15 12:08:00-04:00,PFE,pfizer option alert dec 20 dollars 8 calls sweep 8 near the ask 649 dollars .479 vs 9234 oi ref equals dollars 4.1212,"{'neg': 0.0, 'neu': 0.909, 'pos': 0.091, 'compound': 0.296}",neutral,0.9998594522476196
988429,988429,1000569.0,"The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings",2019-08-15 07:45:00-04:00,PFE,the daily biotech pulse mallinkckrodts terlipressin deciphera offering sellas reboots on earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9948601722717285
988430,988430,1000570.0,"The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering",2019-08-14 07:50:00-04:00,PFE,the daily biotech pulse regenerons bad cholesterol drug aces late stage trial oncolytics offering,"{'neg': 0.212, 'neu': 0.788, 'pos': 0.0, 'compound': -0.5423}",neutral,0.9998599290847778
988431,988431,1000571.0,16 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-08-13 08:36:00-04:00,PFE,16 healthcare stocks moving in tuesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998681545257568
988432,988432,1000572.0,"The Daily Biotech Pulse: Jazz Goes Shopping, Portola Offering, Novelion Delays Quarterly Results",2019-08-13 07:25:00-04:00,PFE,the daily biotech pulse jazz goes shopping portola offering novelion delays quarterly results,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9913873076438904
988433,988433,1000573.0,Pfizer shares are trading lower in sympathy with the overall market as the Treasury yield continues to decline along with ongoing trade tensions with China.,2019-08-12 14:45:00-04:00,PFE,pfizer shares are trading lower in sympathy with the overall market as the treasury yield continues to decline along with ongoing trade tensions with china,"{'neg': 0.156, 'neu': 0.637, 'pos': 0.207, 'compound': 0.1531}",negative,0.9986020922660828
988434,988434,1000574.0,Stocks That Hit 52-Week Lows Of Monday,2019-08-12 11:14:00-04:00,PFE,stocks that hit 52 week lows of monday,"{'neg': 0.205, 'neu': 0.795, 'pos': 0.0, 'compound': -0.2023}",negative,0.99808669090271
988435,988435,1000575.0,Stocks That Fell Through 52-Week Lows Wednesday,2019-08-07 14:22:00-04:00,PFE,stocks that fell through 52 week lows wednesday,"{'neg': 0.205, 'neu': 0.795, 'pos': 0.0, 'compound': -0.2023}",negative,0.9975831508636475
988436,988436,1000576.0,"The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering",2019-08-06 07:22:00-04:00,PFE,the daily biotech pulse sanofis dupixent found effective for pediatric itchy skin novavax gets nod for late stage study allakos offering,"{'neg': 0.087, 'neu': 0.785, 'pos': 0.128, 'compound': 0.25}",positive,0.953322172164917
988437,988437,1000577.0,New 52-Week Lows For Monday Morning,2019-08-05 13:16:00-04:00,PFE,new 52 week lows for monday morning,"{'neg': 0.231, 'neu': 0.769, 'pos': 0.0, 'compound': -0.2023}",negative,0.9879432320594788
988438,988438,1000578.0,Shares of several drug/pharma/medical equipment companies trading lower given weakness in broader stock market following concerns with China trade tensions.,2019-08-05 12:43:00-04:00,PFE,shares of several drug and pharma and medical equipment companies trading lower given weakness in broader stock market following concerns with china trade tensions,"{'neg': 0.258, 'neu': 0.669, 'pos': 0.074, 'compound': -0.6705}",negative,0.9985723495483398
988439,988439,1000579.0,GlycoMimetics Falls 50% After Disappointing Results For Sickle Cell Drug Trial,2019-08-05 08:42:00-04:00,PFE,glycomimetics falls 50 percent after disappointing results for sickle cell drug trial,"{'neg': 0.225, 'neu': 0.775, 'pos': 0.0, 'compound': -0.4939}",negative,0.9987516403198242
988440,988440,1000580.0,GlycoMimetics Earlier Announces Pfizer's Phase 3 Clinical Trial Evaluating Rivipansel in Sickle Cell Disease Did Not Meet its Primary or Key Secondary Endpoints,2019-08-05 07:41:00-04:00,PFE,glycomimetics earlier announces pfizers phase 3 clinical trial evaluating rivipansel in sickle cell disease did not meet its primary or key secondary endpoints,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9335728883743286
988441,988441,1000581.0,"Bulls And Bears Of The Week: Boeing, GM, Pfizer, Starbucks And More",2019-08-03 10:25:00-04:00,PFE,bulls and bears of the week boeing gm pfizer starbucks and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998575448989868
988442,988442,1000582.0,Stocks that Reached Yearly Lows Thursday Morning,2019-08-01 11:09:00-04:00,PFE,stocks that reached yearly lows thursday morning,"{'neg': 0.22, 'neu': 0.61, 'pos': 0.171, 'compound': -0.1027}",negative,0.9979324340820312
988443,988443,1000583.0,"'Fast Money Halftime Report' Traders Share Their Thoughts On Square, Boeing, And More",2019-08-01 07:20:00-04:00,PFE,fast money halftime report traders share their thoughts on square boeing and more,"{'neg': 0.0, 'neu': 0.845, 'pos': 0.155, 'compound': 0.296}",neutral,0.9998559951782227
988444,988444,1000584.0,"The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings",2019-08-01 07:18:00-04:00,PFE,the daily biotech pulse exelixis signs cancer drug licensing deal adamis offering surmodics surges on earnings,"{'neg': 0.227, 'neu': 0.773, 'pos': 0.0, 'compound': -0.6597}",positive,0.9995361566543579
988445,988445,1000585.0,"Biotech Stock On The Radar: Veru, A Catalyst-Rich Biopharma",2019-07-31 13:50:00-04:00,PFE,biotech stock on the radar veru a catalyst rich biopharma,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.5574}",positive,0.9422650337219238
988446,988446,1000586.0,REGENXBIO Announces New License Agreement With Pfizer For The Treatment Of Friedreich's Ataxia Using NAV AAV9 Vector,2019-07-31 07:08:00-04:00,PFE,regenxbio announces new license agreement with pfizer for the treatment of friedreichs ataxia using nav aav9 vector,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.4939}",positive,0.9993508458137512
988447,988447,1000587.0,Morgan Stanley Downgrades Pfizer In Wake Of Upjohn-Mylan Merger,2019-07-30 12:14:00-04:00,PFE,morgan stanley downgrades pfizer in wake of upjohn mylan merger,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9968419075012207
988448,988448,1000588.0,"UPDATE: Bank Of America Downgrades Pfizer To Neutral, Lowers Target From $49 To $41  Based On Firm's 'updated SOTP valuation, including expected dilution from Upjohn spin-merge (Reverse Morris Trust) and valuation outlook for RemainCo'",2019-07-30 10:46:00-04:00,PFE,update bank of america downgrades pfizer to neutral lowers target from dollars 9 to dollars 1 based on firms updated sotp valuation including expected dilution from upjohn spin merge reverse morris trust and valuation outlook for remainco,"{'neg': 0.038, 'neu': 0.879, 'pos': 0.083, 'compound': 0.4215}",negative,0.9985723495483398
988449,988449,1000589.0,"Benzinga's Top Upgrades, Downgrades For July 30, 2019",2019-07-30 09:59:00-04:00,PFE,benzingas top upgrades downgrades for july 30 2019,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",neutral,0.6631674766540527
988450,988450,1000590.0,"UPDATE: Morgan Stanley On Pfizer Also Notes 'Although we view the Upjohn exit to MYL as a strategically sound deal, new 2020 management disclosures revealed earnings power that is much weaker than we realized'",2019-07-30 09:27:00-04:00,PFE,update morgan stanley on pfizer also notes although we view the upjohn exit to myl as a strategically sound deal new 2020 management disclosures revealed earnings power that is much weaker than we realized,"{'neg': 0.081, 'neu': 0.919, 'pos': 0.0, 'compound': -0.4404}",negative,0.9988131523132324
988451,988451,1000591.0,"UPDATE: Morgan Stanley Downgrades Pfizer To Equal-Weight, Lowers Target To $40 As Firm Notes 'Our thesis that Pfizer would outperform due to improving prospects was invalidated by a re-set of earnings on both sides of the business'",2019-07-30 09:27:00-04:00,PFE,update morgan stanley downgrades pfizer to equal weight lowers target to dollars 0 as firm notes our thesis that pfizer would outperform due to improving prospects was invalidated by a re set of earnings on both sides of the business,"{'neg': 0.034, 'neu': 0.851, 'pos': 0.115, 'compound': 0.5423}",negative,0.9977145195007324
988452,988452,1000592.0,33 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-30 09:16:00-04:00,PFE,33 healthcare stocks moving in todays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999869704246521
988453,988453,1000593.0,Array Shares To No Longer Trade As Pfizer Is Taking Over The Co.,2019-07-30 08:21:00-04:00,PFE,array shares to no longer trade as pfizer is taking over the co,"{'neg': 0.143, 'neu': 0.714, 'pos': 0.143, 'compound': 0.0}",neutral,0.9996883869171143
988454,988454,1000594.0,Pfizer shares are trading lower after Morgan Stanley downgraded the company's stock from Overweight to Equal-Weight. The company on Monday reported worse-than-expected Q2 sales.,2019-07-30 08:16:00-04:00,PFE,pfizer shares are trading lower after morgan stanley downgraded the companys stock from overweight to equal weight the company on monday reported worse than expected second quarter sales,"{'neg': 0.229, 'neu': 0.706, 'pos': 0.065, 'compound': -0.6808}",negative,0.9988664388656616
988455,988455,1000595.0,Bank of America Downgrades Pfizer to Neutral,2019-07-30 08:00:00-04:00,PFE,bank of america downgrades pfizer to neutral,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9975874423980713
988456,988456,1000596.0,"The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings",2019-07-30 07:00:00-04:00,PFE,the daily biotech pulse european cheer for merck legal victory for coherus medpace picks up on earnings,"{'neg': 0.0, 'neu': 0.758, 'pos': 0.242, 'compound': 0.5859}",positive,0.9996765851974487
988457,988457,1000597.0,Morgan Stanley Downgrades Pfizer to Equal-Weight,2019-07-30 06:40:00-04:00,PFE,morgan stanley downgrades pfizer to equal weight,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9950659275054932
988458,988458,1000598.0,Mid-Afternoon Market Update: Crude Oil Up Over 1%; Lexicon Pharmaceuticals Shares Plunge,2019-07-29 14:22:00-04:00,PFE,mid afternoon market update crude oil up over 1 percent lexicon pharmaceuticals shares plunge,"{'neg': 0.207, 'neu': 0.67, 'pos': 0.123, 'compound': -0.3612}",positive,0.9959561228752136
988459,988459,1000599.0,Mid-Day Market Update: On Deck Capital Falls On Downbeat Earnings; Medley Management Shares Jump,2019-07-29 12:13:00-04:00,PFE,mid day market update on deck capital falls on downbeat earnings medley management shares jump,"{'neg': 0.0, 'neu': 0.864, 'pos': 0.136, 'compound': 0.296}",negative,0.9987844824790955
988460,988460,1000600.0,"Hearing JP Morgan Commented On Mylan Amid Pfizer Upjohn News, Sees New Valuation $25-$32/Share Based On Higher Pro-Forma Multiple Warranted For NewCo., Combined Co. Will Have Less US Generics Exposure, Less Leverage But Improved Corporate Governance",2019-07-29 11:48:00-04:00,PFE,hearing jp morgan commented on mylan amid pfizer upjohn news sees new valuation dollars 5 dollars based on higher pro forma multiple warranted for newco combined co will have less us generics exposure less leverage but improved corporate governance,"{'neg': 0.0, 'neu': 0.878, 'pos': 0.122, 'compound': 0.6315}",positive,0.9994775652885437
988461,988461,1000601.0,"Mid-Morning Market Update: Markets Mostly Lower; Mylan, Pfizer's Upjohn To Merge",2019-07-29 10:16:00-04:00,PFE,mid morning market update markets mostly lower mylan pfizers upjohn to merge,"{'neg': 0.167, 'neu': 0.833, 'pos': 0.0, 'compound': -0.296}",negative,0.9975472092628479
988462,988462,1000602.0,"Host Of Earnings Loom With Beyond Meat, Apple Among Highlights Ahead Of Fed, Payrolls",2019-07-29 09:50:00-04:00,PFE,host of earnings loom with beyond meat apple among highlights ahead of fed payrolls,"{'neg': 0.128, 'neu': 0.872, 'pos': 0.0, 'compound': -0.2263}",neutral,0.9998120665550232
988463,988463,1000603.0,30 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-29 09:35:00-04:00,PFE,30 healthcare stocks moving in todays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999872088432312
988464,988464,1000604.0,Merck's Keytruda Gets A Double Dose Of Positive News,2019-07-29 09:30:00-04:00,PFE,mercks keytruda gets a double dose of positive news,"{'neg': 0.0, 'neu': 0.69, 'pos': 0.31, 'compound': 0.5574}",positive,0.9990634322166443
988465,988465,1000605.0,Mylan Says Share Repurchases are Possible in 2021 Following Merger Announcement with Pfizer's Upjohn,2019-07-29 08:39:00-04:00,PFE,mylan says share repurchases are possible in 2021 following merger announcement with pfizers upjohn,"{'neg': 0.0, 'neu': 0.855, 'pos': 0.145, 'compound': 0.296}",neutral,0.9998751878738403
988466,988466,1000606.0,Pfizer shares are trading lower after the company reported worse-than-expected Q2 sales results and lowered its FY19 guidance below analyst estimates.,2019-07-29 08:27:00-04:00,PFE,pfizer shares are trading lower after the company reported worse than expected second quarter sales results and lowered its fy19 guidance below analyst estimates,"{'neg': 0.234, 'neu': 0.69, 'pos': 0.076, 'compound': -0.5574}",negative,0.9986874461174011
988467,988467,1000607.0,"Mylan, Pfizer's Upjohn To Merge And Create New Company",2019-07-29 08:01:00-04:00,PFE,mylan pfizers upjohn to merge and create new company,"{'neg': 0.0, 'neu': 0.792, 'pos': 0.208, 'compound': 0.2732}",neutral,0.9997678399085999
988468,988468,1000608.0,"Pfizer Reports Mixed Q2 Earnings, Lowers Guidance",2019-07-29 07:56:00-04:00,PFE,pfizer reports mixed second quarter earnings lowers guidance,"{'neg': 0.176, 'neu': 0.824, 'pos': 0.0, 'compound': -0.128}",negative,0.9986377358436584
988469,988469,1000609.0,A Peek Into The Markets: US Stock Futures Flat; Mylan To Combine With Pfizer's Upjohn Division,2019-07-29 07:32:00-04:00,PFE,a peek into the markets us stock futures flat mylan to combine with pfizers upjohn division,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999882698059082
988470,988470,1000610.0,Pfizer Lowers FY2019 EPS Guidance from $2.83-2.93 to $2.76-2.86 vs $2.91 Est; Lowers FY2019 Sales Guidance from $52B-54B to $50.5B-52.5B vs $53.28B Est,2019-07-29 06:48:00-04:00,PFE,pfizer lowers fy2019 eps guidance from dollars .83 to 2.93 to dollars .76 to 2.86 vs dollars .91 est lowers fy2019 sales guidance from dollars 2 billion 54 billion to dollars 0.5 billion 52.5 billion vs dollars 3.28 billion est,"{'neg': 0.073, 'neu': 0.927, 'pos': 0.0, 'compound': -0.25}",negative,0.9982268214225769
988471,988471,1000611.0,"Pfizer Q2 EPS $0.8 Beats $0.75 Estimate, Sales $13.264B Miss $13.4B Estimate",2019-07-29 06:47:00-04:00,PFE,pfizer second quarter eps dollars .8 beats dollars .75 estimate sales dollars 3.264 billion miss dollars 3.4 billion estimate,"{'neg': 0.082, 'neu': 0.918, 'pos': 0.0, 'compound': -0.1531}",neutral,0.9998503923416138
988472,988472,1000612.0,"Mylan and Pfizer's Upjohn to Merge and Create a New Company, Mylan Shareholders to Own 43% of the New Company",2019-07-29 06:46:00-04:00,PFE,mylan and pfizers upjohn to merge and create a new company mylan shareholders to own 43 percent of the new company,"{'neg': 0.0, 'neu': 0.905, 'pos': 0.095, 'compound': 0.2732}",neutral,0.9998340606689453
988473,988473,1000613.0,"The Week In Cannabis: Tobacco And Retail Stray In The Weeds, Congress Holds SAFE Banking Hearings, New ETFs, And More",2019-07-28 15:51:00-04:00,PFE,the week in cannabis tobacco and retail stray in the weeds congress holds safe banking hearings new etfs and more,"{'neg': 0.0, 'neu': 0.868, 'pos': 0.132, 'compound': 0.4404}",neutral,0.9997666478157043
988474,988474,1000614.0,Pfizer in Talks to Merge Off-patent Drugs Business with Mylan,2019-07-28 08:15:00-04:00,PFE,pfizer in talks to merge off patent drugs business with mylan,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996809959411621
988475,988475,1000615.0,"The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate",2019-07-27 14:32:00-04:00,PFE,the week ahead in biotech pending clinical readouts earnings dominate,"{'neg': 0.143, 'neu': 0.857, 'pos': 0.0, 'compound': -0.128}",neutral,0.9994617104530334
988476,988476,1000616.0,"FDA Has Approved Boxed Warning On Increased Risk Of Blood Clots, Death With Higher Dose Of Pfizer's Arthritis, Ulcerative Colitis Medicine Xeljanz",2019-07-26 11:12:00-04:00,PFE,fda has approved boxed warning on increased risk of blood clots death with higher dose of pfizers arthritis ulcerative colitis medicine xeljanz,"{'neg': 0.277, 'neu': 0.561, 'pos': 0.162, 'compound': -0.5423}",negative,0.7975785136222839
988477,988477,1000617.0,"Jim Cramer Gives His Opinion On eBay, Pfizer And More",2019-07-24 10:25:00-04:00,PFE,jim cramer gives his opinion on ebay pfizer and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998682737350464
988478,988478,1000618.0,Hearing Unconfirmed Chatter Indicating Pfizer Has Made Takeover Offer For Bristol-Meyers,2019-07-24 09:52:00-04:00,PFE,hearing unconfirmed chatter indicating pfizer has made takeover offer for bristol meyers,"{'neg': 0.12, 'neu': 0.88, 'pos': 0.0, 'compound': -0.128}",positive,0.9676712155342102
988479,988479,1000619.0,"Pfizer Announces FDA Has Approved Ruxience (Rituximab-Pvvr) For The Treatment Of Adult Patients With Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, And Granulomatosis With Polyangiiti And Microscopic Polyangiitis",2019-07-23 13:50:00-04:00,PFE,pfizer announces fda has approved ruxience rituximab pvvr for the treatment of adult patients with non hodgkins lymphoma chronic lymphocytic leukemia and granulomatosis with polyangiiti and microscopic polyangiitis,"{'neg': 0.0, 'neu': 0.906, 'pos': 0.094, 'compound': 0.4215}",positive,0.9994255304336548
988480,988480,1000620.0,"ICC International Cannabis, Biotii Technologie Sign Advisory Agreement With Dr. Alexandros Makriyannis",2019-07-23 10:55:00-04:00,PFE,icc international cannabis biotii technologie sign advisory agreement with dr alexandros makriyannis,"{'neg': 0.0, 'neu': 0.775, 'pos': 0.225, 'compound': 0.4939}",positive,0.9991559982299805
988481,988481,1000621.0,"With Earnings On Tap, A Stir In This Leveraged Pharmaceuticals ETF",2019-07-23 09:27:00-04:00,PFE,with earnings on tap a stir in this leveraged pharmaceuticals etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.6089506149291992
988482,988482,1000622.0,"Syapse Reports Strategic Collaboration With Pfizer To Advance Cancer Outcomes Research, No Terms Disclosed",2019-07-23 08:12:00-04:00,PFE,syapse reports strategic collaboration with pfizer to advance cancer outcomes research no terms disclosed,"{'neg': 0.355, 'neu': 0.645, 'pos': 0.0, 'compound': -0.765}",neutral,0.999864935874939
988483,988483,1000623.0,FDA Approves First Generics Of Lyrica,2019-07-22 10:46:00-04:00,PFE,fda approves first generics of lyrica,"{'neg': 0.0, 'neu': 0.649, 'pos': 0.351, 'compound': 0.4019}",neutral,0.9997519850730896
988484,988484,1000624.0,Health Canada Says Pfizer Indicated That It Has Begun Managing Distribution Of Existing Epipen 0.3 Mg Supply To Help Ensure Consistent Access By Patients,2019-07-19 11:47:00-04:00,PFE,health canada says pfizer indicated that it has begun managing distribution of existing epipen 0.3 mg supply to help ensure consistent access by patients,"{'neg': 0.0, 'neu': 0.806, 'pos': 0.194, 'compound': 0.6486}",neutral,0.9914557337760925
988485,988485,1000625.0,Health Canada Says Pfizer Has Confirmed That Epipen 0.3 Mg Supply Is Currently Available And Continues To Be Shipped,2019-07-19 11:44:00-04:00,PFE,health canada says pfizer has confirmed that epipen 0.3 mg supply is currently available and continues to be shipped,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9961563944816589
988486,988486,1000626.0,Health Canada Says Aware That Pfizer Canada Is Reporting That A Shortage Of 0.3 Mg Format Epipen Auto-Injector May Lead To Temporary Supply Constraints; Says Epipen Jr (0.15 Mg) Is Not Affected By Shortage,2019-07-19 10:50:00-04:00,PFE,health canada says aware that pfizer canada is reporting that a shortage of 0.3 mg format epipen auto injector may lead to temporary supply constraints says epipen jr 0.15 mg is not affected by shortage,"{'neg': 0.054, 'neu': 0.861, 'pos': 0.086, 'compound': 0.0475}",negative,0.9943965673446655
988487,988487,1000627.0,"Shares of several drug manufacturing companies are trading lower, potentially on continued weakness after the Trump Administration on Thursday rolled back a proposal to eliminate rebates from government drug plans.",2019-07-12 09:53:00-04:00,PFE,shares of several drug manufacturing companies are trading lower potentially on continued weakness after the trump administration on thursday rolled back a proposal to eliminate rebates from government drug plans,"{'neg': 0.146, 'neu': 0.789, 'pos': 0.064, 'compound': -0.4215}",negative,0.9986661672592163
988488,988488,1000628.0,Study: ViiV Healthcare's 2-Drug HIV Regimen As Effective As 3,2019-07-10 10:15:00-04:00,PFE,study viiv healthcares 2 drug hiv regimen as effective as 3,"{'neg': 0.0, 'neu': 0.763, 'pos': 0.237, 'compound': 0.4767}",neutral,0.9998763799667358
988489,988489,1000629.0,"The Daily Biotech Pulse: Jazz Buys Tumor Drug Program, Sanofi's BLA For Multiple Myeloma Drug Accepted, Positive Results For ViiV",2019-07-10 07:17:00-04:00,PFE,the daily biotech pulse jazz buys tumor drug program sanofis bla for multiple myeloma drug accepted positive results for viiv,"{'neg': 0.103, 'neu': 0.672, 'pos': 0.225, 'compound': 0.4767}",positive,0.9992820620536804
988490,988490,1000630.0,ViiV Healthcare Announces Phase III TANGO Study Meets Primary Endpoint,2019-07-10 04:23:00-04:00,PFE,viiv healthcare announces phase iii tango study meets primary endpoint,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998396635055542
988491,988491,1000631.0,Pfizer Says Anticipates Further Epipen Supply Shirtages Over The Coming Months,2019-07-09 13:45:00-04:00,PFE,pfizer says anticipates further epipen supply shirtages over the coming months,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997304081916809
988492,988492,1000632.0,U.S. Judge Halts Trump Administration Rule Requiring Drug Prices in TV Ads,2019-07-08 18:26:00-04:00,PFE,u s judge halts trump administration rule requiring drug prices in tv ads,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9988705515861511
988493,988493,1000633.0,"Shares of several healthcare companies are trading lower after Trump on Friday said he was preparing an executive order declaring a 'favored nations clause' for drug prices, lowering the price that consumers will pay prescription drugs.",2019-07-08 12:55:00-04:00,PFE,shares of several healthcare companies are trading lower after trump on friday said he was preparing an executive order declaring a favored nations clause for drug prices lowering the price that consumers will pay prescription drugs,"{'neg': 0.135, 'neu': 0.745, 'pos': 0.12, 'compound': 0.1027}",negative,0.5988128185272217
988494,988494,1000634.0,"Sangamo, Pfizer Announce Updated Phase 1/2 Results for SB-525 Investigational Hemophilia A Gene Therapy Showing Sustained Increased Factor VIII Levels",2019-07-06 07:43:00-04:00,PFE,sangamo pfizer announce updated phase .5 results for sb 525 investigational hemophilia a gene therapy showing sustained increased factor viii levels,"{'neg': 0.0, 'neu': 0.905, 'pos': 0.095, 'compound': 0.2732}",positive,0.9983667731285095
988495,988495,1000635.0,"The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief",2019-07-03 07:31:00-04:00,PFE,the daily biotech pulse roches flu drug aces late stage trial acura outlicenses pain medication neuronetics gets new finance chief,"{'neg': 0.247, 'neu': 0.753, 'pos': 0.0, 'compound': -0.7096}",neutral,0.9997442364692688
988496,988496,1000636.0,"Ex-FDA Chief Scott Gottlieb Defends Return To Private Sector, Warren Calls For Resignation",2019-07-02 15:04:00-04:00,PFE,ex fda chief scott gottlieb defends return to private sector warren calls for resignation,"{'neg': 0.145, 'neu': 0.855, 'pos': 0.0, 'compound': -0.296}",neutral,0.9921520352363586
988497,988497,1000637.0,Calithera Biosciences Initiates Phase 1/2 Trial Of Telaglenastat In Combination With Pfizer's CDK4/6 Inhibitor Palbociclib,2019-07-02 08:00:00-04:00,PFE,calithera biosciences initiates phase .5 trial of telaglenastat in combination with pfizers inhibitor palbociclib,"{'neg': 0.091, 'neu': 0.909, 'pos': 0.0, 'compound': -0.0772}",neutral,0.9998835325241089
988498,988498,1000638.0,"UPDATE: RBC Maintains Sarepta At Outperform, Raises Tgt To $220 As Firm Sees Co. 'as the clear leader in this space and are increasing our out-year DMD share/penetration estimates' 'Based on our analysis of PFE's initial DMD gene therapy results'",2019-07-01 10:32:00-04:00,PFE,update rbc maintains sarepta at outperform raises tgt to dollars 20 as firm sees co as the clear leader in this space and are increasing our out year dmd share and penetration estimates based on our analysis of pfes initial dmd gene therapy results,"{'neg': 0.0, 'neu': 0.897, 'pos': 0.103, 'compound': 0.5859}",positive,0.9997172951698303
988499,988499,1000639.0,"Pfizer Announces 'Positive' Top-Line Results from Phase 4 Study of Crisaborole Ointment, 2%, in Children Aged 3 Months to Less Than 24 Months with Mild to Moderate Atopic Dermatitis",2019-07-01 08:01:00-04:00,PFE,pfizer announces positive top line results from phase 4 study of crisaborole ointment 2 percent in children aged 3 months to less than 24 months with mild to moderate atopic dermatitis,"{'neg': 0.0, 'neu': 0.843, 'pos': 0.157, 'compound': 0.6597}",positive,0.9996298551559448
988500,988500,1000640.0,"5 Stocks To Watch For July 1, 2019",2019-07-01 04:26:00-04:00,PFE,5 stocks to watch for july 1 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999846339225769
988501,988501,1000641.0,Pfizer Reports Phase 3 Trial Of Revatio In Newborns With Persistent Pulmonary Hypertension Did Not Meet Primary Efficacy Endpoint,2019-06-28 16:06:00-04:00,PFE,pfizer reports phase 3 trial of revatio in newborns with persistent pulmonary hypertension did not meet primary efficacy endpoint,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.7921392321586609
988502,988502,1000642.0,Meet The 3 Biggest Industries Investing In Cannabis,2019-06-28 15:51:00-04:00,PFE,meet the 3 biggest industries investing in cannabis,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998756647109985
988503,988503,1000643.0,"Sarepta Shares Up 14% For Session; Hearing RBC Recently Suggesting Buying Stock, Said Pfizer Data Removed An Overhang",2019-06-28 11:37:00-04:00,PFE,sarepta shares up 14 percent for session hearing rbc recently suggesting buying stock said pfizer data removed an overhang,"{'neg': 0.0, 'neu': 0.891, 'pos': 0.109, 'compound': 0.296}",positive,0.9997029900550842
988504,988504,1000644.0,Pfizer Presents Initial Preclinical Data On Phase 1b Gene Therapy Study For Duchenne Muscular Dystrophy At Annual Parent Project Muscular Dystrophy Connect Conference,2019-06-28 10:16:00-04:00,PFE,pfizer presents initial preclinical data on phase 1 billion gene therapy study for duchenne muscular dystrophy at annual parent project muscular dystrophy connect conference,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998745918273926
988505,988505,1000645.0,Pfizer Reports Received FDA Approval For ZIRABEV,2019-06-28 07:33:00-04:00,PFE,pfizer reports received fda approval for zirabev,"{'neg': 0.0, 'neu': 0.659, 'pos': 0.341, 'compound': 0.4767}",positive,0.998084545135498
988506,988506,1000646.0,"The Daily Biotech Pulse: Chiasma To Join R3K Index, EU Rejects Amgen's Osteoporosis Drug Application, Karuna IPO",2019-06-28 07:32:00-04:00,PFE,the daily biotech pulse chiasma to join r3 thousand index eu rejects amgens osteoporosis drug application karuna ipo,"{'neg': 0.15, 'neu': 0.748, 'pos': 0.103, 'compound': -0.25}",neutral,0.999872088432312
988507,988507,1000647.0,Former FDA Commissioner Scott Gottlieb Elected To Pfizer's Board Of Directors,2019-06-27 16:19:00-04:00,PFE,former fda commissioner scott gottlieb elected to pfizers board of directors,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998651742935181
988508,988508,1000648.0,Pfizer Says 'Revised Recommendation Reinforces That Prevnar 13 Is Considered Safe And Effective By The Fda And Acip',2019-06-26 16:01:00-04:00,PFE,pfizer says revised recommendation reinforces that prevnar 13 is considered safe and effective by the fda and acip,"{'neg': 0.0, 'neu': 0.727, 'pos': 0.273, 'compound': 0.7184}",positive,0.9994841814041138
988509,988509,1000649.0,"UPDATE: Baird Notes 'We remain positively inclined into this dataset as Sarepta has set the bar so high with its results last year, we think Pfizer is likely to fall short on safety, efficacy or both'; Believes Sarepta Will Retain Clear Advantage",2019-06-26 10:17:00-04:00,PFE,update baird notes we remain positively inclined into this dataset as sarepta has set the bar so high with its results last year we think pfizer is likely to fall short on safety efficacy or both believes sarepta will retain clear advantage,"{'neg': 0.0, 'neu': 0.779, 'pos': 0.221, 'compound': 0.8689}",positive,0.9993441700935364
988510,988510,1000650.0,"Baird Maintains Outperform, $202 Target On Sarepta Therapeutics As Firm Notes 'When Pfizer presents the first data for its DMD gene therapy Friday morning, we expect the results to have meaningful ramifications to Sarepta'",2019-06-26 10:17:00-04:00,PFE,baird maintains outperform dollars 02 target on sarepta therapeutics as firm notes when pfizer presents the first data for its dmd gene therapy friday morning we expect the results to have meaningful ramifications to sarepta,"{'neg': 0.0, 'neu': 0.937, 'pos': 0.063, 'compound': 0.3182}",positive,0.9996592998504639
988511,988511,1000651.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs",2019-06-22 15:07:00-04:00,PFE,the week ahead in biotech conferences pdufa dates clinical trial readouts and ipos,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998807907104492
988512,988512,1000652.0,Pfizer Receives European Commission Approval For Breast Cancer Drug TALZENNA,2019-06-21 11:57:00-04:00,PFE,pfizer receives european commission approval for breast cancer drug talzenna,"{'neg': 0.284, 'neu': 0.516, 'pos': 0.2, 'compound': -0.3182}",positive,0.9713873863220215
988513,988513,1000653.0,BioMarin Receives $15M In Milestone Payments From Pfizer For TALZENNA For Metastatic Breast Cancer Patients With An Inherited BRCA Mutation,2019-06-21 11:32:00-04:00,PFE,biomarin receives dollars 5 million in milestone payments from pfizer for talzenna for metastatic breast cancer patients with an inherited brca mutation,"{'neg': 0.173, 'neu': 0.827, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9745015501976013
988514,988514,1000654.0,"Pfizer Receives European Approval For TALZENNA, A Once-Daily Parp Inhibitor Approved In Europe For Hereditary Breast Cancer",2019-06-21 10:47:00-04:00,PFE,pfizer receives european approval for talzenna a once daily parp inhibitor approved in europe for hereditary breast cancer,"{'neg': 0.223, 'neu': 0.547, 'pos': 0.23, 'compound': 0.0516}",positive,0.998717188835144
988515,988515,1000655.0,Sangamo Announces Upcoming Presentation Of Investigational SB-525 Hemophilia A Gene Therapy Data At ISTH 2019,2019-06-21 09:24:00-04:00,PFE,sangamo announces upcoming presentation of investigational sb 525 hemophilia a gene therapy data at isth 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998875856399536
988516,988516,1000656.0,GlaxoSmithKline Offered Concessions to Address EU Antitrust Concerns Over Planned JV With Pfizer's Consumer Health Business,2019-06-20 04:09:00-04:00,PFE,glaxosmithkline offered concessions to address eu antitrust concerns over planned jv with pfizers consumer health business,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994755387306213
988517,988517,1000657.0,"Russian Parliament OKs Cannabis, Psychotropic Cultivation For Pharmaceutical Reasons",2019-06-19 16:05:00-04:00,PFE,russian parliament oks cannabis psychotropic cultivation for pharmaceutical reasons,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998757839202881
988518,988518,1000658.0,"CEOs From US Firms Including Dow, UPS, Pfizer, Honeywell Meet With Chinese Premier Li In Beijing",2019-06-19 12:08:00-04:00,PFE,ceos from us firms including dow ups pfizer honeywell meet with chinese premier li in beijing,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998538494110107
988519,988519,1000659.0,A Beloved Biotech ETF Could Lure Traders Again,2019-06-19 09:27:00-04:00,PFE,a beloved biotech etf could lure traders again,"{'neg': 0.0, 'neu': 0.68, 'pos': 0.32, 'compound': 0.5106}",positive,0.9990943670272827
988520,988520,1000660.0,"The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale",2019-06-18 07:31:00-04:00,PFE,the daily biotech pulse phasebio pumped up eiger exults on breakthrough therapy designation biohaven slips on stock sale,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9670494794845581
988521,988521,1000661.0,60 Biggest Movers From Yesterday,2019-06-18 04:54:00-04:00,PFE,60 biggest movers from yesterday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998466968536377
988522,988522,1000662.0,Mid-Afternoon Market Update: Crude Oil Down 1.5%; C&J Energy Services Shares Spike Higher,2019-06-17 14:52:00-04:00,PFE,mid afternoon market update crude oil down 1.5 percent c and j energy services shares spike higher,"{'neg': 0.168, 'neu': 0.636, 'pos': 0.195, 'compound': -0.1027}",negative,0.9976497292518616
988523,988523,1000663.0,44 Stocks Moving In Monday's Mid-Day Session,2019-06-17 12:23:00-04:00,PFE,44 stocks moving in mondays mid day session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998760223388672
988524,988524,1000664.0,Mid-Day Market Update: Sotheby's Jumps On Acquisition News; Flex Pharma Shares Slide,2019-06-17 12:12:00-04:00,PFE,mid day market update sothebys jumps on acquisition news flex pharma shares slide,"{'neg': 0.0, 'neu': 0.845, 'pos': 0.155, 'compound': 0.296}",positive,0.9988601207733154
988525,988525,1000665.0,Mid-Morning Market Update: Markets Open Higher; Pfizer To Acquire Array BioPharma For $48/Share,2019-06-17 10:17:00-04:00,PFE,mid morning market update markets open higher pfizer to acquire array biopharma for dollars,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9735898375511169
988526,988526,1000666.0,28 Stocks Moving In Monday's Pre-Market Session,2019-06-17 08:06:00-04:00,PFE,28 stocks moving in mondays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998695850372314
988527,988527,1000667.0,Pfizer To Buy Array BioPharma For $48/Share,2019-06-17 07:55:00-04:00,PFE,pfizer to buy array biopharma for dollars,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998199343681335
988528,988528,1000668.0,Pfizer to Acquire Array BioPharma For $48/Share Cash,2019-06-17 06:50:00-04:00,PFE,pfizer to acquire array biopharma for dollars cash,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998698234558105
988529,988529,1000669.0,"Pfizer Announces Results From XELJANZ XR ORAL Shift Study, The First Phase 3b/4 Study To Evaluate Methotrexate Withdrawal With JAK Inhibitor",2019-06-12 08:12:00-04:00,PFE,pfizer announces results from xeljanz xr oral shift study the first phase study to evaluate methotrexate withdrawal with jak inhibitor,"{'neg': 0.064, 'neu': 0.882, 'pos': 0.054, 'compound': -0.0516}",neutral,0.9995902180671692
988530,988530,1000670.0,"Jim Cramer Weighs In On Tesla, PayPal And More",2019-06-10 07:23:00-04:00,PFE,jim cramer weighs in on tesla paypal and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998528957366943
988531,988531,1000671.0,"BioXcel Pharmaceuticals CEO On Drug Pipeline, How AI Is Changing Sector",2019-06-09 16:09:00-04:00,PFE,bioxcel pharmaceuticals ceo on drug pipeline how ai is changing sector,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998476505279541
988532,988532,1000672.0,"Top 10 Most Overbought Stocks Via Benzinga Pro's Radar Tool For Thur., June 06, 2019",2019-06-06 14:57:00-04:00,PFE,top 10 most overbought stocks via benzinga pros radar tool for thur june 06 2019,"{'neg': 0.0, 'neu': 0.886, 'pos': 0.114, 'compound': 0.2023}",neutral,0.9998196959495544
988533,988533,1000673.0,"Pfizer Shares Closed Up 0.6%, Seemingly Unaffected Following Negative Washington Post Article From Late Tues. 'Pfizer had clues its blockbuster drug could prevent Alzheimer's. Why didn't it tell the world?'",2019-06-05 16:21:00-04:00,PFE,pfizer shares closed up 0.6 percent seemingly unaffected following negative washington post article from late tues pfizer had clues its blockbuster drug could prevent alzheimers why didnt it tell the world,"{'neg': 0.098, 'neu': 0.712, 'pos': 0.19, 'compound': 0.3612}",positive,0.9606054425239563
988534,988534,1000674.0,'I believe it is wrong to charge Americans astronomical prices for life-saving drugs developed with taxpayer dollars. You will not find me encouraging pharmaceutical companies to continue ripping off Americans like my Republican colleagues.' -Sen Sanders,2019-06-04 11:42:00-04:00,PFE,i believe it is wrong to charge americans astronomical prices for life saving drugs developed with taxpayer dollars you will not find me encouraging pharmaceutical companies to continue ripping off americans like my republican colleagues sen sanders,"{'neg': 0.139, 'neu': 0.802, 'pos': 0.059, 'compound': -0.5229}",negative,0.9192805886268616
988535,988535,1000675.0,"UPDATE: Morgan Stanley Initiates Pfizer With Overweight, $48 Target As Firm Notes Co's 'organic growth is set to accelerate next year after two decades of challenges, driven by fading patent expiration pressures and contributions from new revenue drivers'",2019-06-04 11:22:00-04:00,PFE,update morgan stanley initiates pfizer with overweight dollars 8 target as firm notes cos organic growth is set to accelerate next year after two decades of challenges driven by fading patent expiration pressures and contributions from new revenue drivers,"{'neg': 0.11, 'neu': 0.801, 'pos': 0.089, 'compound': -0.2263}",positive,0.9996045231819153
988536,988536,1000676.0,"Morgan Stanley Reinstates Overweight on Pfizer, Announces $48 Price Target",2019-06-04 07:39:00-04:00,PFE,morgan stanley reinstates overweight on pfizer announces dollars 8 price target,"{'neg': 0.2, 'neu': 0.8, 'pos': 0.0, 'compound': -0.3612}",negative,0.9476330876350403
988537,988537,1000677.0,"SIGA Announces TPOXX Promotion Agreement With Meridian Medical Technologies, Inc. (A Pfizer Company) For International Markets",2019-06-03 07:34:00-04:00,PFE,siga announces tpoxx promotion agreement with meridian medical technologies inc a pfizer company for international markets,"{'neg': 0.0, 'neu': 0.824, 'pos': 0.176, 'compound': 0.4939}",positive,0.9995191097259521
988538,988538,1000678.0,Pfizer Announces Phase 3 Study Of LYRICA Did Not Meet Its Primary Endpoint,2019-05-24 16:03:00-04:00,PFE,pfizer announces phase 3 study of lyrica did not meet its primary endpoint,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9774038791656494
988539,988539,1000679.0,PreMarket Prep Opening NYSE Imbalance Update: GE 215k Shares To Sell; Alibaba 69k To Sell; Pfizer 131k To Sell; Coca-Cola 58k To Sell; J&J 32k To Sell,2019-05-20 08:33:00-04:00,PFE,premarket prep opening nyse imbalance update ge 215 thousand shares to sell alibaba 69 thousand to sell pfizer 131 thousand to sell coca cola 58 thousand to sell j and j 32 thousand to sell,"{'neg': 0.0, 'neu': 0.939, 'pos': 0.061, 'compound': 0.296}",neutral,0.9998656511306763
988540,988540,1000680.0,"Pfizer Has Confirmed Initiation Of EU Review Of Tofacitinib With Interim Recommendations, Will Continue To Work With Regulatory Bodies, Taking Steps To Inform Healthcare Professionals In EU/EEA About Interim Guidance",2019-05-17 08:43:00-04:00,PFE,pfizer has confirmed initiation of eu review of tofacitinib with interim recommendations will continue to work with regulatory bodies taking steps to inform healthcare professionals in eu and eea about interim guidance,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999704897403717
988541,988541,1000681.0,FDA Approves First Anticoagulant (Blood Thinner) For Pediatric Patients To Treat Potentially Life-Threatening Blood Clots,2019-05-16 12:28:00-04:00,PFE,fda approves first anticoagulant blood thinner for pediatric patients to treat potentially life threatening blood clots,"{'neg': 0.156, 'neu': 0.596, 'pos': 0.248, 'compound': 0.25}",positive,0.9422194361686707
988542,988542,1000682.0,PreMarket Prep Opening NYSE Imbalance Update: Disney 57k Shares To Buy; Pfizer 262k To Buy; P&G 22k To Buy; Square 22k To Buy; Macy's 60k To Buy; General Electric 331k To Sell,2019-05-15 08:54:00-04:00,PFE,premarket prep opening nyse imbalance update disney 57 thousand shares to buy pfizer 262 thousand to buy p and g 22 thousand to buy square 22 thousand to buy macys 60 thousand to buy general electric 331 thousand to sell,"{'neg': 0.0, 'neu': 0.947, 'pos': 0.053, 'compound': 0.296}",neutral,0.9998703002929688
988543,988543,1000683.0,"The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi",2019-05-15 07:50:00-04:00,PFE,the daily biotech pulse fda greenlights pfizer merck kgaas kidney cancer combo treatment adcom disappointment for daiichi,"{'neg': 0.339, 'neu': 0.661, 'pos': 0.0, 'compound': -0.8271}",negative,0.9953194260597229
988544,988544,1000684.0,Pfizer Reports Top-Line Results From Abrocitinib In Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis: 'Study achieves all co-primary and secondary endpoints ',2019-05-15 06:46:00-04:00,PFE,pfizer reports top line results from abrocitinib in patients aged 12 and older with moderate to severe atopic dermatitis study achieves all co primary and secondary endpoints,"{'neg': 0.088, 'neu': 0.85, 'pos': 0.061, 'compound': -0.2023}",neutral,0.969971776008606
988545,988545,1000685.0,"Pfizer, EM Serono Announce FDA Approves BAVENCIO Plus INLYTA Combination for Patients with Advanced Renal Cell Carcinoma",2019-05-14 19:49:00-04:00,PFE,pfizer em serono announce fda approves bavencio plus inlyta combination for patients with advanced renal cell carcinoma,"{'neg': 0.0, 'neu': 0.761, 'pos': 0.239, 'compound': 0.5719}",positive,0.9988922476768494
988546,988546,1000686.0,Shares of several drug manufacturers are trading lower after the United States filed a lawsuit against Teva alleging price fixing.,2019-05-13 09:53:00-04:00,PFE,shares of several drug manufacturers are trading lower after the united states filed a lawsuit against teva alleging price fixing,"{'neg': 0.163, 'neu': 0.637, 'pos': 0.199, 'compound': 0.2263}",negative,0.9974318146705627
988547,988547,1000687.0,Teva Plummets Amid Massive Price Fixing Accusations; Other Generic Drugmakers Also Fall,2019-05-13 08:40:00-04:00,PFE,teva plummets amid massive price fixing accusations other generic drugmakers also fall,"{'neg': 0.173, 'neu': 0.827, 'pos': 0.0, 'compound': -0.3182}",negative,0.9984733462333679
988548,988548,1000688.0,Pfizer Buys Rare Disease Biotech Therachon For $340M,2019-05-08 11:17:00-04:00,PFE,pfizer buys rare disease biotech therachon for dollars 40 million,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998674392700195
988549,988549,1000689.0,The Cortexyme IPO: What You Need To Know,2019-05-08 09:17:00-04:00,PFE,the cortexyme ipo what you need to know,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998759031295776
988550,988550,1000690.0,Pfizer Acquires Clinical-Stage Biotech Company Therachon For $340M Upfront With Additional $470M In Milestones,2019-05-08 06:46:00-04:00,PFE,pfizer acquires clinical stage biotech company therachon for dollars 40 million upfront with additional dollars 70 million in milestones,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994780421257019
988551,988551,1000691.0,Pfizer's LORVIQUA Approved by the European Commission for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer,2019-05-07 07:35:00-04:00,PFE,pfizers lorviqua approved by the european commission for certain adult patients with previously treated alk positive advanced non small cell lung cancer,"{'neg': 0.138, 'neu': 0.533, 'pos': 0.329, 'compound': 0.6249}",neutral,0.9997665286064148
988552,988552,1000692.0,"Pfizer Reports FDA Approved VYNDAQEL, VYNDAMAX For Treatment Of Cardiomyopathy Of Wild-Type, Hereditary Transthyretin-Mediated Amyloidosis",2019-05-06 06:46:00-04:00,PFE,pfizer reports fda approved vyndaqel vyndamax for treatment of cardiomyopathy of wild type hereditary transthyretin mediated amyloidosis,"{'neg': 0.0, 'neu': 0.851, 'pos': 0.149, 'compound': 0.4215}",positive,0.9983406066894531
988553,988553,1000693.0,IPO Outlook For The Week: Uber (And 11 Others),2019-05-04 17:25:00-04:00,PFE,ipo outlook for the week uber and 11 others,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998705387115479
988554,988554,1000694.0,"Baird Out Defending Sarepta, Says Pfizer's DMD Program Is 'Too Little Too Late' To Be A Meaningful Competitor To Sarepta's Program",2019-05-01 06:21:00-04:00,PFE,baird out defending sarepta says pfizers dmd program is too little too late to be a meaningful competitor to sareptas program,"{'neg': 0.0, 'neu': 0.897, 'pos': 0.103, 'compound': 0.3182}",negative,0.8183436393737793
988555,988555,1000695.0,"Pfizer Ceo Albert Bourla Says Significant Growth Coming From China; Says Firm To Grow Based On Volume, Not Price; Says Drug Prices Will Not Be A Growth Driver",2019-04-30 12:36:00-04:00,PFE,pfizer ceo albert bourla says significant growth coming from china says firm to grow based on volume not price says drug prices will not be a growth driver,"{'neg': 0.069, 'neu': 0.792, 'pos': 0.139, 'compound': 0.2996}",positive,0.9996944665908813
988556,988556,1000696.0,From Pfizer Conference Call; Co. Says Will Look At Bolt-On Deals Of 'A Few Billion Dollars' To Complement Pipeline,2019-04-30 10:39:00-04:00,PFE,from pfizer conference call co says will look at bolt on deals of a few billion dollars to complement pipeline,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999775230884552
988557,988557,1000697.0,Alphabet Revenue Disappoints Ahead Of Apple Earnings After The Bell,2019-04-30 10:05:00-04:00,PFE,alphabet revenue disappoints ahead of apple earnings after the bell,"{'neg': 0.224, 'neu': 0.776, 'pos': 0.0, 'compound': -0.3818}",negative,0.9986569881439209
988558,988558,1000698.0,Pfizer shares are trading higher after the company reported better-than-expected Q1 earnings and raised guidance.,2019-04-30 08:59:00-04:00,PFE,pfizer shares are trading higher after the company reported better than expected first quarter earnings and raised guidance,"{'neg': 0.0, 'neu': 0.758, 'pos': 0.242, 'compound': 0.6249}",positive,0.9996998310089111
988559,988559,1000699.0,"The Daily Biotech Pulse: Earnings Deluge, G1 Therapeutics Positive FDA Meeting, Mustang Bio Offering",2019-04-30 08:06:00-04:00,PFE,the daily biotech pulse earnings deluge g1 therapeutics positive fda meeting mustang bio offering,"{'neg': 0.0, 'neu': 0.667, 'pos': 0.333, 'compound': 0.7184}",positive,0.9860087037086487
988560,988560,1000700.0,"Pfizer Raises FY19 Adj. EPS From $2.82-$2.92 To $2.83-$2.93 vs $2.89 Est., Sees Sales $52B-$54B vs $53.25B Est.",2019-04-30 06:48:00-04:00,PFE,pfizer raises fy19 adj eps from dollars .82 dollars .92 to dollars .83 dollars .93 vs dollars .89 est sees sales dollars 2 billion dollars 4 billion vs dollars 3.25 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9712011218070984
988561,988561,1000701.0,"Pfizer Q1 EPS Adj. $0.85 Beats $0.75 Estimate, Sales $12.12B Miss $13B Estimate",2019-04-30 06:47:00-04:00,PFE,pfizer first quarter eps adj dollars .85 beats dollars .75 estimate sales dollars 2.12 billion miss dollars 3 billion estimate,"{'neg': 0.078, 'neu': 0.922, 'pos': 0.0, 'compound': -0.1531}",neutral,0.9997442364692688
988562,988562,1000702.0,"15 Stocks To Watch For April 30, 2019",2019-04-30 06:37:00-04:00,PFE,15 stocks to watch for april 30 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998714923858643
988563,988563,1000703.0,"Earnings Scheduled For April 30, 2019",2019-04-30 06:18:00-04:00,PFE,earnings scheduled for april 30 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998846054077148
988564,988564,1000704.0,Pfizer Reports Received Positive CHMP Opinion For TALZENNA,2019-04-26 11:00:00-04:00,PFE,pfizer reports received positive chmp opinion for talzenna,"{'neg': 0.0, 'neu': 0.66, 'pos': 0.34, 'compound': 0.5574}",positive,0.9994882345199585
988565,988565,1000705.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,PFE,shares of several healthcare stocks are trading higher in a potential rebound from last weeks selloff in an upgrade of hca healthcare raymond james analysts noted the selloff was based on legislation that has almost no chance of passing,"{'neg': 0.067, 'neu': 0.879, 'pos': 0.054, 'compound': 0.1142}",positive,0.9994731545448303
988566,988566,1000706.0,"Eli Lilly-Pfizer's Non-Opioid Painkiller Faces Safety, Efficacy Concerns",2019-04-22 10:24:00-04:00,PFE,eli lilly pfizers non opioid painkiller faces safety efficacy concerns,"{'neg': 0.0, 'neu': 0.763, 'pos': 0.237, 'compound': 0.4215}",negative,0.987287163734436
988567,988567,1000707.0,"Pfizer, Eli Lilly Late Thurs. Announced Top-Line Results From Long-Term Phase 3 Study Of Tanezumab In Patients With Osteoarthritis",2019-04-22 08:23:00-04:00,PFE,pfizer eli lilly late thurs announced top line results from long term phase 3 study of tanezumab in patients with osteoarthritis,"{'neg': 0.0, 'neu': 0.917, 'pos': 0.083, 'compound': 0.2023}",neutral,0.9900906085968018
988568,988568,1000708.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,2019-04-18 10:51:00-04:00,PFE,shares of several drug companies are trading lower amid continued efforts from washington to curb prescription drug prices the overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy,"{'neg': 0.182, 'neu': 0.764, 'pos': 0.054, 'compound': -0.6369}",negative,0.9987220168113708
988569,988569,1000709.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,2019-04-17 10:31:00-04:00,PFE,shares of several drug companies are trading lower amid continued efforts from washington to curb prescription drug prices the overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy,"{'neg': 0.182, 'neu': 0.764, 'pos': 0.054, 'compound': -0.6369}",negative,0.9987220168113708
988570,988570,1000710.0,Shares of several drug companies are trading lower. Weakness may be tied to uncertainty over healthcare policy going into the 2020 primaries and Washington's recent efforts to curb prescription drug prices.,2019-04-16 15:34:00-04:00,PFE,shares of several drug companies are trading lower weakness may be tied to uncertainty over healthcare policy going into the 2020 primaries and washingtons recent efforts to curb prescription drug prices,"{'neg': 0.202, 'neu': 0.738, 'pos': 0.06, 'compound': -0.6369}",negative,0.9984425902366638
988571,988571,1000711.0,Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older,2019-04-14 09:49:00-04:00,PFE,pfizer announces presentation of data from a phase 2 study of its 20 valent pneumococcal conjugate vaccine candidate being investigated for the prevention of invasive disease and pneumonia in adults aged 18 years and older,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998741149902344
988572,988572,1000712.0,PreMarket Prep Opening NYSE Imbalance Update: GE 652k Shares To Sell; ExxonMobil 66k Shares To Sell; BofA 123 To Sell; Citi 52k To Sell; P&G 40k sell; J&J 41k To sell; Pfizer 96k To Sell,2019-04-09 08:34:00-04:00,PFE,premarket prep opening nyse imbalance update ge 652 thousand shares to sell exxonmobil 66 thousand shares to sell bofa 123 to sell citi 52 thousand to sell p and g 40 thousand sell j and j 41 thousand to sell pfizer 96 thousand to sell,"{'neg': 0.0, 'neu': 0.907, 'pos': 0.093, 'compound': 0.5267}",neutral,0.9998705387115479
988573,988573,1000713.0,"The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing",2019-04-09 08:10:00-04:00,PFE,the daily biotech pulse phasebio gets breakthrough therapy designation fda shoots down zogenix epilepsy regulatory filing,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9956555366516113
988574,988574,1000714.0,"Pfizer, GlaxoSmithKline Reports Its ViiV Healthcare Co. Received FDA Approval For Dovato Drug Regimen For Treatment-Naive HIV-1 Adults",2019-04-08 16:52:00-04:00,PFE,pfizer glaxosmithkline reports its viiv healthcare co received fda approval for dovato drug regimen for treatment naive hiv 1 adults,"{'neg': 0.091, 'neu': 0.776, 'pos': 0.134, 'compound': 0.25}",positive,0.9995118379592896
988575,988575,1000715.0,FDA Says Granted Approval Of Dovato To Viiv Healthcare,2019-04-08 15:39:00-04:00,PFE,fda says granted approval of dovato to viiv healthcare,"{'neg': 0.0, 'neu': 0.579, 'pos': 0.421, 'compound': 0.6249}",positive,0.9991629123687744
988576,988576,1000716.0,FDA Approves First Two-Drug Complete Regimen For HIV-Infected Patients Who Have Never Received Antiretroviral Treatment,2019-04-08 15:33:00-04:00,PFE,fda approves first two drug complete regimen for hiv infected patients who have never received antiretroviral treatment,"{'neg': 0.153, 'neu': 0.718, 'pos': 0.129, 'compound': -0.128}",neutral,0.9936543703079224
988577,988577,1000717.0,"Bulls & Bears Of The Week: Dow, Lyft, Pfizer, Schlumberger, Tesla And More",2019-04-07 16:32:00-04:00,PFE,bulls and bears of the week dow lyft pfizer schlumberger tesla and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999862790107727
988578,988578,1000718.0,FDA Says Extending The Indication Of Ibrance (Palbociclib) Capsules,2019-04-04 14:15:00-04:00,PFE,fda says extending the indication of ibrance palbociclib capsules,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9980504512786865
988579,988579,1000719.0,A Healthy Rating On A Big Health Care ETF,2019-04-04 11:49:00-04:00,PFE,a healthy rating on a big health care etf,"{'neg': 0.0, 'neu': 0.543, 'pos': 0.457, 'compound': 0.7096}",positive,0.9988080263137817
988580,988580,1000720.0,Pfizer Reports VIZIMPRO Received Marketing Authorization In EU For Treatment of Adult Patients with EGFR-Mutated Non-Small Cell Lung Cancer,2019-04-03 09:49:00-04:00,PFE,pfizer reports vizimpro received marketing authorization in eu for treatment of adult patients with egfr mutated non small cell lung cancer,"{'neg': 0.18, 'neu': 0.82, 'pos': 0.0, 'compound': -0.6597}",positive,0.9992684721946716
988581,988581,1000721.0,Sangamo Soars Amid Multiple Development Pipeline Updates,2019-04-02 12:47:00-04:00,PFE,sangamo soars amid multiple development pipeline updates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9827905893325806
988582,988582,1000722.0,UPDATE: Safety Monitoring Committee Recommended Cohort Expansion At The 3E13 Vg/Kg Dose Of SB-525,2019-04-02 07:07:00-04:00,PFE,update safety monitoring committee recommended cohort expansion at the 3 e13 vg and kg dose of sb 525,"{'neg': 0.0, 'neu': 0.777, 'pos': 0.223, 'compound': 0.5574}",neutral,0.9987136125564575
988583,988583,1000723.0,Sangamo And Pfizer Announce Phase 1/2 Interim Data For Investigational Hemophilia A Gene Therapy; SB-525 Was Well Tolerated And Demonstrated A Dose-Dependent Increase In Factor VIII (FVIII) Levels,2019-04-02 07:07:00-04:00,PFE,sangamo and pfizer announce phase .5 interim data for investigational hemophilia a gene therapy sb 525 was well tolerated and demonstrated a dose dependent increase in factor viii fviii levels,"{'neg': 0.0, 'neu': 0.864, 'pos': 0.136, 'compound': 0.5267}",positive,0.9994906187057495
988584,988584,1000724.0,"Bank Of America Hikes Pfizer Price Target, Estimates Citing Orphan Drug Catalysts",2019-04-01 13:03:00-04:00,PFE,bank of america hikes pfizer price target estimates citing orphan drug catalysts,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.8067300319671631
988585,988585,1000725.0,"BofA Offers Top 10 US Ideas For Q2: Bullish Burlington Stores, Dover, Masco, Norfolk Southern, Pfizer, Synovus, Thermo Fisher, United Rentals, Bearish Hawaiian Air, ServiceMaster",2019-04-01 11:05:00-04:00,PFE,bofa offers top 10 us ideas for second quarter bullish burlington stores dover masco norfolk southern pfizer synovus thermo fisher united rentals bearish hawaiian air servicemaster,"{'neg': 0.0, 'neu': 0.839, 'pos': 0.161, 'compound': 0.5574}",positive,0.9987001419067383
988586,988586,1000726.0,6 Gene Therapy M&A Targets On The Radar,2019-03-27 12:45:00-04:00,PFE,6 gene therapy m and a targets on the radar,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998911619186401
988587,988587,1000727.0,Cyclacel Drops After Study Supporting Cancer Drug's Mechanism Of Action,2019-03-26 12:46:00-04:00,PFE,cyclacel drops after study supporting cancer drugs mechanism of action,"{'neg': 0.288, 'neu': 0.523, 'pos': 0.19, 'compound': -0.3612}",negative,0.9950246214866638
988588,988588,1000728.0,"The Daily Biotech Pulse: FDA Nod For Sage's Postpartum Depression Drug, Pfizer Invests In Gene Therapy Company",2019-03-20 07:46:00-04:00,PFE,the daily biotech pulse fda nod for sages postpartum depression drug pfizer invests in gene therapy company,"{'neg': 0.188, 'neu': 0.812, 'pos': 0.0, 'compound': -0.5719}",neutral,0.999860405921936
988589,988589,1000729.0,Pfizer Secures Exclusive Option To Acquire 15% Equity Interest In Gene Therapy Company Vivet Therapeutics' Pfizer Paid ~$51M Upon Signing And MAy Pay Up To $635.8M,2019-03-20 06:46:00-04:00,PFE,pfizer secures exclusive option to acquire 15 percent equity interest in gene therapy company vivet therapeutics pfizer paid dollars 1 million upon signing and may pay up to dollars 35.8 million,"{'neg': 0.04, 'neu': 0.767, 'pos': 0.193, 'compound': 0.6597}",neutral,0.9990922212600708
988590,988590,1000730.0,"Merck KGaA, Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer",2019-03-19 20:16:00-04:00,PFE,merck kgaa pfizer announce discontinuation of phase iii javelin ovarian parp 100 trial in previously untreated advanced ovarian cancer,"{'neg': 0.188, 'neu': 0.726, 'pos': 0.085, 'compound': -0.5267}",neutral,0.9535644054412842
988591,988591,1000731.0,A New Look For The Barron's 400 ETF,2019-03-19 08:51:00-04:00,PFE,a new look for the barrons 400 etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998680353164673
988592,988592,1000732.0,"Morgan Stanley Drops Bearish Exelixis Stance, Sees 'Limited Downside Risk'",2019-03-18 14:26:00-04:00,PFE,morgan stanley drops bearish exelixis stance sees limited downside risk,"{'neg': 0.462, 'neu': 0.538, 'pos': 0.0, 'compound': -0.6124}",negative,0.9982321858406067
988593,988593,1000733.0,Pfizer's Drug TRAZIMERA Wins FDA Approval,2019-03-11 16:29:00-04:00,PFE,pfizers drug trazimera wins fda approval,"{'neg': 0.0, 'neu': 0.37, 'pos': 0.63, 'compound': 0.7783}",positive,0.9992129802703857
988594,988594,1000734.0,"Shares of several biotech companies are trading lower after FDA commissioner Scott Gottlieb announced he will resign; he pushed to spur the development of new drugs and with his absence, there is concern on future FDA approvals.",2019-03-06 11:59:00-05:00,PFE,shares of several biotech companies are trading lower after fda commissioner scott gottlieb announced he will resign he pushed to spur the development of new drugs and with his absence there is concern on future fda approvals,"{'neg': 0.113, 'neu': 0.833, 'pos': 0.054, 'compound': -0.34}",negative,0.9974047541618347
988595,988595,1000735.0,"The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings",2019-03-05 07:24:00-05:00,PFE,the daily biotech pulse novartis psoriasis drug found superior ascendis offering adamas earnings,"{'neg': 0.0, 'neu': 0.774, 'pos': 0.226, 'compound': 0.5423}",positive,0.9992073178291321
988596,988596,1000736.0,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,2019-03-04 11:50:00-05:00,PFE,attention biotech investors mark your calendar for these march pdufa dates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998832941055298
988597,988597,1000737.0,"BioXcel Therapeutics Announces Addition Of Merck KGaA, Darmstadt, Germany, And Pfizer To Clinical Collaboration With Nektar For Development Of Triple-combination Therapy In Pancreatic Cancer",2019-03-04 08:13:00-05:00,PFE,bioxcel therapeutics announces addition of merck kgaa darmstadt germany and pfizer to clinical collaboration with nektar for development of triple combination therapy in pancreatic cancer,"{'neg': 0.155, 'neu': 0.845, 'pos': 0.0, 'compound': -0.6597}",positive,0.9953165054321289
988598,988598,1000738.0,BioXcel Therapeutics Announces Merck and Pfizer Join its Clinical Collaboration with Nektar Therapeutics to Evaluate a Triple Therapy for Pancreatic Cancer,2019-03-04 08:07:00-05:00,PFE,bioxcel therapeutics announces merck and pfizer join its clinical collaboration with nektar therapeutics to evaluate a triple therapy for pancreatic cancer,"{'neg': 0.172, 'neu': 0.742, 'pos': 0.086, 'compound': -0.4939}",neutral,0.7659597992897034
988599,988599,1000739.0,Barron's On: Pharma's Big Hope,2019-03-03 10:47:00-05:00,PFE,barrons on pharmas big hope,"{'neg': 0.0, 'neu': 0.58, 'pos': 0.42, 'compound': 0.4404}",positive,0.9103179574012756
988600,988600,1000740.0,"Mylan's Disappointing Outlook Rattles Analysts, Investors",2019-02-27 16:04:00-05:00,PFE,mylans disappointing outlook rattles analysts investors,"{'neg': 0.39, 'neu': 0.61, 'pos': 0.0, 'compound': -0.4939}",negative,0.9986045956611633
988601,988601,1000741.0,It Could Be Time For This Pharma ETF,2019-02-26 09:42:00-05:00,PFE,it could be time for this pharma etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997547268867493
988602,988602,1000742.0,"The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote",2019-02-26 07:56:00-05:00,PFE,the daily biotech pulse immunomedics ceo departs ultragenyx offering karyopharm awaits fda panel vote,"{'neg': 0.0, 'neu': 0.909, 'pos': 0.091, 'compound': 0.0772}",neutral,0.9998552799224854
988603,988603,1000743.0,FDA Is Working With Pfizer To Evaluate Other Currently Available Safety Info For Tofacitinib,2019-02-25 15:56:00-05:00,PFE,fda is working with pfizer to evaluate other currently available safety info for tofacitinib,"{'neg': 0.0, 'neu': 0.823, 'pos': 0.177, 'compound': 0.4215}",neutral,0.9998332262039185
988604,988604,1000744.0,"Supreme Court Rejects Maryland's Bid To Revive A Law Aimed At Preventing Price Gouging By Pharmaceutical Companies, Reuters Reports",2019-02-19 10:04:00-05:00,PFE,supreme court rejects marylands bid to revive a law aimed at preventing price gouging by pharmaceutical companies reuters reports,"{'neg': 0.17, 'neu': 0.593, 'pos': 0.237, 'compound': 0.4019}",neutral,0.9551630616188049
988605,988605,1000745.0,"Pfizer Reports Received European Approval For ZIRABEV, A Biosimilar To Avastin",2019-02-19 09:32:00-05:00,PFE,pfizer reports received european approval for zirabev a biosimilar to avastin,"{'neg': 0.0, 'neu': 0.763, 'pos': 0.237, 'compound': 0.4767}",positive,0.9988975524902344
988606,988606,1000746.0,Pfizer And Lilly Announce Top-line Results From Phase 3 Study Of Tanezumab In Chronic Low Back Pain; Tanezumab Met Primary Endpoint,2019-02-19 06:48:00-05:00,PFE,pfizer and lilly announce top line results from phase 3 study of tanezumab in chronic low back pain tanezumab met primary endpoint,"{'neg': 0.206, 'neu': 0.725, 'pos': 0.069, 'compound': -0.5574}",neutral,0.9974303841590881
988607,988607,1000747.0,Pfizer Announces Pivotal Phase III Data for BAVENCIO Plus INLYTA in Advanced RCC Published in the New England Journal of Medicine,2019-02-17 08:42:00-05:00,PFE,pfizer announces pivotal phase iii data for bavencio plus inlyta in advanced rcc published in the new england journal of medicine,"{'neg': 0.0, 'neu': 0.909, 'pos': 0.091, 'compound': 0.25}",neutral,0.9062099456787109
988608,988608,1000748.0,"PreMarket Prep Opening NYSE Imbalance Update: Bank Of America 335k Shares To Buy, JP Morgan 143k To Buy; Coca-Cola 274k To Buy,  Pfizer 251k To Buy, AT&T 224K To Buy, Verizon 130k To Buy",2019-02-15 09:03:00-05:00,PFE,premarket prep opening nyse imbalance update bank of america 335 thousand shares to buy jp morgan 143 thousand to buy coca cola 274 thousand to buy pfizer 251 thousand to buy at and t 224 thousand to buy verizon 130 thousand to buy,"{'neg': 0.0, 'neu': 0.83, 'pos': 0.17, 'compound': 0.802}",neutral,0.9998564720153809
988609,988609,1000749.0,"The Daily Biotech Pulse: Vanda Q4 Results, Inovio Debt Offering, Caladrius Diabetes Drug Flunks Mid-Stage Trial",2019-02-14 07:50:00-05:00,PFE,the daily biotech pulse vanda fourth quarter results inovio debt offering caladrius diabetes drug flunks mid stage trial,"{'neg': 0.249, 'neu': 0.751, 'pos': 0.0, 'compound': -0.6486}",negative,0.994611382484436
988610,988610,1000750.0,"Hearing Alliance Bernstein Reduces Stakes In Apple, Facebook, Amazon, Citigroup, Crown Castle; Raises Stakes In Vertex Pharmaceuticals, Procter & Gamble, Regency Centers, Microsoft, Pfizer",2019-02-13 13:14:00-05:00,PFE,hearing alliance bernstein reduces stakes in apple facebook amazon citigroup crown castle raises stakes in vertex pharmaceuticals procter and gamble regency centers microsoft pfizer,"{'neg': 0.0, 'neu': 0.931, 'pos': 0.069, 'compound': 0.1779}",positive,0.9926323294639587
988611,988611,1000751.0,PreMarket Prep Opening NYSE Imbalance Update: Pfizer 112k Shares To Sell; Bank of America 90k To Sell; Square 40k To Buy,2019-02-12 08:32:00-05:00,PFE,premarket prep opening nyse imbalance update pfizer 112 thousand shares to sell bank of america 90 thousand to sell square 40 thousand to buy,"{'neg': 0.0, 'neu': 0.913, 'pos': 0.087, 'compound': 0.296}",neutral,0.9998576641082764
988612,988612,1000752.0,"The Daily Biotech Pulse: NASH Disappointment For Gilead, Xeris To Offer Shares",2019-02-12 08:04:00-05:00,PFE,the daily biotech pulse nash disappointment for gilead xeris to offer shares,"{'neg': 0.213, 'neu': 0.645, 'pos': 0.142, 'compound': -0.2732}",negative,0.844599187374115
988613,988613,1000753.0,FDA Accepts Pfeizer's sBLA And Grants Priority Review For BAVENCIO Plus INLYTA For The Treatment Of Advanced Renal Cell Carcinoma,2019-02-11 17:51:00-05:00,PFE,fda accepts pfeizers sbla and grants priority review for bavencio plus inlyta for the treatment of advanced renal cell carcinoma,"{'neg': 0.0, 'neu': 0.733, 'pos': 0.267, 'compound': 0.6369}",positive,0.9807054400444031
988614,988614,1000754.0,Pfizer Reports Results From Phase 3 ARCHES Trial In Men With mHSPC: Showed XTANDI Plus ADT Met Primary Endpoint 'by significantly reducing the risk of radiographic progression or death by 61% versus ADT alone',2019-02-11 17:01:00-05:00,PFE,pfizer reports results from phase 3 arches trial in men with mhspc showed xtandi plus adt met primary endpoint by significantly reducing the risk of radiographic progression or death by 61 percent versus adt alone,"{'neg': 0.2, 'neu': 0.8, 'pos': 0.0, 'compound': -0.7906}",positive,0.9996235370635986
988615,988615,1000755.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials",2019-02-10 17:37:00-05:00,PFE,the week ahead in biotech conferences pdufa dates and clinical trials,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998906850814819
988616,988616,1000756.0,"Barron's Picks And Pans: BB&T, Best Buy, Boeing And More",2019-02-10 16:38:00-05:00,PFE,barrons picks and pans bb and t best buy boeing and more,"{'neg': 0.0, 'neu': 0.724, 'pos': 0.276, 'compound': 0.6369}",neutral,0.9998736381530762
988617,988617,1000757.0,Solid Biosciences Shares Crash After Data Release On Muscular Dystrophy Candidate,2019-02-07 12:57:00-05:00,PFE,solid biosciences shares crash after data release on muscular dystrophy candidate,"{'neg': 0.186, 'neu': 0.552, 'pos': 0.262, 'compound': 0.0258}",negative,0.9971396923065186
988618,988618,1000758.0,Trump At State Of The Union Will Ask For Drug Pricing Cuts,2019-02-01 15:36:00-05:00,PFE,trump at state of the union will ask for drug pricing cuts,"{'neg': 0.167, 'neu': 0.833, 'pos': 0.0, 'compound': -0.296}",neutral,0.9993672966957092
988619,988619,1000759.0,Pharma Catches Another Case Of M&A Fever,2019-02-01 10:15:00-05:00,PFE,pharma catches another case of m and a fever,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.5670923590660095
988620,988620,1000760.0,Pfizer Receives Positive CHMP Opinion For Vizimpro For The First-line Treatment Of Adult Patients With Locally Advanced Or Metastatic Non-small Cell Lung Cancer With Egfr-activating Mutations,2019-02-01 09:18:00-05:00,PFE,pfizer receives positive chmp opinion for vizimpro for the first line treatment of adult patients with locally advanced or metastatic non small cell lung cancer with egfr activating mutations,"{'neg': 0.122, 'neu': 0.722, 'pos': 0.156, 'compound': 0.0516}",positive,0.999454915523529
988621,988621,1000761.0,UPDATE: Credit Suisse Upgrades Pfizer As Firm Notes Co 'has been working through a dark period with extensive patent expirations that have hampered its ability to grow' And Firm Believes 'That period is now nearing an end',2019-01-31 10:47:00-05:00,PFE,update credit suisse upgrades pfizer as firm notes co has been working through a dark period with extensive patent expirations that have hampered its ability to grow and firm believes that period is now nearing an end,"{'neg': 0.0, 'neu': 0.877, 'pos': 0.123, 'compound': 0.5994}",negative,0.9981697797775269
988622,988622,1000762.0,"Benzinga's Top Upgrades, Downgrades For January 31, 2019",2019-01-31 09:11:00-05:00,PFE,benzingas top upgrades downgrades for january 31 2019,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",neutral,0.9252099990844727
988623,988623,1000763.0,"Argus Upgrades Pfizer to Outperform, Announces $55 Price Target",2019-01-31 07:19:00-05:00,PFE,argus upgrades pfizer to outperform announces dollars 5 price target,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999639630317688
988624,988624,1000764.0,Credit Suisse Upgrades Pfizer to Outperform,2019-01-31 07:18:00-05:00,PFE,credit suisse upgrades pfizer to outperform,"{'neg': 0.0, 'neu': 0.658, 'pos': 0.342, 'compound': 0.3818}",positive,0.9996192455291748
988625,988625,1000765.0,"Apple, Boeing And The Fed: A Full Day Ahead As Earnings Help Recharge Wall Street",2019-01-30 10:03:00-05:00,PFE,apple boeing and the fed a full day ahead as earnings help recharge wall street,"{'neg': 0.0, 'neu': 0.838, 'pos': 0.162, 'compound': 0.4019}",positive,0.9976605176925659
988626,988626,1000766.0,How To Approach Q4 Earnings: The Technical Perspective,2019-01-29 13:11:00-05:00,PFE,how to approach fourth quarter earnings the technical perspective,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998699426651001
988627,988627,1000767.0,"Apple Today, Powell Tomorrow: Busy Earnings And Fed Week Continues",2019-01-29 12:22:00-05:00,PFE,apple today powell tomorrow busy earnings and fed week continues,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998142123222351
988628,988628,1000768.0,From Pfizer Q4 Earnings Conference Call: Sees Pricing In US Flat Over 2019,2019-01-29 11:05:00-05:00,PFE,from pfizer fourth quarter earnings conference call sees pricing in us flat over 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.998760461807251
988629,988629,1000769.0,Pfizer shares are trading lower after the company said it expects 2019 EPS of $2.82 to $2.92 versus the $3.04 analyst estimate.,2019-01-29 08:35:00-05:00,PFE,pfizer shares are trading lower after the company said it expects 2019 eps of dollars .82 to dollars .92 versus the dollars .04 analyst estimate,"{'neg': 0.08, 'neu': 0.839, 'pos': 0.08, 'compound': 0.0}",negative,0.9985645413398743
988630,988630,1000770.0,24 Stocks Moving In Tuesday's Pre-Market Session,2019-01-29 08:09:00-05:00,PFE,24 stocks moving in tuesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998745918273926
988631,988631,1000771.0,"The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive",2019-01-29 07:25:00-05:00,PFE,the daily biotech pulse big pharma earnings kiniksa offering fda decision day for aquestive,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998679161071777
988632,988632,1000772.0,"Pfizer Sees FY19 Adj. EPS $2.82-$2.92 vs $3.04 Est., Sales $52B-$54B vs $54.36B Est.",2019-01-29 06:53:00-05:00,PFE,pfizer sees fy19 adj eps dollars .82 dollars .92 vs dollars .04 est sales dollars 2 billion dollars 4 billion vs dollars 4.36 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998766183853149
988633,988633,1000773.0,"Pfizer Q4 Adj. EPS $0.64, Inline, Sales $13.98B Beat $13.95B Estimate",2019-01-29 06:51:00-05:00,PFE,pfizer fourth quarter adj eps dollars .64 inline sales dollars 3.98 billion beat dollars 3.95 billion estimate,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999804675579071
988634,988634,1000774.0,Pfizer And Lilly Announce Second Phase 3 Study Of Tanezumab In Osteoarthritis Pain Met All Three Co-Primary Endpoints At 24 Weeks,2019-01-29 06:39:00-05:00,PFE,pfizer and lilly announce second phase 3 study of tanezumab in osteoarthritis pain met all three co primary endpoints at 24 weeks,"{'neg': 0.136, 'neu': 0.864, 'pos': 0.0, 'compound': -0.5106}",neutral,0.999845027923584
988635,988635,1000775.0,A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Earnings,2019-01-29 06:35:00-05:00,PFE,a peek into the markets us stock futures edge lower ahead of earnings,"{'neg': 0.155, 'neu': 0.845, 'pos': 0.0, 'compound': -0.296}",negative,0.9980205297470093
988636,988636,1000776.0,"12 Stocks To Watch For January 29, 2019",2019-01-29 04:35:00-05:00,PFE,12 stocks to watch for january 29 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998716115951538
988637,988637,1000777.0,"Earnings Scheduled For January 29, 2019",2019-01-29 04:13:00-05:00,PFE,earnings scheduled for january 29 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998806715011597
988638,988638,1000778.0,Q4 Earnings Outlook For Pfizer,2019-01-28 13:20:00-05:00,PFE,q4 earnings outlook for pfizer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999256432056427
988639,988639,1000779.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings",2019-01-27 16:07:00-05:00,PFE,the week ahead in biotech conferences pdufa dates clinical trials and earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999884843826294
988640,988640,1000780.0,UBS Downgrades Pfizer to Neutral,2019-01-23 06:56:00-05:00,PFE,ubs downgrades pfizer to neutral,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9983231425285339
988641,988641,1000781.0,Aileron Therapeutics Commences Enrollment In Phase 2a Expansion Cohort For ALRN-6924 In Combination With Pfizer's IBRANCE In Patients With MDM2-Amplified Cancers,2019-01-16 12:48:00-05:00,PFE,aileron therapeutics commences enrollment in phase 2 a expansion cohort for alrn 6924 in combination with pfizers ibrance in patients with mdm2 amplified cancers,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998816251754761
988642,988642,1000782.0,How To Approach Q4 Earnings: The Global Perspective,2019-01-14 11:29:00-05:00,PFE,how to approach fourth quarter earnings the global perspective,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998589754104614
988643,988643,1000783.0,Pfizer Reports FDA Accepted Regulatory Submissions For Review Of Tafamidis To Treat Transthyretin Amyloid Cardiomyopathy,2019-01-14 08:05:00-05:00,PFE,pfizer reports fda accepted regulatory submissions for review of tafamidis to treat transthyretin amyloid cardiomyopathy,"{'neg': 0.0, 'neu': 0.73, 'pos': 0.27, 'compound': 0.5859}",neutral,0.9965730905532837
988644,988644,1000784.0,How 7 New Laws Affected Stocks In The Last Week,2019-01-09 16:59:00-05:00,PFE,how 7 new laws affected stocks in the last week,"{'neg': 0.151, 'neu': 0.849, 'pos': 0.0, 'compound': -0.1531}",neutral,0.9994994401931763
988645,988645,1000785.0,"UPDATE: Pfizer Says Closing 2 India Plants Amid 'Very Significant' Long-Term Loss Of Product Demand, Says Manufacturing At IKKT, Aurangabad Sites Not Viable",2019-01-09 09:45:00-05:00,PFE,update pfizer says closing 2 india plants amid very significant long term loss of product demand says manufacturing at ikkt aurangabad sites not viable,"{'neg': 0.141, 'neu': 0.781, 'pos': 0.078, 'compound': -0.1796}",negative,0.9984610080718994
988646,988646,1000786.0,"Pfizer Conducted Thorough Evaluation Of IKKT, Aurangabad Sites In India, Sites Will Immediately Cease Manufacturing With Intent To Exit Both Sites ASAP In 2019",2019-01-09 09:44:00-05:00,PFE,pfizer conducted thorough evaluation of ikkt aurangabad sites in india sites will immediately cease manufacturing with intent to exit both sites asap in 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9967696666717529
988647,988647,1000787.0,"TD Ameritrade IMX Continued Its Dip In December, Falling To A More Than Two-Year Low",2019-01-08 13:39:00-05:00,PFE,td ameritrade imx continued its dip in december falling to a more than two year low,"{'neg': 0.209, 'neu': 0.791, 'pos': 0.0, 'compound': -0.4019}",negative,0.998838484287262
988648,988648,1000788.0,Investor Movement Index December Summary,2019-01-07 16:52:00-05:00,PFE,investor movement index december summary,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998862743377686
988649,988649,1000789.0,5 Top-Selling Drugs With Growth Potential In 2019,2019-01-07 15:04:00-05:00,PFE,5 top selling drugs with growth potential in 2019,"{'neg': 0.0, 'neu': 0.614, 'pos': 0.386, 'compound': 0.5267}",positive,0.9988429546356201
988650,988650,1000790.0,CytoReason Signs Collaboration Agreement With Pfizer Inc. To Utilize CytoReason's Machine Learning Model Of Immune System For Drug Discovery,2019-01-07 08:28:00-05:00,PFE,cytoreason signs collaboration agreement with pfizer inc to utilize cytoreasons machine learning model of immune system for drug discovery,"{'neg': 0.0, 'neu': 0.759, 'pos': 0.241, 'compound': 0.6597}",positive,0.9995418787002563
988651,988651,1000791.0,Pfizer Reports Initiation Of Phase 2b/3 Trial For PF-06651600 For Treatment of Patients with Moderate to Severe Alopecia Areata,2019-01-03 08:34:00-05:00,PFE,pfizer reports initiation of phase trial for pf 06651600 for treatment of patients with moderate to severe alopecia areata,"{'neg': 0.126, 'neu': 0.874, 'pos': 0.0, 'compound': -0.3818}",neutral,0.9998542070388794
988652,988652,1000792.0,"Adamis Has 'Favorable' Pipeline Setup, Says Bullish Raymond James",2019-01-02 10:21:00-05:00,PFE,adamis has favorable pipeline setup says bullish raymond james,"{'neg': 0.0, 'neu': 0.721, 'pos': 0.279, 'compound': 0.4767}",positive,0.9996017813682556
988653,988653,1000793.0,The Week Ahead In Biotech: Focus Shifts To Year-End Clinical Trial Results,2018-12-23 10:37:00-05:00,PFE,the week ahead in biotech focus shifts to year end clinical trial results,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998437166213989
988654,988654,1000794.0,"UPDATE: Merck KGaA Germany, Pfizer Say Interim Analysis Of Phase III Javelin Study Did Not Support Study's Initial Hypothesis",2018-12-21 14:01:00-05:00,PFE,update merck kgaa germany pfizer say interim analysis of phase iii javelin study did not support studys initial hypothesis,"{'neg': 0.111, 'neu': 0.889, 'pos': 0.0, 'compound': -0.3089}",neutral,0.984045147895813
988655,988655,1000795.0,"Merck KGaA Germany, Pfizer Offer Update On Javelin Ovarian 100 Trial OF Avelumab",2018-12-21 14:00:00-05:00,PFE,merck kgaa germany pfizer offer update on javelin ovarian 100 trial of avelumab,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997944235801697
988656,988656,1000796.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,PFE,the daily biotech pulse proteostasis delays data akron gets new ceo pfizer halts vaccine trial,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9949693083763123
988657,988657,1000797.0,Pfizer Reports Independent Data Monitoring Committee Has Recommended Discontinuation Of Phase 2b STRIVE Trial Of Staphylococcus Aureus Vaccine Following Planned Interim Analysis,2018-12-20 16:31:00-05:00,PFE,pfizer reports independent data monitoring committee has recommended discontinuation of phase 2 billion strive trial of staphylococcus aureus vaccine following planned interim analysis,"{'neg': 0.0, 'neu': 0.924, 'pos': 0.076, 'compound': 0.2023}",negative,0.9188091158866882
988658,988658,1000798.0,"Competition Bureau Has Closed Abuse-Of-Dominance Investigation Into Celgene, Pfizer, Sanofi Practices",2018-12-20 16:00:00-05:00,PFE,competition bureau has closed abuse of dominance investigation into celgene pfizer sanofi practices,"{'neg': 0.247, 'neu': 0.647, 'pos': 0.106, 'compound': -0.5267}",neutral,0.8975501656532288
988659,988659,1000799.0,"Astellas Pharma, Pfizer Reports Topline Phase 3 ARCHES Trial Results For XTANDI in Men with Metastatic Hormone-Sensitive Prostate Cancer",2018-12-20 09:01:00-05:00,PFE,astellas pharma pfizer reports topline phase 3 arches trial results for xtandi in men with metastatic hormone sensitive prostate cancer,"{'neg': 0.188, 'neu': 0.812, 'pos': 0.0, 'compound': -0.6597}",neutral,0.999506950378418
988660,988660,1000800.0,"GlaxoSmithKline, Pfizer To Merge Consumer Health Care Businesses",2018-12-19 12:01:00-05:00,PFE,glaxosmithkline pfizer to merge consumer health care businesses,"{'neg': 0.0, 'neu': 0.686, 'pos': 0.314, 'compound': 0.4939}",neutral,0.9997245669364929
988661,988661,1000801.0,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",2018-12-19 07:46:00-05:00,PFE,the daily biotech pulse pfizer glaxo set up consumer health care venture new patent for adamas,"{'neg': 0.0, 'neu': 0.824, 'pos': 0.176, 'compound': 0.4939}",neutral,0.9732399582862854
988662,988662,1000802.0,Dan Nathan Sees Unusual Options Activity In Pfizer,2018-12-19 07:28:00-05:00,PFE,dan nathan sees unusual options activity in pfizer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9943344593048096
988663,988663,1000803.0,UPDATE: Pfizer to Hold 32% Stake in JV; GlaxoSmithKline 68%,2018-12-19 04:21:00-05:00,PFE,update pfizer to hold 32 percent stake in jv glaxosmithkline 68 percent,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998772144317627
988664,988664,1000804.0,"Pfizer, GlaxoSmithKline Announce JV to Create Premier Global Consumer Healthcare Company",2018-12-19 04:19:00-05:00,PFE,pfizer glaxosmithkline announce jv to create premier global consumer healthcare company,"{'neg': 0.0, 'neu': 0.826, 'pos': 0.174, 'compound': 0.2732}",neutral,0.9994358420372009
988665,988665,1000805.0,Biotechs Were Innovators In 2018: Here Are The Top New Molecules That Were Approved,2018-12-18 08:55:00-05:00,PFE,biotechs were innovators in 2018 here are the top new molecules that were approved,"{'neg': 0.0, 'neu': 0.723, 'pos': 0.277, 'compound': 0.5574}",neutral,0.999889612197876
988666,988666,1000806.0,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",2018-12-18 08:00:00-05:00,PFE,the daily biotech pulse puma aces late stage trial chinese cheer for fibrogen j and j dollars b buyback plan,"{'neg': 0.0, 'neu': 0.852, 'pos': 0.148, 'compound': 0.5106}",positive,0.9910449981689453
988667,988667,1000807.0,"Pfizer Announces a Research Collaboration and License Agreement with Kineta for Cancer Immunotherapies, Will Make a $15M Upfront Payment",2018-12-17 08:07:00-05:00,PFE,pfizer announces a research collaboration and license agreement with kineta for cancer immunotherapies will make a dollars 5 million upfront payment,"{'neg': 0.165, 'neu': 0.714, 'pos': 0.12, 'compound': -0.296}",positive,0.9930382370948792
988668,988668,1000808.0,Pfizer Raises Qtr. Dividend From $0.34 To $0.36/Share,2018-12-14 12:11:00-05:00,PFE,pfizer raises qtr dividend from dollars .34 to dollars,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990725517272949
988669,988669,1000809.0,Pfizer Reports $10B Buyback,2018-12-14 12:10:00-05:00,PFE,pfizer reports dollars 0 billion buyback,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9979670643806458
988670,988670,1000810.0,Pfizer Reports Received Positive CHMP Opinion For ZIRABEV,2018-12-14 10:29:00-05:00,PFE,pfizer reports received positive chmp opinion for zirabev,"{'neg': 0.0, 'neu': 0.66, 'pos': 0.34, 'compound': 0.5574}",positive,0.9995313882827759
988671,988671,1000811.0,Pfizer Reports Initiation Of Phase 3 Program For 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older,2018-12-14 08:03:00-05:00,PFE,pfizer reports initiation of phase 3 program for 20 valent pneumococcal conjugate vaccine for the prevention of invasive disease and pneumonia in adults aged 18 years and older,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999840497970581
988672,988672,1000812.0,"Benzinga's Top Upgrades, Downgrades For December 11, 2018",2018-12-11 09:18:00-05:00,PFE,benzingas top upgrades downgrades for december 11 2018,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",positive,0.640822172164917
988673,988673,1000813.0,A Peek Into The Markets: US Stock Futures Surge Ahead Of Producer Price Index,2018-12-11 07:18:00-05:00,PFE,a peek into the markets us stock futures surge ahead of producer price index,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9982790946960449
988674,988674,1000814.0,"JP Morgan Downgrades Pfizer to Neutral, Announces $46 Price Target",2018-12-11 06:38:00-05:00,PFE,jp morgan downgrades pfizer to neutral announces dollars 6 price target,"{'neg': 0.0, 'neu': 0.847, 'pos': 0.153, 'compound': 0.2023}",negative,0.9984799027442932
988675,988675,1000815.0,PreMarket Prep Opening NYSE Imbalance Update: Square 95k Shares To Sell; Pfizer 107K To Sell; Visa 56k To Sell; Citigroup 131k To Sell,2018-12-10 08:57:00-05:00,PFE,premarket prep opening nyse imbalance update square 95 thousand shares to sell pfizer 107 thousand to sell visa 56 thousand to sell citigroup 131 thousand to sell,"{'neg': 0.0, 'neu': 0.922, 'pos': 0.078, 'compound': 0.296}",neutral,0.9998615980148315
988676,988676,1000816.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-12-07 16:09:00-05:00,PFE,pot stocks etfs top news and data from the cannabis industry this week,"{'neg': 0.0, 'neu': 0.87, 'pos': 0.13, 'compound': 0.2023}",neutral,0.9998798370361328
988677,988677,1000817.0,"The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering",2018-12-06 07:56:00-05:00,PFE,the daily biotech pulse abbvie halts lung cancer trial oncomed merges with mereo momenta offering,"{'neg': 0.239, 'neu': 0.761, 'pos': 0.0, 'compound': -0.6597}",negative,0.9873248338699341
988678,988678,1000818.0,"Stocks Which Set New 52-Week High Yesterday, Mon., Dec. 3, 2018",2018-12-04 09:20:00-05:00,PFE,stocks which set new 52 week high yesterday mon dec 3 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9991300702095032
988679,988679,1000819.0,"The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO",2018-12-04 07:59:00-05:00,PFE,the daily biotech pulse ash presentations take the spotlight eiger gets a new cfo,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998106360435486
988680,988680,1000820.0,Pfizer Presents Positive 26-Week Data For PF-05280586 Potential Biosimilar To Rituximab at ASH 2018,2018-12-02 18:29:00-05:00,PFE,pfizer presents positive 26 week data for pf 05280586 potential biosimilar to rituximab at ash 2018,"{'neg': 0.0, 'neu': 0.806, 'pos': 0.194, 'compound': 0.5574}",positive,0.9996306896209717
988681,988681,1000821.0,"The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs",2018-12-02 17:51:00-05:00,PFE,the week ahead in biotech ash presentations pick up pace pdufa dates clinical trials and ipos,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9981038570404053
988682,988682,1000822.0,AbbVie shares are trading up 3.4% after the company announced a global patent license with Pfizer for HUMIRA; Pfizer shares up 1.3%.,2018-11-30 13:58:00-05:00,PFE,abbvie shares are trading up 3.4 percent after the company announced a global patent license with pfizer for humira pfizer shares up 1.3 percent,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.5267}",positive,0.9997096657752991
988683,988683,1000823.0,"Stocks Which Set New 52-Week High Yesterday, Thurs., Nov. 29, 2018",2018-11-30 10:25:00-05:00,PFE,stocks which set new 52 week high yesterday thurs nov 29 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992614388465881
988684,988684,1000824.0,Pfizer Reaches a Global Agreement With AbbVie For Biosimilar To HUMIRA,2018-11-30 10:01:00-05:00,PFE,pfizer reaches a global agreement with abbvie for biosimilar to humira,"{'neg': 0.0, 'neu': 0.672, 'pos': 0.328, 'compound': 0.5267}",positive,0.9994298815727234
988685,988685,1000825.0,PreMarket Prep Opening NYSE Imbalance Update: AT&T 135k Shares To Sell; Pfizer 172k To Sell; GE 263k To Sell,2018-11-30 08:40:00-05:00,PFE,premarket prep opening nyse imbalance update at and t 135 thousand shares to sell pfizer 172 thousand to sell ge 263 thousand to sell,"{'neg': 0.0, 'neu': 0.913, 'pos': 0.087, 'compound': 0.296}",neutral,0.9998660087585449
988686,988686,1000826.0,"The Daily Biotech Pulse: EC Nod For Shire, Mirati Gets FDA Clearance For Cancer Drug Trials, PhaseBio's First Earnings",2018-11-30 08:25:00-05:00,PFE,the daily biotech pulse ec nod for shire mirati gets fda clearance for cancer drug trials phasebios first earnings,"{'neg': 0.196, 'neu': 0.804, 'pos': 0.0, 'compound': -0.6597}",positive,0.9831901788711548
988687,988687,1000827.0,"The Daily Biotech Pulse: IntelliPharmaCeutics Generic Antidepressant Gets FDA Nod, GW Pharma Earnings",2018-11-28 07:46:00-05:00,PFE,the daily biotech pulse intellipharmaceutics generic antidepressant gets fda nod gw pharma earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992117881774902
988688,988688,1000828.0,"Pfizer Reports Received 6-Month Pediatric Exclusivity For LYRICA, To Jun. 30, 2019",2018-11-27 15:05:00-05:00,PFE,pfizer reports received 6 month pediatric exclusivity for lyrica to jun 30 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999858021736145
988689,988689,1000829.0,GlaxoSmithKline and J&J's HIV Drug Juluca Received Approval In Japan,2018-11-27 14:43:00-05:00,PFE,glaxosmithkline and j and js hiv drug juluca received approval in japan,"{'neg': 0.0, 'neu': 0.78, 'pos': 0.22, 'compound': 0.4767}",positive,0.9983785152435303
988690,988690,1000830.0,Aileron Enters Clinical Trial Collaboration With Pfizer To Evaluate ALRN-6924 In Combination With IBRANCE In MDM2-Amplified Cancers,2018-11-27 08:07:00-05:00,PFE,aileron enters clinical trial collaboration with pfizer to evaluate alrn 6924 in combination with ibrance in mdm2 amplified cancers,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998658895492554
988691,988691,1000831.0,"Data Dive, Trade Talks And Powell: Busy Post-Holiday Week On The Way",2018-11-26 09:41:00-05:00,PFE,data dive trade talks and powell busy post holiday week on the way,"{'neg': 0.0, 'neu': 0.816, 'pos': 0.184, 'compound': 0.4019}",neutral,0.9998559951782227
988692,988692,1000832.0,9 Policy Catalysts For Health Care Investors To Watch Before Year's End,2018-11-25 09:35:00-05:00,PFE,9 policy catalysts for health care investors to watch before years end,"{'neg': 0.0, 'neu': 0.775, 'pos': 0.225, 'compound': 0.4939}",neutral,0.9998030066490173
988693,988693,1000833.0,Pfizer Shares Tick Slightly Higher Following FDA Approval Of Daurismo,2018-11-21 12:55:00-05:00,PFE,pfizer shares tick slightly higher following fda approval of daurismo,"{'neg': 0.0, 'neu': 0.602, 'pos': 0.398, 'compound': 0.6486}",positive,0.9996045231819153
988694,988694,1000834.0,"Hearing Jana Is Pressuring Exact Sciences To Sell Itself, Pfizer Could Be Interested",2018-11-21 11:04:00-05:00,PFE,hearing jana is pressuring exact sciences to sell itself pfizer could be interested,"{'neg': 0.149, 'neu': 0.683, 'pos': 0.168, 'compound': 0.0772}",neutral,0.9969757795333862
988695,988695,1000835.0,October's Biggest Losers And Most Surprising Winners,2018-11-21 10:48:00-05:00,PFE,octobers biggest losers and most surprising winners,"{'neg': 0.258, 'neu': 0.304, 'pos': 0.438, 'compound': 0.3338}",neutral,0.9996131062507629
988696,988696,1000836.0,Merck and Pfizer's Avelumab in Platinum-Resistant/Refractory Ovarian Cancer Did Not Meet Primary Endpoints,2018-11-19 07:15:00-05:00,PFE,merck and pfizers avelumab in platinum resistant and refractory ovarian cancer did not meet primary endpoints,"{'neg': 0.227, 'neu': 0.773, 'pos': 0.0, 'compound': -0.6597}",neutral,0.8035260438919067
988697,988697,1000837.0,Pfizer To Raise Prices On 41 Drugs,2018-11-16 14:57:00-05:00,PFE,pfizer to raise prices on 41 drugs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9496563673019409
988698,988698,1000838.0,October's biggest Losers And Most Surprising Winners,2018-11-12 13:19:00-05:00,PFE,octobers biggest losers and most surprising winners,"{'neg': 0.258, 'neu': 0.304, 'pos': 0.438, 'compound': 0.3338}",neutral,0.9996131062507629
988699,988699,1000839.0,"Stocks Trading Ex Dividend For Thurs., Nov. 8, 2018",2018-11-08 10:55:00-05:00,PFE,stocks trading ex dividend for thurs nov 8 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998881816864014
988700,988700,1000840.0,"Tariffs, Drug Prices, Legislative Gridlock: What Economists Are Watching Following The Midterm Election",2018-11-07 11:30:00-05:00,PFE,tariffs drug prices legislative gridlock what economists are watching following the midterm election,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9836930632591248
988701,988701,1000841.0,Here's What's At Stake For Your Investments In The 2018 Midterms,2018-11-06 08:54:00-05:00,PFE,heres whats at stake for your investments in the 2018 midterms,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998724460601807
988702,988702,1000842.0,"Bulls & Bears Of The Week: Amazon, Apple, Ford, GE And More",2018-11-05 16:03:00-05:00,PFE,bulls and bears of the week amazon apple ford ge and more,"{'neg': 0.0, 'neu': 0.866, 'pos': 0.134, 'compound': 0.1779}",neutral,0.9998854398727417
988703,988703,1000843.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,PFE,the week ahead in biotech earnings conferences pdufa dates clinical trial results and ipos,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998855590820312
988704,988704,1000844.0,U.S. FDA Approves Pfeizer's LORBRENA For Previously-Treated ALK-Positive Metastatic NSCLC,2018-11-02 16:42:00-04:00,PFE,u s fda approves pfeizers lorbrena for previously treated alk positive metastatic nsclc,"{'neg': 0.0, 'neu': 0.636, 'pos': 0.364, 'compound': 0.743}",positive,0.9837071299552917
988705,988705,1000845.0,"BMO Downgrades Pfizer After Q3 Print, Says Risk-Reward 'Fairly Balanced'",2018-11-01 10:54:00-04:00,PFE,bmo downgrades pfizer after third quarter print says risk reward fairly balanced,"{'neg': 0.133, 'neu': 0.633, 'pos': 0.234, 'compound': 0.3818}",positive,0.9988774657249451
988706,988706,1000846.0,"High-Dividend, Wide Moat ETFs Debut",2018-11-01 10:12:00-04:00,PFE,high dividend wide moat etfs debut,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998642206192017
988707,988707,1000847.0,"Benzinga's Top Upgrades, Downgrades For November 1, 2018",2018-11-01 09:48:00-04:00,PFE,benzingas top upgrades downgrades for november 1 2018,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",positive,0.9855250716209412
988708,988708,1000848.0,Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates,2018-11-01 09:26:00-04:00,PFE,attention biotech investors mark your calendar for these november pdufa dates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998844861984253
988709,988709,1000849.0,Hearing Pfizer Considering Sale Of Its Women's Health Portfolio,2018-11-01 08:49:00-04:00,PFE,hearing pfizer considering sale of its womens health portfolio,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998654127120972
988710,988710,1000850.0,A Peek Into The Markets: US Stock Futures Rise As Investors Await Earnings,2018-11-01 07:04:00-04:00,PFE,a peek into the markets us stock futures rise as investors await earnings,"{'neg': 0.0, 'neu': 0.896, 'pos': 0.104, 'compound': 0.1027}",positive,0.6978017687797546
988711,988711,1000851.0,BMO Capital Downgrades Pfizer to Market Perform,2018-11-01 06:33:00-04:00,PFE,bmo capital downgrades pfizer to market perform,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9985091090202332
988712,988712,1000852.0,From Pfizer Q3 Earnings Conference Call: Sees Taking Price Increase Decisions In Jan.,2018-10-30 10:48:00-04:00,PFE,from pfizer third quarter earnings conference call sees taking price increase decisions in jan,"{'neg': 0.0, 'neu': 0.85, 'pos': 0.15, 'compound': 0.3182}",positive,0.9992133378982544
988713,988713,1000853.0,Wild Times: Market Seems To Seek Solid Ground After Monday's Manic,2018-10-30 10:45:00-04:00,PFE,wild times market seems to seek solid ground after mondays manic,"{'neg': 0.0, 'neu': 0.862, 'pos': 0.138, 'compound': 0.1531}",positive,0.9995325803756714
988714,988714,1000854.0,From Pfizer Conference Call; CEO Says Hopes Trump Administration Plans To Base Medicare Part B Drug Prices On Cheaper Prices Paid Outside US,2018-10-30 10:42:00-04:00,PFE,from pfizer conference call ceo says hopes trump administration plans to base medicare part b drug prices on cheaper prices paid outside us,"{'neg': 0.0, 'neu': 0.887, 'pos': 0.113, 'compound': 0.4215}",positive,0.9912676215171814
988715,988715,1000855.0,From Pfizer Conference Call: CEO Says 'We Continue Not To See The Need For Any Large Scale M&A Activity At This Time',2018-10-30 10:25:00-04:00,PFE,from pfizer conference call ceo says we continue not to see the need for any large scale m and a activity at this time,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998036026954651
988716,988716,1000856.0,"From Pfizer Conference Call: CEO Says 'We Are Supportive Of Developing A Market-Based alternative To The Current Buy-And-Bill System...A System Facilitated By Many Vendors, Not Just One Or Two PBM's'",2018-10-30 10:19:00-04:00,PFE,from pfizer conference call ceo says we are supportive of developing a market based alternative to the current buy and bill system a system facilitated by many vendors not just one or two pbms,"{'neg': 0.0, 'neu': 0.937, 'pos': 0.062, 'compound': 0.296}",positive,0.9907756447792053
988717,988717,1000857.0,"The Daily Biotech Pulse: Pfizer And Allergan Earnings, CFO Departures At Acadia And Assertio",2018-10-30 08:00:00-04:00,PFE,the daily biotech pulse pfizer and allergan earnings cfo departures at acadia and assertio,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998877048492432
988718,988718,1000858.0,Pfizer Reaffirms FY18 Adj. EPS Guidance $2.98-$3.02,2018-10-30 06:46:00-04:00,PFE,pfizer reaffirms fy18 adj eps guidance dollars .98 dollars .02,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.7904767990112305
988719,988719,1000859.0,"Pfizer, Inc. Q3 EPS $0.78 Beats $0.75 Estimate, Sales $13.298B Miss $13.55B Estimate",2018-10-30 06:45:00-04:00,PFE,pfizer inc third quarter eps dollars .78 beats dollars .75 estimate sales dollars 3.298 billion miss dollars 3.55 billion estimate,"{'neg': 0.078, 'neu': 0.922, 'pos': 0.0, 'compound': -0.1531}",neutral,0.9998156428337097
988720,988720,1000860.0,A Peek Into The Markets: US Stock Futures Gain Ahead Of Earnings,2018-10-30 06:20:00-04:00,PFE,a peek into the markets us stock futures gain ahead of earnings,"{'neg': 0.0, 'neu': 0.764, 'pos': 0.236, 'compound': 0.5267}",positive,0.9989141225814819
988721,988721,1000861.0,"14 Stocks To Watch For October 30, 2018",2018-10-30 04:36:00-04:00,PFE,14 stocks to watch for october 30 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998733997344971
988722,988722,1000862.0,"Earnings Scheduled For October 30, 2018",2018-10-30 04:01:00-04:00,PFE,earnings scheduled for october 30 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999882698059082
988723,988723,1000863.0,Pfizer's Q3 Earnings Preview,2018-10-29 14:18:00-04:00,PFE,pfizers third quarter earnings preview,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998409748077393
988724,988724,1000864.0,"Benzinga's Week Ahead: Can Facebook, Apple Earnings Rescue The Stock Market?",2018-10-29 13:10:00-04:00,PFE,benzingas week ahead can facebook apple earnings rescue the stock market,"{'neg': 0.0, 'neu': 0.752, 'pos': 0.248, 'compound': 0.5106}",positive,0.9992252588272095
988725,988725,1000865.0,"These Are The Biggest Stocks Reporting Earnings This Week, And Their Recent Track Records",2018-10-29 10:39:00-04:00,PFE,these are the biggest stocks reporting earnings this week and their recent track records,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998747110366821
988726,988726,1000866.0,GlaxoSmithKlein's and Pfizer's ViiV Gives an Update on its Two-Drug HIV Regimen,2018-10-29 06:24:00-04:00,PFE,glaxosmithkleins and pfizers viiv gives an update on its two drug hiv regimen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998193383216858
988727,988727,1000867.0,"Novartis, Pfizer Announce Clinical Collaboration to Advance Treatment of NASH",2018-10-29 04:08:00-04:00,PFE,novartis pfizer announce clinical collaboration to advance treatment of nash,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990274906158447
988728,988728,1000868.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs",2018-10-27 10:23:00-04:00,PFE,the week ahead in biotech conferences pdufa dates clinical trial results earnings and ipos,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998832941055298
988729,988729,1000869.0,"Pfizer, Lilly Announce Complete Results from First Study in Ongoing Phase 3 Program for Tanezumab Demonstrated Significant Improvement in Pain and Function in Osteoarthritis Patients",2018-10-24 03:46:00-04:00,PFE,pfizer lilly announce complete results from first study in ongoing phase 3 program for tanezumab demonstrated significant improvement in pain and function in osteoarthritis patients,"{'neg': 0.11, 'neu': 0.731, 'pos': 0.159, 'compound': 0.128}",positive,0.9996187686920166
988730,988730,1000870.0,How To Use Pivot Points In Your Trading,2018-10-23 15:17:00-04:00,PFE,how to use pivot points in your trading,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999870777130127
988731,988731,1000871.0,"Pfizer, Bain Capital Report Formation Of New Central Nervous System Co., Cerevel Therapeutics; Bain Committed $350M",2018-10-23 08:33:00-04:00,PFE,pfizer bain capital report formation of new central nervous system co cerevel therapeutics bain committed dollars 50 million,"{'neg': 0.104, 'neu': 0.792, 'pos': 0.104, 'compound': 0.0}",neutral,0.9998384714126587
988732,988732,1000872.0,Allogene Therapeutics 13D Filing From Pfizer Shows 18.7% Stake,2018-10-22 16:35:00-04:00,PFE,allogene therapeutics 1 3 dimensional filing from pfizer shows 18.7 percent stake,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998831748962402
988733,988733,1000873.0,"Pfizer On Saturday Presented Overall Survival Data From PALOMA-3 Trial Of IBRANCE (palbociclib) In Patients With HR+, HER2- Metastatic Breast Cancer",2018-10-22 07:49:00-04:00,PFE,pfizer on saturday presented overall survival data from paloma 3 trial of ibrance palbociclib in patients with hr her2 metastatic breast cancer,"{'neg': 0.173, 'neu': 0.827, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9997801184654236
988734,988734,1000874.0,"The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut",2018-10-19 08:28:00-04:00,PFE,the daily biotech pulse novartis positive liver drug trials krytstal prices offering logicbio to debut,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.5574}",neutral,0.999859094619751
988735,988735,1000875.0,"Mylan Highlights US Launch Of Medroxyprogesterone Acetate Injectable Suspension USP, 150 mg/mL Single-Dose vial, Generic Version Of Pfizer's Depo-Provera",2018-10-18 16:50:00-04:00,PFE,mylan highlights us launch of medroxyprogesterone acetate injectable suspension usp 150 mg and ml single dose vial generic version of pfizers depo provera,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999889612197876
988736,988736,1000876.0,"GlaxoSmithKline And Pfizer Joint Venture, ViiV, Submits HIV 2DR Regulatory Application To FDA",2018-10-18 11:03:00-04:00,PFE,glaxosmithkline and pfizer joint venture viiv submits hiv 2 days r regulatory application to fda,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998108744621277
988737,988737,1000877.0,Merck Says 'Pivotal Phase 3 KEYNOTE-426 Trial Met Both Primary Endpoints; Data to be Filed with Global Regulatory Authorities',2018-10-18 06:58:00-04:00,PFE,merck says pivotal phase 3 keynote 426 trial met both primary endpoints data to be filed with global regulatory authorities,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998953342437744
988738,988738,1000878.0,"Merck Reports KEYTRUDA In Combo With Pfizer's Inlyta Improved Overall Survival, Progression-Free Survival As First-Line Therapy For Advanced, Metastatic Renal Cell Carcinoma",2018-10-18 06:57:00-04:00,PFE,merck reports keytruda in combo with pfizers inlyta improved overall survival progression free survival as first line therapy for advanced metastatic renal cell carcinoma,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.8126}",positive,0.9996833801269531
988739,988739,1000880.0,"Midterms And The Stock Market: Potential Winners, Losers From The Coming Election",2018-10-13 12:21:00-04:00,PFE,midterms and the stock market potential winners losers from the coming election,"{'neg': 0.206, 'neu': 0.606, 'pos': 0.188, 'compound': -0.0772}",neutral,0.9850000143051147
988740,988740,1000881.0,"Stocks Which Set New 52-Week High Yesterday, October 9th",2018-10-10 10:57:00-04:00,PFE,stocks which set new 52 week high yesterday october 9,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992607235908508
988741,988741,1000882.0,"The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares",2018-10-10 07:56:00-04:00,PFE,the daily biotech pulse novartis blood disorder drug improves patient outcomes audentes to offer shares,"{'neg': 0.137, 'neu': 0.609, 'pos': 0.254, 'compound': 0.3182}",positive,0.9989752769470215
988742,988742,1000883.0,Myriad Announces New Laboratory Agreement with Pfizer; Myriad Will Provide BRACAnalysis CDx Testing In Phase 2 Study Evaluating Pfizer's Talazoparib,2018-10-10 07:07:00-04:00,PFE,myriad announces new laboratory agreement with pfizer myriad will provide bracanalysis cdx testing in phase 2 study evaluating pfizers talazoparib,"{'neg': 0.0, 'neu': 0.856, 'pos': 0.144, 'compound': 0.4939}",positive,0.9304974675178528
988743,988743,1000884.0,"The Daily Biotech Pulse: Affimed's Cancer Drug Placed On Clinical Hold, Celgene's Positive Scalp Psoriasis Trial",2018-10-09 08:03:00-04:00,PFE,the daily biotech pulse affimeds cancer drug placed on clinical hold celgenes positive scalp psoriasis trial,"{'neg': 0.2, 'neu': 0.636, 'pos': 0.164, 'compound': -0.2023}",neutral,0.9998748302459717
988744,988744,1000885.0,"Stocks That Made New 52-Week Highs So Far Today Include: Ameren, Pfizer, Eli Lilly, Envision Healthcare, AES, McCormick, Archer-Daniels Midland, and Ball Corp.",2018-10-08 13:32:00-04:00,PFE,stocks that made new 52 week highs so far today include ameren pfizer eli lilly envision healthcare aes mccormick archer daniels midland and ball corp,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9986428618431091
988745,988745,1000886.0,"Stocks Which Set New 52-Week High Friday, October 5th",2018-10-08 09:22:00-04:00,PFE,stocks which set new 52 week high friday october 5,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9882246255874634
988746,988746,1000887.0,"IPO Outlook For The Week: Biotechs, Batteries And Business Solutions",2018-10-07 15:41:00-04:00,PFE,ipo outlook for the week biotechs batteries and business solutions,"{'neg': 0.0, 'neu': 0.841, 'pos': 0.159, 'compound': 0.1779}",neutral,0.9998798370361328
988747,988747,1000888.0,"Stocks Which Set New 52-Week High Yesterday, October 3rd",2018-10-04 11:18:00-04:00,PFE,stocks which set new 52 week high yesterday october 3,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992863535881042
988748,988748,1000889.0,"The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut",2018-10-04 07:59:00-04:00,PFE,the daily biotech pulse atricures guidance guardant health and kodiak to debut,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998780488967896
988749,988749,1000890.0,"Stocks Which Set New 52-Week High Yesterday, October 1st",2018-10-02 09:20:00-04:00,PFE,stocks which set new 52 week high yesterday october 1,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9991959929466248
988750,988750,1000891.0,"The Daily Biotech Pulse: TransEnterix's Positive Pre-Announcement, Merit Medical Opens Wallet, GW Pharma To Offer ADS Shares",2018-10-02 09:10:00-04:00,PFE,the daily biotech pulse transenterixs positive pre announcement merit medical opens wallet gw pharma to offer ads shares,"{'neg': 0.0, 'neu': 0.636, 'pos': 0.364, 'compound': 0.8225}",positive,0.9973002076148987
988751,988751,1000892.0,"Pfizer Confirms CEO Ian Read to Step Down End of Year, COO Albert Bourla to Become CEO",2018-10-01 06:47:00-04:00,PFE,pfizer confirms ceo ian read to step down end of year coo albert bourla to become ceo,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.5807590484619141
988752,988752,1000893.0,"Pfizer CEO to Step Aside at End of Year, COO to Become CEO",2018-10-01 06:42:00-04:00,PFE,pfizer ceo to step aside at end of year coo to become ceo,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998470544815063
988753,988753,1000894.0,REMINDER: Pfizer Has FDA PDUFA Date For Dacomitinib Due By End of September (Exact Date Not Provided),2018-09-28 08:56:00-04:00,PFE,reminder pfizer has fda pdufa date for dacomitinib due by end of september exact date not provided,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998741149902344
988754,988754,1000895.0,"The Daily Biotech Pulse: FDA Nods For Adamis, Eli Lilly, Pfizer; Spero, Obseva Report Positive Trial Results",2018-09-28 08:10:00-04:00,PFE,the daily biotech pulse fda nods for adamis eli lilly pfizer spero obseva report positive trial results,"{'neg': 0.0, 'neu': 0.816, 'pos': 0.184, 'compound': 0.5574}",positive,0.9992358684539795
988755,988755,1000896.0,FDA Approves Pfizer's VIZIMPRO (dacomitinib) In Lung Cancer Patients,2018-09-27 17:42:00-04:00,PFE,fda approves pfizers vizimpro dacomitinib in lung cancer patients,"{'neg': 0.312, 'neu': 0.496, 'pos': 0.191, 'compound': -0.4019}",positive,0.993330180644989
988756,988756,1000897.0,"Analyst: Amarin's Vascepa Results Create Unicorn Potential, M&A Opportunity",2018-09-25 12:43:00-04:00,PFE,analyst amarins vascepa results create unicorn potential m and a opportunity,"{'neg': 0.0, 'neu': 0.647, 'pos': 0.353, 'compound': 0.5994}",positive,0.999265730381012
988757,988757,1000898.0,"Stocks Which Set New 52-Week High Yesterday, September 24th",2018-09-25 09:06:00-04:00,PFE,stocks which set new 52 week high yesterday september 24,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992462396621704
988758,988758,1000899.0,"The Daily Biotech Pulse: Syndax Lung Cancer Trial Disappoints, Gemphire To Trim Workforce, Opiant's Offering",2018-09-25 08:30:00-04:00,PFE,the daily biotech pulse syndax lung cancer trial disappoints gemphire to trim workforce opiants offering,"{'neg': 0.35, 'neu': 0.65, 'pos': 0.0, 'compound': -0.7906}",negative,0.99806147813797
988759,988759,1000900.0,"Stocks That Made New 52-Week Highs So Far Today Include: Amgen, Ross Stores, Marathon Petroleum, Marathon Oil, Medtronic, Humana, Pfizer, Boston Scientific, Edward Lifesciences, and Abbott Labs",2018-09-24 13:13:00-04:00,PFE,stocks that made new 52 week highs so far today include amgen ross stores marathon petroleum marathon oil medtronic humana pfizer boston scientific edward lifesciences and abbott labs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9977540373802185
988760,988760,1000901.0,"Stocks Which Set New 52-Week High Friday, September 21",2018-09-24 09:43:00-04:00,PFE,stocks which set new 52 week high friday september 21,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9873154163360596
988761,988761,1000902.0,"Stocks That Made New 52-Week Highs So Far Today Include: Mosaic, Cooper Companies, Pfizer, Gartner, Yum Brands, Danaher, Anthem, Nike, Cisco, Honeywell, Advance Auto Parts, and Clorox",2018-09-21 12:55:00-04:00,PFE,stocks that made new 52 week highs so far today include mosaic cooper companies pfizer gartner yum brands danaher anthem nike cisco honeywell advance auto parts and clorox,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990197420120239
988762,988762,1000903.0,"The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping, Opiant Snags BARDA Funding",2018-09-21 08:51:00-04:00,PFE,the daily biotech pulse exelixis liver cancer drug on track for european approval medtronic goes shopping opiant snags barda funding,"{'neg': 0.173, 'neu': 0.706, 'pos': 0.122, 'compound': -0.3182}",negative,0.9981312155723572
988763,988763,1000904.0,"Stocks Which Set New 52-Week High Yesterday, September 20th",2018-09-21 08:16:00-04:00,PFE,stocks which set new 52 week high yesterday september 20,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992582201957703
988764,988764,1000905.0,Merck Or Pfizer: Which Is The Better Large-Cap Pharma Stock?,2018-09-20 15:55:00-04:00,PFE,merck or pfizer which is the better large cap pharma stock,"{'neg': 0.0, 'neu': 0.775, 'pos': 0.225, 'compound': 0.4404}",neutral,0.999852180480957
988765,988765,1000906.0,"Stocks That Made New 52-Week Highs So Far Today Include: Corning, Visa, Pfizer, ADP, Anthem, Microsoft, Nike, Sherwin-Williams, Lowe's, Honeywell, Yum Brands, Medtronic, ConocoPhillips, Amgen, Cooper Companies, and Boston Scientific",2018-09-20 12:04:00-04:00,PFE,stocks that made new 52 week highs so far today include corning visa pfizer adp anthem microsoft nike sherwin williams lowes honeywell yum brands medtronic conocophillips amgen cooper companies and boston scientific,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9982864260673523
988766,988766,1000907.0,"Stocks Which Set New 52-Week High Yesterday, September 19th",2018-09-20 11:24:00-04:00,PFE,stocks which set new 52 week high yesterday september 19,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999210000038147
988767,988767,1000908.0,"The Daily Biotech Pulse: Adverum Snags Fast Track Designation, Crispr To Offer Shares, Elanco Animal Health To Debut",2018-09-20 09:02:00-04:00,PFE,the daily biotech pulse adverum snags fast track designation crispr to offer shares elanco animal health to debut,"{'neg': 0.0, 'neu': 0.885, 'pos': 0.115, 'compound': 0.296}",negative,0.9841713309288025
988768,988768,1000909.0,"Pfizer Reports Its 20-Valent Pneumococcal Conjugate Vaccine For Prevention Of Invasive Disease, Pneumonia In Adults Aged 18+ Was Granted Breakthrough Therapy Designation",2018-09-20 08:01:00-04:00,PFE,pfizer reports its 20 valent pneumococcal conjugate vaccine for prevention of invasive disease pneumonia in adults aged 18 was granted breakthrough therapy designation,"{'neg': 0.0, 'neu': 0.917, 'pos': 0.083, 'compound': 0.25}",positive,0.9994999170303345
988769,988769,1000910.0,"The Daily Biotech Pulse: Johnson & Johnson's Generic Unit Files NDA For Urinary Tract Cancer Drug, G1 Therapeutics Prices Offering",2018-09-19 08:47:00-04:00,PFE,the daily biotech pulse johnson and johnsons generic unit files nda for urinary tract cancer drug g1 therapeutics prices offering,"{'neg': 0.177, 'neu': 0.726, 'pos': 0.097, 'compound': -0.4588}",neutral,0.9998779296875
988770,988770,1000911.0,"FDA Issues New Safety Measures For Immediate-Release, Extended-Release, and Long-Acting Opioid Analgesics",2018-09-18 15:17:00-04:00,PFE,fda issues new safety measures for immediate release extended release and long acting opioid analgesics,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.4215}",neutral,0.977910578250885
988771,988771,1000912.0,"Stocks That Made New 52-Week Highs So Far Today Include: Allegion, Boston Scientific, Arthur J. Gallagher, United Technologies, Waste Management, Qualcomm, Pfizer, Mastercard, Nike, Lowe's, Union Pacific, Norfolk Southern, and Aetna",2018-09-18 14:21:00-04:00,PFE,stocks that made new 52 week highs so far today include allegion boston scientific arthur j gallagher united technologies waste management qualcomm pfizer mastercard nike lowes union pacific norfolk southern and aetna,"{'neg': 0.079, 'neu': 0.843, 'pos': 0.079, 'compound': 0.0}",positive,0.9986097812652588
988772,988772,1000913.0,"Stocks Which Set New 52-Week High Yesterday, September 17th",2018-09-18 09:25:00-04:00,PFE,stocks which set new 52 week high yesterday september 17,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992062449455261
988773,988773,1000914.0,"UPDATE: Pfizer On Tafamidis Says '29% and 31% reduction in the risk of death observed in wild-type and hereditary sub-groups, respectively'",2018-09-18 09:04:00-04:00,PFE,update pfizer on tafamidis says 29 percent and 31 percent reduction in the risk of death observed in wild type and hereditary sub groups respectively,"{'neg': 0.197, 'neu': 0.724, 'pos': 0.079, 'compound': -0.5574}",positive,0.9993919134140015
988774,988774,1000915.0,Pfizer Reports Results Of New Phase 3 Analyses Of Tafamidis Favored Candidate Across All Sub Groups,2018-09-18 09:03:00-04:00,PFE,pfizer reports results of new phase 3 analyses of tafamidis favored candidate across all sub groups,"{'neg': 0.0, 'neu': 0.843, 'pos': 0.157, 'compound': 0.4215}",neutral,0.9998430013656616
988775,988775,1000916.0,"The Daily Biotech Pulse: Morphosys Expands Collaboration, Osiris Announces Product Launch, Argenx To Offer Shares",2018-09-18 08:44:00-04:00,PFE,the daily biotech pulse morphosys expands collaboration osiris announces product launch argenx to offer shares,"{'neg': 0.0, 'neu': 0.783, 'pos': 0.217, 'compound': 0.3818}",positive,0.9957982897758484
988776,988776,1000917.0,"Stocks Which Set New 52-Week High Friday, September 14th",2018-09-17 09:28:00-04:00,PFE,stocks which set new 52 week high friday september 14,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9871199131011963
988777,988777,1000918.0,Pfizer to Evaluate Atomwise's Platform to Select Drug Candidates for Up to 3 Proteins,2018-09-17 08:28:00-04:00,PFE,pfizer to evaluate atomwises platform to select drug candidates for up to 3 proteins,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998828172683716
988778,988778,1000919.0,"Stocks Which Set New 52-Week High Yesterday, September 13th",2018-09-14 09:26:00-04:00,PFE,stocks which set new 52 week high yesterday september 13,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992722868919373
988779,988779,1000920.0,"The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut",2018-09-14 08:38:00-04:00,PFE,the daily biotech pulse fda nod for staar supernus opens wallet principia biopharma to debut,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9982342720031738
988780,988780,1000921.0,"Stocks That Made New 52-Week Highs So Far Today Include: NiSource, Pfizer, United Continental, UDR, Kellogg, Arthur J. Gallagher, PerkinElmer, Paypal, Thermo Fisher, Honeywell, Visa, American Express, Nike, Intuit, Boston Scientific, Microsoft, and AMD",2018-09-13 11:43:00-04:00,PFE,stocks that made new 52 week highs so far today include nisource pfizer united continental udr kellogg arthur j gallagher perkinelmer paypal thermo fisher honeywell visa american express nike intuit boston scientific microsoft and amd,"{'neg': 0.0, 'neu': 0.924, 'pos': 0.076, 'compound': 0.4215}",positive,0.9986180067062378
988781,988781,1000922.0,"Stocks Which Set New 52-Week High Yesterday, September 12",2018-09-13 09:44:00-04:00,PFE,stocks which set new 52 week high yesterday september 12,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992641806602478
988782,988782,1000923.0,"The Daily Biotech Pulse: Progenics Posts Mixed Trial Results, Antitrust Nod For Galapagos-MorphoSys Collaboration, New CEO For Biopharmx",2018-09-13 08:42:00-04:00,PFE,the daily biotech pulse progenics posts mixed trial results antitrust nod for galapagos morphosys collaboration new ceo for biopharmx,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9302818179130554
988783,988783,1000924.0,"Stocks That Made New 52-Week Highs So Far Today Include: AMD, Salesforce, Jacobs Engineering, Church & Dwight, Simon Property Group, Verizon, Lowe's, Hormel, Adobe, Kohl's, Total System Services, Union Pacific, Home Depot, American Express, & Pfizer",2018-09-12 15:35:00-04:00,PFE,stocks that made new 52 week highs so far today include amd salesforce jacobs engineering church and dwight simon property group verizon lowes hormel adobe kohls total system services union pacific home depot american express and pfizer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9987932443618774
988784,988784,1000925.0,Investors Try To Read The Trade Tea Leaves In The Latest IMX Report,2018-09-12 15:15:00-04:00,PFE,investors try to read the trade tea leaves in the latest imx report,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998792409896851
988785,988785,1000926.0,"Market Appears To Be in Wait-and-See Mode Ahead of Apple, Central Bank Events",2018-09-12 10:27:00-04:00,PFE,market appears to be in wait and see mode ahead of apple central bank events,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998268485069275
988786,988786,1000927.0,Investor Movement Index August Summary,2018-09-11 11:08:00-04:00,PFE,investor movement index august summary,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998801946640015
988787,988787,1000928.0,Health Care Has Been On Fire. Will The Uptrend Continue?,2018-09-07 14:40:00-04:00,PFE,health care has been on fire will the uptrend continue,"{'neg': 0.176, 'neu': 0.588, 'pos': 0.235, 'compound': 0.2023}",negative,0.927699625492096
988788,988788,1000929.0,"CBS, Constellation Brands, Pfizer, Taiwan Semi: 'Fast Money' Picks For September 7",2018-09-07 07:32:00-04:00,PFE,cbs constellation brands pfizer taiwan semi fast money picks for september 7,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9968805313110352
988789,988789,1000930.0,Credit Suisse Joins Consensus To Prescribe Sarepta,2018-09-06 14:47:00-04:00,PFE,credit suisse joins consensus to prescribe sarepta,"{'neg': 0.0, 'neu': 0.698, 'pos': 0.302, 'compound': 0.3818}",neutral,0.965527355670929
988790,988790,1000931.0,"Pfizer Receives Breakthrough Therapy Designation from FDA for PF-06651600, Co. Announces Phase 2 Data Is Accepted For Late-Breaker News Session At 2018 EADV Congress",2018-09-05 08:50:00-04:00,PFE,pfizer receives breakthrough therapy designation from fda for pf 06651600 co announces phase 2 data is accepted for late breaker news session at 2018 eadv congress,"{'neg': 0.0, 'neu': 0.923, 'pos': 0.077, 'compound': 0.2732}",positive,0.9382152557373047
988791,988791,1000932.0,"The Daily Biotech Pulse: Biohaven In-Licenses Drug, Retrophin's Debt Offering, ProQR And Bluebird Report Positive Trial Results",2018-09-05 08:28:00-04:00,PFE,the daily biotech pulse biohaven in licenses drug retrophins debt offering proqr and bluebird report positive trial results,"{'neg': 0.113, 'neu': 0.724, 'pos': 0.163, 'compound': 0.2732}",positive,0.9994407296180725
988792,988792,1000933.0,Pfizer Estimates its Own Brexit Costs at $100M,2018-09-04 05:03:00-04:00,PFE,pfizer estimates its own brexit costs at dollars 00 million,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999873161315918
988793,988793,1000934.0,Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates,2018-08-31 15:06:00-04:00,PFE,attention biotech investors mark your calendar for these september pdufa dates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998854398727417
988794,988794,1000935.0,Pfizer Reports Termination Of PF-06252616 Studies,2018-08-30 08:00:00-04:00,PFE,pfizer reports termination of pf 06252616 studies,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9545781016349792
988795,988795,1000936.0,Pfizer Press Earlier Announced Voluntary Nationwide Recall Of One Lot of Children's Advil Bubble Gum Flavored 4 Oz. Bottle,2018-08-28 11:31:00-04:00,PFE,pfizer press earlier announced voluntary nationwide recall of one lot of childrens advil bubble gum flavored 4 oz bottle,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9992690682411194
988796,988796,1000937.0,Hearing Pfizer Announces Nationwide Recall Of Children's Advil,2018-08-28 11:23:00-04:00,PFE,hearing pfizer announces nationwide recall of childrens advil,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9986918568611145
988797,988797,1000938.0,"The Daily Biotech Pulse: Regulatory Roadblock For Akcea-Ionis, Affimed's Alliance, FDA Nod For Tetraphase's Antibiotic",2018-08-28 08:13:00-04:00,PFE,the daily biotech pulse regulatory roadblock for akcea ionis affimeds alliance fda nod for tetraphases antibiotic,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997443556785583
988798,988798,1000939.0,Pfizer Slips Despite Mostly Positive Tafamidis Data; 4 Pharma Stocks Make Sympathy Moves,2018-08-27 14:59:00-04:00,PFE,pfizer slips despite mostly positive tafamidis data 4 pharma stocks make sympathy moves,"{'neg': 0.178, 'neu': 0.67, 'pos': 0.152, 'compound': -0.1088}",negative,0.9986932873725891
988799,988799,1000940.0,Eidos Therapeutics shares now down 31.9%; Drop is being attributed to rival company Pfizer's positive clinical data from its trial of tafamidis.,2018-08-27 12:26:00-04:00,PFE,eidos therapeutics shares now down 31.9 percent drop is being attributed to rival company pfizers positive clinical data from its trial of tafamidis,"{'neg': 0.075, 'neu': 0.717, 'pos': 0.208, 'compound': 0.5719}",negative,0.9987834095954895
988800,988800,1000941.0,"PreMarket Prep Opening NYSE Imbalance Update: SYSCO 161K Share Sell Imbalance, Pfizer 63K Sell Imbalance",2018-08-27 09:12:00-04:00,PFE,premarket prep opening nyse imbalance update sysco 161 thousand share sell imbalance pfizer 63 thousand sell imbalance,"{'neg': 0.0, 'neu': 0.879, 'pos': 0.121, 'compound': 0.296}",neutral,0.9998482465744019
988801,988801,1000942.0,Pfizer Earlier Announced Primary Results From Phase 3 Transthyretin Amyloid Cardiomyopathy Study; Study Showed Tafamidis Significantly Reduced Combination Of All-Cause Mortality And Cardiovascular-Related Hospitalizations,2018-08-27 08:31:00-04:00,PFE,pfizer earlier announced primary results from phase 3 transthyretin amyloid cardiomyopathy study study showed tafamidis significantly reduced combination of all cause mortality and cardiovascular related hospitalizations,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996442794799805
988802,988802,1000943.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Results",2018-08-26 15:40:00-04:00,PFE,the week ahead in biotech conferences pdufa dates and clinical trial results,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998903274536133
988803,988803,1000944.0,"Barron's Picks And Pans: Electronic Arts, GlaxoSmithKline, Microsoft, Tesla And More",2018-08-25 18:16:00-04:00,PFE,barrons picks and pans electronic arts glaxosmithkline microsoft tesla and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998800754547119
988804,988804,1000945.0,"The Daily Biotech Pulse: Novartis Breast Cancer Trial Meets Endpoint, Medpace's Offering, Dexcom Buys TypeZero",2018-08-23 08:23:00-04:00,PFE,the daily biotech pulse novartis breast cancer trial meets endpoint medpaces offering dexcom buys typezero,"{'neg': 0.239, 'neu': 0.761, 'pos': 0.0, 'compound': -0.6597}",neutral,0.999489426612854
988805,988805,1000946.0,"Morgan Stanley Maintains Overweight on Pfizer, Raises Price Target to $45",2018-08-23 07:43:00-04:00,PFE,morgan stanley maintains overweight on pfizer raises price target to dollars 5,"{'neg': 0.185, 'neu': 0.815, 'pos': 0.0, 'compound': -0.3612}",negative,0.8249215483665466
988806,988806,1000947.0,"Barclays Maintains Equal-Weight on Pfizer, Raises Price Target to $40",2018-08-23 07:37:00-04:00,PFE,barclays maintains equal weight on pfizer raises price target to dollars 0,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993587136268616
988807,988807,1000948.0,"Pfizer and Astellas Pharmas Amed Protocals To 2 Phase 3 Trials (ARCHES and EMBARK), Moves Up Anticipated Completion Dates; ARCHES Date Changed From April 2020 to Late 2018, EMBARK Date Changed From March 2021 to Mid-2020",2018-08-22 17:02:00-04:00,PFE,pfizer and astellas pharmas amed protocals to 2 phase 3 trials arches and embark moves up anticipated completion dates arches date changed from april 2020 to late 2018 embark date changed from march 2021 to mid 2020,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9987635612487793
988808,988808,1000949.0,Stifel Drops Bullish Zoetis Thesis After 108% Outperformance,2018-08-22 09:40:00-04:00,PFE,stifel drops bullish zoetis thesis after 108 percent outperformance,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9986289739608765
988809,988809,1000950.0,From Exact Sciences Call To Discuss Cologuard Deal With Pfizer: Sees Deal Impacting Cologuard Sales Throughout 2019,2018-08-22 09:20:00-04:00,PFE,from exact sciences call to discuss cologuard deal with pfizer sees deal impacting cologuard sales throughout 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9965317845344543
988810,988810,1000951.0,Exact Sciences Shares Unaffected Following Comment By CEO On Co. Conference Call To Discuss Pfizer Deal For Cologuard: Pfizer Deal Will Have 'Very Little' Impact On Cologuard Sales This Year,2018-08-22 08:17:00-04:00,PFE,exact sciences shares unaffected following comment by ceo on co conference call to discuss pfizer deal for cologuard pfizer deal will have very little impact on cologuard sales this year,"{'neg': 0.0, 'neu': 0.929, 'pos': 0.071, 'compound': 0.296}",neutral,0.9682565927505493
988811,988811,1000952.0,24 Stocks Moving In Wednesday's Pre-Market Session,2018-08-22 08:00:00-04:00,PFE,24 stocks moving in wednesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998760223388672
988812,988812,1000953.0,"Exact Sciences And Pfizer Enter Into U.S. Promotion Agreement For Cologuard; Pfizer Will Join Exact Sciences' Sales Reps I Reaching Both Physicians And Health systems, Will Actively Help In Extending Cologuard Marketing Campaign",2018-08-22 06:12:00-04:00,PFE,exact sciences and pfizer enter into u s promotion agreement for cologuard pfizer will join exact sciences sales reps i reaching both physicians and health systems will actively help in extending cologuard marketing campaign,"{'neg': 0.0, 'neu': 0.704, 'pos': 0.296, 'compound': 0.8807}",positive,0.9866966605186462
988813,988813,1000954.0,Pfizer Is Coordinating With The FDA To Extend Expiration Dates Of Specific Lots Of EpiPen Auto Injectors And Its Authorized Generic Version After Review Of Stability  Data,2018-08-21 10:21:00-04:00,PFE,pfizer is coordinating with the fda to extend expiration dates of specific lots of epipen auto injectors and its authorized generic version after review of stability data,"{'neg': 0.0, 'neu': 0.939, 'pos': 0.061, 'compound': 0.1779}",neutral,0.9995667338371277
988814,988814,1000955.0,"The Daily Biotech Pulse: Merck's Keytruda Secures Approval For Expanded Label, ProPhase Labs Q2 Loss Narrows",2018-08-21 08:40:00-04:00,PFE,the daily biotech pulse mercks keytruda secures approval for expanded label prophase labs second quarter loss narrows,"{'neg': 0.106, 'neu': 0.645, 'pos': 0.249, 'compound': 0.4767}",positive,0.9993143081665039
988815,988815,1000956.0,"BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza, BioNTech To Receive $120M Upfront With $305M IN Potential Milestone Payments Along With Double-Digit Royalties",2018-08-16 06:08:00-04:00,PFE,biontech signs collaboration agreement with pfizer to develop mrna based vaccines for prevention of influenza biontech to receive dollars 20 million upfront with dollars 05 million in potential milestone payments along with double digit royalties,"{'neg': 0.0, 'neu': 0.914, 'pos': 0.086, 'compound': 0.4939}",positive,0.9995392560958862
988816,988816,1000957.0,"Shares of GlaxoSmithKline are up 1.5% and shares of Pfizer are up 0.7% after ViiV Healthcare, a joint venture between the two companies, announced positive 48-week study results for HIV treatment regimen.",2018-08-15 11:38:00-04:00,PFE,shares of glaxosmithkline are up 1.5 percent and shares of pfizer are up 0.7 percent after viiv healthcare a joint venture between the two companies announced positive 48 week study results for hiv treatment regimen,"{'neg': 0.0, 'neu': 0.8, 'pos': 0.2, 'compound': 0.7906}",positive,0.9997175335884094
988817,988817,1000958.0,"ViiV Healthcare Announces Positive 48-week Results for First Pivotal, Phase III Study for Novel, Long-acting, Injectable HIV-treatment Regimen",2018-08-15 04:34:00-04:00,PFE,viiv healthcare announces positive 48 week results for first pivotal phase iii study for novel long acting injectable hiv treatment regimen,"{'neg': 0.0, 'neu': 0.763, 'pos': 0.237, 'compound': 0.7096}",positive,0.9995811581611633
988818,988818,1000959.0,Tudor Investment Corporation Shows New 28.23K Share Stake In Pfizer,2018-08-14 15:48:00-04:00,PFE,tudor investment corporation shows new 28.23 thousand share stake in pfizer,"{'neg': 0.0, 'neu': 0.82, 'pos': 0.18, 'compound': 0.296}",neutral,0.9998607635498047
988819,988819,1000960.0,"Goldman Drops Alnylam From Conviction List, But Continues To See 'Blockbuster Potential'",2018-08-13 14:14:00-04:00,PFE,goldman drops alnylam from conviction list but continues to see blockbuster potential,"{'neg': 0.0, 'neu': 0.673, 'pos': 0.327, 'compound': 0.7469}",positive,0.9972389936447144
988820,988820,1000961.0,PreMarket Prep Opening NYSE Imbalance Update: Pfizer 125k Shares To Sell; Alibaba 52k To Sell; GE 153k To Sell; Deutsche Bank 14k to sell: Taiwan Semiconductor 81k To Sell,2018-08-10 08:37:00-04:00,PFE,premarket prep opening nyse imbalance update pfizer 125 thousand shares to sell alibaba 52 thousand to sell ge 153 thousand to sell deutsche bank 14 thousand to sell taiwan semiconductor 81 thousand to sell,"{'neg': 0.0, 'neu': 0.937, 'pos': 0.062, 'compound': 0.296}",neutral,0.9998677968978882
988821,988821,1000962.0,UPDATE: Pfizer 10-Q Shows Dept. Of Justice Requested In Jul. 2018 Documents Related To Contracts With The Iraqi Ministry Of Health; Co. To Comply With Request,2018-08-09 16:42:00-04:00,PFE,update pfizer 10 q shows dept of justice requested in jul 2018 documents related to contracts with the iraqi ministry of health co to comply with request,"{'neg': 0.0, 'neu': 0.884, 'pos': 0.116, 'compound': 0.5267}",neutral,0.9998359680175781
988822,988822,1000963.0,Pfizer 10-Q Just Out,2018-08-09 16:41:00-04:00,PFE,pfizer 10 q just out,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998568296432495
988823,988823,1000964.0,"Stocks Which Set New 52-Week High Yesterday, August 8th",2018-08-09 11:03:00-04:00,PFE,stocks which set new 52 week high yesterday august 8,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993727803230286
988824,988824,1000965.0,"The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings",2018-08-09 08:39:00-04:00,PFE,the daily biotech pulse ampio slides on offering sangamos positive trial results insys earnings,"{'neg': 0.0, 'neu': 0.783, 'pos': 0.217, 'compound': 0.5574}",positive,0.9992530941963196
988825,988825,1000966.0,PreMarket Prep Opening NYSE Imbalance Update: Pfizer 237k Shares To Sell; GE 79k To Sell; Alibaba 24k To Buy,2018-08-09 08:35:00-04:00,PFE,premarket prep opening nyse imbalance update pfizer 237 thousand shares to sell ge 79 thousand to sell alibaba 24 thousand to buy,"{'neg': 0.0, 'neu': 0.905, 'pos': 0.095, 'compound': 0.296}",neutral,0.9998637437820435
988826,988826,1000967.0,"Stocks That Made New 52-Week Highs So Far Today Include: Medtronic, Amazon, Pfizer, AES, W.W. Grainger, Centene, Chipotle, Emerson Electric, Zoetis, Michael Kors, United Continental, VF, Aetna, Ross Stores, and UnitedHealth Group",2018-08-08 12:03:00-04:00,PFE,stocks that made new 52 week highs so far today include medtronic amazon pfizer aes w w grainger centene chipotle emerson electric zoetis michael kors united continental vf aetna ross stores and unitedhealth group,"{'neg': 0.0, 'neu': 0.877, 'pos': 0.123, 'compound': 0.5423}",positive,0.9983903169631958
988827,988827,1000968.0,"Stocks Which Set New 52-Week High Yesterday, August 7th",2018-08-08 11:01:00-04:00,PFE,stocks which set new 52 week high yesterday august 7,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993752837181091
988828,988828,1000969.0,Mylan CEO On Conf. Call Says They Have Good Months Of Epipen Supply From Pfizer And Then Suddenly Get Erratic Supply; Says They're Working Closely With Pfizer,2018-08-08 10:44:00-04:00,PFE,mylan ceo on conf call says they have good months of epipen supply from pfizer and then suddenly get erratic supply says theyre working closely with pfizer,"{'neg': 0.0, 'neu': 0.9, 'pos': 0.1, 'compound': 0.4404}",negative,0.48757436871528625
988829,988829,1000970.0,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",2018-08-08 08:15:00-04:00,PFE,the daily biotech pulse fda panel backs insmed eidos maiden earnings paratek awaits adcom verdict,"{'neg': 0.075, 'neu': 0.745, 'pos': 0.18, 'compound': 0.1779}",neutral,0.999715268611908
988830,988830,1000971.0,"Stocks That Made New 52-Week Highs Earlier Today Include: SL Green Realty, Verisk Analytics, Medtronics, Pfizer, Conoco Phillips, Archer-Daniels, Eli Lilly, Merck, Phillips 66, Costco, Advance Auto Parts, Norfolk Southern, CSX, Zoetis, Apple, and Disney",2018-08-07 11:49:00-04:00,PFE,stocks that made new 52 week highs earlier today include sl green realty verisk analytics medtronics pfizer conoco phillips archer daniels eli lilly merck phillips 66 costco advance auto parts norfolk southern csx zoetis apple and disney,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9983398914337158
988831,988831,1000972.0,"Stocks Which Set New 52-Week High Yesterday, August 6th",2018-08-07 11:27:00-04:00,PFE,stocks which set new 52 week high yesterday august 6,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993640780448914
988832,988832,1000973.0,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",2018-08-07 08:23:00-04:00,PFE,the daily biotech pulse fda snub for gemphire ligand earnings insmeds antibiotic faces fda panel,"{'neg': 0.167, 'neu': 0.833, 'pos': 0.0, 'compound': -0.4215}",neutral,0.9998384714126587
988833,988833,1000974.0,"AT&T, Disney, Pfizer, Wynn Resorts: 'Fast Money' Picks For August 7",2018-08-07 07:26:00-04:00,PFE,at and t disney pfizer wynn resorts fast money picks for august 7,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9985723495483398
988834,988834,1000975.0,52 Biggest Movers From Yesterday,2018-08-07 05:19:00-04:00,PFE,52 biggest movers from yesterday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998480081558228
988835,988835,1000976.0,"UPDATE: Gemphire Says Royalty Period Has Been Extended, Royalty Rates Have Increased 'Slightly,' From High Single Digits To Mid-Teens",2018-08-06 16:16:00-04:00,PFE,update gemphire says royalty period has been extended royalty rates have increased slightly from high single digits to mid teens,"{'neg': 0.0, 'neu': 0.9, 'pos': 0.1, 'compound': 0.2732}",positive,0.9996823072433472
988836,988836,1000977.0,"UPDATE: Gemphire Adjustment To Gemcabene Deal With Pfizer Includes Extension Of Date For Deadline For First Commercial Sale Of Gemcabene: Pfizer Has Right To Terminate License If First Sale Has Not Occurred By Apr. 2024, Up From Apr. 2021 Previously",2018-08-06 16:15:00-04:00,PFE,update gemphire adjustment to gemcabene deal with pfizer includes extension of date for deadline for first commercial sale of gemcabene pfizer has right to terminate license if first sale has not occurred by apr 2024 up from apr 2021 previously,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9883974194526672
988837,988837,1000978.0,"Gemphire Reports Amended, Restated License Deal With Pfizer For Gemcabene",2018-08-06 16:14:00-04:00,PFE,gemphire reports amended restated license deal with pfizer for gemcabene,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9877750873565674
988838,988838,1000979.0,"Stocks That Made New 52-Week Highs So Far Today Include: CSX, Jacobs Engineering, Medtronic, United Continental, Cintas, Advance Auto Parts, O'Reilly Automotive, Robert Half, Norfolk Southern, Verisk Analytics, NextEra Energy, Pfizer, Apple, & Illumina",2018-08-06 15:50:00-04:00,PFE,stocks that made new 52 week highs so far today include csx jacobs engineering medtronic united continental cintas advance auto parts oreilly automotive robert half norfolk southern verisk analytics nextera energy pfizer apple and illumina,"{'neg': 0.0, 'neu': 0.871, 'pos': 0.129, 'compound': 0.5994}",positive,0.9986664056777954
988839,988839,1000980.0,"Stocks Which Set New 52-Week Highs Friday, August 3rd",2018-08-06 13:02:00-04:00,PFE,stocks which set new 52 week highs friday august 3,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9985458850860596
988840,988840,1000981.0,44 Stocks Moving In Monday's Mid-Day Session,2018-08-06 12:39:00-04:00,PFE,44 stocks moving in mondays mid day session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998760223388672
988841,988841,1000982.0,PreMarket Prep Opening NYSE Imbalance Update: Berkshire Hathaway 101k Shares To Buy; Pfizer 161k To Sell; Disney 69k Shares To Buy,2018-08-06 08:52:00-04:00,PFE,premarket prep opening nyse imbalance update berkshire hathaway 101 thousand shares to buy pfizer 161 thousand to sell disney 69 thousand shares to buy,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.5267}",neutral,0.9998642206192017
988842,988842,1000983.0,Benzinga Pro's 5 Stocks To Watch Today,2018-08-06 08:51:00-04:00,PFE,benzinga pros 5 stocks to watch today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998247027397156
988843,988843,1000984.0,Antares Pharma Announces a Development Agreement with Pfizer for Drug Rescue Pen,2018-08-06 07:09:00-04:00,PFE,antares pharma announces a development agreement with pfizer for drug rescue pen,"{'neg': 0.0, 'neu': 0.606, 'pos': 0.394, 'compound': 0.7579}",positive,0.9992673993110657
988844,988844,1000985.0,"Stocks That Made New 52-Week Highs Earlier Today Include: Pfizer, AES, Simon Property Group, HCA Healthcare, Church & Dwight, Kellogg, Advanced Auto Parts, McCormick, Target, O'Reilly Automotive, Ross Stores, Mosaic, and CF Industries",2018-08-03 11:21:00-04:00,PFE,stocks that made new 52 week highs earlier today include pfizer aes simon property group hca healthcare church and dwight kellogg advanced auto parts mccormick target oreilly automotive ross stores mosaic and cf industries,"{'neg': 0.0, 'neu': 0.943, 'pos': 0.057, 'compound': 0.25}",positive,0.9983012080192566
988845,988845,1000986.0,"Stocks Trading Ex Dividend For Thurs., Aug. 2, 2018",2018-08-02 11:10:00-04:00,PFE,stocks trading ex dividend for thurs aug 2 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998914003372192
988846,988846,1000987.0,"Stocks Which Set New 52-Week High Yesterday, August 1st",2018-08-02 10:56:00-04:00,PFE,stocks which set new 52 week high yesterday august 1,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992990493774414
988847,988847,1000988.0,"Stocks That Have Made New 52 Week Highs Thus Far Today Include: Robert Half, Eli Lilly, Pfizer, Phillips 66, Humana, HCA Healthcare, Genworth, Republic Services, Illumina, Aflac, Medtronic, Waste Management, and Apple",2018-08-01 13:32:00-04:00,PFE,stocks that have made new 52 week highs thus far today include robert half eli lilly pfizer phillips 66 humana hca healthcare genworth republic services illumina aflac medtronic waste management and apple,"{'neg': 0.083, 'neu': 0.917, 'pos': 0.0, 'compound': -0.4215}",positive,0.9989390969276428
988848,988848,1000989.0,"Stocks Which Set New 52-Week High Yesterday, July 31",2018-08-01 12:04:00-04:00,PFE,stocks which set new 52 week high yesterday july 31,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993454813957214
988849,988849,1000990.0,"Price Action In Several Major Healthcare Names Mixed, Stocks Appear Largely Unaffected Following Late-Tues. NY Times Article 'Justice Dept. Investigating Claims That Drug Companies Funded Terrorism in Iraq'",2018-08-01 10:59:00-04:00,PFE,price action in several major healthcare names mixed stocks appear largely unaffected following late tues ny times article justice dept investigating claims that drug companies funded terrorism in iraq,"{'neg': 0.131, 'neu': 0.771, 'pos': 0.097, 'compound': -0.296}",neutral,0.9903562068939209
988850,988850,1000991.0,"Morgan Stanley Buys Into Sarepta Amid Sell-Off, Sees $600M Recurring Opportunity In DMD Candidate",2018-08-01 10:03:00-04:00,PFE,morgan stanley buys into sarepta amid sell off sees dollars 00 million recurring opportunity in dmd candidate,"{'neg': 0.0, 'neu': 0.851, 'pos': 0.149, 'compound': 0.4215}",negative,0.9934252500534058
988851,988851,1000992.0,"BMO Capital Maintains Outperform on Pfizer, Raises Price Target to $44",2018-08-01 09:41:00-04:00,PFE,bmo capital maintains outperform on pfizer raises price target to dollars 4,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996869564056396
988852,988852,1000993.0,"Benzinga's Biotech Pulse: Pfizer's Xeljanz Gets EU Nod, NewLink Losses Narrow, Neuralstem Commences Stroke Drug Trial",2018-08-01 09:01:00-04:00,PFE,benzingas biotech pulse pfizers xeljanz gets eu nod newlink losses narrow neuralstem commences stroke drug trial,"{'neg': 0.153, 'neu': 0.847, 'pos': 0.0, 'compound': -0.4019}",negative,0.9826252460479736
988853,988853,1000994.0,"Credit Suisse Maintains Neutral on Pfizer, Raises Price Target to $40",2018-08-01 08:59:00-04:00,PFE,credit suisse maintains neutral on pfizer raises price target to dollars 0,"{'neg': 0.0, 'neu': 0.809, 'pos': 0.191, 'compound': 0.3818}",positive,0.9994275569915771
988854,988854,1000995.0,"Apple, Caterpillar, CBS, Pfizer: 'Fast Money' Picks For August 1",2018-08-01 07:46:00-04:00,PFE,apple caterpillar cbs pfizer fast money picks for august 1,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997745156288147
988855,988855,1000996.0,XELJANZ Receives EU Marketing Authorization for Moderately to Severely Active Ulcerative Colitis,2018-08-01 03:44:00-04:00,PFE,xeljanz receives eu marketing authorization for moderately to severely active ulcerative colitis,"{'neg': 0.191, 'neu': 0.637, 'pos': 0.172, 'compound': -0.0772}",positive,0.7574414610862732
988856,988856,1000997.0,"'$PFE CEO Read also downplays prospects of a big deal, saying ""we'd be better off focusing on developing our pipeline.""'-WSJ Reporter Jonathan Rockoff",2018-07-31 13:14:00-04:00,PFE,pfe ceo read also downplays prospects of a big deal saying wed be better off focusing on developing our pipeline wsj reporter jonathan rockoff,"{'neg': 0.0, 'neu': 0.812, 'pos': 0.188, 'compound': 0.6249}",negative,0.996297299861908
988857,988857,1000998.0,Pfizer CEO Says He Sees A 'Huge Sense Of Urgency' In Trump Admin To Act On Drug Rebates,2018-07-31 10:53:00-04:00,PFE,pfizer ceo says he sees a huge sense of urgency in trump admin to act on drug rebates,"{'neg': 0.0, 'neu': 0.881, 'pos': 0.119, 'compound': 0.3182}",positive,0.9975082874298096
988858,988858,1000999.0,"A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings, Economic Data",2018-07-31 07:01:00-04:00,PFE,a peek into the markets us stock futures up ahead of earnings economic data,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997692704200745
988859,988859,1001000.0,Pfizer Continues To Evaluate Strategic Alternatives For Consumer Healthcare Business; Decision Expected In 2018,2018-07-31 06:50:00-04:00,PFE,pfizer continues to evaluate strategic alternatives for consumer healthcare business decision expected in 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9988866448402405
988860,988860,1001001.0,Pfizer Cuts FY18 Sales Guidance From $53.5B-$55.5B To $53B-$55B vs $54.29B Est.,2018-07-31 06:48:00-04:00,PFE,pfizer cuts fy18 sales guidance from dollars 3.5 billion dollars 5.5 billion to dollars 3 billion dollars 5 billion vs dollars 4.29 billion est,"{'neg': 0.087, 'neu': 0.913, 'pos': 0.0, 'compound': -0.296}",negative,0.996379554271698
988861,988861,1001002.0,Pfizer Raises FY18 Adj. EPS Guidance From $2.90-$3.00 To $2.95-$3.05 vs $2.95 Est.,2018-07-31 06:47:00-04:00,PFE,pfizer raises fy18 adj eps guidance from dollars .90 dollars .00 to dollars .95 dollars .05 vs dollars .95 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999548614025116
988862,988862,1001003.0,"Pfizer Q2 Adj. EPS $0.81 Beats $0.74 Estimate, Sales $13.5B Beat $13.31B Estimate",2018-07-31 06:46:00-04:00,PFE,pfizer second quarter adj eps dollars .81 beats dollars .74 estimate sales dollars 3.5 billion beat dollars 3.31 billion estimate,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9995410442352295
988863,988863,1001004.0,"Pfizer Receives European Approval For Oncology Biosimilar, TRAZIMERA (trastuzumab)",2018-07-31 06:00:00-04:00,PFE,pfizer receives european approval for oncology biosimilar trazimera trastuzumab,"{'neg': 0.0, 'neu': 0.721, 'pos': 0.279, 'compound': 0.4767}",positive,0.9988952875137329
988864,988864,1001005.0,"12 Stocks To Watch For July 31, 2018",2018-07-31 04:46:00-04:00,PFE,12 stocks to watch for july 31 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998655319213867
988865,988865,1001006.0,"Earnings Scheduled For July 31, 2018",2018-07-31 04:37:00-04:00,PFE,earnings scheduled for july 31 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998817443847656
988866,988866,1001007.0,Pfizer Q2 Earnings Preview,2018-07-30 15:43:00-04:00,PFE,pfizer second quarter earnings preview,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998214840888977
988867,988867,1001008.0,"The Week Ahead: Apple And Tesla Earnings, FOMC Meeting, Sonos IPO",2018-07-30 13:46:00-04:00,PFE,the week ahead apple and tesla earnings fomc meeting sonos ipo,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998641014099121
988868,988868,1001009.0,"Apple To Report Earnings Amid A Busy Week Filled With Economic Data, Fed Meeting And More",2018-07-30 10:57:00-04:00,PFE,apple to report earnings amid a busy week filled with economic data fed meeting and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9995495676994324
988869,988869,1001010.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs",2018-07-28 14:04:00-04:00,PFE,the week ahead in biotech conferences pdufa dates earnings and ipos,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999884843826294
988870,988870,1001011.0,"Caterpillar Earnings Preview: Economic Outlook Seems Good, Tariffs Adding Uncertainty",2018-07-27 11:26:00-04:00,PFE,caterpillar earnings preview economic outlook seems good tariffs adding uncertainty,"{'neg': 0.18, 'neu': 0.602, 'pos': 0.218, 'compound': 0.128}",positive,0.9977953433990479
988871,988871,1001012.0,"Sarepta's Clinical Hold Could Be A Solid Biosciences Catalyst, Says Bullish Chardan Analyst",2018-07-26 10:30:00-04:00,PFE,sareptas clinical hold could be a solid biosciences catalyst says bullish chardan analyst,"{'neg': 0.0, 'neu': 0.882, 'pos': 0.118, 'compound': 0.1531}",positive,0.9995564818382263
988872,988872,1001013.0,"Pfizer Shares Spike ~0.5% As Traders Circulate Questionable, Unconfirmed Chatter Of Activist Interest",2018-07-26 09:59:00-04:00,PFE,pfizer shares spike 0.5 percent as traders circulate questionable unconfirmed chatter of activist interest,"{'neg': 0.196, 'neu': 0.529, 'pos': 0.275, 'compound': 0.3612}",positive,0.9993218183517456
988873,988873,1001014.0,"GlycoMimetics 8-K Shows Pfizer Said Ongoing Phase 3 Trial With Rivipansel Is ~75% Enrolled, Pfizer Delayed Timeline For Complete Enrollment From 2H'18 To Early 2019, Top-Line Data Available From End OF 2018 To Q2'19",2018-07-25 08:41:00-04:00,PFE,glycomimetics 8 k shows pfizer said ongoing phase 3 trial with rivipansel is 75 percent enrolled pfizer delayed timeline for complete enrollment from 2 hour 18 to early 2019 top line data available from end of 2018 to second quarter 19,"{'neg': 0.044, 'neu': 0.913, 'pos': 0.042, 'compound': -0.0258}",neutral,0.997557520866394
988874,988874,1001015.0,"Pfizer To Build Sterile Injectable Facility In Michigan, Investing $465M And Creating More Than 450 Jobs With Production Beginning In 2024",2018-07-24 13:43:00-04:00,PFE,pfizer to build sterile injectable facility in michigan investing dollars 65 million and creating more than 450 jobs with production beginning in 2024,"{'neg': 0.0, 'neu': 0.909, 'pos': 0.091, 'compound': 0.296}",neutral,0.9061971306800842
988875,988875,1001016.0,Reuters Reports 'Dutch trial with Viagra halted after 11 babies die',2018-07-24 13:23:00-04:00,PFE,reuters reports dutch trial with viagra halted after 11 babies die,"{'neg': 0.281, 'neu': 0.719, 'pos': 0.0, 'compound': -0.5994}",negative,0.8560648560523987
988876,988876,1001017.0,"Pfizer And GlaxoSmithKline Joint Venture, ViiV Healthcare Presents Phase III Data at AIDS 2018 From GEMINI Studies Showing Two-Drug Regimen Of Dolutegravir And Lamivudine Has Similar Efficacy To Three-Drug Regimen In Treatment Of Naïve HIV Patient",2018-07-24 08:18:00-04:00,PFE,pfizer and glaxosmithkline joint venture viiv healthcare presents phase iii data at aids 2018 from gemini studies showing two drug regimen of dolutegravir and lamivudine has similar efficacy to three drug regimen in treatment of naïve hiv patient,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.5488359332084656
988877,988877,1001018.0,"Leap Therapeutics Announces Collaboration with Merck and Pfizer to Evaluate Combination of TRX518, Avelumab, and Chemotherapy in Advanced Solid Tumors",2018-07-23 07:31:00-04:00,PFE,leap therapeutics announces collaboration with merck and pfizer to evaluate combination of trx518 avelumab and chemotherapy in advanced solid tumors,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.3818}",neutral,0.7835390567779541
988878,988878,1001019.0,FDA Approves Pfizer's Biosimilar NIVESTYM (filgrastim-aafi),2018-07-20 16:25:00-04:00,PFE,fda approves pfizers biosimilar nivestym filgrastim aafi,"{'neg': 0.0, 'neu': 0.69, 'pos': 0.31, 'compound': 0.4019}",neutral,0.7413061857223511
988879,988879,1001020.0,Merck Announces Plans To Cut Drug Prices,2018-07-20 11:49:00-04:00,PFE,merck announces plans to cut drug prices,"{'neg': 0.259, 'neu': 0.741, 'pos': 0.0, 'compound': -0.2732}",neutral,0.8503603339195251
988880,988880,1001021.0,"'Thank you to Novartis for not increasing your prices on prescription drugs. Likewise to Pfizer. We are making a big push to actually reduce the prices, maybe substantially, on prescription drugs.' -Tweet From Pres Trump",2018-07-19 06:30:00-04:00,PFE,thank you to novartis for not increasing your prices on prescription drugs likewise to pfizer we are making a big push to actually reduce the prices maybe substantially on prescription drugs tweet from pres trump,"{'neg': 0.0, 'neu': 0.932, 'pos': 0.068, 'compound': 0.3612}",positive,0.9991143345832825
988881,988881,1001022.0,Benzinga Pro's 5 Stocks To Watch Today,2018-07-18 08:32:00-04:00,PFE,benzinga pros 5 stocks to watch today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998247027397156
988882,988882,1001023.0,"PFizer, Eli Lilly Report Phase 3 Trial Of Tanezumab Met All Thre Co-Primary Endpoints",2018-07-18 06:46:00-04:00,PFE,pfizer eli lilly report phase 3 trial of tanezumab met all thre co primary endpoints,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998815059661865
988883,988883,1001024.0,Pfizer Reports Initiation Of Pivotal Phase 3 Program For Investigation Hemophilia B Gene Therapy,2018-07-16 10:32:00-04:00,PFE,pfizer reports initiation of pivotal phase 3 program for investigation hemophilia b gene therapy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9995524287223816
988884,988884,1001025.0,PreMarket Prep Opening NYSE Imbalance Update: ExxonMobil 55k Shares To Sell; Pfizer 50k To Sell; Merck 26k To Sell; Coca-Cola 54k To Sell; Johnson & Johnson 54k To Sell; Ford 103k To Sell; Kroger 90k To Sell,2018-07-16 09:02:00-04:00,PFE,premarket prep opening nyse imbalance update exxonmobil 55 thousand shares to sell pfizer 50 thousand to sell merck 26 thousand to sell coca cola 54 thousand to sell johnson and johnson 54 thousand to sell ford 103 thousand to sell kroger 90 thousand to sell,"{'neg': 0.0, 'neu': 0.952, 'pos': 0.048, 'compound': 0.296}",neutral,0.999868631362915
988885,988885,1001026.0,"Astellas Pharma Inc., Pfizer Announce U.S. FDA Approves XTANDI",2018-07-13 14:30:00-04:00,PFE,astellas pharma inc pfizer announce u s fda approves xtandi,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.4019}",positive,0.8534290194511414
988886,988886,1001027.0,"Canopy Growth, Delta, GE, Pfizer: 'Fast Money' Picks For July 12",2018-07-12 07:27:00-04:00,PFE,canopy growth delta ge pfizer fast money picks for july 12,"{'neg': 0.0, 'neu': 0.794, 'pos': 0.206, 'compound': 0.3818}",positive,0.6962295770645142
988887,988887,1001028.0,Pfizer Separates Consumer Health Care Unit,2018-07-11 12:35:00-04:00,PFE,pfizer separates consumer health care unit,"{'neg': 0.0, 'neu': 0.61, 'pos': 0.39, 'compound': 0.4939}",neutral,0.9998781681060791
988888,988888,1001029.0,"Hearing Trump, Pfizer's CEO Read Spoke For 10-15 Minutes About Price Hikes On Tuesday; Admin Officials Felt Pfizer Price Incrases Had Complicated Push Ford Admin's Drug Price Plan",2018-07-11 10:45:00-04:00,PFE,hearing trump pfizers ceo read spoke for 10 to 15 minutes about price hikes on tuesday admin officials felt pfizer price incrases had complicated push ford admins drug price plan,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9720316529273987
988889,988889,1001030.0,"Pfizer Shares Nearly Flat Premarket As The Co. Announced That They Will Organize The Co. Into 3 Separate Units Called Innovative Medicines, Established Medicines And Consumer Healthcare",2018-07-11 09:13:00-04:00,PFE,pfizer shares nearly flat premarket as the co announced that they will organize the co into 3 separate units called innovative medicines established medicines and consumer healthcare,"{'neg': 0.0, 'neu': 0.831, 'pos': 0.169, 'compound': 0.6249}",negative,0.9971820116043091
988890,988890,1001031.0,"Benzinga's Daily Biotech Pulse: Pfizer To Defer Price Hikes, Idera-BioCryst Merger Falls Through, ArQule To Offer Shares",2018-07-11 08:15:00-04:00,PFE,benzingas daily biotech pulse pfizer to defer price hikes idera biocryst merger falls through arqule to offer shares,"{'neg': 0.108, 'neu': 0.784, 'pos': 0.108, 'compound': 0.0}",negative,0.9957237243652344
988891,988891,1001032.0,Pfizer's Announces It Will Defer Company's Price Increases,2018-07-11 04:09:00-04:00,PFE,pfizers announces it will defer companys price increases,"{'neg': 0.239, 'neu': 0.761, 'pos': 0.0, 'compound': -0.296}",positive,0.6820945739746094
988892,988892,1001033.0,"@realDonaldTrump Tweet Earlier: Just talked with Pfizer CEO and @SecAzar on our drug pricing blueprint. Pfizer is rolling back price hikes, so American patients don't pay more. We applaud Pfizer for this decision",2018-07-10 20:28:00-04:00,PFE,tweet earlier just talked with pfizer ceo and on our drug pricing blueprint pfizer is rolling back price hikes so american patients dont pay more we applaud pfizer for this decision,"{'neg': 0.0, 'neu': 0.864, 'pos': 0.136, 'compound': 0.5536}",positive,0.6142553091049194
988893,988893,1001034.0,This ETF Is Looking Healthy (For Now),2018-07-10 09:17:00-04:00,PFE,this etf is looking healthy for now,"{'neg': 0.0, 'neu': 0.69, 'pos': 0.31, 'compound': 0.4019}",positive,0.99912029504776
988894,988894,1001035.0,Health Care Sector Outlook: Checking In Ahead Of Q2 Earnings Reports,2018-07-09 14:39:00-04:00,PFE,health care sector outlook checking in ahead of second quarter earnings reports,"{'neg': 0.0, 'neu': 0.775, 'pos': 0.225, 'compound': 0.4939}",neutral,0.999788224697113
988895,988895,1001036.0,"Trump Tweets (2/2): , while at the same time giving bargain basement prices to other countries in Europe & elsewhere. We will respond!",2018-07-09 13:10:00-04:00,PFE,trump tweets while at the same time giving bargain basement prices to other countries in europe and elsewhere we will respond,"{'neg': 0.0, 'neu': 0.819, 'pos': 0.181, 'compound': 0.4939}",neutral,0.9998067021369934
988896,988896,1001037.0,Trump Tweets (1/2): 'Pfizer & others should be ashamed that they have raised drug prices for no reason. They are merely taking advantage of the poor & others unable to defend themselves',2018-07-09 13:10:00-04:00,PFE,trump tweets .5 pfizer and others should be ashamed that they have raised drug prices for no reason they are merely taking advantage of the poor and others unable to defend themselves,"{'neg': 0.219, 'neu': 0.729, 'pos': 0.052, 'compound': -0.7506}",negative,0.5979982018470764
988897,988897,1001038.0,A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year,2018-07-05 12:25:00-04:00,PFE,a look at biotech in 2018 and the biggest catalysts coming up in the second half of the year,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998536109924316
988898,988898,1001039.0,PreMarket Prep Opening NYSE Imbalance Update: Coca-Cola 146k Shares To Sell; Pfizer 147k To Sell; IBM 76k To Sell; BofA 75K To Sell,2018-07-02 08:38:00-04:00,PFE,premarket prep opening nyse imbalance update coca cola 146 thousand shares to sell pfizer 147 thousand to sell ibm 76 thousand to sell bofa 75 thousand to sell,"{'neg': 0.0, 'neu': 0.925, 'pos': 0.075, 'compound': 0.296}",neutral,0.9998582601547241
988899,988899,1001040.0,Pfizer's XELJANZ Receives Marketing Authorization in the European Union for Active Psoriatic Arthritis,2018-06-28 13:49:00-04:00,PFE,pfizers xeljanz receives marketing authorization in the european union for active psoriatic arthritis,"{'neg': 0.0, 'neu': 0.816, 'pos': 0.184, 'compound': 0.4019}",neutral,0.9950586557388306
988900,988900,1001041.0,Pfizer Reports FDA Granted Priority Review For Co.'s New Drug Application For Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia,2018-06-27 08:06:00-04:00,PFE,pfizer reports fda granted priority review for co s new drug application for glasdegib in patients with previously untreated acute myeloid leukemia,"{'neg': 0.0, 'neu': 0.913, 'pos': 0.087, 'compound': 0.25}",positive,0.9993304014205933
988901,988901,1001042.0,Analyst: Solid Biosciences A Solid Buy On Sarepta's Progress,2018-06-25 08:53:00-04:00,PFE,analyst solid biosciences a solid buy on sareptas progress,"{'neg': 0.0, 'neu': 0.5, 'pos': 0.5, 'compound': 0.6124}",positive,0.9996148347854614
988902,988902,1001043.0,PFizer Reports Phase 3 PALOMA-3 Trial Missed Statistical Significance In Overall Survival Endpoint,2018-06-25 08:08:00-04:00,PFE,pfizer reports phase 3 paloma 3 trial missed statistical significance in overall survival endpoint,"{'neg': 0.135, 'neu': 0.736, 'pos': 0.129, 'compound': -0.0258}",negative,0.9963387250900269
988903,988903,1001044.0,Why GE's Removal From The Dow Could Help Investors,2018-06-20 12:57:00-04:00,PFE,why ges removal from the dow could help investors,"{'neg': 0.0, 'neu': 0.748, 'pos': 0.252, 'compound': 0.4019}",positive,0.9951039552688599
988904,988904,1001045.0,Deciphera Pharma Hit With Sell-Side Downgrade On Valuation After 50% Gain,2018-06-19 09:34:00-04:00,PFE,deciphera pharma hit with sell side downgrade on valuation after 50 percent gain,"{'neg': 0.0, 'neu': 0.779, 'pos': 0.221, 'compound': 0.5267}",negative,0.9984729886054993
988905,988905,1001046.0,Myriad's BRACAnalysis CDx Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Talazoparib in Metastatic Breast Cancer,2018-06-18 07:23:00-04:00,PFE,myriads bracanalysis cdx supplementary pma accepted by fda for review as a companion diagnostic for talazoparib in metastatic breast cancer,"{'neg': 0.18, 'neu': 0.735, 'pos': 0.086, 'compound': -0.5106}",neutral,0.9998310804367065
988906,988906,1001047.0,PreMarket Prep Opening NYSE Imbalance Update: Twitter 131k Shares To Buy; General Electric 108k To Buy; AT&T 182k To Buy; Verizon 70k Buy; Pfizer 85k To Buy; IBM 73k Shares To Sell,2018-06-12 09:07:00-04:00,PFE,premarket prep opening nyse imbalance update twitter 131 thousand shares to buy general electric 108 thousand to buy at and t 182 thousand to buy verizon 70 thousand buy pfizer 85 thousand to buy ibm 73 thousand shares to sell,"{'neg': 0.086, 'neu': 0.817, 'pos': 0.097, 'compound': -0.128}",neutral,0.9998664855957031
988907,988907,1001048.0,"Pharma Stock Roundup: Merck, Eli Lilly, AbbVie And More",2018-06-08 16:33:00-04:00,PFE,pharma stock roundup merck eli lilly abbvie and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998643398284912
988908,988908,1001049.0,UPDATE: Pfizer Says New Drug Application In US For Talazoparib Granted FDA Priority Review,2018-06-07 08:06:00-04:00,PFE,update pfizer says new drug application in us for talazoparib granted fda priority review,"{'neg': 0.0, 'neu': 0.867, 'pos': 0.133, 'compound': 0.25}",positive,0.9772133827209473
988909,988909,1001050.0,"Pfizer Reports FDA, EMA Accepted Regulatory Submissions For Review Of Talazoparib For Metastatic Breast Cancer Patients With Inherited BRCA Mutation",2018-06-07 08:00:00-04:00,PFE,pfizer reports fda ema accepted regulatory submissions for review of talazoparib for metastatic breast cancer patients with inherited brca mutation,"{'neg': 0.18, 'neu': 0.735, 'pos': 0.086, 'compound': -0.5106}",neutral,0.9931572079658508
988910,988910,1001051.0,UPDATE: Pfizer Ventures Seeks To Invest ~25% Of $150M In Available Capital In Early-Stage Neuroscience Cos.,2018-06-06 08:15:00-04:00,PFE,update pfizer ventures seeks to invest 25 percent of dollars 50 million in available capital in early stage neuroscience cos,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998288154602051
988911,988911,1001052.0,"Pfizer Reports Plan To Invest $600M In Biotech, Other Emerging Growth Cos. Through Its Pfizer Ventures Investment Vehicle",2018-06-06 08:15:00-04:00,PFE,pfizer reports plan to invest dollars 00 million in biotech other emerging growth cos through its pfizer ventures investment vehicle,"{'neg': 0.0, 'neu': 0.88, 'pos': 0.12, 'compound': 0.3818}",neutral,0.9998303651809692
988912,988912,1001053.0,"Watching Shares of Allergan As Traders In Chatrooms Circulate Chatter Of A Potential Bid From Pfizer, Unconfirmed",2018-06-05 14:15:00-04:00,PFE,watching shares of allergan as traders in chatrooms circulate chatter of a potential bid from pfizer unconfirmed,"{'neg': 0.08, 'neu': 0.802, 'pos': 0.118, 'compound': 0.1779}",neutral,0.9998270869255066
988913,988913,1001054.0,At ASCO: Pfizer Announces ARCHER 1050 Dacomitinib Trial Data Shows Median 34.1 Months Overall Survival,2018-06-04 17:38:00-04:00,PFE,at asco pfizer announces archer 1050 dacomitinib trial data shows median 34.1 months overall survival,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9992583394050598
988914,988914,1001055.0,Merck Gives an Update on its Pivotal Trial of JAVELIN into ASCO,2018-06-04 08:24:00-04:00,PFE,merck gives an update on its pivotal trial of javelin into asco,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998764991760254
988915,988915,1001056.0,"Donald Trump Tweets: 'We had Repeal & Replace done (and the saving to our country of one trillion dollars) except for one person, but it is getting done anyway'...'less expensive plans will be announced this month. Drug prices coming down & Right to Try!'",2018-06-04 08:22:00-04:00,PFE,donald trump tweets we had repeal and replace done and the saving to our country of one trillion dollars except for one person but it is getting done anyway less expensive plans will be announced this month drug prices coming down and right to try,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.99802565574646
988916,988916,1001057.0,The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines,2018-06-03 19:27:00-04:00,PFE,the week ahead in biotech asco presentations dominate the headlines,"{'neg': 0.143, 'neu': 0.857, 'pos': 0.0, 'compound': -0.128}",neutral,0.999866247177124
988917,988917,1001058.0,"Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, TRAZIMERA",2018-06-01 07:31:00-04:00,PFE,pfizer receives positive chmp opinion for oncology biosimilar trazimera,"{'neg': 0.0, 'neu': 0.69, 'pos': 0.31, 'compound': 0.5574}",positive,0.9994590878486633
988918,988918,1001060.0,U.S. FDA Expands Approval Of Pfizer's Xeljanz To Include Adults With Moderately To Severely Active Ulcerative Colitis,2018-05-30 11:56:00-04:00,PFE,u s fda expands approval of pfizers xeljanz to include adults with moderately to severely active ulcerative colitis,"{'neg': 0.124, 'neu': 0.579, 'pos': 0.298, 'compound': 0.4939}",positive,0.9995032548904419
988919,988919,1001061.0,Pfizer's XALKORI Receives FDA Breakthrough Therapy Designation in Two New Indications,2018-05-29 08:01:00-04:00,PFE,pfizers xalkori receives fda breakthrough therapy designation in two new indications,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9991756081581116
988920,988920,1001062.0,Novartis Gets Approval For Remicade Biosimilar In Europe,2018-05-25 13:51:00-04:00,PFE,novartis gets approval for remicade biosimilar in europe,"{'neg': 0.0, 'neu': 0.693, 'pos': 0.307, 'compound': 0.4767}",positive,0.9893779158592224
988921,988921,1001063.0,Justice Dept. Says Pfizer Agrees To Pay $23.85M To Resolve Allegations That It Paid Kickbacks Through A Co-Pay Assistance Foundation,2018-05-24 10:06:00-04:00,PFE,justice dept says pfizer agrees to pay dollars 3.85 million to resolve allegations that it paid kickbacks through a co pay assistance foundation,"{'neg': 0.098, 'neu': 0.629, 'pos': 0.273, 'compound': 0.7184}",positive,0.9994316697120667
988922,988922,1001064.0,Pfizer Reports FDA Granted Breakthrough Therapy Designation For Tafamidis For Treatment Of Patients With Transthyretin Cardiomyopathy,2018-05-23 08:04:00-04:00,PFE,pfizer reports fda granted breakthrough therapy designation for tafamidis for treatment of patients with transthyretin cardiomyopathy,"{'neg': 0.0, 'neu': 0.882, 'pos': 0.118, 'compound': 0.25}",positive,0.9995774626731873
988923,988923,1001065.0,Pfizer Reports Study Of Prevnar 13 In Adults Age 65+ Showed Association With Reduced Risk Of Hospitalization From Vaccine-Type Community-Acquired Pneumonia In Older Adults,2018-05-22 13:32:00-04:00,PFE,pfizer reports study of prevnar 13 in adults age 65 showed association with reduced risk of hospitalization from vaccine type community acquired pneumonia in older adults,"{'neg': 0.077, 'neu': 0.923, 'pos': 0.0, 'compound': -0.2732}",positive,0.9993451237678528
988924,988924,1001066.0,Pfizer Begins Phase 1/2 Study To Evaluate Respiratory Syncytial Virus (RSV) Vaccine,2018-05-22 08:06:00-04:00,PFE,pfizer begins phase .5 study to evaluate respiratory syncytial virus rsv vaccine,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998890161514282
988925,988925,1001067.0,"Spark Therapeutics, Pfizer Announce Data from 15 Participants with Hemophilia B Showing Persistent and Sustained Factor IX Levels with No Serious Adverse Events",2018-05-22 03:47:00-04:00,PFE,spark therapeutics pfizer announce data from 15 participants with hemophilia b showing persistent and sustained factor ix levels with no serious adverse events,"{'neg': 0.0, 'neu': 0.793, 'pos': 0.207, 'compound': 0.4993}",neutral,0.9915391802787781
988926,988926,1001068.0,12 Dow 30 Companies With Above-Average Salaries,2018-05-19 17:21:00-04:00,PFE,12 dow 30 companies with above average salaries,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998694658279419
988927,988927,1001069.0,"UPDATE: FDA Offers Guidelines, Background For Reference Listed Drug Access Inquiries, Related To Claim Of Blocking Generic Rivals",2018-05-17 12:38:00-04:00,PFE,update fda offers guidelines background for reference listed drug access inquiries related to claim of blocking generic rivals,"{'neg': 0.133, 'neu': 0.867, 'pos': 0.0, 'compound': -0.3818}",neutral,0.9998770952224731
988928,988928,1001070.0,"FDA Commissioner Scot Gottlieb Highlights List Of Cos. Which Have Potentially Blocked Access To Samples Of Their Branded Products: Pfizer, Biogen, INSYS, VIVUS, Valeant, Corcept Therapeutics",2018-05-17 09:57:00-04:00,PFE,fda commissioner scot gottlieb highlights list of cos which have potentially blocked access to samples of their branded products pfizer biogen insys vivus valeant corcept therapeutics,"{'neg': 0.077, 'neu': 0.923, 'pos': 0.0, 'compound': -0.2732}",negative,0.9741878509521484
988929,988929,1001071.0,PreMarket Prep Opening NYSE Imbalance Update: Alibaba 118k Shares To Sell; Pfizer 111k To Sell; Square 60k To Sell; Walmart 51k To Buy; GE 107k To Buy,2018-05-17 08:52:00-04:00,PFE,premarket prep opening nyse imbalance update alibaba 118 thousand shares to sell pfizer 111 thousand to sell square 60 thousand to sell walmart 51 thousand to buy ge 107 thousand to buy,"{'neg': 0.0, 'neu': 0.934, 'pos': 0.066, 'compound': 0.296}",neutral,0.9998621940612793
988930,988930,1001072.0,Pfizer Reports LYRICA Oral Solution CV Phase 3 Trial In Pediatric Epilepsy Met Primary Endpoint,2018-05-17 08:03:00-04:00,PFE,pfizer reports lyrica oral solution cv phase 3 trial in pediatric epilepsy met primary endpoint,"{'neg': 0.0, 'neu': 0.859, 'pos': 0.141, 'compound': 0.3182}",neutral,0.9987685084342957
988931,988931,1001073.0,Pfizer Reports Biosimilar RETACRIT Approved By FDA,2018-05-15 14:40:00-04:00,PFE,pfizer reports biosimilar retacrit approved by fda,"{'neg': 0.0, 'neu': 0.682, 'pos': 0.318, 'compound': 0.4215}",neutral,0.9996080994606018
988932,988932,1001074.0,FDA Says It Granted Approval of Retacrit To Pfizer Co. Hospira,2018-05-15 11:46:00-04:00,PFE,fda says it granted approval of retacrit to pfizer co hospira,"{'neg': 0.0, 'neu': 0.638, 'pos': 0.362, 'compound': 0.6249}",positive,0.9991284012794495
988933,988933,1001075.0,"Jim Cramer Gives His Opinion On Exxon Mobil, Pfizer And Cisco",2018-05-09 07:12:00-04:00,PFE,jim cramer gives his opinion on exxon mobil pfizer and cisco,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998432397842407
988934,988934,1001076.0,UPDATE: Pfizer Says Apr. EpiPen Shipments Exceeded Projections,2018-05-08 15:18:00-04:00,PFE,update pfizer says apr epipen shipments exceeded projections,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994038343429565
988935,988935,1001077.0,"Pfizer, Manufacturer Of Mylan's EpiPen, Says It Is Currently Shipping Product, Shipments Have Been Increasing Over Last Few Months",2018-05-08 15:17:00-04:00,PFE,pfizer manufacturer of mylans epipen says it is currently shipping product shipments have been increasing over last few months,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995673298835754
988936,988936,1001078.0,"Mylan Says Is Currently Receiving Continual Supply Of EpiPen From Meridian Medical Technologies, Informed FDA 'Few Months Ago' It Had Intermittent Supply Constraints, Cited Manufacturing Delays From Pfizer",2018-05-08 15:00:00-04:00,PFE,mylan says is currently receiving continual supply of epipen from meridian medical technologies informed fda few months ago it had intermittent supply constraints cited manufacturing delays from pfizer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9941444993019104
988937,988937,1001079.0,"Mylan Shares Drop Sharply, Hearing Epipen Is Said To Be In Short Supply After Manufacturing Issues",2018-05-08 13:54:00-04:00,PFE,mylan shares drop sharply hearing epipen is said to be in short supply after manufacturing issues,"{'neg': 0.115, 'neu': 0.765, 'pos': 0.12, 'compound': 0.0258}",negative,0.9984856247901917
988938,988938,1001080.0,Xtalpi Announces Strategic Research Partnership With Pfizer TO Develop A Hybrid Physics And AI-Powered Software Platform,2018-05-08 10:33:00-04:00,PFE,xtalpi announces strategic research partnership with pfizer to develop a hybrid physics and ai powered software platform,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9714473485946655
988939,988939,1001081.0,Portola Pharma Rips 20% Higher After FDA Approves Andexxa Antidote,2018-05-04 14:14:00-04:00,PFE,portola pharma rips 20 percent higher after fda approves andexxa antidote,"{'neg': 0.0, 'neu': 0.787, 'pos': 0.213, 'compound': 0.4019}",positive,0.9995161294937134
988940,988940,1001082.0,PreMarket Prep Opening NYSE Imbalance Update: Coca-Cola 155k Shares To Buy; Alibaba 87k To Buy; AT&T 46k to Buy; Pfizer 43k To Buy; General Electric 159k To Buy; Square 168k To Sell; Verizon 47k To Buy,2018-05-03 09:06:00-04:00,PFE,premarket prep opening nyse imbalance update coca cola 155 thousand shares to buy alibaba 87 thousand to buy at and t 46 thousand to buy pfizer 43 thousand to buy general electric 159 thousand to buy square 168 thousand to sell verizon 47 thousand to buy,"{'neg': 0.0, 'neu': 0.953, 'pos': 0.047, 'compound': 0.296}",neutral,0.999864935874939
988941,988941,1001083.0,Mid-Afternoon Market Update: NASDAQ Up 0.5%; Inogen Shares Spike Higher,2018-05-01 15:01:00-04:00,PFE,mid afternoon market update nasdaq up 0.5 percent inogen shares spike higher,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.296}",positive,0.9996218681335449
988942,988942,1001084.0,Mid-Day Market Update: Crude Oil Down 1.8%;  Nutrisystem Shares Climb On Upbeat Earnings,2018-05-01 12:15:00-04:00,PFE,mid day market update crude oil down 1.8 percent nutrisystem shares climb on upbeat earnings,"{'neg': 0.196, 'neu': 0.688, 'pos': 0.116, 'compound': -0.3612}",positive,0.9756233096122742
988943,988943,1001085.0,Mid-Morning Market Update: Markets Open Lower; Pfizer Posts Mixed Q1 Results,2018-05-01 10:38:00-04:00,PFE,mid morning market update markets open lower pfizer posts mixed first quarter results,"{'neg': 0.155, 'neu': 0.845, 'pos': 0.0, 'compound': -0.296}",negative,0.997276246547699
988944,988944,1001086.0,"Apple Results, Fed Decision, Jobs Report In Focus; Merck, Pfizer Reports Mixed",2018-05-01 10:23:00-04:00,PFE,apple results fed decision jobs report in focus merck pfizer reports mixed,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9490452408790588
988945,988945,1001087.0,"Pfizer CEO Says Co. Hasn't Received An Acceptable Offer For Its Consumer Health Business, May Decide To Retain It",2018-05-01 10:12:00-04:00,PFE,pfizer ceo says co hasnt received an acceptable offer for its consumer health business may decide to retain it,"{'neg': 0.098, 'neu': 0.902, 'pos': 0.0, 'compound': -0.2411}",positive,0.9979992508888245
988946,988946,1001088.0,Pfizer Has Not Received Acceptable Offer For Its Consumer Health Unit,2018-05-01 10:11:00-04:00,PFE,pfizer has not received acceptable offer for its consumer health unit,"{'neg': 0.164, 'neu': 0.836, 'pos': 0.0, 'compound': -0.2411}",negative,0.9597296118736267
988947,988947,1001089.0,"A Peek Into The Markets: US Stock Futures Flat, Apple Earnings In Focus",2018-05-01 07:56:00-04:00,PFE,a peek into the markets us stock futures flat apple earnings in focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998674392700195
988948,988948,1001090.0,"Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings",2018-05-01 07:51:00-04:00,PFE,benzingas daily biotech pulse karyopharms storm study inogen rallies on earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9986876845359802
988949,988949,1001091.0,Pfizer Reaffirms FY18 Guidance,2018-05-01 06:50:00-04:00,PFE,pfizer reaffirms fy18 guidance,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9976245760917664
988950,988950,1001092.0,"Pfizer Reports Q1 Adj. EPS $0.77 Beats $0.75 Est., Sales $12.91B Misses $13.15B Est.",2018-05-01 06:49:00-04:00,PFE,pfizer reports first quarter adj eps dollars .77 beats dollars .75 est sales dollars 2.91 billion misses dollars 3.15 billion est,"{'neg': 0.087, 'neu': 0.913, 'pos': 0.0, 'compound': -0.2263}",neutral,0.9998239874839783
988951,988951,1001093.0,"15 Stocks To Watch For May 1, 2018",2018-05-01 05:02:00-04:00,PFE,15 stocks to watch for may 1 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998644590377808
988952,988952,1001094.0,"Earnings Scheduled For May 1, 2018",2018-05-01 04:59:00-04:00,PFE,earnings scheduled for may 1 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998797178268433
988953,988953,1001095.0,Upcoming Earnings: Tech Giant Apple Reports After Tuesday's Close,2018-04-30 12:14:00-04:00,PFE,upcoming earnings tech giant apple reports after tuesdays close,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998692274093628
988954,988954,1001096.0,Pharmaceutical Earnings: Pfizer And Merck Are Slated To Report Tuesday Morning,2018-04-30 11:58:00-04:00,PFE,pharmaceutical earnings pfizer and merck are slated to report tuesday morning,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998679161071777
988955,988955,1001097.0,"Busy Week Begins With McDonald's Beating Estimates; Fed Meeting, Jobs Data Loom",2018-04-30 10:07:00-04:00,PFE,busy week begins with mcdonalds beating estimates fed meeting jobs data loom,"{'neg': 0.329, 'neu': 0.671, 'pos': 0.0, 'compound': -0.5994}",neutral,0.9994144439697266
988956,988956,1001098.0,"The Week Ahead In Biotech: PDUFA Dates, Clinical Trials, Merck And Pfizer Earnings On Tap",2018-04-29 08:11:00-04:00,PFE,the week ahead in biotech pdufa dates clinical trials merck and pfizer earnings on tap,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998272061347961
988957,988957,1001099.0,Upcoming Earnings: McDonald's Reports On Monday As It Continues On New Growth Plan,2018-04-27 15:38:00-04:00,PFE,upcoming earnings mcdonalds reports on monday as it continues on new growth plan,"{'neg': 0.0, 'neu': 0.822, 'pos': 0.178, 'compound': 0.3818}",neutral,0.9998611211776733
988958,988958,1001100.0,Earnings Preview: Oil Giants Chevron And ExxonMobil Report Friday Morning,2018-04-26 12:18:00-04:00,PFE,earnings preview oil giants chevron and exxonmobil report friday morning,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998679161071777
988959,988959,1001101.0,PreMarket Prep Opening NYSE Imbalance Update: Verizon 90k Shares To Sell; Pfizer 164k Shares To Sell; Bank Of America 105k Shares To Sell; Altria 68 To Sell; Walmart 19k To Sell; Square 203k Shares To Buy,2018-04-25 08:51:00-04:00,PFE,premarket prep opening nyse imbalance update verizon 90 thousand shares to sell pfizer 164 thousand shares to sell bank of america 105 thousand shares to sell altria 68 to sell walmart 19 thousand to sell square 203 thousand shares to buy,"{'neg': 0.0, 'neu': 0.808, 'pos': 0.192, 'compound': 0.7783}",neutral,0.9998704195022583
988960,988960,1001102.0,Earnings Preview: Checking In On The Automakers With Reports From Ford And GM Coming Up,2018-04-24 12:54:00-04:00,PFE,earnings preview checking in on the automakers with reports from ford and gm coming up,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998825788497925
988961,988961,1001103.0,"Top Ideas From The 2018 Sohn Conference: Box, Bitcoin, Facebook, Palo Alto And More",2018-04-23 18:23:00-04:00,PFE,top ideas from the 2018 sohn conference box bitcoin facebook palo alto and more,"{'neg': 0.0, 'neu': 0.878, 'pos': 0.122, 'compound': 0.2023}",neutral,0.9998838901519775
988962,988962,1001104.0,"'Palihapitiya: major companies are already using $BOX services, everything from $PFE to $AMZN, etc. It has 10 million paid subscribers and has been consistently growing revenue. #sohn2018'- MarketWatch's Ryan Vlastelica Tweet",2018-04-23 13:17:00-04:00,PFE,palihapitiya major companies are already using box services everything from pfe to amzn etc it has 10 million paid subscribers and has been consistently growing revenue to marketwatchs ryan vlastelica tweet,"{'neg': 0.0, 'neu': 0.946, 'pos': 0.054, 'compound': 0.1779}",positive,0.9996981620788574
988963,988963,1001105.0,"From Sohn Conference: Ecor1's Nodelman On Ascendis Pharma Highlighted 10 Potential Buyers Of Co., Including Eli Lilly, Pfizer",2018-04-23 10:58:00-04:00,PFE,from sohn conference ecor1 nodelman on ascendis pharma highlighted 10 potential buyers of co including eli lilly pfizer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998145699501038
988964,988964,1001106.0,Pfizer Granted FDA Breakthrough Therapy Designation for TRUMENBA,2018-04-23 08:06:00-04:00,PFE,pfizer granted fda breakthrough therapy designation for trumenba,"{'neg': 0.0, 'neu': 0.778, 'pos': 0.222, 'compound': 0.25}",positive,0.9992076754570007
988965,988965,1001107.0,Pfizer Gets Feedback from the RDA that Additional Information is Needed for its Trastuzumab Biosimilar,2018-04-23 07:48:00-04:00,PFE,pfizer gets feedback from the rda that additional information is needed for its trastuzumab biosimilar,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998559951782227
988966,988966,1001108.0,Pfizer Received A Complete Response Letter From The FDA In Response To the Biologics License Application For The Co.'s Proposed trastumzumab Biosimilar,2018-04-23 07:46:00-04:00,PFE,pfizer received a complete response letter from the fda in response to the biologics license application for the co s proposed trastumzumab biosimilar,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996544122695923
988967,988967,1001109.0,"Pfizer's MYLOTARG Approved In The EU For The Treatment Of Previously Untreated, De Novo, CD33-positive Acute Myeloid Leukemia In Combination With Chemotherapy",2018-04-23 07:33:00-04:00,PFE,pfizers mylotarg approved in the eu for the treatment of previously untreated de novo cd33 positive acute myeloid leukemia in combination with chemotherapy,"{'neg': 0.0, 'neu': 0.766, 'pos': 0.234, 'compound': 0.7506}",neutral,0.9871023297309875
988968,988968,1001110.0,"FDA Staff Review Of Eli Lilly's Rheumatoid Arthritis Treatment Says Supportive Of 2mg Dose, But Not 4mg Dose",2018-04-19 07:58:00-04:00,PFE,fda staff review of eli lillys rheumatoid arthritis treatment says supportive of 2 million g dose but not 4 million g dose,"{'neg': 0.0, 'neu': 0.929, 'pos': 0.071, 'compound': 0.1531}",neutral,0.9998452663421631
988969,988969,1001111.0,"Health Canada Is Working With FDA, Pfizer Related To Addressing Canadian Shortage Of Mylan's Epipen",2018-04-17 14:50:00-04:00,PFE,health canada is working with fda pfizer related to addressing canadian shortage of mylans epipen,"{'neg': 0.125, 'neu': 0.875, 'pos': 0.0, 'compound': -0.25}",neutral,0.9993352293968201
988970,988970,1001112.0,Pfizer Reports Dosing Of First Patient In Investigational Mini-Dystrophin Gene Therapy For Treatment Of Duchenne Muscular Dystrophy,2018-04-12 08:00:00-04:00,PFE,pfizer reports dosing of first patient in investigational mini dystrophin gene therapy for treatment of duchenne muscular dystrophy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996751546859741
988971,988971,1001113.0,PreMarket Prep Opening NYSE Imbalance Update: Pfizer 149k Shares To Buy: ExxonMobil 81k Shares To Buy; Merck 50k Shares To Buy; General Electric 114k Shares To Sell; Ford 42k Shares To Buy,2018-04-11 08:59:00-04:00,PFE,premarket prep opening nyse imbalance update pfizer 149 thousand shares to buy exxonmobil 81 thousand shares to buy merck 50 thousand shares to buy general electric 114 thousand shares to sell ford 42 thousand shares to buy,"{'neg': 0.0, 'neu': 0.744, 'pos': 0.256, 'compound': 0.8402}",neutral,0.9998687505722046
988972,988972,1001114.0,Pfizer Reports  Data Monitoring Committee For Phase 3 ATLAS Trial Recommended Stopping The Trail At A Planned Interim Analysis Due To Futility,2018-04-10 14:03:00-04:00,PFE,pfizer reports data monitoring committee for phase 3 atlas trial recommended stopping the trail at a planned interim analysis due to futility,"{'neg': 0.068, 'neu': 0.855, 'pos': 0.077, 'compound': 0.0516}",neutral,0.7572870254516602
988973,988973,1001115.0,"Benzinga's Top Upgrades, Downgrades For April 5, 2018",2018-04-05 09:23:00-04:00,PFE,benzingas top upgrades downgrades for april 5 2018,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",positive,0.9694849252700806
988974,988974,1001116.0,"The Market In 5 Minutes: Ackman, Amazon, AMD And More",2018-04-05 09:00:00-04:00,PFE,the market in 5 minutes ackman amazon amd and more,"{'neg': 0.0, 'neu': 0.841, 'pos': 0.159, 'compound': 0.1779}",neutral,0.9998816251754761
988975,988975,1001117.0,Barclays Downgrades Pfizer to Equal-Weight,2018-04-05 06:39:00-04:00,PFE,barclays downgrades pfizer to equal weight,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9938275218009949
988976,988976,1001118.0,Pfizer Announces U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Dacomitinib,2018-04-04 08:00:00-04:00,PFE,pfizer announces u s fda and european medicines agency accept regulatory submissions for review of dacomitinib,"{'neg': 0.0, 'neu': 0.852, 'pos': 0.148, 'compound': 0.3818}",neutral,0.9998434782028198
988977,988977,1001119.0,Pfizer In Discussions With P&G Related To Sale Of Consumer Business,2018-04-03 10:29:00-04:00,PFE,pfizer in discussions with p and g related to sale of consumer business,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998914003372192
988978,988978,1001120.0,"Pfizer, Allogene Therapeutics Enter into Asset Contribution Agreement for Pfizer's Allogeneic CAR T Immuno-oncology Portfolio",2018-04-03 08:02:00-04:00,PFE,pfizer allogene therapeutics enter into asset contribution agreement for pfizers allogeneic car t immuno oncology portfolio,"{'neg': 0.0, 'neu': 0.711, 'pos': 0.289, 'compound': 0.6908}",positive,0.990459680557251
988979,988979,1001121.0,"With Alnylam Pharma Down More Than 15%, Analyst Says Buy The Dip",2018-04-02 14:04:00-04:00,PFE,with alnylam pharma down more than 15 percent analyst says buy the dip,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9979159235954285
988980,988980,1001122.0,UPDATE: B. Riley FBR Offered 3 Reasons To Buy The Weakness In Alnylam Following Pfizer News On ATTR-ACT,2018-04-02 11:19:00-04:00,PFE,update b riley fbr offered 3 reasons to buy the weakness in alnylam following pfizer news on attr act,"{'neg': 0.135, 'neu': 0.865, 'pos': 0.0, 'compound': -0.4215}",negative,0.994915246963501
988981,988981,1001123.0,"Smoking Is Just One Way To Use Marijuana: An Introduction To Vaporizers, Edibles, Oils, Tinctures, Dabs And Other Cannabis Products",2018-03-30 09:37:00-04:00,PFE,smoking is just one way to use marijuana an introduction to vaporizers edibles oils tinctures dabs and other cannabis products,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998772144317627
988982,988982,1001124.0,"Alnylam Pharma Shares Down ~3.5% Over Last Few Mins, Ionis Pharma Down 2.8%, Akcea Down 2.5% Following Results From Pfizer Related To Its Tafamidis News",2018-03-29 12:58:00-04:00,PFE,alnylam pharma shares down 3.5 percent over last few mins ionis pharma down 2.8 percent akcea down 2.5 percent following results from pfizer related to its tafamidis news,"{'neg': 0.0, 'neu': 0.925, 'pos': 0.075, 'compound': 0.296}",negative,0.9983034133911133
988983,988983,1001125.0,"Pfizer Announces Results From Phase 3 ATTR-ACT Study of Tafamidis, Met Its Primary Endpoint",2018-03-29 12:45:00-04:00,PFE,pfizer announces results from phase 3 attr act study of tafamidis met its primary endpoint,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997912049293518
988984,988984,1001126.0,GlaxoSmithKline To Buy Novartis' Stake in Consumer Health Care JV For $13 Billion,2018-03-27 10:53:00-04:00,PFE,glaxosmithkline to buy novartis stake in consumer health care jv for dollars 3 billion,"{'neg': 0.0, 'neu': 0.802, 'pos': 0.198, 'compound': 0.4939}",neutral,0.9998183846473694
988985,988985,1001127.0,Pfizer Reports Top-Line Results From CHANTIX/CHAMPIX Study In Adolescent Smokers: Did Not Meet Primary Endpoint,2018-03-23 08:00:00-04:00,PFE,pfizer reports top line results from chantix and champix study in adolescent smokers did not meet primary endpoint,"{'neg': 0.0, 'neu': 0.904, 'pos': 0.096, 'compound': 0.2023}",neutral,0.9997398257255554
988986,988986,1001128.0,"Glaxo, Pfizer's ViiV Healthcare Reports Winning Of Positive CHMP Opinion For Juluca In Europe Recommending Marketing Authorization",2018-03-23 07:32:00-04:00,PFE,glaxo pfizers viiv healthcare reports winning of positive chmp opinion for juluca in europe recommending marketing authorization,"{'neg': 0.0, 'neu': 0.682, 'pos': 0.318, 'compound': 0.7906}",positive,0.9996188879013062
988987,988987,1001129.0,"ICYMI: GameStop, Omeros, Congress Impacts Biotechs",2018-03-23 06:56:00-04:00,PFE,icymi gamestop omeros congress impacts biotechs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998511075973511
988988,988988,1001130.0,GlaxsoSmithKline did Not Submit Final Bid for Pfizer's Consumer Healthcare Unit,2018-03-23 06:15:00-04:00,PFE,glaxsosmithkline did not submit final bid for pfizers consumer healthcare unit,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.99986732006073
988989,988989,1001131.0,"Pfizer Says Continues to Evaluate Potential Strategic Alternatives for Consumer Healthcare Business, Including Spin-off, Sale; Says Expects Decision in 2018",2018-03-23 04:56:00-04:00,PFE,pfizer says continues to evaluate potential strategic alternatives for consumer healthcare business including spin off sale says expects decision in 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9992762207984924
988990,988990,1001132.0,Biotech Winners And Losers From Congress' Latest Funding Bill,2018-03-22 11:46:00-04:00,PFE,biotech winners and losers from congress latest funding bill,"{'neg': 0.252, 'neu': 0.519, 'pos': 0.23, 'compound': -0.0772}",neutral,0.9982481002807617
988991,988991,1001133.0,Reckitt Benckiser Ends Discussions with Pfizer over Purchase of Consumer Healthcare Business,2018-03-22 04:29:00-04:00,PFE,reckitt benckiser ends discussions with pfizer over purchase of consumer healthcare business,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998152852058411
988992,988992,1001134.0,Checking In On The Healthcare Sector Ahead Of Q1 Earnings Season,2018-03-20 11:29:00-04:00,PFE,checking in on the healthcare sector ahead of first quarter earnings season,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998154044151306
988993,988993,1001135.0,U.S. FDA Grants Priority Review for a Supplemental New Drug Application (sNDA) for XTANDI,2018-03-19 16:15:00-04:00,PFE,u s fda grants priority review for a supplemental new drug application snda for xtandi,"{'neg': 0.0, 'neu': 0.881, 'pos': 0.119, 'compound': 0.2263}",positive,0.684082567691803
988994,988994,1001136.0,BioDuro Partnership with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent,2018-03-19 07:05:00-04:00,PFE,bioduro partnership with pfizer inc leads to creation of a shelf stable fluorosulfation reagent,"{'neg': 0.0, 'neu': 0.736, 'pos': 0.264, 'compound': 0.5106}",positive,0.7474039793014526
988995,988995,1001137.0,Biogen to Acquire a Phase 2b Ready Asset for Cognitive Impairment from Pfizer for $75M Upfront and Up to $515M in Milestones and Royalties,2018-03-12 07:34:00-04:00,PFE,biogen to acquire a phase 2 billion ready asset for cognitive impairment from pfizer for dollars 5 million upfront and up to dollars 15 million in milestones and royalties,"{'neg': 0.0, 'neu': 0.844, 'pos': 0.156, 'compound': 0.6124}",neutral,0.9998408555984497
988996,988996,1001138.0,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",2018-03-11 16:58:00-04:00,PFE,the week ahead in biotech earnings pdufa dates and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998695850372314
988997,988997,1001139.0,Pfizer Release Confirms FDA Panel On XELJANZ For Moderately-To-Severely Active UC Voted In Favor (15-0) On 2 Dosing Questions,2018-03-08 16:52:00-05:00,PFE,pfizer release confirms fda panel on xeljanz for moderately to severely active uc voted in favor 15 to 0 on 2 dosing questions,"{'neg': 0.106, 'neu': 0.704, 'pos': 0.19, 'compound': 0.34}",neutral,0.999393105506897
988998,988998,1001140.0,FDA Advisory Panel Votes In Favor Of Pfizer's Xeljanz For Patients With Moderate to Severe Ulcerative Colitis,2018-03-08 14:18:00-05:00,PFE,fda advisory panel votes in favor of pfizers xeljanz for patients with moderate to severe ulcerative colitis,"{'neg': 0.128, 'neu': 0.739, 'pos': 0.133, 'compound': 0.0258}",neutral,0.9995467066764832
988999,988999,1001141.0,REMINDER: Pfizer Has FDA AdCom Meeting Regarding Xeljanz for Ulcerative Colitis Today,2018-03-08 07:32:00-05:00,PFE,reminder pfizer has fda adcom meeting regarding xeljanz for ulcerative colitis today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997969269752502
989000,989000,1001142.0,Height Casts 65% Odds That Congress Rolls Back Pharma Discounts,2018-03-07 11:31:00-05:00,PFE,height casts 65 percent odds that congress rolls back pharma discounts,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9960726499557495
989001,989001,1001143.0,PreMarket Prep Opening Imbalance Update: Square 215k Shares To Sell; Salesforce 43K To Sell; GE 96k To Buy; Alibaba 68k To Sell; Twitter 25k To Sell; Pfizer 56k To Sell; ConocoPhillips 27k To Sell,2018-03-07 08:35:00-05:00,PFE,premarket prep opening imbalance update square 215 thousand shares to sell salesforce 43 thousand to sell ge 96 thousand to buy alibaba 68 thousand to sell twitter 25 thousand to sell pfizer 56 thousand to sell conocophillips 27 thousand to sell,"{'neg': 0.0, 'neu': 0.948, 'pos': 0.052, 'compound': 0.296}",neutral,0.9998754262924194
989002,989002,1001144.0,The Week Ahead: Discount Retailers Close Out Earnings Season,2018-03-05 14:17:00-05:00,PFE,the week ahead discount retailers close out earnings season,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998359680175781
989003,989003,1001145.0,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",2018-03-02 14:12:00-05:00,PFE,the week ahead in biotech earnings pdufa dates and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998695850372314
989004,989004,1001146.0,Vetr Crowd Upgrades Pfizer,2018-03-02 07:21:00-05:00,PFE,vetr crowd upgrades pfizer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9953802824020386
989005,989005,1001147.0,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,2018-02-28 10:08:00-05:00,PFE,attention biotech investors mark your calendar for these march pdufa dates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998832941055298
989006,989006,1001148.0,Pfizer Filing Shows Registration For Mixed Securities Shelf Offering,2018-02-26 16:14:00-05:00,PFE,pfizer filing shows registration for mixed securities shelf offering,"{'neg': 0.0, 'neu': 0.784, 'pos': 0.216, 'compound': 0.296}",neutral,0.9998733997344971
989007,989007,1001149.0,"Pfizer Receives Positive CHMP Opinion for Two Hematology Medicines, MYLOTARG and BOSULIF",2018-02-23 09:00:00-05:00,PFE,pfizer receives positive chmp opinion for two hematology medicines mylotarg and bosulif,"{'neg': 0.0, 'neu': 0.753, 'pos': 0.247, 'compound': 0.5574}",positive,0.9994441866874695
989008,989008,1001150.0,Pfizer Says EMA Has Recommended Against Expanding Use Of SUTENT To Include Adjuvant Treatment Of Adult Patients At High Risk Of RCC Following Nephrectomy,2018-02-23 08:33:00-05:00,PFE,pfizer says ema has recommended against expanding use of sutent to include adjuvant treatment of adult patients at high risk of rcc following nephrectomy,"{'neg': 0.081, 'neu': 0.849, 'pos': 0.069, 'compound': -0.0772}",neutral,0.9963996410369873
989009,989009,1001151.0,Solid Biosciences Snags Bullish Initiation As It Develops Gene Therapy For Muscular Dystrophy,2018-02-21 09:18:00-05:00,PFE,solid biosciences snags bullish initiation as it develops gene therapy for muscular dystrophy,"{'neg': 0.0, 'neu': 0.882, 'pos': 0.118, 'compound': 0.1531}",negative,0.7415745258331299
989010,989010,1001152.0,Goldman Sachs Gets Firm On Solid Biosciences,2018-02-20 13:25:00-05:00,PFE,goldman sachs gets firm on solid biosciences,"{'neg': 0.0, 'neu': 0.789, 'pos': 0.211, 'compound': 0.1531}",positive,0.9993098974227905
989011,989011,1001153.0,How McKesson Will Stand The Test Of Amazon,2018-02-20 11:06:00-05:00,PFE,how mckesson will stand the test of amazon,"{'neg': 0.0, 'neu': 0.805, 'pos': 0.195, 'compound': 0.1779}",neutral,0.9998548030853271
989012,989012,1001154.0,PreMarket Prep Opening NYSE Imbalance Update: 186k Shares To Sell; MS 60k sell; Twitter 68k Share To Sell; Nike 41k Shares To Sell; Square 41 Shares To Buy; Pfizer 81k Shares To Sell,2018-02-20 08:33:00-05:00,PFE,premarket prep opening nyse imbalance update 186 thousand shares to sell ms 60 thousand sell twitter 68 thousand share to sell nike 41 thousand shares to sell square 41 shares to buy pfizer 81 thousand shares to sell,"{'neg': 0.0, 'neu': 0.75, 'pos': 0.25, 'compound': 0.8402}",neutral,0.9998593330383301
989013,989013,1001155.0,Spark Therapeutics to Manufacture and Deliver SPARK-9001 to Pfizer in a $14M Agreement,2018-02-20 07:56:00-05:00,PFE,spark therapeutics to manufacture and deliver spark 9001 to pfizer in a dollars 4 million agreement,"{'neg': 0.0, 'neu': 0.65, 'pos': 0.35, 'compound': 0.7184}",neutral,0.9998888969421387
989014,989014,1001156.0,Deciphera Pharma Scores A Sell-Side Recommendation,2018-02-16 12:59:00-05:00,PFE,deciphera pharma scores a sell side recommendation,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992326498031616
989015,989015,1001157.0,Cramer Looks At The Dow's Biggest Losers,2018-02-14 10:31:00-05:00,PFE,cramer looks at the dows biggest losers,"{'neg': 0.362, 'neu': 0.638, 'pos': 0.0, 'compound': -0.5267}",negative,0.9795721173286438
989016,989016,1001158.0,Pfizer Receives Breakthrough Therapy Designation from FDA for PF-04965842,2018-02-14 08:32:00-05:00,PFE,pfizer receives breakthrough therapy designation from fda for pf 04965842,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9983841180801392
989017,989017,1001159.0,Premarket Opening NYSE Imbalance Update: Pfizer 217k Shares To Buy; ExxonMobil 176k Shares To Buy; Proctor & Gamble 123k Shares To Buy; General Electric 339k Shares To Buy; American Express 20k Shares To Buy; Boeing 32k Shares To Buy,2018-02-12 08:56:00-05:00,PFE,premarket opening nyse imbalance update pfizer 217 thousand shares to buy exxonmobil 176 thousand shares to buy proctor and gamble 123 thousand shares to buy general electric 339 thousand shares to buy american express 20 thousand shares to buy boeing 32 thousand shares to buy,"{'neg': 0.0, 'neu': 0.747, 'pos': 0.253, 'compound': 0.8807}",neutral,0.9998593330383301
989018,989018,1001160.0,"U.S., EU and Japan Health Authorities Accept Regulatory Submissions for Review of Pfizer's Third-Generation ALK Inhibitor Lorlatinib, U.S. New Drug Application Granted FDA Priority Review",2018-02-12 08:10:00-05:00,PFE,u s eu and japan health authorities accept regulatory submissions for review of pfizers third generation alk inhibitor lorlatinib u s new drug application granted fda priority review,"{'neg': 0.042, 'neu': 0.809, 'pos': 0.149, 'compound': 0.5106}",neutral,0.8801926970481873
989019,989019,1001161.0,Pfizer Announces the FDA Accepted and Granted Priority Review to the Company's NDA for Lorlantinib,2018-02-12 08:03:00-05:00,PFE,pfizer announces the fda accepted and granted priority review to the companys nda for lorlantinib,"{'neg': 0.0, 'neu': 0.76, 'pos': 0.24, 'compound': 0.4767}",positive,0.9917524456977844
989020,989020,1001162.0,The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease,2018-02-08 09:41:00-05:00,PFE,the alzheimers drug pipeline high failure rates in research on an increasingly common disease,"{'neg': 0.202, 'neu': 0.798, 'pos': 0.0, 'compound': -0.5106}",negative,0.9946730732917786
989021,989021,1001163.0,PreMarket Opening NYSE Imbalance Update: Twitter 206k Shares To Buy; Alibaba 60k Shares To Buy; Proctor Gamble 25k Shares Buy; Pfizer 35k Shares To Buy; Ford 71k Shares To Buy; JP Morgan 33k Shares To Buy; Square 63k Shares To Buy,2018-02-08 08:35:00-05:00,PFE,premarket opening nyse imbalance update twitter 206 thousand shares to buy alibaba 60 thousand shares to buy proctor gamble 25 thousand shares buy pfizer 35 thousand shares to buy ford 71 thousand shares to buy jp morgan 33 thousand shares to buy square 63 thousand shares to buy,"{'neg': 0.0, 'neu': 0.699, 'pos': 0.301, 'compound': 0.9217}",neutral,0.9998641014099121
989022,989022,1001164.0,GSK Says ‍ViiV Healthcare Launches New Two-Drug HIV Study,2018-02-08 04:42:00-05:00,PFE,gsk says ‍viiv healthcare launches new two drug hiv study,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9991219639778137
989023,989023,1001165.0,Worst Day In 6 Years Offers 8 Great Buying Opportunities,2018-02-06 09:39:00-05:00,PFE,worst day in 6 years offers 8 great buying opportunities,"{'neg': 0.23, 'neu': 0.393, 'pos': 0.376, 'compound': 0.3818}",positive,0.9804461598396301
989024,989024,1001166.0,"Astellas, Pfizer Report Phase 3 PROSPER Trial Shows XTANDI Significantly Reduced Risk Of Metastasis, Death By ~71% In Men With Non-Metastatic Castration-Resistant Prostate Cancer",2018-02-05 17:12:00-05:00,PFE,astellas pfizer report phase 3 prosper trial shows xtandi significantly reduced risk of metastasis death by 71 percent in men with non metastatic castration resistant prostate cancer,"{'neg': 0.302, 'neu': 0.698, 'pos': 0.0, 'compound': -0.886}",positive,0.9996224641799927
989025,989025,1001167.0,"Barclays Maintains Overweight on Pfizer, Raises Price Target to $41.00",2018-01-31 11:50:00-05:00,PFE,barclays maintains overweight on pfizer raises price target to dollars 1.00,"{'neg': 0.2, 'neu': 0.8, 'pos': 0.0, 'compound': -0.3612}",negative,0.9630298018455505
989026,989026,1001168.0,Mid-Afternoon Market Update: Dow Falls Over 300 Points; Callidus Software Shares Rise On Acquisition News,2018-01-30 14:32:00-05:00,PFE,mid afternoon market update dow falls over 300 points callidus software shares rise on acquisition news,"{'neg': 0.0, 'neu': 0.872, 'pos': 0.128, 'compound': 0.296}",positive,0.9993072748184204
989027,989027,1001169.0,"CNBC's Meg Tirrell Tweets 'Spoke w $PFE mgmt team after the call...about gene therapy safety concerns...pointed out none with $PFE $AVXS $ONCE $BMRN studies. Said...surprised Wilson & $SLDB ""didn't have any way to resolve"" concerns [properly]'",2018-01-30 12:48:00-05:00,PFE,cnbcs meg tirrell tweets spoke w pfe mgmt team after the call about gene therapy safety concerns pointed out none with pfe avxs once bmrn studies said surprised wilson and sldb didnt have any way to resolve concerns properly,"{'neg': 0.0, 'neu': 0.831, 'pos': 0.169, 'compound': 0.743}",neutral,0.9504445195198059
989028,989028,1001170.0,Mid-Day Market Update: Crude Oil Down 2%; Thomson Reuters Shares Spike Higher,2018-01-30 12:00:00-05:00,PFE,mid day market update crude oil down 2 percent thomson reuters shares spike higher,"{'neg': 0.207, 'neu': 0.67, 'pos': 0.123, 'compound': -0.3612}",negative,0.996992826461792
989029,989029,1001171.0,Hang On: Rate Fears In Focus As Futures Point Lower After Monday's Big Losses,2018-01-30 10:47:00-05:00,PFE,hang on rate fears in focus as futures point lower after mondays big losses,"{'neg': 0.412, 'neu': 0.588, 'pos': 0.0, 'compound': -0.7717}",negative,0.7133150696754456
989030,989030,1001172.0,From Pfizer Q4 Earnings Conference Call: Co. To Repatriate Majority Of Its Overseas Cash During '18,2018-01-30 10:36:00-05:00,PFE,from pfizer fourth quarter earnings conference call co to repatriate majority of its overseas cash during 18,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997298121452332
989031,989031,1001173.0,Mid-Morning Market Update: Markets Open Lower; Pfizer Beats Q4 Expectations,2018-01-30 10:18:00-05:00,PFE,mid morning market update markets open lower pfizer beats fourth quarter expectations,"{'neg': 0.167, 'neu': 0.833, 'pos': 0.0, 'compound': -0.296}",negative,0.998380184173584
989032,989032,1001174.0,Benzinga Pro's 7 Stocks To Watch Today,2018-01-30 09:19:00-05:00,PFE,benzinga pros 7 stocks to watch today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998375177383423
989033,989033,1001175.0,PreMarket Opening NYSE Imbalance Update: Coke 104k Shares To Sell; JP Morgan 111k To Sell; BofA 260k To Sell; Pfizer 361k to Sell; CVS 28k To Sell; Alibaba 86k To Sell; Juniper 33k To Sell; Twitter 95k To Buy,2018-01-30 09:11:00-05:00,PFE,premarket opening nyse imbalance update coke 104 thousand shares to sell jp morgan 111 thousand to sell bofa 260 thousand to sell pfizer 361 thousand to sell cvs 28 thousand to sell alibaba 86 thousand to sell juniper 33 thousand to sell twitter 95 thousand to buy,"{'neg': 0.051, 'neu': 0.87, 'pos': 0.079, 'compound': 0.1027}",neutral,0.9998722076416016
989034,989034,1001176.0,A Peek Into The Markets: U.S. Stock Futures Tumble Ahead Of Fed Meeting,2018-01-30 07:01:00-05:00,PFE,a peek into the markets u s stock futures tumble ahead of fed meeting,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9930523633956909
989035,989035,1001177.0,"Pfizer Sees FY18 Adj. EPS $2.90 to $3.00 vs $2.78 Est., Sales $53.5B to $55.5B vs $53.9B Est.",2018-01-30 06:49:00-05:00,PFE,pfizer sees fy18 adj eps dollars .90 to dollars .00 vs dollars .78 est sales dollars 3.5 billion to dollars 5.5 billion vs dollars 3.9 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998725652694702
989036,989036,1001178.0,"Pfizer Reports Q4 Adj. EPS $0.62 vs $0.56 Est., Sales $13.70B vs $13.68B Est.",2018-01-30 06:48:00-05:00,PFE,pfizer reports fourth quarter adj eps dollars .62 vs dollars .56 est sales dollars 3.70 billion vs dollars 3.68 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999876856803894
989037,989037,1001179.0,"10 Stocks To Watch For January 30, 2018",2018-01-30 04:24:00-05:00,PFE,10 stocks to watch for january 30 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998608827590942
989038,989038,1001180.0,"Earnings Scheduled For January 30, 2018",2018-01-30 04:02:00-05:00,PFE,earnings scheduled for january 30 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998809099197388
989039,989039,1001181.0,"The Week Ahead: Big Tech Earnings, Fed Rate Decision Likely To Dominate Headlines",2018-01-29 14:45:00-05:00,PFE,the week ahead big tech earnings fed rate decision likely to dominate headlines,"{'neg': 0.111, 'neu': 0.889, 'pos': 0.0, 'compound': -0.128}",neutral,0.9933607578277588
989040,989040,1001182.0,"PFE, LLY, MRK Write Up 'Scripts For Q4",2018-01-29 10:52:00-05:00,PFE,pfe lly mrk write up scripts for fourth quarter,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998632669448853
989041,989041,1001183.0,"Fed, Earnings Are Meaty Filling Between Slices Of Job, Price Data",2018-01-29 09:55:00-05:00,PFE,fed earnings are meaty filling between slices of job price data,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998778104782104
989042,989042,1001184.0,"J&J No Longer Candidate For Purchase Of Pfizer's Consumer Unit; GlaxoSmithKline, Reckitt Benickser Working With Banks To Make A Bid",2018-01-25 09:34:00-05:00,PFE,j and j no longer candidate for purchase of pfizers consumer unit glaxosmithkline reckitt benickser working with banks to make a bid,"{'neg': 0.095, 'neu': 0.905, 'pos': 0.0, 'compound': -0.296}",neutral,0.9996174573898315
989043,989043,1001185.0,Pfizer Reports Top-Line Results For Potential Biosimilar To Rituxan/MabThera: REFLECTIONS B3281006 Study Showed 'Equivalence in Patients with Indolent Follicular Lymphoma',2018-01-24 08:31:00-05:00,PFE,pfizer reports top line results for potential biosimilar to rituxan and mabthera reflections b3281006 study showed equivalence in patients with indolent follicular lymphoma,"{'neg': 0.0, 'neu': 0.924, 'pos': 0.076, 'compound': 0.2023}",positive,0.9336548447608948
989044,989044,1001186.0,"Ford Earnings Preview: After Last Week's Wall Street Presentation, Not Much New Expected",2018-01-23 11:20:00-05:00,PFE,ford earnings preview after last weeks wall street presentation not much new expected,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997784495353699
989045,989045,1001187.0,Biotech M&A Off To A Strong Start In 2018: More Deals To Follow?,2018-01-23 10:58:00-05:00,PFE,biotech m and a off to a strong start in 2018 more deals to follow,"{'neg': 0.0, 'neu': 0.809, 'pos': 0.191, 'compound': 0.5106}",positive,0.999352753162384
989046,989046,1001188.0,"J&J Shares Unaffected Amid Word US Appeals Court Invalidated Co. Patent On Remicade, Ruling Prevents Co. From Challenging Pfizer's '16 Launch Of Cheaper Version Of Remicade",2018-01-23 10:41:00-05:00,PFE,j and j shares unaffected amid word us appeals court invalidated co patent on remicade ruling prevents co from challenging pfizers 16 launch of cheaper version of remicade,"{'neg': 0.0, 'neu': 0.831, 'pos': 0.169, 'compound': 0.4767}",negative,0.7854952216148376
989047,989047,1001189.0,A CURE For The Typical Healthcare Trade,2018-01-22 16:55:00-05:00,PFE,a cure for the typical healthcare trade,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998216032981873
989048,989048,1001190.0,The Top 10 Value Stocks In The S&P 500,2018-01-19 13:12:00-05:00,PFE,the top 10 value stocks in the SP500 500,"{'neg': 0.0, 'neu': 0.625, 'pos': 0.375, 'compound': 0.4939}",neutral,0.9998912811279297
989049,989049,1001191.0,Pfizer Partners with Foundation Medicine to Develop Companion Diagnostics for its Oncology Portfolio,2018-01-16 07:07:00-05:00,PFE,pfizer partners with foundation medicine to develop companion diagnostics for its oncology portfolio,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997884631156921
989050,989050,1001192.0,A Strategy That Beat The S&P 500: Here Are Your 2018 'Dogs Of The Dow',2018-01-11 17:14:00-05:00,PFE,a strategy that beat the SP500 500 here are your 2018 dogs of the dow,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998757839202881
989051,989051,1001193.0,Key Takeaways From The J.P. Morgan Healthcare Conference,2018-01-11 12:06:00-05:00,PFE,key takeaways from the j p morgan healthcare conference,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998871088027954
989052,989052,1001194.0,Basilea Announces Completion of License Agreement Extension With Pfizer for Antifungal Cresemba for China and Asia Pacific,2018-01-10 04:01:00-05:00,PFE,basilea announces completion of license agreement extension with pfizer for antifungal cresemba for china and asia pacific,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.4939}",positive,0.9994550347328186
989053,989053,1001195.0,Vetr Crowd Upgrades Pfizer To Buy,2018-01-09 17:47:00-05:00,PFE,vetr crowd upgrades pfizer to buy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9718464016914368
989054,989054,1001196.0,"GSK CEO On Pfizer Consumer Business, We Don't Need It, Wouldn't Overpay For It",2018-01-09 14:08:00-05:00,PFE,gsk ceo on pfizer consumer business we dont need it wouldnt overpay for it,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997901320457458
989055,989055,1001197.0,Alzheimer's Takes Another Hit As Pfizer Ends Research In The Area,2018-01-08 12:22:00-05:00,PFE,alzheimers takes another hit as pfizer ends research in the area,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.996764063835144
989056,989056,1001198.0,"JP Morgan Healthcare Conference Begins Today, Presenters Include: Gilead, Illumina, Seattle Genetics, Biogen, Incyte, Baxter, Regeneron, Walgreens, Alnylam, Edwards Lifesciences, Molina, Alexion, Celgene, Pfizer, Neurocrine Biosciences, and Jazz Pharma",2018-01-08 09:00:00-05:00,PFE,jp morgan healthcare conference begins today presenters include gilead illumina seattle genetics biogen incyte baxter regeneron walgreens alnylam edwards lifesciences molina alexion celgene pfizer neurocrine biosciences and jazz pharma,"{'neg': 0.0, 'neu': 0.94, 'pos': 0.06, 'compound': 0.2023}",neutral,0.9998767375946045
989057,989057,1001199.0,"Argus Shares Eli Lilly's Optimism, Upgrades To Buy",2018-01-05 13:54:00-05:00,PFE,argus shares eli lillys optimism upgrades to buy,"{'neg': 0.0, 'neu': 0.513, 'pos': 0.487, 'compound': 0.6908}",positive,0.9996384382247925
989058,989058,1001200.0,The 'Bomb Cyclone' Portfolio: Winners And Losers,2018-01-05 11:58:00-05:00,PFE,the bomb cyclone portfolio winners and losers,"{'neg': 0.482, 'neu': 0.292, 'pos': 0.226, 'compound': -0.5423}",neutral,0.9998233914375305
989059,989059,1001201.0,Arvinas Announces Research Collaboration and License Agreement with Pfizer for the Discovery and Development of Protein Degradation Drug Candidates,2018-01-04 03:59:00-05:00,PFE,arvinas announces research collaboration and license agreement with pfizer for the discovery and development of protein degradation drug candidates,"{'neg': 0.144, 'neu': 0.72, 'pos': 0.136, 'compound': -0.0516}",positive,0.9987886548042297
989060,989060,1001202.0,"The Market In 5 Minutes: South Korea Cracks Down On Crypto, Tim Cook's Big Payday, Jobless Claims Steady",2017-12-28 09:12:00-05:00,PFE,the market in 5 minutes south korea cracks down on crypto tim cooks big payday jobless claims steady,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9977070093154907
989061,989061,1001203.0,"Merck Shares Down 0.12%, Pfizer Shares Up 0.11%; Earlier Companies Together Announced FDA Approvla For Their Collaboration Treatment STEGLATRO, STEGLUJAN and SEGLUROMET",2017-12-26 15:48:00-05:00,PFE,merck shares down 0.12 percent pfizer shares up 0.11 percent earlier companies together announced fda approvla for their collaboration treatment steglatro steglujan and segluromet,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.5267}",negative,0.9985906481742859
989062,989062,1001204.0,Merck's Diabetes Drugs Get FDA Nod As Adjunct Therapies,2017-12-26 12:45:00-05:00,PFE,mercks diabetes drugs get fda nod as adjunct therapies,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997995495796204
989063,989063,1001205.0,The Companies That Led 2017's Biotech Rally,2017-12-22 09:50:00-05:00,PFE,the companies that led 2017 biotech rally,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998306035995483
989064,989064,1001206.0,Merck Reports FDA Granted Breakthrough Therapy Designation For Avelumab In Combo With INLYTA In Advanced Renal Cell Carcinoma,2017-12-21 13:01:00-05:00,PFE,merck reports fda granted breakthrough therapy designation for avelumab in combo with inlyta in advanced renal cell carcinoma,"{'neg': 0.0, 'neu': 0.8, 'pos': 0.2, 'compound': 0.4588}",positive,0.9995386600494385
989065,989065,1001207.0,Shares of Pfizer Down 0.88% On Negative Article From The Daily Mail On Chantix,2017-12-20 14:24:00-05:00,PFE,shares of pfizer down 0.88 percent on negative article from the daily mail on chantix,"{'neg': 0.196, 'neu': 0.688, 'pos': 0.116, 'compound': -0.3612}",negative,0.9985809326171875
989066,989066,1001208.0,Pfizer Reports FDA Approved Co.'s BOSULIF For Treatment Of Patients With Newly-Diagnosed Ph+ CML,2017-12-19 16:12:00-05:00,PFE,pfizer reports fda approved co s bosulif for treatment of patients with newly diagnosed ph cml,"{'neg': 0.0, 'neu': 0.843, 'pos': 0.157, 'compound': 0.4215}",positive,0.9985176920890808
989067,989067,1001209.0,Pfizer Raises Qtr. Dividend From $0.32 To $0.34/Share,2017-12-18 11:45:00-05:00,PFE,pfizer raises qtr dividend from dollars .32 to dollars,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990643858909607
989068,989068,1001210.0,Pfizer Reports $10B Buyback Plan,2017-12-18 11:44:00-05:00,PFE,pfizer reports dollars 0 billion buyback plan,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9982548356056213
989069,989069,1001211.0,"Lightning Round: Jim Cramer Shares His Thoughts On T-Mobile, Electronic Arts, And More",2017-12-15 07:33:00-05:00,PFE,lightning round jim cramer shares his thoughts on t mobile electronic arts and more,"{'neg': 0.0, 'neu': 0.855, 'pos': 0.145, 'compound': 0.296}",neutral,0.9998836517333984
989070,989070,1001212.0,Pfizer Announces FDA Approval of XELJANZ and XELJANZ XR for the Treatment of Active Psoriatic Arthritis,2017-12-15 06:25:00-05:00,PFE,pfizer announces fda approval of xeljanz and xeljanz xr for the treatment of active psoriatic arthritis,"{'neg': 0.0, 'neu': 0.707, 'pos': 0.293, 'compound': 0.7003}",positive,0.9990540146827698
989071,989071,1001213.0,"STAT News' Adam Feuerstein Responds To Tweet Highlighting '$PFE $AGN rumor - no source': 'The other day I heard $PFE for $BMY,' 'Also $ABBV for $BMY'",2017-12-14 10:05:00-05:00,PFE,stat news adam feuerstein responds to tweet highlighting pfe agn rumor to no source the other day i heard pfe for bmy also abbv for bmy,"{'neg': 0.081, 'neu': 0.919, 'pos': 0.0, 'compound': -0.296}",neutral,0.9998086094856262
989072,989072,1001214.0,Pfizer Reports Initiation Of Phase 3 Program For PF-04965842 For Moderate-To-Severe Atopic Dermatitis,2017-12-14 07:38:00-05:00,PFE,pfizer reports initiation of phase 3 program for pf 04965842 for moderate to severe atopic dermatitis,"{'neg': 0.148, 'neu': 0.852, 'pos': 0.0, 'compound': -0.3818}",neutral,0.9998540878295898
989073,989073,1001215.0,Pfizer Reports FDA Approved New Biosimilar Medicine IXIFI,2017-12-13 18:05:00-05:00,PFE,pfizer reports fda approved new biosimilar medicine ixifi,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.4215}",positive,0.9989649057388306
989074,989074,1001216.0,Pfizer Reports Phase 3 TRUMENBA Data Published In NEJM Showed All 5 Co-Primary Immunogenicity Endpoints Were Met,2017-12-13 17:08:00-05:00,PFE,pfizer reports phase 3 trumenba data published in nejm showed all 5 co primary immunogenicity endpoints were met,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998747110366821
989075,989075,1001217.0,PreMarket Opening NYSE Imbalance Update: AT&T 168k Shares To Sell; Nike 54k Shares To Sell; Square 33k To Buy; Disney 41k To Buy; US Steel 53k Shares To Sell; Pfizer 50k Shares To Sell; Merck 28k Shares To Buy;,2017-12-13 09:06:00-05:00,PFE,premarket opening nyse imbalance update at and t 168 thousand shares to sell nike 54 thousand shares to sell square 33 thousand to buy disney 41 thousand to buy us steel 53 thousand shares to sell pfizer 50 thousand shares to sell merck 28 thousand shares to buy,"{'neg': 0.0, 'neu': 0.796, 'pos': 0.204, 'compound': 0.8402}",neutral,0.9998780488967896
989076,989076,1001218.0,Cellectis Up Premarket As Co. Announced Prelim. Data Yesterday From Servier and Pfizer's UCART19 Product Candidate Showing High Complete Remission Rate Across 2 Acute Lymphoblastic Leukemia Trials,2017-12-13 08:36:00-05:00,PFE,cellectis up premarket as co announced prelim data yesterday from servier and pfizers ucart19 product candidate showing high complete remission rate across 2 acute lymphoblastic leukemia trials,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992376565933228
989077,989077,1001219.0,"FDA Extends Action Date For Pfizer's XELJANZ (Tofacitinib) By 3 Months, Estimates PDUFA Date June 2018",2017-12-12 16:54:00-05:00,PFE,fda extends action date for pfizers xeljanz tofacitinib by 3 months estimates pdufa date june 2018,"{'neg': 0.0, 'neu': 0.909, 'pos': 0.091, 'compound': 0.128}",positive,0.7498012185096741
989078,989078,1001220.0,3 Stocks In Focus As Biotech M&A Hopes For 2018 Rise,2017-12-11 12:52:00-05:00,PFE,3 stocks in focus as biotech m and a hopes for 2018 rise,"{'neg': 0.0, 'neu': 0.811, 'pos': 0.189, 'compound': 0.4215}",positive,0.9995785355567932
989079,989079,1001221.0,"Spark Therapeutics, Pfizer Report Longer-Term Prelim. Data Showing Consistent, Sustained Factor IX Levels In Hemophilia B",2017-12-11 07:04:00-05:00,PFE,spark therapeutics pfizer report longer term prelim data showing consistent sustained factor ix levels in hemophilia b,"{'neg': 0.0, 'neu': 0.894, 'pos': 0.106, 'compound': 0.2263}",positive,0.9969467520713806
989080,989080,1001222.0,Pfizer Reports Updated Data From Phase III Study On Ibrance,2017-12-08 12:40:00-05:00,PFE,pfizer reports updated data from phase iii study on ibrance,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998875856399536
989081,989081,1001223.0,Pfizer Reports Talazoparib Significantly Extended PFS In Phase 3 EMBRACA Trial Of Patients With Metastatic Breast Cancer,2017-12-08 08:31:00-05:00,PFE,pfizer reports talazoparib significantly extended pfs in phase 3 embraca trial of patients with metastatic breast cancer,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.6597}",positive,0.999664306640625
989082,989082,1001224.0,"Spark Therapeutics, Pfizer Publish Interim Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Hemophilia B In NE Journal of Medicine",2017-12-06 17:06:00-05:00,PFE,spark therapeutics pfizer publish interim data from phase .5 clinical trial of investigational gene therapy for hemophilia b in ne journal of medicine,"{'neg': 0.0, 'neu': 0.921, 'pos': 0.079, 'compound': 0.2263}",neutral,0.9998798370361328
989083,989083,1001225.0,"Pfizer Gives Updates Data From its Phase 3 Trial of IBRANCE Plus LLetrozole in ER+, HER2- Metastatic Breast Cancer",2017-12-06 07:31:00-05:00,PFE,pfizer gives updates data from its phase 3 trial of ibrance plus lletrozole in er her2 metastatic breast cancer,"{'neg': 0.196, 'neu': 0.804, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9998615980148315
989084,989084,1001226.0,GlaxoSmithKline Begins Phase III Study On Injection To Prevent HIV,2017-12-01 12:38:00-05:00,PFE,glaxosmithkline begins phase iii study on injection to prevent hiv,"{'neg': 0.0, 'neu': 0.891, 'pos': 0.109, 'compound': 0.0258}",neutral,0.9998716115951538
989085,989085,1001227.0,Premarket Opening NYSE Imbalance Update: General Electric 174k Shares To Sell; Alibaba 52k Shares To Buy; Twitter 43k Shares To Sell; Square 39k Shares To Buy; Snap 79k Shares To Sell; Pfizer 126k Shares To Sell; ExxonMobil 59k Shares To Sell,2017-12-01 08:56:00-05:00,PFE,premarket opening nyse imbalance update general electric 174 thousand shares to sell alibaba 52 thousand shares to buy twitter 43 thousand shares to sell square 39 thousand shares to buy snap 79 thousand shares to sell pfizer 126 thousand shares to sell exxonmobil 59 thousand shares to sell,"{'neg': 0.0, 'neu': 0.727, 'pos': 0.273, 'compound': 0.9081}",neutral,0.9998714923858643
989086,989086,1001228.0,"Pfizer, Basilea to Develop and Commercialize CRESEMBA in China and Asia Pacific Region",2017-12-01 04:09:00-05:00,PFE,pfizer basilea to develop and commercialize cresemba in china and asia pacific region,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999881386756897
989087,989087,1001229.0,Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates,2017-11-30 08:34:00-05:00,PFE,attention biotech investors mark your calendar for these december pdufa dates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998856782913208
989088,989088,1001230.0,A Lazarus Act For This Pharma ETF,2017-11-29 17:03:00-05:00,PFE,a lazarus act for this pharma etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998757839202881
989089,989089,1001231.0,Pfizer Reportedly Wins UK Approval To Sell Viagra Without Prescription,2017-11-28 09:54:00-05:00,PFE,pfizer reportedly wins uk approval to sell viagra without prescription,"{'neg': 0.0, 'neu': 0.541, 'pos': 0.459, 'compound': 0.7783}",positive,0.9995711445808411
989090,989090,1001232.0,"UPDATE: Merck, Pfizer On JAVELIN Trial Of Avelumab, Say, 'Safety profile was consistent with that observed in previously reported studies of avelumab; no new safety signals were identified'",2017-11-28 08:04:00-05:00,PFE,update merck pfizer on javelin trial of avelumab say safety profile was consistent with that observed in previously reported studies of avelumab no new safety signals were identified,"{'neg': 0.14, 'neu': 0.773, 'pos': 0.087, 'compound': -0.1857}",positive,0.9921257495880127
989091,989091,1001233.0,"UPDATE: Merck, Pfizer Says Phase III JAVELIN Study Investigating Avelumab 'did not meet its pre-specified primary endpoint of superior overall survival compared to chemotherapy'",2017-11-28 08:04:00-05:00,PFE,update merck pfizer says phase iii javelin study investigating avelumab did not meet its pre specified primary endpoint of superior overall survival compared to chemotherapy,"{'neg': 0.0, 'neu': 0.873, 'pos': 0.127, 'compound': 0.5423}",positive,0.9542402029037476
989092,989092,1001234.0,"Merck, Pfizer Offer Update Related To Phase III JAVELIN Gastric 300 Study In Patients With Pre-Treated Advanced Gastric Cancer",2017-11-28 08:03:00-05:00,PFE,merck pfizer offer update related to phase iii javelin gastric 300 study in patients with pre treated advanced gastric cancer,"{'neg': 0.18, 'neu': 0.738, 'pos': 0.082, 'compound': -0.5267}",neutral,0.9987358450889587
989093,989093,1001235.0,Premarket NYSE Imbalance Update: Square 447k Shares To Buy; AT&T 158k Shares To Sell; Pfizer 106k Shares To Sell; Alibaba 132k Shares To Buy; General Electric 181k Shares To Buy; HPQ 158k Shares To Sell; Nike 82K Shares To Sell; Pepsi 39k Shares To Sell;,2017-11-22 09:02:00-05:00,PFE,premarket nyse imbalance update square 447 thousand shares to buy at and t 158 thousand shares to sell pfizer 106 thousand shares to sell alibaba 132 thousand shares to buy general electric 181 thousand shares to buy hpq 158 thousand shares to sell nike 82 thousand shares to sell pepsi 39 thousand shares to sell,"{'neg': 0.0, 'neu': 0.728, 'pos': 0.272, 'compound': 0.9274}",neutral,0.9998751878738403
989094,989094,1001236.0,These 2 Stocks Are Bill Stone's Pure Plays On Tax Reform,2017-11-20 13:20:00-05:00,PFE,these 2 stocks are bill stones pure plays on tax reform,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.25}",neutral,0.9998611211776733
989095,989095,1001237.0,Pfizer Receives FDA Approval For SUTENT,2017-11-16 16:58:00-05:00,PFE,pfizer receives fda approval for sutent,"{'neg': 0.0, 'neu': 0.617, 'pos': 0.383, 'compound': 0.4767}",positive,0.9566510319709778
989096,989096,1001238.0,FDA Says It's Granted The Approval Of Sutent to Pfizer,2017-11-16 15:20:00-05:00,PFE,fda says its granted the approval of sutent to pfizer,"{'neg': 0.0, 'neu': 0.611, 'pos': 0.389, 'compound': 0.6249}",positive,0.5691612362861633
989097,989097,1001239.0,PreMarket NYSE Imbalance Update: GE 294k Shares To Buy; BABA 105k Shares To Buy; SQ 125k Shares To Buy; VZ 49k Shares To Sell; SNAP 59k Shares To Buy; PFE 88k Shares To Sell; BMY 39k Shares To Sell,2017-11-16 08:57:00-05:00,PFE,premarket nyse imbalance update ge 294 thousand shares to buy baba 105 thousand shares to buy sq 125 thousand shares to buy vz 49 thousand shares to sell snap 59 thousand shares to buy pfe 88 thousand shares to sell bmy 39 thousand shares to sell,"{'neg': 0.0, 'neu': 0.717, 'pos': 0.283, 'compound': 0.9081}",neutral,0.9998602867126465
989098,989098,1001240.0,Analyst: Is The Street Ignoring Pfizer And Its Upcoming Catalysts?,2017-11-13 11:23:00-05:00,PFE,analyst is the street ignoring pfizer and its upcoming catalysts,"{'neg': 0.231, 'neu': 0.769, 'pos': 0.0, 'compound': -0.4019}",neutral,0.9998880624771118
989099,989099,1001241.0,Pfizer Announces Albert Bourla COO,2017-11-13 09:21:00-05:00,PFE,pfizer announces albert bourla coo,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998724460601807
989100,989100,1001242.0,"Lightning Round: Jim Cramer Is A Seller Of Pandora, Lost Faith In Chipotle",2017-11-10 07:46:00-05:00,PFE,lightning round jim cramer is a seller of pandora lost faith in chipotle,"{'neg': 0.143, 'neu': 0.683, 'pos': 0.174, 'compound': 0.128}",negative,0.9897547364234924
989101,989101,1001243.0,Pharma ETFs Down Post Q3 Earnings,2017-11-09 12:34:00-05:00,PFE,pharma etfs down post third quarter earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.997852087020874
989102,989102,1001244.0,REMINDER: Pfizer Expecting FDA AdCom Meeting Today For Staphylococcus Aureus Vaccine,2017-11-07 09:11:00-05:00,PFE,reminder pfizer expecting fda adcom meeting today for staphylococcus aureus vaccine,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.99983811378479
989103,989103,1001245.0,Pre-Market Imbalance Update: General Electric 258k Shares To Buy; Alibaba 121k Shares To Buy; Square 168k Shares To Buy; Pfizer 41k Shares To Sell; Bristol-Myers 51k Shares To Sell; Disney 70k Shares To Buy,2017-11-07 08:58:00-05:00,PFE,pre market imbalance update general electric 258 thousand shares to buy alibaba 121 thousand shares to buy square 168 thousand shares to buy pfizer 41 thousand shares to sell bristol myers 51 thousand shares to sell disney 70 thousand shares to buy,"{'neg': 0.0, 'neu': 0.732, 'pos': 0.268, 'compound': 0.8807}",neutral,0.9998663663864136
989104,989104,1001246.0,"Spark Therapeutics, Pfizer Amend License Agreement for Investigational SPK-9001 in Hemophilia B; Spark To Receive Up To An Additional $25M Per Terms Of Amendment",2017-11-07 07:30:00-05:00,PFE,spark therapeutics pfizer amend license agreement for investigational spk 9001 in hemophilia b spark to receive up to an additional dollars 5 million per terms of amendment,"{'neg': 0.0, 'neu': 0.774, 'pos': 0.226, 'compound': 0.7184}",positive,0.9540835618972778
989105,989105,1001247.0,"Pharma Stock Roundup: Pfizer, Teva, Novartis, And More",2017-11-06 12:19:00-05:00,PFE,pharma stock roundup pfizer teva novartis and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998624324798584
989106,989106,1001248.0,"The Week Ahead: Earnings Season Continues, Several IPOs, Notable Conferences On The Docket",2017-11-06 10:48:00-05:00,PFE,the week ahead earnings season continues several ipos notable conferences on the docket,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998233914375305
989107,989107,1001249.0,Pfizer Says It Still Believes Annual Eucrisa Sales Will Eventually Exceed $2B,2017-10-31 11:09:00-04:00,PFE,pfizer says it still believes annual eucrisa sales will eventually exceed dollars b,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9976962208747864
989108,989108,1001250.0,"Pfizer CEO On Conf. Call, Regarding Amazon, Says That Any Distribution That Would Cut Costs And Get Wide Availability Of Products To Patients Is Something The Whole Industry Would Be Interested In",2017-10-31 10:41:00-04:00,PFE,pfizer ceo on conf call regarding amazon says that any distribution that would cut costs and get wide availability of products to patients is something the whole industry would be interested in,"{'neg': 0.059, 'neu': 0.817, 'pos': 0.124, 'compound': 0.3182}",positive,0.9991772770881653
989109,989109,1001251.0,"Meg Tirrell Tweets: ""We anticipate there will be broad interest from potential acquirers"" of consumer health unit, $PFE CEO says",2017-10-31 10:15:00-04:00,PFE,meg tirrell tweets we anticipate there will be broad interest from potential acquirers of consumer health unit pfe ceo says,"{'neg': 0.0, 'neu': 0.864, 'pos': 0.136, 'compound': 0.4588}",positive,0.9934810400009155
989110,989110,1001252.0,11 Technical Levels Discussed On Tuesday's PreMarket Prep,2017-10-31 09:34:00-04:00,PFE,11 technical levels discussed on tuesdays premarket prep,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998904466629028
989111,989111,1001253.0,28 Stocks Moving In Tuesday's Pre-Market Session,2017-10-31 08:09:00-04:00,PFE,28 stocks moving in tuesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998736381530762
989112,989112,1001254.0,Here's What's Coming Up On PreMarket Prep For October 31,2017-10-31 08:04:00-04:00,PFE,heres whats coming up on premarket prep for october 31,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998911619186401
989113,989113,1001255.0,"A Peek Into The Markets: U.S. Stock Futures Rise Ahead Of Mastercard, Kellogg Earnings",2017-10-31 07:14:00-04:00,PFE,a peek into the markets u s stock futures rise ahead of mastercard kellogg earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9959589838981628
989114,989114,1001256.0,Pfizer Narrows FY17 Sales Guidance From $52B-$54B To $52.4B-$53.1B,2017-10-31 06:46:00-04:00,PFE,pfizer narrows fy17 sales guidance from dollars 2 billion dollars 4 billion to dollars 2.4 billion dollars 3.1 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9788147807121277
989115,989115,1001257.0,Pfizer Raises FY17 Adj. EPS Outlook From $2.50-$2.60 As Of Jan. 31 To $2.58-$2.62,2017-10-31 06:46:00-04:00,PFE,pfizer raises fy17 adj eps outlook from dollars .50 dollars .60 as of jan 31 to dollars .58 dollars .62,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994654059410095
989116,989116,1001258.0,"Pfizer Reports Q3 Adj. EPS $0.67 vs $0.64 Est., Sales $13.2B vs $13.19B Est.",2017-10-31 06:45:00-04:00,PFE,pfizer reports third quarter adj eps dollars .67 vs dollars .64 est sales dollars 3.2 billion vs dollars 3.19 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999875545501709
989117,989117,1001259.0,"12 Stocks To Watch For October 31, 2017",2017-10-31 04:46:00-04:00,PFE,12 stocks to watch for october 31 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998757839202881
989118,989118,1001260.0,"Earnings Scheduled For October 31, 2017",2017-10-31 04:12:00-04:00,PFE,earnings scheduled for october 31 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998812675476074
989119,989119,1001261.0,"Najarian Brothers See Unusual Options Activity In Melco, Pfizer, Nvidia and Abbvie",2017-10-30 15:38:00-04:00,PFE,najarian brothers see unusual options activity in melco pfizer nvidia and abbvie,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9970762729644775
989120,989120,1001262.0,Upcoming Earnings: Pfizer Reports Tomorrow As Management Explores Alternatives For Consumer Healthcare,2017-10-30 13:32:00-04:00,PFE,upcoming earnings pfizer reports tomorrow as management explores alternatives for consumer healthcare,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998492002487183
989121,989121,1001263.0,"Pre-Market Imbalance Update: GE 526K To Sell, Alibaba 221K To Buy, GM 183K To Sell, Square 169K To Buy, BofA 136K To Sell, Twitter 116K To Sell, AT&T 108K To Buy, Pfizer 106K To Sell, Coca-Cola 59K To Sell, Verizon 51K To Sell, Mastercard 38K To Buy",2017-10-30 09:05:00-04:00,PFE,pre market imbalance update ge 526 thousand to sell alibaba 221 thousand to buy gm 183 thousand to sell square 169 thousand to buy bofa 136 thousand to sell twitter 116 thousand to sell at and t 108 thousand to buy pfizer 106 thousand to sell coca cola 59 thousand to sell verizon 51 thousand to sell mastercard 38 thousand to buy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999866247177124
989122,989122,1001264.0,GSK's ViiV Healthcare Announces Positive Phase 3 Results from BRIGHTE Study of Fostemsavir in Heavily Treatment-experienced Patients with HIV,2017-10-27 04:28:00-04:00,PFE,gsks viiv healthcare announces positive phase 3 results from brighte study of fostemsavir in heavily treatment experienced patients with hiv,"{'neg': 0.0, 'neu': 0.841, 'pos': 0.159, 'compound': 0.5574}",positive,0.9995930790901184
989123,989123,1001265.0,"Wall Street's M&A Chatter From October 25: Sprint-T-Mobile, Trade Desk, Pfizer, Dynegy",2017-10-26 07:35:00-04:00,PFE,wall streets m and a chatter from october 25 sprint t mobile trade desk pfizer dynegy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998886585235596
989124,989124,1001266.0,"Pfizer Will Launch $15B+ Consumer Health Sale In Nov., Glaxo Has Hired Citi Related To Pfizer Unit Auction",2017-10-25 14:33:00-04:00,PFE,pfizer will launch dollars 5 billion consumer health sale in nov glaxo has hired citi related to pfizer unit auction,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998347759246826
989125,989125,1001267.0,"Pre-Market Imbalance Update: GE 578K Shares To Sell, AT&T 198K To Sell, Square 128K Shares To Buy, Pfizer 93K To Sell, Alibaba 60K To Buy, GM 50K To Sell",2017-10-25 09:11:00-04:00,PFE,pre market imbalance update ge 578 thousand shares to sell at and t 198 thousand to sell square 128 thousand shares to buy pfizer 93 thousand to sell alibaba 60 thousand to buy gm 50 thousand to sell,"{'neg': 0.0, 'neu': 0.891, 'pos': 0.109, 'compound': 0.5267}",neutral,0.999868631362915
989126,989126,1001268.0,Healthcare ETFs Set To Soar As Q3 Earnings Unfold,2017-10-24 12:35:00-04:00,PFE,healthcare etfs set to soar as third quarter earnings unfold,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996374845504761
989127,989127,1001269.0,"Pre-Market Imbalance Update: BofA 374K Shares To Sell, GE 131K To Sell, ExxonMobil 90K To Sell, Square 63K To Sell, Pfizer 62K To Sell, JP Morgan 62K To Sell, IBM 60K To Sell, Twitter 54K To Sell, Citi 52K To Sell",2017-10-19 09:17:00-04:00,PFE,pre market imbalance update bofa 374 thousand shares to sell ge 131 thousand to sell exxonmobil 90 thousand to sell square 63 thousand to sell pfizer 62 thousand to sell jp morgan 62 thousand to sell ibm 60 thousand to sell twitter 54 thousand to sell citi 52 thousand to sell,"{'neg': 0.0, 'neu': 0.925, 'pos': 0.075, 'compound': 0.4588}",neutral,0.9998682737350464
989128,989128,1001270.0,"Pre-Market Imbalance Update: IBM 219K Shares To Buy, Alibaba 133K To Buy, Coca-Cola 131K To Sell, Twitter 88K To Sell, Square 79K To Buy, AT&T 73K To Buy, Pfizer 71K To Sell, Ford 67K To Sell, J&J 55K To Sell",2017-10-18 09:06:00-04:00,PFE,pre market imbalance update ibm 219 thousand shares to buy alibaba 133 thousand to buy coca cola 131 thousand to sell twitter 88 thousand to sell square 79 thousand to buy at and t 73 thousand to buy pfizer 71 thousand to sell ford 67 thousand to sell j and j 55 thousand to sell,"{'neg': 0.0, 'neu': 0.961, 'pos': 0.039, 'compound': 0.296}",neutral,0.9998747110366821
989129,989129,1001271.0,Pfizer Presents Phase 2 Results from Lorlatinib,2017-10-16 07:03:00-04:00,PFE,pfizer presents phase 2 results from lorlatinib,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999879002571106
989130,989130,1001272.0,Pfizer Says They Saw Durable Responses Seen Against Long Tumors And Brian Metastases Across Multiple Lines Of Therapy In Phase 2 Study Of ALK-Inhibitor Lorlatinib in ALK-Positive and ROS1-Positive Advanced Non-Small Cell Lung Cancer,2017-10-16 07:03:00-04:00,PFE,pfizer says they saw durable responses seen against long tumors and brian metastases across multiple lines of therapy in phase 2 study of alk inhibitor lorlatinib in alk positive and ros1 positive advanced non small cell lung cancer,"{'neg': 0.119, 'neu': 0.689, 'pos': 0.192, 'compound': 0.5423}",positive,0.9995220899581909
989131,989131,1001273.0,"Pharma Stock Roundup: Pfizer Mulls Options For Consumer Healthcare, Eli Lilly's Pipeline Setback",2017-10-13 12:19:00-04:00,PFE,pharma stock roundup pfizer mulls options for consumer healthcare eli lillys pipeline setback,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.678903341293335
989132,989132,1001274.0,3 Highlights From A Spark Therapeutics Fireside Chat,2017-10-13 09:36:00-04:00,PFE,3 highlights from a spark therapeutics fireside chat,"{'neg': 0.0, 'neu': 0.787, 'pos': 0.213, 'compound': 0.2263}",neutral,0.999874472618103
989133,989133,1001275.0,Pfizer Reports FDA Approval Of LYRICA ER Tablets CV,2017-10-12 08:02:00-04:00,PFE,pfizer reports fda approval of lyrica er tablets cv,"{'neg': 0.0, 'neu': 0.721, 'pos': 0.279, 'compound': 0.4767}",positive,0.9969826340675354
989134,989134,1001276.0,Why Jefferies Upgraded Johnson & Johnson,2017-10-11 15:47:00-04:00,PFE,why jefferies upgraded johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998646974563599
989135,989135,1001277.0,A Deep Dive Into MannKind's Big Bet On Afrezza,2017-10-11 11:45:00-04:00,PFE,a deep dive into mannkinds big bet on afrezza,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997313618659973
989136,989136,1001278.0,"Pre-Market Imbalance Update: GE 285K Shares To Sell, NIKE 78K Shares To Buy, Colgate-Palmolive 47K To Buy, Pfizer 45K To Sell, Alibaba 45K To Buy",2017-10-11 09:03:00-04:00,PFE,pre market imbalance update ge 285 thousand shares to sell nike 78 thousand shares to buy colgate palmolive 47 thousand to buy pfizer 45 thousand to sell alibaba 45 thousand to buy,"{'neg': 0.0, 'neu': 0.872, 'pos': 0.128, 'compound': 0.5267}",neutral,0.9998406171798706
989137,989137,1001279.0,These Were The Most Bought And Sold Stocks In September,2017-10-10 16:12:00-04:00,PFE,these were the most bought and sold stocks in september,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999891996383667
989138,989138,1001280.0,5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings,2017-10-10 12:52:00-04:00,PFE,5 pharma and biotech stocks that could be big winners in third quarter earnings,"{'neg': 0.0, 'neu': 0.807, 'pos': 0.193, 'compound': 0.4767}",positive,0.9995594620704651
989139,989139,1001281.0,UPDATE: Pfizer Highlights Co.'s Consumer Healthcare Unit Had '16 Sales Of ~$3.4B,2017-10-10 06:45:00-04:00,PFE,update pfizer highlights co s consumer healthcare unit had 16 sales of dollars .4 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998928308486938
989140,989140,1001282.0,Pfizer Reports Review Of Strategic Alternatives Related To Consumer Healthcare Unit,2017-10-10 06:45:00-04:00,PFE,pfizer reports review of strategic alternatives related to consumer healthcare unit,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997051358222961
989141,989141,1001283.0,Health Care Sector Back In Focus In Congress Ahead Of Q3 Earnings Result,2017-10-09 15:56:00-04:00,PFE,health care sector back in focus in congress ahead of third quarter earnings result,"{'neg': 0.0, 'neu': 0.802, 'pos': 0.198, 'compound': 0.4939}",positive,0.9129107594490051
989142,989142,1001284.0,"Pre-Market Imbalance Update: GE Shares 198K To Buy, Macy's 75K To Buy, Pfizer 71K To Sell, Merck 56K To Buy, Citi 50K To Buy, P&G 40K To Buy, ExxonMobil 38K To Sell, Barrick Gold 30K To Buy, BofA 28K To Buy, Chevron 25K To Sell, JP Morgan 10K To Buy",2017-10-09 09:14:00-04:00,PFE,pre market imbalance update ge shares 198 thousand to buy macys 75 thousand to buy pfizer 71 thousand to sell merck 56 thousand to buy citi 50 thousand to buy p and g 40 thousand to buy exxonmobil 38 thousand to sell barrick gold 30 thousand to buy bofa 28 thousand to buy chevron 25 thousand to sell jp morgan 10 thousand to buy,"{'neg': 0.0, 'neu': 0.939, 'pos': 0.061, 'compound': 0.4588}",neutral,0.9998718500137329
989143,989143,1001285.0,Heaps Of Healthy Health Care ETFs,2017-10-06 10:02:00-04:00,PFE,heaps of healthy health care etfs,"{'neg': 0.0, 'neu': 0.404, 'pos': 0.596, 'compound': 0.7096}",neutral,0.9998825788497925
989144,989144,1001286.0,"The South African Competition Commission is Still Investigating Complaints Against Pfizer, Genetech and Roche, According to Reuters",2017-10-04 07:37:00-04:00,PFE,the south african competition commission is still investigating complaints against pfizer genetech and roche according to reuters,"{'neg': 0.144, 'neu': 0.856, 'pos': 0.0, 'compound': -0.4019}",neutral,0.999779999256134
989145,989145,1001287.0,Meg Tirrell Tweets: Missed this Fri: federal court ruled Obama admn acted unlawfully in rules that resulted in $PFE abandoning $AGN deal uk.reuters.com/article/uk-usa…,2017-10-02 13:47:00-04:00,PFE,meg tirrell tweets missed this fri federal court ruled obama admn acted unlawfully in rules that resulted in pfe abandoning agn deal uk reuters com and article and uk usa…,"{'neg': 0.146, 'neu': 0.854, 'pos': 0.0, 'compound': -0.5859}",negative,0.9791020750999451
989146,989146,1001288.0,The Market In 5 Minutes: Tragedy Rocks The Vegas Strip,2017-10-02 08:33:00-04:00,PFE,the market in 5 minutes tragedy rocks the vegas strip,"{'neg': 0.328, 'neu': 0.672, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9076008796691895
989147,989147,1001289.0,"Jim Cramer Shares His Thoughts On DowDuPont, Pfizer And More",2017-09-29 09:02:00-04:00,PFE,jim cramer shares his thoughts on dowdupont pfizer and more,"{'neg': 0.0, 'neu': 0.804, 'pos': 0.196, 'compound': 0.296}",neutral,0.9998711347579956
989148,989148,1001290.0,Notable Premarket Imbalances: SQ 77k To Buy; PFE 130k To Sell; BABA 44k sell; BAC 88; To Sell;,2017-09-25 09:02:00-04:00,PFE,notable premarket imbalances sq 77 thousand to buy pfe 130 thousand to sell baba 44 thousand sell bac 88 to sell,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.976051926612854
989149,989149,1001291.0,Cramer's Guide To Profit From Market Rotations,2017-09-23 08:56:00-04:00,PFE,cramers guide to profit from market rotations,"{'neg': 0.0, 'neu': 0.674, 'pos': 0.326, 'compound': 0.4404}",neutral,0.9998117089271545
989150,989150,1001292.0,The Street Has Finally Recognized The Exelixis Clinical Program Potential,2017-09-22 13:13:00-04:00,PFE,the street has finally recognized the exelixis clinical program potential,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9964883327484131
989151,989151,1001293.0,What Do Versartis' Troubles Mean For Opko Health?,2017-09-22 11:26:00-04:00,PFE,what do versartis troubles mean for opko health,"{'neg': 0.3, 'neu': 0.7, 'pos': 0.0, 'compound': -0.4588}",neutral,0.9995341300964355
989152,989152,1001294.0,Versartis' Somavaratan Still Has A Path Forward; Cantor Reiterates Buy,2017-09-22 09:20:00-04:00,PFE,versartis somavaratan still has a path forward cantor reiterates buy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.973193883895874
989153,989153,1001295.0,Merck and Pfizer Get European Commission Approval for Bavencio,2017-09-21 06:25:00-04:00,PFE,merck and pfizer get european commission approval for bavencio,"{'neg': 0.0, 'neu': 0.721, 'pos': 0.279, 'compound': 0.4767}",positive,0.7840321660041809
989154,989154,1001296.0,"Pfizer Should Outperform, Morgan Stanley Upgrades",2017-09-20 09:45:00-04:00,PFE,pfizer should outperform morgan stanley upgrades,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995988011360168
989155,989155,1001297.0,"Benzinga's Top Upgrades, Downgrades For September 20, 2017",2017-09-20 09:12:00-04:00,PFE,benzingas top upgrades downgrades for september 20 2017,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",neutral,0.7979323267936707
989156,989156,1001298.0,Pfizer Reports Filing Of Suit In US District Court In Pennsylvania Against J&J Related To Allegations J&J 'Engaged in Unlawful Conduct to Stifle Competition From Inflectra',2017-09-20 09:12:00-04:00,PFE,pfizer reports filing of suit in us district court in pennsylvania against j and j related to allegations j and j engaged in unlawful conduct to stifle competition from inflectra,"{'neg': 0.0, 'neu': 0.915, 'pos': 0.085, 'compound': 0.4019}",neutral,0.998995840549469
989157,989157,1001299.0,The Market In 5 Minutes,2017-09-20 07:50:00-04:00,PFE,the market in 5 minutes,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998767375946045
989158,989158,1001300.0,A Peek Into The Markets: U.S. Stock Futures Flat; All Eyes On Fed Decision,2017-09-20 07:18:00-04:00,PFE,a peek into the markets u s stock futures flat all eyes on fed decision,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998262524604797
989159,989159,1001301.0,Morgan Stanley Upgrades Pfizer to Overweight,2017-09-20 06:08:00-04:00,PFE,morgan stanley upgrades pfizer to overweight,"{'neg': 0.333, 'neu': 0.667, 'pos': 0.0, 'compound': -0.3612}",positive,0.9986737966537476
989160,989160,1001302.0,Morgan Stanley Upgrades Pfizer to Overweight from Equal-Weight; Raises PT to $39 from $35,2017-09-20 04:53:00-04:00,PFE,morgan stanley upgrades pfizer to overweight from equal weight raises point to dollars 9 from dollars 5,"{'neg': 0.135, 'neu': 0.865, 'pos': 0.0, 'compound': -0.3612}",positive,0.9994194507598877
989161,989161,1001303.0,"Pfizer Reports FDA Panel Voted 6 For, 6 Against Benefit-Risk Profile Of SUTENT",2017-09-19 13:17:00-04:00,PFE,pfizer reports fda panel voted 6 for 6 against benefit risk profile of sutent,"{'neg': 0.123, 'neu': 0.702, 'pos': 0.175, 'compound': 0.2263}",neutral,0.9953018426895142
989162,989162,1001304.0,"Pfizer, Astellas Announce Phase 3 Prosper Trial of Xtandi in Patients with Non-Metastatic Castration-Resistant Prostate Cancer Met Its Primary Endpoint​",2017-09-14 05:12:00-04:00,PFE,pfizer astellas announce phase 3 prosper trial of xtandi in patients with non metastatic castration resistant prostate cancer met its primary endpoint​,"{'neg': 0.173, 'neu': 0.827, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9972272515296936
989163,989163,1001305.0,"Morgan Stanley Healthcare Conference Concludes Today, Presenters Include Ironwood Pharmaceuticals, Sage Therapeutics, Pfizer, TherapeuticsMD, Alnylam, bluebird bio, and Cigna",2017-09-13 09:24:00-04:00,PFE,morgan stanley healthcare conference concludes today presenters include ironwood pharmaceuticals sage therapeutics pfizer therapeuticsmd alnylam bluebird bio and cigna,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998865127563477
989164,989164,1001306.0,"Pre-Market Imbalance Update: Bristol-Myers Squibb 152K Shares To Sell, GE 145K To Sell, Pfizer 108K to Sell, Home Depot 102K Shares To Buy, Alibaba 101K Shares To Buy, USG 94K To Buy, Lowe's 48K To Buy, Heritage Insurance 43K To Buy, Rockwell Collins 38K",2017-09-11 08:57:00-04:00,PFE,pre market imbalance update bristol myers squibb 152 thousand shares to sell ge 145 thousand to sell pfizer 108 thousand to sell home depot 102 thousand shares to buy alibaba 101 thousand shares to buy usg 94 thousand to buy lowes 48 thousand to buy heritage insurance 43 thousand to buy rockwell collins 38 thousand,"{'neg': 0.0, 'neu': 0.887, 'pos': 0.113, 'compound': 0.6808}",neutral,0.9998619556427002
989165,989165,1001307.0,"Pfizer Reports Overall Survival Data Of XALKORI In Patients With ALK-Positive Advanced NSCLC: Median Survival Was Not Reached, Was 47.5 Months For Patients Randomized To Chemo",2017-09-11 07:02:00-04:00,PFE,pfizer reports overall survival data of xalkori in patients with alk positive advanced nsclc median survival was not reached was 47.5 months for patients randomized to chemo,"{'neg': 0.042, 'neu': 0.777, 'pos': 0.181, 'compound': 0.649}",neutral,0.9996324777603149
989166,989166,1001308.0,Pfizer Presents Positive Pivotal Data for PF-05280014 at ESMO 2017,2017-09-10 09:43:00-04:00,PFE,pfizer presents positive pivotal data for pf 05280014 at esmo 2017,"{'neg': 0.0, 'neu': 0.735, 'pos': 0.265, 'compound': 0.5574}",positive,0.9996128678321838
989167,989167,1001309.0,What Pharmaceuticals Spend On Lobbying To Influence Trump,2017-09-09 16:28:00-04:00,PFE,what pharmaceuticals spend on lobbying to influence trump,"{'neg': 0.157, 'neu': 0.843, 'pos': 0.0, 'compound': -0.0772}",neutral,0.9998573064804077
989168,989168,1001310.0,"This Drug, An Alternative To Marijuana And Ketamine, Could Treat Suicidal Depression And PTSD",2017-09-07 13:02:00-04:00,PFE,this drug an alternative to marijuana and ketamine could treat suicidal depression and points d,"{'neg': 0.358, 'neu': 0.524, 'pos': 0.118, 'compound': -0.7579}",neutral,0.7644619345664978
989169,989169,1001311.0,Attention Biotech Investors: September Ushers In Another Slew Of PDUFA Catalysts,2017-09-01 14:03:00-04:00,PFE,attention biotech investors september ushers in another slew of pdufa catalysts,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998843669891357
989170,989170,1001312.0,Pfizer Receives FDA Approval For MYLOTARG,2017-09-01 11:09:00-04:00,PFE,pfizer receives fda approval for mylotarg,"{'neg': 0.0, 'neu': 0.617, 'pos': 0.383, 'compound': 0.4767}",positive,0.9962931275367737
989171,989171,1001313.0,Pfizer's BOSULIF Regulatory Submissions Accepted by the FDA and European Medicines Agency,2017-08-29 07:06:00-04:00,PFE,pfizers bosulif regulatory submissions accepted by the fda and european medicines agency,"{'neg': 0.0, 'neu': 0.84, 'pos': 0.16, 'compound': 0.2732}",neutral,0.9998810291290283
989172,989172,1001314.0,"Bristol-Myers Squibb, Pfizer Present Observational Real-World Data Analysis on Effectiveness and Safety of Eliquis vs to Warfarin in Select High-Risk Patients with NVAF",2017-08-28 04:22:00-04:00,PFE,bristol myers squibb pfizer present observational real world data analysis on effectiveness and safety of eliquis vs to warfarin in select high risk patients with nvaf,"{'neg': 0.073, 'neu': 0.83, 'pos': 0.097, 'compound': 0.1779}",neutral,0.9998608827590942
989173,989173,1001315.0,From A(erie) To Z(ynerba): Biotech Catalysts Lined Up For Second Half Of 2017,2017-08-25 09:07:00-04:00,PFE,from aerie to zynerba biotech catalysts lined up for second half of 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998879432678223
989174,989174,1001316.0,"Sangamo Therapeutics, Pfizer Report First Patient Received Treatment In Phase 1/2 Trial Evaluating SB-525",2017-08-25 08:02:00-04:00,PFE,sangamo therapeutics pfizer report first patient received treatment in phase .5 trial evaluating sb 525,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998462200164795
989175,989175,1001317.0,"Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $SNAP +354K, $GE -262K, $PFE -122K, $JNJ -92K, $BABA +81K",2017-08-21 09:25:00-04:00,PFE,premarket prep host dennis dick tweets notable opening imbalances snap positive 354 thousand ge negative 262 thousand pfe negative 122 thousand jnj negative 92 thousand baba positive 81 thousand,"{'neg': 0.323, 'neu': 0.516, 'pos': 0.161, 'compound': -0.802}",negative,0.9590502381324768
989176,989176,1001318.0,"Bristol-Myers Squibb, Pfizer to Highlight Commitment to Reducing the Risk of Stroke Caused by Non-Valvular Atrial Fibrillation and Treating Deep Vein Thrombosis/Pulmonary Embolism  at ESC Congress 2017",2017-08-18 07:00:00-04:00,PFE,bristol myers squibb pfizer to highlight commitment to reducing the risk of stroke caused by non valvular atrial fibrillation and treating deep vein thrombosis and pulmonary embolism at esc congress 2017,"{'neg': 0.06, 'neu': 0.798, 'pos': 0.142, 'compound': 0.4404}",positive,0.9924633502960205
989177,989177,1001319.0,Pfizer Granted Approval Of Besponsa From FDA,2017-08-17 13:28:00-04:00,PFE,pfizer granted approval of besponsa from fda,"{'neg': 0.0, 'neu': 0.495, 'pos': 0.505, 'compound': 0.6249}",positive,0.998591959476471
989178,989178,1001320.0,Market Reaction To Bristol-Myers' Mixed Clinical Results: 'A Little Excessive',2017-08-16 11:59:00-04:00,PFE,market reaction to bristol myers mixed clinical results a little excessive,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9813281297683716
989179,989179,1001321.0,5 Biggest Price Target Changes For Tuesday,2017-08-15 10:18:00-04:00,PFE,5 biggest price target changes for tuesday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999804675579071
989180,989180,1001322.0,13F From Tepper's Appaloosa Shows Liquidated ~3M Share Position In Pfizer,2017-08-14 16:25:00-04:00,PFE,13 f from teppers appaloosa shows liquidated 3 million share position in pfizer,"{'neg': 0.0, 'neu': 0.845, 'pos': 0.155, 'compound': 0.296}",neutral,0.9993725419044495
989181,989181,1001323.0,Pfizer 10-Q Just Filed,2017-08-10 16:24:00-04:00,PFE,pfizer 10 q just filed,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998729228973389
989182,989182,1001324.0,"Pfizer, Sanofi, Glaxo Shares Unaffected Amid Comment From Mexican Anti-Trust Agency Official Suggesting Drugs Sold By Those Cos. Do Not Face Competition From Generics Readily Available Elsewhere",2017-08-09 10:56:00-04:00,PFE,pfizer sanofi glaxo shares unaffected amid comment from mexican anti trust agency official suggesting drugs sold by those cos do not face competition from generics readily available elsewhere,"{'neg': 0.07, 'neu': 0.762, 'pos': 0.168, 'compound': 0.4939}",negative,0.9934661984443665
989183,989183,1001325.0,"Wall Street's M&A Chatter From August 4-7: Acadia Pharma, United Technologies-Rockwell Collins, United Therapeutics",2017-08-07 07:19:00-04:00,PFE,wall streets m and a chatter from august 4 to 7 acadia pharma united technologies rockwell collins united therapeutics,"{'neg': 0.0, 'neu': 0.752, 'pos': 0.248, 'compound': 0.6808}",neutral,0.9998724460601807
989184,989184,1001326.0,Pfizer Reports FDA Advisory Committee Votes in Favor of XELJANZ 10 to 1,2017-08-03 14:10:00-04:00,PFE,pfizer reports fda advisory committee votes in favor of xeljanz 10 to 1,"{'neg': 0.0, 'neu': 0.816, 'pos': 0.184, 'compound': 0.4019}",neutral,0.9997846484184265
989185,989185,1001327.0,"Benzinga's Top Upgrades, Downgrades For August 2, 2017",2017-08-02 09:24:00-04:00,PFE,benzingas top upgrades downgrades for august 2 2017,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",positive,0.9700722098350525
989186,989186,1001328.0,BMO Capital Upgrades Pfizer to Outperform,2017-08-02 08:10:00-04:00,PFE,bmo capital upgrades pfizer to outperform,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996241331100464
989187,989187,1001329.0,Mid-Afternoon Market Update: Crude Oil Down 2.5%; Horizon Global Shares Spike Higher,2017-08-01 14:30:00-04:00,PFE,mid afternoon market update crude oil down 2.5 percent horizon global shares spike higher,"{'neg': 0.207, 'neu': 0.67, 'pos': 0.123, 'compound': -0.3612}",negative,0.9962701797485352
989188,989188,1001330.0,Key FDA Events To Watch Out For In August 2017,2017-08-01 12:39:00-04:00,PFE,key fda events to watch out for in august 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998775720596313
989189,989189,1001331.0,Mid-Day Market Update: Pitney Bowes Drops On Earnings Miss; Lumber Liquidators Shares Climb,2017-08-01 12:03:00-04:00,PFE,mid day market update pitney bowes drops on earnings miss lumber liquidators shares climb,"{'neg': 0.101, 'neu': 0.759, 'pos': 0.139, 'compound': 0.1531}",negative,0.9987757802009583
989190,989190,1001332.0,All Eyes On iPhone As Apple Kicks Off August With Earnings After Closing Bell,2017-08-01 10:27:00-04:00,PFE,all eyes on iphone as apple kicks off august with earnings after closing bell,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9990891218185425
989191,989191,1001333.0,Mid-Morning Market Update: Markets Open Higher; Pfizer Sales Miss Estimates,2017-08-01 10:11:00-04:00,PFE,mid morning market update markets open higher pfizer sales miss estimates,"{'neg': 0.138, 'neu': 0.862, 'pos': 0.0, 'compound': -0.1531}",negative,0.9978284239768982
989192,989192,1001334.0,August PDUFA Dates: Biotech Investors Stay Tuned To A Month Of Plenty,2017-08-01 09:20:00-04:00,PFE,august pdufa dates biotech investors stay tuned to a month of plenty,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999876856803894
989193,989193,1001335.0,A Peek Into The Markets: U.S. Stock Futures Climb; Apple Earnings In Focus,2017-08-01 07:23:00-04:00,PFE,a peek into the markets u s stock futures climb apple earnings in focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9988969564437866
989194,989194,1001336.0,"Pfizer Raises FY 2017 EPS Guidance to $2.54-$2.60 from $2.50-$2.60 vs $2.55 Est., Reaffirms Sales Guidance",2017-08-01 06:48:00-04:00,PFE,pfizer raises fy 2017 eps guidance to dollars .54 dollars .60 from dollars .50 dollars .60 vs dollars .55 est reaffirms sales guidance,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996788501739502
989195,989195,1001337.0,Pfizer Raises Guidance,2017-08-01 06:47:00-04:00,PFE,pfizer raises guidance,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9991833567619324
989196,989196,1001338.0,"Pfizer Q2 EPS $0.67 vs $0.66 Est., Sales $12.9B vs $13.1B Est.",2017-08-01 06:47:00-04:00,PFE,pfizer second quarter eps dollars .67 vs dollars .66 est sales dollars 2.9 billion vs dollars 3.1 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998773336410522
989197,989197,1001339.0,"10 Stocks To Watch For August 1, 2017",2017-08-01 05:31:00-04:00,PFE,10 stocks to watch for august 1 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998565912246704
989198,989198,1001340.0,"Earnings Scheduled For August 1, 2017",2017-08-01 04:34:00-04:00,PFE,earnings scheduled for august 1 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998862743377686
989199,989199,1001341.0,Earnings Preview: Pharma Giant Pfizer Reports Q2 Results Tomorrow Morning,2017-07-31 10:46:00-04:00,PFE,earnings preview pharma giant pfizer reports second quarter results tomorrow morning,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998691082000732
989200,989200,1001342.0,"Earnings Watch: Apple, Tesla, Pfizer, Activision-Blizzard On Tap For Next Week",2017-07-28 15:45:00-04:00,PFE,earnings watch apple tesla pfizer activision blizzard on tap for next week,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998401403427124
989201,989201,1001343.0,"Lightning Round: Jim Cramer Shares His Thoughts On Freeport-McMoRan, Pfizer And More",2017-07-28 07:17:00-04:00,PFE,lightning round jim cramer shares his thoughts on freeport mcmoran pfizer and more,"{'neg': 0.0, 'neu': 0.845, 'pos': 0.155, 'compound': 0.296}",neutral,0.9998748302459717
989202,989202,1001344.0,Why Is AstraZeneca Sinking Today?,2017-07-27 09:18:00-04:00,PFE,why is astrazeneca sinking today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.7746961712837219
989203,989203,1001345.0,"Samsung, Amazon — Everyone Is Getting Into Pharmaceuticals",2017-07-27 08:36:00-04:00,PFE,samsung amazon — everyone is getting into pharmaceuticals,"{'neg': 0.0, 'neu': 0.805, 'pos': 0.195, 'compound': 0.1779}",neutral,0.999887228012085
989204,989204,1001346.0,2 Ways To Trade This Week's Healthcare Earnings,2017-07-24 11:51:00-04:00,PFE,2 ways to trade this weeks healthcare earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998635053634644
989205,989205,1001347.0,Pfizer Reports Top-Line Results From Comparative REFLECTIONS B7391003 Study For PF-05439535,2017-07-24 08:35:00-04:00,PFE,pfizer reports top line results from comparative reflections b7391003 study for pf 05439535,"{'neg': 0.0, 'neu': 0.87, 'pos': 0.13, 'compound': 0.2023}",neutral,0.9998835325241089
989206,989206,1001348.0,Merck and Pfizer's Avelumab Recommended for Approval by the EU Medicines Agency,2017-07-21 07:20:00-04:00,PFE,merck and pfizers avelumab recommended for approval by the eu medicines agency,"{'neg': 0.0, 'neu': 0.671, 'pos': 0.329, 'compound': 0.5994}",neutral,0.9998351335525513
989207,989207,1001349.0,Hearing Merck Has Said Corning Will Make Initial $500M Investment Related To Modernization Of Pharmaceutical Glass Packaging,2017-07-20 15:21:00-04:00,PFE,hearing merck has said corning will make initial dollars 00 million investment related to modernization of pharmaceutical glass packaging,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997722506523132
989208,989208,1001350.0,"Trump Says Merck, Pfizer And Corning Announce That Glass Packaging Will Be Made In America",2017-07-20 15:07:00-04:00,PFE,trump says merck pfizer and corning announce that glass packaging will be made in america,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998874664306641
989209,989209,1001351.0,Analyst Prescribes Neutral Rating For Pfizer Shares,2017-07-20 10:57:00-04:00,PFE,analyst prescribes neutral rating for pfizer shares,"{'neg': 0.0, 'neu': 0.732, 'pos': 0.268, 'compound': 0.296}",neutral,0.9992897510528564
989210,989210,1001352.0,"Benzinga's Top Upgrades, Downgrades For July 20, 2017",2017-07-20 09:27:00-04:00,PFE,benzingas top upgrades downgrades for july 20 2017,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",positive,0.9286279082298279
989211,989211,1001353.0,The Market In 5 Minutes,2017-07-20 09:05:00-04:00,PFE,the market in 5 minutes,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998767375946045
989212,989212,1001354.0,"Lightning Round: Jim Cramer Shares His Thoughts On GameStop, Pfizer And More",2017-07-20 07:34:00-04:00,PFE,lightning round jim cramer shares his thoughts on gamestop pfizer and more,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.296}",neutral,0.9998668432235718
989213,989213,1001355.0,A Peek Into The Markets: U.S. Stock Futures Edge Higher Ahead Of Earnings,2017-07-20 07:06:00-04:00,PFE,a peek into the markets u s stock futures edge higher ahead of earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996306896209717
989214,989214,1001356.0,Credit Suisse Downgrades Pfizer to Neutral,2017-07-20 06:30:00-04:00,PFE,credit suisse downgrades pfizer to neutral,"{'neg': 0.0, 'neu': 0.658, 'pos': 0.342, 'compound': 0.3818}",negative,0.998397171497345
989215,989215,1001357.0,Pfizer Completes License Agreement for Exclusive Commercialization Rights in Europe for CRESEMBA to Treat Potentially Life-Threatening Fungal Infections Among Immunocompromised Patients,2017-07-20 04:10:00-04:00,PFE,pfizer completes license agreement for exclusive commercialization rights in europe for cresemba to treat potentially life threatening fungal infections among immunocompromised patients,"{'neg': 0.118, 'neu': 0.625, 'pos': 0.257, 'compound': 0.4588}",positive,0.9995280504226685
989216,989216,1001358.0,"Pre-Market Imbalance Update: Alibaba 120K Shares To Buy, AT&T 69K Shares To Sell, Target 67K to Buy, US Steel 44K To Buy, Colgate-Palmolive 36K To Sell, HP 32K To Sell, Pfizer 27K To Sell",2017-07-13 09:06:00-04:00,PFE,pre market imbalance update alibaba 120 thousand shares to buy at and t 69 thousand shares to sell target 67 thousand to buy us steel 44 thousand to buy colgate palmolive 36 thousand to sell hp 32 thousand to sell pfizer 27 thousand to sell,"{'neg': 0.0, 'neu': 0.907, 'pos': 0.093, 'compound': 0.5267}",neutral,0.9998651742935181
989217,989217,1001359.0,Pfizer Reports FDA Acceptance Of SNDA For XELJANZ For Treatment Of Moderately To Severely Active Ulcerative Colitis,2017-07-13 08:01:00-04:00,PFE,pfizer reports fda acceptance of snda for xeljanz for treatment of moderately to severely active ulcerative colitis,"{'neg': 0.132, 'neu': 0.617, 'pos': 0.251, 'compound': 0.4019}",positive,0.9992929697036743
989218,989218,1001360.0,J&J To Commence Pharma Q2 Earnings Season: What's Up?,2017-07-12 14:44:00-04:00,PFE,j and j to commence pharma second quarter earnings season whats up,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9971500039100647
989219,989219,1001361.0,5 Reasons To Be Increasing Your Large Cap Exposure Right Now,2017-07-12 11:50:00-04:00,PFE,5 reasons to be increasing your large cap exposure right now,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9964126944541931
989220,989220,1001362.0,Pfizer Reports FDA Panel Voted In Favor Of Co.'s MYLOTARG For Acute Myeloid Leukemia,2017-07-11 16:33:00-04:00,PFE,pfizer reports fda panel voted in favor of co s mylotarg for acute myeloid leukemia,"{'neg': 0.0, 'neu': 0.838, 'pos': 0.162, 'compound': 0.4019}",neutral,0.9990057349205017
989221,989221,1001363.0,The Royalty-Amassing Strategy Of Royalty Pharma,2017-07-10 16:11:00-04:00,PFE,the royalty amassing strategy of royalty pharma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998934268951416
989222,989222,1001364.0,"Pre-Market Imbalance Update: GE 357K Shares To Sell, NY Times 228K To Sell, BofA 73K Shares To Buy, Pfizer 48K To Sell, Visa 48K To Buy, Square 26K To Buy",2017-07-07 09:09:00-04:00,PFE,pre market imbalance update ge 357 thousand shares to sell ny times 228 thousand to sell bofa 73 thousand shares to buy pfizer 48 thousand to sell visa 48 thousand to buy square 26 thousand to buy,"{'neg': 0.0, 'neu': 0.888, 'pos': 0.112, 'compound': 0.5267}",neutral,0.9998475313186646
989223,989223,1001365.0,"Healthcare Repeal Bad For GlaxoSmithKline, Other HIV Treatment Stocks",2017-07-05 12:17:00-04:00,PFE,healthcare repeal bad for glaxosmithkline other hiv treatment stocks,"{'neg': 0.304, 'neu': 0.696, 'pos': 0.0, 'compound': -0.5423}",negative,0.9977326393127441
989224,989224,1001366.0,"Pre-Market Imbalance Update: Pfizer 454K Shares To Sell, NIKE 352K To Sell, Verizon 215K To Sell, ExxonMobil 182K To Sell, BofA 169K Shares To Buy, Chevron 145K To Sell, IBM 94K To Sell, General Mills 92K To Sell",2017-07-03 09:07:00-04:00,PFE,pre market imbalance update pfizer 454 thousand shares to sell nike 352 thousand to sell verizon 215 thousand to sell exxonmobil 182 thousand to sell bofa 169 thousand shares to buy chevron 145 thousand to sell ibm 94 thousand to sell general mills 92 thousand to sell,"{'neg': 0.075, 'neu': 0.841, 'pos': 0.084, 'compound': -0.128}",neutral,0.9998741149902344
989225,989225,1001367.0,UPDATE: Pfizer Reports BESPONSA PDUFA Goal Date Set For Aug. 2017,2017-06-30 07:41:00-04:00,PFE,update pfizer reports besponsa pdufa goal date set for aug 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998699426651001
989226,989226,1001368.0,Pfizer Reports BESPONSA Approved In EU For Adult Patients With Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia,2017-06-30 07:30:00-04:00,PFE,pfizer reports besponsa approved in eu for adult patients with relapsed or refractory b cell precursor acute lymphoblastic leukemia,"{'neg': 0.0, 'neu': 0.865, 'pos': 0.135, 'compound': 0.4215}",neutral,0.9721693396568298
989227,989227,1001369.0,"Jefferies Highlights A Pair Trade In Pharma: Buy ICON, Hold Tight On INC Research",2017-06-29 14:46:00-04:00,PFE,jefferies highlights a pair trade in pharma buy icon hold tight on inc research,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9558207392692566
989228,989228,1001370.0,"Pfizer, Alcyone Lifesciences Enter Feasibility Study To Evaluate Alycone's Pulsar Delivery Platform Tech For Use In Gene Therapy",2017-06-29 08:31:00-04:00,PFE,pfizer alcyone lifesciences enter feasibility study to evaluate alycones pulsar delivery platform tech for use in gene therapy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997608065605164
989229,989229,1001374.0,Pfizer To Hire 80 Additional Employees To Support Research At New R&D Facility In Missouri,2017-06-27 09:05:00-04:00,PFE,pfizer to hire 80 additional employees to support research at new r and d facility in missouri,"{'neg': 0.0, 'neu': 0.856, 'pos': 0.144, 'compound': 0.4019}",neutral,0.9973658919334412
989230,989230,1001375.0,"A Surprisingly Clean, Straightforward Approval Gives Portola Pharma Shares A Shot Of Upside",2017-06-26 14:03:00-04:00,PFE,a surprisingly clean straightforward approval gives portola pharma shares a shot of upside,"{'neg': 0.0, 'neu': 0.469, 'pos': 0.531, 'compound': 0.8481}",positive,0.9995904564857483
989231,989231,1001376.0,Attention To Details: Neos' ADHD Portfolio,2017-06-26 09:05:00-04:00,PFE,attention to details neos adhd portfolio,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998905658721924
989232,989232,1001379.0,"S&P Companies Spending 18% Less On Buybacks, But What Does It Mean For Investors?",2017-06-22 14:05:00-04:00,PFE,SP500 companies spending 18 percent less on buybacks but what does it mean for investors,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.937445878982544
989233,989233,1001382.0,"Wall Street's M&A Chatter From June 21: Staples-Sycamore Partners, Diageo-Casamigos, Bristol-Myers, Acadia Pharma",2017-06-22 07:06:00-04:00,PFE,wall streets m and a chatter from june 21 staples sycamore partners diageo casamigos bristol myers acadia pharma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998824596405029
989234,989234,1001383.0,Pfizer Downgraded To 3 Stars By Vetr Crowd,2017-06-21 11:28:00-04:00,PFE,pfizer downgraded to 3 stars by vetr crowd,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9939252734184265
989235,989235,1001386.0,Pfizer Receives Expanded Health Canada Approval For Ibrance,2017-06-21 08:03:00-04:00,PFE,pfizer receives expanded health canada approval for ibrance,"{'neg': 0.0, 'neu': 0.693, 'pos': 0.307, 'compound': 0.4767}",positive,0.999339759349823
989236,989236,1001389.0,Pfizer Reports Commencement Of Phase 1 Trial To Evaluate Investigational Group B Streptococcus Vaccine,2017-06-19 08:00:00-04:00,PFE,pfizer reports commencement of phase 1 trial to evaluate investigational group b streptococcus vaccine,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998691082000732
989237,989237,1001392.0,Pfizer Announces Overall Efficacy and Safety XELJANZ in The Lancet; Presented at #EULAR2017,2017-06-16 04:40:00-04:00,PFE,pfizer announces overall efficacy and safety xeljanz in the lancet presented at,"{'neg': 0.0, 'neu': 0.797, 'pos': 0.203, 'compound': 0.4215}",neutral,0.7135039567947388
989238,989238,1001393.0,"Regeneron Lower Day After 8-K Filing, Increased Competition For Pain Remedy",2017-06-15 15:09:00-04:00,PFE,regeneron lower day after 8 k filing increased competition for pain remedy,"{'neg': 0.331, 'neu': 0.542, 'pos': 0.127, 'compound': -0.5267}",negative,0.9972568154335022
989239,989239,1001395.0,"Pre-Market Imbalance Update: Barrick Gold 193K Shares To Sell, BofA 102K To Sell, Verizon 77K Shares To Buy, GE 54K To Buy, AT&T 50K To Buy, General Mills 48K To Buy, Pfizer 45K To Sell",2017-06-15 08:50:00-04:00,PFE,pre market imbalance update barrick gold 193 thousand shares to sell bofa 102 thousand to sell verizon 77 thousand shares to buy ge 54 thousand to buy at and t 50 thousand to buy general mills 48 thousand to buy pfizer 45 thousand to sell,"{'neg': 0.0, 'neu': 0.907, 'pos': 0.093, 'compound': 0.5267}",neutral,0.9998694658279419
989240,989240,1001396.0,"Basilea Pharma Reports License Deal With Pfizer For Cresemba For Europe, Russia, Turkey, Israel",2017-06-14 13:18:00-04:00,PFE,basilea pharma reports license deal with pfizer for cresemba for europe russia turkey israel,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993009567260742
989241,989241,1001400.0,"Pfizer, Eli Lilly Report Tanezumab Received FDA Fast Track Designation",2017-06-13 08:01:00-04:00,PFE,pfizer eli lilly report tanezumab received fda fast track designation,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9823185801506042
989242,989242,1001401.0,5 Biggest Price Target Changes For Monday,2017-06-12 10:10:00-04:00,PFE,5 biggest price target changes for monday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998231530189514
989243,989243,1001402.0,"Pre-Market Imbalance Update: Pfizer 74K Shares To Sell, Citi 61K To Sell, JP Morgan 35K Shares To Buy, Merck 33K To Buy",2017-06-12 08:52:00-04:00,PFE,pre market imbalance update pfizer 74 thousand shares to sell citi 61 thousand to sell jp morgan 35 thousand shares to buy merck 33 thousand to buy,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.6369}",neutral,0.999868631362915
989244,989244,1001403.0,"Merck, Pfizer Announce that Investigational SGLT-2 Inhibitor Ertugliflozin Met Primary Endpoint in Two Phase 3 Studies at #2017ADA",2017-06-11 11:52:00-04:00,PFE,merck pfizer announce that investigational sglt 2 inhibitor ertugliflozin met primary endpoint in two phase 3 studies at,"{'neg': 0.071, 'neu': 0.929, 'pos': 0.0, 'compound': -0.0772}",positive,0.9990197420120239
989245,989245,1001404.0,"Astellas and Pfizer Announce Amendment That Accelerates Anticipated PROSPER Top-Line Results By 2 Years, Target Sample Size Reduced To ~1,440 Patients With Completion Date Of Une 2017",2017-06-09 08:01:00-04:00,PFE,astellas and pfizer announce amendment that accelerates anticipated prosper top line results by 2 years target sample size reduced to 1440 patients with completion date of une 2017,"{'neg': 0.0, 'neu': 0.938, 'pos': 0.062, 'compound': 0.2023}",positive,0.9996581077575684
989246,989246,1001406.0,"Pfizer Japan, Eisai Launch Lyrica OD Tablet Formulation in Japan",2017-06-08 04:19:00-04:00,PFE,pfizer japan eisai launch lyrica od tablet formulation in japan,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998643398284912
989247,989247,1001407.0,"Sangamo Therapeutics, Pfizer Report SB-525 Received Orphan Medicinal Production Designation from EMA",2017-06-07 07:31:00-04:00,PFE,sangamo therapeutics pfizer report sb 525 received orphan medicinal production designation from ema,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.92626953125
989248,989248,1001408.0,Pfizer Receives FDA Fast Track Designation for Tafamidis,2017-06-06 08:00:00-04:00,PFE,pfizer receives fda fast track designation for tafamidis,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.8098485469818115
989249,989249,1001409.0,"OxOnc Reports Co-Development Partner, Pfizer, Has Received Regulatory Approval in Both Japan, Taiwan to Market Crizotinib 200 mg/250 mg Capsules for Treatment of ROS1-Positive Advanced NSCLC",2017-06-02 10:10:00-04:00,PFE,oxonc reports co development partner pfizer has received regulatory approval in both japan taiwan to market crizotinib 200 mg capsules for treatment of ros1 positive advanced nsclc,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.8271}",positive,0.9995657801628113
989250,989250,1001410.0,Hearing Appeals Court Has Upheld Dismissal of Suit Against Pfizer Which Claims Zoloft Causes Birth Defects,2017-06-02 08:54:00-04:00,PFE,hearing appeals court has upheld dismissal of suit against pfizer which claims zoloft causes birth defects,"{'neg': 0.153, 'neu': 0.847, 'pos': 0.0, 'compound': -0.4019}",positive,0.9854458570480347
989251,989251,1001411.0,Consult Your Doctor: FDA Thinks Big Pharma Might Be Intentionally Confusing You With Too Much Information,2017-06-01 08:40:00-04:00,PFE,consult your doctor fda thinks big pharma might be intentionally confusing you with too much information,"{'neg': 0.112, 'neu': 0.888, 'pos': 0.0, 'compound': -0.2263}",neutral,0.9289103150367737
989252,989252,1001412.0,"Pre-Market Imbalance Update: Pfizer 82K Shares to Buy, McDonald's 50K to Buy, Twitter 47K Shares to Sell",2017-06-01 08:34:00-04:00,PFE,pre market imbalance update pfizer 82 thousand shares to buy mcdonalds 50 thousand to buy twitter 47 thousand shares to sell,"{'neg': 0.0, 'neu': 0.812, 'pos': 0.188, 'compound': 0.5267}",neutral,0.9998569488525391
989253,989253,1001413.0,Adam Feuerstein Tweets 'I would say $PFE $MDVN deal is a cautionary tale that makes potential $TSRO suitors hesitant.',2017-05-31 16:11:00-04:00,PFE,adam feuerstein tweets i would say pfe mdvn deal is a cautionary tale that makes potential tsro suitors hesitant,"{'neg': 0.1, 'neu': 0.9, 'pos': 0.0, 'compound': -0.25}",negative,0.9956661462783813
989254,989254,1001414.0,"Pfizer Reports Acceptance of Regulatory Submissions by FDA, EMA for SUTENT for Adjuvant Treatment of Adult Patients at High Risk of Reccurent Renal Cell Carcinoma After Surgery",2017-05-31 08:31:00-04:00,PFE,pfizer reports acceptance of regulatory submissions by fda ema for sutent for adjuvant treatment of adult patients at high risk of reccurent renal cell carcinoma after surgery,"{'neg': 0.07, 'neu': 0.831, 'pos': 0.1, 'compound': 0.2263}",positive,0.7348591685295105
989255,989255,1001415.0,European Commission Approves Pfizer's Trumenba To Help Prevent Meningococcal Group B Disease,2017-05-30 10:02:00-04:00,PFE,european commission approves pfizers trumenba to help prevent meningococcal group b disease,"{'neg': 0.0, 'neu': 0.581, 'pos': 0.419, 'compound': 0.6705}",neutral,0.5205474495887756
989256,989256,1001416.0,How Much The Opioid Epidemic Actually Costs The Non-User,2017-05-28 15:15:00-04:00,PFE,how much the opioid epidemic actually costs the non user,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999529242515564
989257,989257,1001417.0,Amended 13D from Pfizer on pSivida Shows 4.7% Stake,2017-05-26 12:48:00-04:00,PFE,amended 1 3 dimensional from pfizer on psivida shows 4.7 percent stake,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998875856399536
989258,989258,1001418.0,8-K from Pfizer Shows Co. Received Notice of Unsolicited Mini-Tender Offer by TRC Cap for Purchasing of Up to 4M Shares at $31.60/Share,2017-05-25 16:27:00-04:00,PFE,8 k from pfizer shows co received notice of unsolicited mini tender offer by trc cap for purchasing of up to 4 million shares at dollars 1,"{'neg': 0.0, 'neu': 0.922, 'pos': 0.078, 'compound': 0.296}",neutral,0.9994725584983826
989259,989259,1001419.0,FDA Advisory Committee Recommends Approval of Pfizer's Proposed Biosimilar to Epogen/Procrit Across All Indications,2017-05-25 13:17:00-04:00,PFE,fda advisory committee recommends approval of pfizers proposed biosimilar to epogen and procrit across all indications,"{'neg': 0.0, 'neu': 0.737, 'pos': 0.263, 'compound': 0.6124}",neutral,0.999832272529602
989260,989260,1001420.0,The Current State Of The Breast Cancer Treatment Space,2017-05-23 08:59:00-04:00,PFE,the current state of the breast cancer treatment space,"{'neg': 0.355, 'neu': 0.645, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9998970031738281
989261,989261,1001421.0,Exclusive: Corium CEO Gives The Scoop On His Company's Latest Alzheimer's Data,2017-05-18 16:07:00-04:00,PFE,exclusive corium ceo gives the scoop on his companys latest alzheimers data,"{'neg': 0.0, 'neu': 0.763, 'pos': 0.237, 'compound': 0.2732}",neutral,0.9998856782913208
989262,989262,1001422.0,Corium CEO Peter Staple In Benzinga.com Interview Regarding Corplex Alzheimer's Treatment: 'We know with a high degree of confidence that we have a bioequivalent product' To Pfizer's FDA-Approved Aricept,2017-05-18 16:00:00-04:00,PFE,corium ceo peter staple in benzinga com interview regarding corplex alzheimers treatment we know with a high degree of confidence that we have a bioequivalent product to pfizers fda approved aricept,"{'neg': 0.0, 'neu': 0.826, 'pos': 0.174, 'compound': 0.7269}",positive,0.9992133378982544
989263,989263,1001423.0,"Pre-Market Imbalance Update: Alibaba 160K Shares to Sell, BofA 121K to Sell, Chesapeake Energy 95K to Sell, Pfizer 84K to Sell, Colgate-Palmolive 75K to Sell, Wells Fargo 72K to Sell, Visa 51K to Sell, Mastercard 38K to Sell, Macy's 34K to Sell",2017-05-18 09:00:00-04:00,PFE,pre market imbalance update alibaba 160 thousand shares to sell bofa 121 thousand to sell chesapeake energy 95 thousand to sell pfizer 84 thousand to sell colgate palmolive 75 thousand to sell wells fargo 72 thousand to sell visa 51 thousand to sell mastercard 38 thousand to sell macys 34 thousand to sell,"{'neg': 0.0, 'neu': 0.888, 'pos': 0.112, 'compound': 0.6486}",neutral,0.999868631362915
989264,989264,1001424.0,Citi Prefers These 4 Stocks Over Pfizer On Bottom-Line Concerns,2017-05-16 11:15:00-04:00,PFE,citi prefers these 4 stocks over pfizer on bottom line concerns,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.996597945690155
989265,989265,1001425.0,"Benzinga's Top Upgrades, Downgrades For May 16, 2017",2017-05-16 09:12:00-04:00,PFE,benzingas top upgrades downgrades for may 16 2017,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",neutral,0.8261141777038574
989266,989266,1001426.0,Citigroup Downgrades Pfizer to Sell,2017-05-16 07:35:00-04:00,PFE,citigroup downgrades pfizer to sell,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9956141710281372
989267,989267,1001427.0,"13F Shows Appaloosa Reduced Stake In Hain Celestial,  & Pfizer",2017-05-12 16:26:00-04:00,PFE,13 f shows appaloosa reduced stake in hain celestial and pfizer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.7154478430747986
989268,989268,1001428.0,Mid-Afternoon Market Update: Crude Oil Up 1.25%; Straight Path Shares Plunge,2017-05-11 14:33:00-04:00,PFE,mid afternoon market update crude oil up 1.25 percent straight path shares plunge,"{'neg': 0.208, 'neu': 0.562, 'pos': 0.23, 'compound': -0.1531}",positive,0.99725741147995
989269,989269,1001429.0,12 Biggest Mid-Day Gainers For Thursday,2017-05-11 12:22:00-04:00,PFE,12 biggest mid day gainers for thursday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996447563171387
989270,989270,1001430.0,Mid-Day Market Update: Snap Tumbles After Q1 Report; Sangamo Shares Surge,2017-05-11 12:02:00-04:00,PFE,mid day market update snap tumbles after first quarter report sangamo shares surge,"{'neg': 0.0, 'neu': 0.845, 'pos': 0.155, 'compound': 0.296}",negative,0.9028638005256653
989271,989271,1001431.0,Mid-Morning Market Update: Markets Open Lower; Macy's Profit Misses Expectations,2017-05-11 10:05:00-04:00,PFE,mid morning market update markets open lower macys profit misses expectations,"{'neg': 0.273, 'neu': 0.533, 'pos': 0.193, 'compound': -0.0516}",negative,0.9985373020172119
989272,989272,1001432.0,A New ETF Is An Active Idea For Income,2017-05-11 08:26:00-04:00,PFE,a new etf is an active idea for income,"{'neg': 0.0, 'neu': 0.748, 'pos': 0.252, 'compound': 0.4019}",neutral,0.999887228012085
989273,989273,1001433.0,20 Stocks Moving In Thursday's Pre-Market Session,2017-05-11 08:17:00-04:00,PFE,20 stocks moving in thursdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998701810836792
989274,989274,1001434.0,"Sangamo+40% Premarket @$6.10 Following Wednesday Earnings Report, Co Announced Strategic Collaboration with Pfizer for Hemophilia A Phase 1/2 Therapy Program",2017-05-11 07:32:00-04:00,PFE,sangamopositive 40 percent premarket dollars .10 following wednesday earnings report co announced strategic collaboration with pfizer for hemophilia a phase .5 therapy program,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9964371919631958
989275,989275,1001435.0,Sangamo Reports Strategic Collaboration with Pfizer for Hemophilia A Phase 1/2 Therapy Program,2017-05-10 16:04:00-04:00,PFE,sangamo reports strategic collaboration with pfizer for hemophilia a phase .5 therapy program,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997722506523132
989276,989276,1001436.0,Pfizer Issues Release Highlighting FDA Granted Approval for BAVENCIO for Common Type of Advanced Bladder Cancer,2017-05-09 15:55:00-04:00,PFE,pfizer issues release highlighting fda granted approval for bavencio for common type of advanced bladder cancer,"{'neg': 0.187, 'neu': 0.511, 'pos': 0.302, 'compound': 0.1779}",positive,0.9989343285560608
989277,989277,1001437.0,Hearing FDA Grants Accelerated Approval for Pfizer's Avelumab for Urothelial Carcinoma,2017-05-09 12:19:00-04:00,PFE,hearing fda grants accelerated approval for pfizers avelumab for urothelial carcinoma,"{'neg': 0.0, 'neu': 0.643, 'pos': 0.357, 'compound': 0.6124}",positive,0.9995231628417969
989278,989278,1001438.0,Pershing Shows It Isn't Done With The Biotech World After Valeant,2017-05-08 12:42:00-04:00,PFE,pershing shows it isnt done with the biotech world after valeant,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998533725738525
989279,989279,1001439.0,Will TherapeuticsMD's Yuvvexy Pass The FDA Muster?,2017-05-07 14:29:00-04:00,PFE,will therapeuticsmds yuvvexy pass the fda muster,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9987723231315613
989280,989280,1001440.0,Near-Term Events Cast Shadow Of Uncertainty On Bristol-Myers,2017-05-06 09:03:00-04:00,PFE,near term events cast shadow of uncertainty on bristol myers,"{'neg': 0.211, 'neu': 0.789, 'pos': 0.0, 'compound': -0.34}",negative,0.9608192443847656
989281,989281,1001441.0,Apple Is The World's Biggest Dividend Payer,2017-05-03 10:07:00-04:00,PFE,apple is the worlds biggest dividend payer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998830556869507
989282,989282,1001442.0,Pfizer Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for XELJANZ,2017-05-03 09:03:00-04:00,PFE,pfizer announces u s fda filing acceptance of supplemental new drug application for xeljanz,"{'neg': 0.0, 'neu': 0.812, 'pos': 0.188, 'compound': 0.4588}",positive,0.7082935571670532
989283,989283,1001443.0,Mid-Afternoon Market Update: Crude Oil Down 2.5%; Chegg Surges Higher,2017-05-02 14:43:00-04:00,PFE,mid afternoon market update crude oil down 2.5 percent chegg surges higher,"{'neg': 0.252, 'neu': 0.748, 'pos': 0.0, 'compound': -0.5719}",negative,0.9975894689559937
989284,989284,1001444.0,Mid-Day Market Update: Medpace Drops After Weak Earnings; Angie's List Shares Spike Higher,2017-05-02 12:07:00-04:00,PFE,mid day market update medpace drops after weak earnings angies list shares spike higher,"{'neg': 0.17, 'neu': 0.702, 'pos': 0.129, 'compound': -0.1779}",positive,0.964827299118042
989285,989285,1001445.0,Pfizer Lower After Mixed Q1 Report,2017-05-02 11:45:00-04:00,PFE,pfizer lower after mixed first quarter report,"{'neg': 0.268, 'neu': 0.732, 'pos': 0.0, 'compound': -0.296}",negative,0.9985700845718384
989286,989286,1001446.0,"Apple Earnings In Focus, But Fed Meeting, Auto Sales Also Could Grab Headlines",2017-05-02 10:58:00-04:00,PFE,apple earnings in focus but fed meeting auto sales also could grab headlines,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9683319926261902
989287,989287,1001447.0,Mid-Morning Market Update: Markets Mostly Flat; Pfizer Profit Beats Views,2017-05-02 10:10:00-04:00,PFE,mid morning market update markets mostly flat pfizer profit beats views,"{'neg': 0.0, 'neu': 0.775, 'pos': 0.225, 'compound': 0.4404}",positive,0.9989290833473206
989288,989288,1001448.0,A Peek Into The Markets: U.S. Stock Futures Mostly Lower; Apple Earnings In Focus,2017-05-02 07:15:00-04:00,PFE,a peek into the markets u s stock futures mostly lower apple earnings in focus,"{'neg': 0.136, 'neu': 0.864, 'pos': 0.0, 'compound': -0.296}",negative,0.9983507394790649
989289,989289,1001449.0,"Pfizer Reaffirms FY 2017 Guidance, Sees EPS $2.50 to $2.60 vs $2.55 Est, Sales $52.0B to $54.0B vs $53.2B Est",2017-05-02 06:47:00-04:00,PFE,pfizer reaffirms fy 2017 guidance sees eps dollars .50 to dollars .60 vs dollars .55 est sales dollars 2.0 billion to dollars 4.0 billion vs dollars 3.2 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.917619526386261
989290,989290,1001450.0,"Pfizer Q1 EPS $0.69 vs $0.67 Est, Sales $12.78B vs $13.09B Est",2017-05-02 06:46:00-04:00,PFE,pfizer first quarter eps dollars .69 vs dollars .67 est sales dollars 2.78 billion vs dollars 3.09 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998784065246582
989291,989291,1001451.0,"12 Stocks To Watch For May 2, 2017",2017-05-02 05:06:00-04:00,PFE,12 stocks to watch for may 2 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998646974563599
989292,989292,1001452.0,"Earnings Scheduled For May 2, 2017",2017-05-02 04:31:00-04:00,PFE,earnings scheduled for may 2 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998805522918701
989293,989293,1001453.0,"Earnings Preview: Q1 Results From Pfizer, Merck, And Gilead Sciences This Week",2017-05-01 10:56:00-04:00,PFE,earnings preview first quarter results from pfizer merck and gilead sciences this week,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998906850814819
989294,989294,1001454.0,Feuerstein On Neurotrope: The Study Failed And There Was Never 'A Lot Of Hope Here',2017-05-01 09:24:00-04:00,PFE,feuerstein on neurotrope the study failed and there was never a lot of hope here,"{'neg': 0.172, 'neu': 0.677, 'pos': 0.151, 'compound': -0.1027}",negative,0.9948992133140564
989295,989295,1001455.0,"Pre-Market Imbalance Update: AT&T 397K Shares to Sell, Verizon 213K to Sell, Pfizer 152K to Sell, Twitter 145K Shares to Buy, Coca-Cola 123K to Sell",2017-05-01 09:11:00-04:00,PFE,pre market imbalance update at and t 397 thousand shares to sell verizon 213 thousand to sell pfizer 152 thousand to sell twitter 145 thousand shares to buy coca cola 123 thousand to sell,"{'neg': 0.0, 'neu': 0.879, 'pos': 0.121, 'compound': 0.5267}",neutral,0.9998722076416016
989296,989296,1001456.0,"Looking For Action? Week Ahead Brings Heavy Load With Earnings, Data, Fed Meeting",2017-05-01 08:13:00-04:00,PFE,looking for action week ahead brings heavy load with earnings data fed meeting,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9980935454368591
989297,989297,1001457.0,"Weed Vs. Opioids: Nontraditional And Traditional Biotech Take On Wall Street, But Who's Winning?",2017-04-30 12:38:00-04:00,PFE,weed vs opioids nontraditional and traditional biotech take on wall street but whos winning,"{'neg': 0.0, 'neu': 0.739, 'pos': 0.261, 'compound': 0.6808}",neutral,0.9997323155403137
989298,989298,1001458.0,Drug Trials Heating Up In The Breast and Ovarian Cancer Treatment Space,2017-04-27 12:55:00-04:00,PFE,drug trials heating up in the breast and ovarian cancer treatment space,"{'neg': 0.286, 'neu': 0.714, 'pos': 0.0, 'compound': -0.6597}",neutral,0.99977046251297
989299,989299,1001459.0,Pfizer's Lorlatinib Granted Breakthrough Therapy Designation From FDA,2017-04-27 08:02:00-04:00,PFE,pfizers lorlatinib granted breakthrough therapy designation from fda,"{'neg': 0.0, 'neu': 0.778, 'pos': 0.222, 'compound': 0.25}",positive,0.9994719624519348
989300,989300,1001460.0,"Jim Cramer Gives His Opinion On Tesla, Pfizer And UnitedHealth",2017-04-27 06:59:00-04:00,PFE,jim cramer gives his opinion on tesla pfizer and unitedhealth,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999861478805542
989301,989301,1001461.0,"Aquinnah Pharma Reports Received $10M Investment from Pfizer, AbbVie for Research Breakthrough Approach to Neurodegenerative Disease",2017-04-25 08:08:00-04:00,PFE,aquinnah pharma reports received dollars 0 million investment from pfizer abbvie for research breakthrough approach to neurodegenerative disease,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9989126920700073
989302,989302,1001462.0,"Earnings: Caterpillar, Lockheed Martin, and Eli Lilly Report Tomorrow",2017-04-24 13:45:00-04:00,PFE,earnings caterpillar lockheed martin and eli lilly report tomorrow,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999868631362915
989303,989303,1001463.0,Pfizer Says Pivotal Phase III Study Underscores Efficacy Of Zavicefta,2017-04-24 05:47:00-04:00,PFE,pfizer says pivotal phase iii study underscores efficacy of zavicefta,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9991451501846313
989304,989304,1001464.0,"Pfizer Reports Positive CHMP Opinion for BESPONSA for Treatment of Relapsed, Refractory Acute Lymphoblastic Leukemia",2017-04-21 15:11:00-04:00,PFE,pfizer reports positive chmp opinion for besponsa for treatment of relapsed refractory acute lymphoblastic leukemia,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.5574}",positive,0.9995087385177612
989305,989305,1001465.0,EMA Recommends Approval Of Pfizer's Besponsa For Acute Lymphoblastic Leukemia,2017-04-21 13:28:00-04:00,PFE,ema recommends approval of pfizers besponsa for acute lymphoblastic leukemia,"{'neg': 0.0, 'neu': 0.615, 'pos': 0.385, 'compound': 0.6124}",neutral,0.9994860887527466
989306,989306,1001466.0,What Would A $5.8 Billion NIH Cut Look Like? Devastation,2017-04-20 13:38:00-04:00,PFE,what would a dollars .8 billion nih cut look like devastation,"{'neg': 0.318, 'neu': 0.519, 'pos': 0.162, 'compound': -0.34}",neutral,0.5977082252502441
989307,989307,1001467.0,The Lucky Beneficiaries Of Tax Day,2017-04-20 08:23:00-04:00,PFE,the lucky beneficiaries of tax day,"{'neg': 0.0, 'neu': 0.417, 'pos': 0.583, 'compound': 0.6808}",neutral,0.9998704195022583
989308,989308,1001468.0,Hearing Pfizer Has Said It Received Grand Jury Subpoena Related to DoJ's Antitrust Probe of IV Saline Solution,2017-04-19 10:46:00-04:00,PFE,hearing pfizer has said it received grand jury subpoena related to dojs antitrust probe of iv saline solution,"{'neg': 0.0, 'neu': 0.751, 'pos': 0.249, 'compound': 0.6486}",neutral,0.9991900324821472
989309,989309,1001469.0,8-K from ICU Medical Shows Co. Received Grand Jury Subpoena Related to Investigation by DoJ's Antitrust Unit for Pfizer/Hospira Infusion Systems Deal,2017-04-18 16:48:00-04:00,PFE,8 k from icu medical shows co received grand jury subpoena related to investigation by dojs antitrust unit for pfizer and hospira infusion systems deal,"{'neg': 0.0, 'neu': 0.889, 'pos': 0.111, 'compound': 0.4588}",neutral,0.9911571741104126
989310,989310,1001470.0,"HitGen, Pfizer Enter Research Collaboration, License Agreement to Build, Screen Novel DNA-Encoded Libraries",2017-04-18 03:56:00-04:00,PFE,hitgen pfizer enter research collaboration license agreement to build screen novel dna encoded libraries,"{'neg': 0.0, 'neu': 0.686, 'pos': 0.314, 'compound': 0.6705}",positive,0.9994955062866211
989311,989311,1001471.0,Healthcare Sector Earnings: Making A Comeback In Q1 2017?,2017-04-12 11:46:00-04:00,PFE,healthcare sector earnings making a comeback in first quarter 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996436834335327
989312,989312,1001472.0,Cardiovascular Players Could Be Eyeing Esperion,2017-04-10 11:53:00-04:00,PFE,cardiovascular players could be eyeing esperion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9995065927505493
989313,989313,1001473.0,FDA Warns Of Dangerous Hidden Ingredient In 5 OTC Male Sexual Enhancement Supplements,2017-04-07 12:25:00-04:00,PFE,fda warns of dangerous hidden ingredient in 5 otc male sexual enhancement supplements,"{'neg': 0.29, 'neu': 0.71, 'pos': 0.0, 'compound': -0.5423}",negative,0.9650090932846069
989314,989314,1001474.0,There Is Value To Be Had With The Right Healthcare ETFs,2017-04-05 08:32:00-04:00,PFE,there is value to be had with the right healthcare etfs,"{'neg': 0.0, 'neu': 0.806, 'pos': 0.194, 'compound': 0.34}",neutral,0.9993639588356018
989315,989315,1001475.0,"Benzinga Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $PFE -243K, $MRK -93K, $BABA +115K, $KO +104K, $T +111K, $CAT -55K, $IBM -42K",2017-04-03 09:24:00-04:00,PFE,benzinga premarket prep host dennis dick tweets notable opening imbalances pfe negative 243 thousand mrk negative 93 thousand baba positive 115 thousand ko positive 104 thousand t positive 111 thousand cat negative 55 thousand ibm negative 42 thousand,"{'neg': 0.307, 'neu': 0.509, 'pos': 0.183, 'compound': -0.8074}",negative,0.9894439578056335
989316,989316,1001476.0,Pfizer Subsidiary Meridian Medical Tech Has Expanded A Voluntary Recall Of Select Lots Of Mylan's EpiPen,2017-03-31 17:13:00-04:00,PFE,pfizer subsidiary meridian medical tech has expanded a voluntary recall of select lots of mylans epipen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994184970855713
989317,989317,1001477.0,"Pfizer Announces FDA sNDA Approval, Expanded Indication For IBRANCE",2017-03-31 14:04:00-04:00,PFE,pfizer announces fda snda approval expanded indication for ibrance,"{'neg': 0.0, 'neu': 0.721, 'pos': 0.279, 'compound': 0.4767}",positive,0.9995170831680298
989318,989318,1001478.0,Pfizer Shares Volatile Over Last Few Mins as Traders Circulating FDA.gov Page Showing FDA Granted Regular Approval to IBRANCE for Treatment of HR Positive,2017-03-31 13:16:00-04:00,PFE,pfizer shares volatile over last few mins as traders circulating fda gov page showing fda granted regular approval to ibrance for treatment of hr positive,"{'neg': 0.0, 'neu': 0.658, 'pos': 0.342, 'compound': 0.872}",positive,0.9059783220291138
989319,989319,1001479.0,"If Gender Confirmation Becomes A Legal Human Right, Which Corporations Could Benefit?",2017-03-28 13:05:00-04:00,PFE,if gender confirmation becomes a legal human right which corporations could benefit,"{'neg': 0.0, 'neu': 0.69, 'pos': 0.31, 'compound': 0.5423}",neutral,0.9989142417907715
989320,989320,1001480.0,Regeneron's Dupixent Passes The FDA Muster; Baird Sees Strong Launch,2017-03-28 12:41:00-04:00,PFE,regenerons dupixent passes the fda muster baird sees strong launch,"{'neg': 0.0, 'neu': 0.732, 'pos': 0.268, 'compound': 0.5106}",positive,0.9995042085647583
989321,989321,1001481.0,"Tesaro Gets Approval For Zejula, Expect U.S. Launch Late April",2017-03-28 10:26:00-04:00,PFE,tesaro gets approval for zejula expect u s launch late april,"{'neg': 0.0, 'neu': 0.763, 'pos': 0.237, 'compound': 0.4767}",neutral,0.9997634291648865
989322,989322,1001482.0,Anatomy Of A Decision Series Highlights Skills Necessary To Climb To The Top Of The Corporate Ladder,2017-03-27 14:16:00-04:00,PFE,anatomy of a decision series highlights skills necessary to climb to the top of the corporate ladder,"{'neg': 0.0, 'neu': 0.899, 'pos': 0.101, 'compound': 0.2023}",neutral,0.9998319149017334
989323,989323,1001483.0,Pfizer Receives Positive CHMP Opinion For TRUMENBA From European Medicines Agency,2017-03-24 10:18:00-04:00,PFE,pfizer receives positive chmp opinion for trumenba from european medicines agency,"{'neg': 0.0, 'neu': 0.735, 'pos': 0.265, 'compound': 0.5574}",positive,0.9995030164718628
989324,989324,1001484.0,Pfizer Reports EU Medicines Recommends Approval Of Trumenba Drug For Prophylaxis Against Invasive Meningococcal Disease,2017-03-24 08:06:00-04:00,PFE,pfizer reports eu medicines recommends approval of trumenba drug for prophylaxis against invasive meningococcal disease,"{'neg': 0.0, 'neu': 0.722, 'pos': 0.278, 'compound': 0.6124}",positive,0.9890888333320618
989325,989325,1001485.0,Adam Feuerstein Tweets: $PFE Merck KgAa — FDA approves avelumab for merkel cell carcinoma. Brand name: Bavencio.,2017-03-23 14:23:00-04:00,PFE,adam feuerstein tweets pfe merck kgaa — fda approves avelumab for merkel cell carcinoma brand name bavencio,"{'neg': 0.0, 'neu': 0.856, 'pos': 0.144, 'compound': 0.4019}",neutral,0.9451910853385925
989326,989326,1001486.0,Pfizer Shares Unaffected Following Report Advent Has Pulled bid for Co.'s Brazil Generic Drugs Venture,2017-03-22 15:42:00-04:00,PFE,pfizer shares unaffected following report advent has pulled bid for co s brazil generic drugs venture,"{'neg': 0.0, 'neu': 0.872, 'pos': 0.128, 'compound': 0.296}",negative,0.9975728392601013
989327,989327,1001487.0,"PreMarket Prep Recap, March 21: We Haven't Seen A 2% Correction Since The Election",2017-03-21 09:46:00-04:00,PFE,premarket prep recap march 21 we havent seen a 2 percent correction since the election,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9983150959014893
989328,989328,1001488.0,"Anatomy Of A Decision, Part 1: The C-Suite",2017-03-20 16:12:00-04:00,PFE,anatomy of a decision part 1 the c suite,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998873472213745
989329,989329,1001489.0,"Benzinga's Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $BAC -984K, $JPM -86K, $PFE +115K, $BABA +54K, $GE -88K, $KO +72K, $NKE +64K",2017-03-20 09:27:00-04:00,PFE,benzingas premarket prep host dennis dick tweets notable opening imbalances bac negative 984 thousand jpm negative 86 thousand pfe positive 115 thousand baba positive 54 thousand ge negative 88 thousand ko positive 72 thousand nke positive 64 thousand,"{'neg': 0.281, 'neu': 0.48, 'pos': 0.238, 'compound': -0.3818}",negative,0.9931778907775879
989330,989330,1001490.0,"Cronos Group Execs Talk About Cannabis Co., Recent 'Bought Deal' And Expansion Plans",2017-03-18 18:28:00-04:00,PFE,cronos group execs talk about cannabis co recent bought deal and expansion plans,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9923313856124878
989331,989331,1001491.0,"Bank Of America, Coach, Pfizer: Fast Money Picks For March 17",2017-03-17 06:53:00-04:00,PFE,bank of america coach pfizer fast money picks for march 17,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998577833175659
989332,989332,1001492.0,That Was Fast: Healthcare ETF Races To New Highs,2017-03-16 08:09:00-04:00,PFE,that was fast healthcare etf races to new highs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993676543235779
989333,989333,1001493.0,Pfizer Announces Approval By China FDA of XELJANZ for Treatment of Adult Patients With Moderately to Severely Active RA,2017-03-16 04:03:00-04:00,PFE,pfizer announces approval by china fda of xeljanz for treatment of adult patients with moderately to severely active ra,"{'neg': 0.121, 'neu': 0.645, 'pos': 0.234, 'compound': 0.4215}",positive,0.9923200011253357
989334,989334,1001494.0,"Barclays Global Healthcare Conference Continues Today; Presenters Include HCA Holdings, Valeant, Incyte, Celgene, Cotiviti, Aetna, Anthem, Seattle Genetics, Teva Pharma, Pfizer, & Bristol-Myers",2017-03-15 08:25:00-04:00,PFE,barclays global healthcare conference continues today presenters include hca holdings valeant incyte celgene cotiviti aetna anthem seattle genetics teva pharma pfizer and bristol myers,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999874472618103
989335,989335,1001495.0,"PreMarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $CAT -197K, $GE -156K, $BABA -46K, $CL -44K, $PFE -92K, $XOM -30K, $CVX -26K",2017-03-14 09:24:00-04:00,PFE,premarket prep host dennis dick tweets notable opening imbalances cat negative 197 thousand ge negative 156 thousand baba negative 46 thousand cl negative 44 thousand pfe negative 92 thousand xom negative 30 thousand cvx negative 26 thousand,"{'neg': 0.502, 'neu': 0.498, 'pos': 0.0, 'compound': -0.9837}",neutral,0.9047130346298218
989336,989336,1001496.0,How The Ultra-Wealthy Are Helping Advance Health And Life Sciences,2017-03-10 15:58:00-05:00,PFE,how the ultra wealthy are helping advance health and life sciences,"{'neg': 0.0, 'neu': 0.657, 'pos': 0.343, 'compound': 0.5719}",positive,0.7692853808403015
989337,989337,1001497.0,"Servier, Pfizer, Cellectis Announce FDA Clearance of IND Application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia",2017-03-09 04:19:00-05:00,PFE,servier pfizer cellectis announce fda clearance of ind application for ucart19 in adult relapsed and refractory acute lymphoblastic leukemia,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.991255521774292
989338,989338,1001498.0,"Cowen Annual Healthcare Conference Continues Today; Presenters Include Regulus, Eli Lilly, Oculus, DexCom, Illumina, Allergan, Kite Pharma, Pfizer, and bluebird bio",2017-03-07 08:59:00-05:00,PFE,cowen annual healthcare conference continues today presenters include regulus eli lilly oculus dexcom illumina allergan kite pharma pfizer and bluebird bio,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998902082443237
989339,989339,1001499.0,"Benzinga Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $XRX +467K, $BAC -353K, $PFE -133K, $CRM -129K, $PEP -89K, $JNJ -72K, $PG -50K",2017-03-06 09:18:00-05:00,PFE,benzinga premarket prep host dennis dick tweets notable opening imbalances xrx positive 467 thousand bac negative 353 thousand pfe negative 133 thousand crm negative 129 thousand pep negative 89 thousand jnj negative 72 thousand pg negative 50 thousand,"{'neg': 0.431, 'neu': 0.508, 'pos': 0.061, 'compound': -0.9716}",negative,0.9971466660499573
989340,989340,1001500.0,"Merck, Pfizer Report U.S. FDA and EMA Filing Acceptances of 3 Marketing Applications for Ertugliflozin-Containing Medicines For Adult Type 2 Diabetes Patients",2017-03-06 08:02:00-05:00,PFE,merck pfizer report u s fda and ema filing acceptances of 3 marketing applications for ertugliflozin containing medicines for adult type 2 diabetes patients,"{'neg': 0.0, 'neu': 0.895, 'pos': 0.105, 'compound': 0.4019}",neutral,0.9998489618301392
989341,989341,1001501.0,PR Confirms Earlier Reports That Spark Therapeutics and Pfizer SPK-9001 Granted Access To PRIME Program By EMA,2017-03-01 16:20:00-05:00,PFE,pr confirms earlier reports that spark therapeutics and pfizer spk 9001 granted access to prime program by ema,"{'neg': 0.0, 'neu': 0.804, 'pos': 0.196, 'compound': 0.4404}",positive,0.999019980430603
989342,989342,1001502.0,Short Sellers Pile On Pfizer After Buyout Rumors,2017-03-01 06:54:00-05:00,PFE,short sellers pile on pfizer after buyout rumors,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9952677488327026
989343,989343,1001503.0,Pfizer Receives FDA Warning For Drugs Contaminated With Cardboard At Kansas Facility,2017-02-28 17:22:00-05:00,PFE,pfizer receives fda warning for drugs contaminated with cardboard at kansas facility,"{'neg': 0.179, 'neu': 0.821, 'pos': 0.0, 'compound': -0.34}",negative,0.9895780086517334
989344,989344,1001504.0,"EMD Serono, A Unit Of Merck KGaA and Pfizer Announces FDA Approval Of Biologics License Application for Avelumab For Priority Review",2017-02-28 07:04:00-05:00,PFE,emd serono a unit of merck kgaa and pfizer announces fda approval of biologics license application for avelumab for priority review,"{'neg': 0.0, 'neu': 0.866, 'pos': 0.134, 'compound': 0.4767}",neutral,0.6427423357963562
989345,989345,1001505.0,Carl Icahn's Track Record In Big Pharma,2017-02-24 09:40:00-05:00,PFE,carl icahns track record in big pharma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9990573525428772
989346,989346,1001506.0,Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?,2017-02-21 16:48:00-05:00,PFE,icahn takes bristol myers stake with m and a in mind who could be the acquirer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998775720596313
989347,989347,1001507.0,"Boeing, Pfizer And Others Band Together To Ask Congress For More Taxes",2017-02-21 13:28:00-05:00,PFE,boeing pfizer and others band together to ask congress for more taxes,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996947050094604
989348,989348,1001508.0,"Pfizer Announces FDA Acceptance Of Regulatory Submission For Inotuzumab Ozogamicin, Sees PDUFA Date In August 2017",2017-02-21 08:04:00-05:00,PFE,pfizer announces fda acceptance of regulatory submission for inotuzumab ozogamicin sees pdufa date in august 2017,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.4588}",neutral,0.972583532333374
989349,989349,1001509.0,Momenta Pharmaceuticals Announces FDA Warning Letter to Contracted Glatopa Fill/Finish Manufacturer,2017-02-17 18:02:00-05:00,PFE,momenta pharmaceuticals announces fda warning letter to contracted glatopa fill and finish manufacturer,"{'neg': 0.167, 'neu': 0.833, 'pos': 0.0, 'compound': -0.34}",negative,0.9933265447616577
989350,989350,1001510.0,Border Tax Polarizes U.S Companies As Exporters Take Side With Trump Team,2017-02-16 09:17:00-05:00,PFE,border tax polarizes u s companies as exporters take side with trump team,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.6639816164970398
989351,989351,1001511.0,UPDATE: Pfizer XELJANZ 5mg Monotherapy Did Not Meet Primary Endpoint of Non-Inferiority vs. Humira; While XELJANZ plus MTX Met Primary Endpoint vs. Humira,2017-02-16 08:09:00-05:00,PFE,update pfizer xeljanz 5 million g monotherapy did not meet primary endpoint of non inferiority vs humira while xeljanz plus mtx met primary endpoint vs humira,"{'neg': 0.077, 'neu': 0.923, 'pos': 0.0, 'compound': -0.2732}",negative,0.705615222454071
989352,989352,1001512.0,Pfizer Reports Top-Line Results from Oral Strategy Trial of XELJANZ vs Humira,2017-02-16 08:00:00-05:00,PFE,pfizer reports top line results from oral strategy trial of xeljanz vs humira,"{'neg': 0.0, 'neu': 0.87, 'pos': 0.13, 'compound': 0.2023}",neutral,0.999035120010376
989353,989353,1001513.0,Deutsche Bank Casts Doubt On Pfizer's Rumored Takeover Approach To Bristol-Myers,2017-02-15 14:26:00-05:00,PFE,deutsche bank casts doubt on pfizers rumored takeover approach to bristol myers,"{'neg': 0.185, 'neu': 0.815, 'pos': 0.0, 'compound': -0.3612}",negative,0.9748268127441406
989354,989354,1001514.0,Deutsche Bank on Bristol-Myers Unconfirmed Takeover Chatter Tuesday: 'we would be surprised to see PFE make a move on BMY at this stage',2017-02-15 09:18:00-05:00,PFE,deutsche bank on bristol myers unconfirmed takeover chatter tuesday we would be surprised to see pfe make a move on bmy at this stage,"{'neg': 0.059, 'neu': 0.866, 'pos': 0.075, 'compound': 0.1027}",neutral,0.997576892375946
989355,989355,1001515.0,"13F from Tepper's Appaloosa Shows New Stakes in Mylan, Pfizer, Teva",2017-02-14 16:19:00-05:00,PFE,13 f from teppers appaloosa shows new stakes in mylan pfizer teva,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.993293046951294
989356,989356,1001516.0,Pfizer Inc Reports 16.4% Stake In Icu Medical as of Feb 3 in 13D,2017-02-13 16:22:00-05:00,PFE,pfizer inc reports 16.4 percent stake in icu medical as of feb 3 in 1 3 dimensional,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998860359191895
989357,989357,1001517.0,How China Lifting Its One-Child Policy Played Into Reckitt Benckiser's $90/Share Offer For Mead Johnson,2017-02-05 17:41:00-05:00,PFE,how china lifting its one child policy played into reckitt benckisers dollars offer for mead johnson,"{'neg': 0.0, 'neu': 0.862, 'pos': 0.138, 'compound': 0.34}",positive,0.9273372292518616
989358,989358,1001518.0,Mylan Tests Resistance After Pfizer Takeover Rumor,2017-02-03 11:40:00-05:00,PFE,mylan tests resistance after pfizer takeover rumor,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.789900541305542
989359,989359,1001519.0,Pfizer Begins $5 Billion Accelerated Share Repurchase,2017-02-03 08:10:00-05:00,PFE,pfizer begins dollars billion accelerated share repurchase,"{'neg': 0.0, 'neu': 0.732, 'pos': 0.268, 'compound': 0.296}",neutral,0.9998077750205994
989360,989360,1001520.0,Hearing Pfizer Has Hired JP Morgan to Consider $2B Portfolio Sale,2017-02-02 12:24:00-05:00,PFE,hearing pfizer has hired jp morgan to consider dollars b portfolio sale,"{'neg': 0.0, 'neu': 0.859, 'pos': 0.141, 'compound': 0.2023}",neutral,0.9998196959495544
989361,989361,1001521.0,"FedEx, Freeport-McMoran, Pfizer: Fast Money Picks For February 1",2017-02-01 06:54:00-05:00,PFE,fedex freeport mcmoran pfizer fast money picks for february 1,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997329115867615
989362,989362,1001522.0,Pfizer Flat After Q4 Miss,2017-01-31 12:05:00-05:00,PFE,pfizer flat after fourth quarter miss,"{'neg': 0.242, 'neu': 0.758, 'pos': 0.0, 'compound': -0.1531}",negative,0.9984874725341797
989363,989363,1001523.0,Q4 2016 Real-Time Call Brief,2017-01-31 11:43:00-05:00,PFE,q4 2016 real time call brief,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998748302459717
989364,989364,1001524.0,"President Trump Doubles Down On Healthcare Criticism, Says Drug Prices Are 'Astronomical'",2017-01-31 10:57:00-05:00,PFE,president trump doubles down on healthcare criticism says drug prices are astronomical,"{'neg': 0.209, 'neu': 0.791, 'pos': 0.0, 'compound': -0.4404}",negative,0.9785563945770264
989365,989365,1001525.0,Pfizer CEO States They Are Not Changing Philosophy On Drug Pricing Or When Co. Takes Increases,2017-01-31 10:45:00-05:00,PFE,pfizer ceo states they are not changing philosophy on drug pricing or when co takes increases,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998421669006348
989366,989366,1001526.0,"Fed Meeting Starts Today, But Focus Remains On Key Earnings Data",2017-01-31 10:20:00-05:00,PFE,fed meeting starts today but focus remains on key earnings data,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998612403869629
989367,989367,1001527.0,"The Market In 5 Minutes: Under Armour's Miss, Apple's Q1 Primer",2017-01-31 09:04:00-05:00,PFE,the market in 5 minutes under armours miss apples first quarter primer,"{'neg': 0.127, 'neu': 0.873, 'pos': 0.0, 'compound': -0.1531}",neutral,0.9998070597648621
989368,989368,1001528.0,"Healthcare Q4: Eli Lilly Beats, Pfizer Misses",2017-01-31 08:57:00-05:00,PFE,healthcare fourth quarter eli lilly beats pfizer misses,"{'neg': 0.213, 'neu': 0.787, 'pos': 0.0, 'compound': -0.2263}",positive,0.9599072933197021
989369,989369,1001529.0,A Peek Into The Markets: U.S. Stock Futures Down; Apple Earnings In Focus,2017-01-31 07:47:00-05:00,PFE,a peek into the markets u s stock futures down apple earnings in focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.947180986404419
989370,989370,1001530.0,"Pfizer Sees FY17 Sales $52B-$54B vs $54.03B Est., Adj. EPS $2.50-$2.60 vs $2.57 Est.",2017-01-31 06:46:00-05:00,PFE,pfizer sees fy17 sales dollars 2 billion dollars 4 billion vs dollars 4.03 billion est adj eps dollars .50 dollars .60 vs dollars .57 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999870777130127
989371,989371,1001531.0,"Pfizer Reports Q4 Adj. EPS $0.47 vs $0.50 Est., Sales $13.6B vs $13.63B Est.",2017-01-31 06:45:00-05:00,PFE,pfizer reports fourth quarter adj eps dollars .47 vs dollars .50 est sales dollars 3.6 billion vs dollars 3.63 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998753070831299
989372,989372,1001532.0,15 Stocks You Should Be Watching Today,2017-01-31 05:27:00-05:00,PFE,15 stocks you should be watching today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998483657836914
989373,989373,1001533.0,"Earnings Scheduled For January 31, 2017",2017-01-31 05:08:00-05:00,PFE,earnings scheduled for january 31 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998786449432373
989374,989374,1001534.0,"A Mixed Bag of Earnings Ahead: Eli Lilly, Pfizer, Exxon Mobil, And Under Armour",2017-01-30 12:26:00-05:00,PFE,a mixed bag of earnings ahead eli lilly pfizer exxon mobil and under armour,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9633767604827881
989375,989375,1001535.0,"Mixing It Up: Markets Await Host Of Economic Data, Key Earnings, And Fed Meeting",2017-01-30 10:07:00-05:00,PFE,mixing it up markets await host of economic data key earnings and fed meeting,"{'neg': 0.0, 'neu': 0.903, 'pos': 0.097, 'compound': 0.1027}",neutral,0.9998244643211365
989376,989376,1001536.0,"Pre-Market Prep Host Dennis Dick Tweets: Notable opening imbalances: $BABA -105K, $C -115K, $BAC -139K, $MS -92K, $BA -109K, $GE -170K, $PFE +111K, $BMY +69K",2017-01-30 09:19:00-05:00,PFE,pre market prep host dennis dick tweets notable opening imbalances baba negative 105 thousand c negative 115 thousand bac negative 139 thousand ms negative 92 thousand ba negative 109 thousand ge negative 170 thousand pfe positive 111 thousand bmy positive 69 thousand,"{'neg': 0.388, 'neu': 0.502, 'pos': 0.11, 'compound': -0.9601}",negative,0.9596052169799805
989377,989377,1001537.0,"The Market In 5 Minutes: Walgreens-Rite Aid, Personal Income And Trump's Executive Order",2017-01-30 09:03:00-05:00,PFE,the market in 5 minutes walgreens rite aid personal income and trumps executive order,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997472167015076
989378,989378,1001538.0,Can Merck And Pfizer Beat Low Expectations?,2017-01-30 07:16:00-05:00,PFE,can merck and pfizer beat low expectations,"{'neg': 0.259, 'neu': 0.741, 'pos': 0.0, 'compound': -0.2732}",positive,0.9986979961395264
989379,989379,1001539.0,"A Mutual Fund For Special Occasions: A Conversation With Value Fund Manager Tobias Carlisle, Part 1",2017-01-27 08:22:00-05:00,PFE,a mutual fund for special occasions a conversation with value fund manager tobias carlisle part 1,"{'neg': 0.0, 'neu': 0.733, 'pos': 0.267, 'compound': 0.6249}",neutral,0.9998890161514282
989380,989380,1001540.0,UPDATE: Pfizer Says Positive CHMP Opinion on XELJANZ Will Be Sent to EC For Final Decision,2017-01-27 07:01:00-05:00,PFE,update pfizer says positive chmp opinion on xeljanz will be sent to ec for final decision,"{'neg': 0.0, 'neu': 0.806, 'pos': 0.194, 'compound': 0.5574}",neutral,0.9989818930625916
989381,989381,1001541.0,Pfizer Reports Received CHMP Opinion in Europe for XELJANZ for Treatment of Moderate to Severe Active RA,2017-01-27 07:01:00-05:00,PFE,pfizer reports received chmp opinion in europe for xeljanz for treatment of moderate to severe active ra,"{'neg': 0.128, 'neu': 0.739, 'pos': 0.133, 'compound': 0.0258}",neutral,0.9982596039772034
989382,989382,1001542.0,Pfizer Reports Positive Top-Line Results from Phase 2 Study of Investigational Clostridium difficile Vaccine for the Prevention of C. difficile Infection,2017-01-26 08:00:00-05:00,PFE,pfizer reports positive top line results from phase 2 study of investigational clostridium difficile vaccine for the prevention of c difficile infection,"{'neg': 0.0, 'neu': 0.787, 'pos': 0.213, 'compound': 0.6597}",positive,0.9995889067649841
989383,989383,1001543.0,Watch These 7 Huge Put Purchases In Tuesday Trade,2017-01-24 04:31:00-05:00,PFE,watch these 7 huge put purchases in tuesday trade,"{'neg': 0.0, 'neu': 0.777, 'pos': 0.223, 'compound': 0.3182}",neutral,0.9993896484375
989384,989384,1001544.0,Benzinga's Option Alert Recap From January 23,2017-01-23 17:12:00-05:00,PFE,benzingas option alert recap from january 23,"{'neg': 0.0, 'neu': 0.732, 'pos': 0.268, 'compound': 0.296}",neutral,0.9998701810836792
989385,989385,1001545.0,"Option Alert: Pfizer Sept. $32 Puts at the Bid: Volume of 3,000 at $2.39 vs Open Interest of 654",2017-01-23 10:58:00-05:00,PFE,option alert pfizer sept dollars 2 puts at the bid volume of 3000 at dollars .39 vs open interest of 654,"{'neg': 0.0, 'neu': 0.785, 'pos': 0.215, 'compound': 0.6369}",neutral,0.9998811483383179
989386,989386,1001546.0,"Hearing Gilead, Pfizer CEOs Currently Meeting At Davos, Traders Speculating M&A Talks",2017-01-18 11:46:00-05:00,PFE,hearing gilead pfizer ceos currently meeting at davos traders speculating m and a talks,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998689889907837
989387,989387,1001547.0,Orphan Drugs Among 2015's Top 10 Best-Selling Medications,2017-01-18 10:40:00-05:00,PFE,orphan drugs among 2015 top 10 best selling medications,"{'neg': 0.0, 'neu': 0.538, 'pos': 0.462, 'compound': 0.7184}",neutral,0.9947273135185242
989388,989388,1001548.0,"Incyte PDUFA Date Pushed Back, JMP Discusses Impact",2017-01-17 08:13:00-05:00,PFE,incyte pdufa date pushed back jmp discusses impact,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9527604579925537
989389,989389,1001549.0,All The Markets Trump Moved During His Speech Today,2017-01-11 15:51:00-05:00,PFE,all the markets trump moved during his speech today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998749494552612
989390,989390,1001550.0,Trump: Drug Industry Is 'Getting Away With Murder',2017-01-11 12:15:00-05:00,PFE,trump drug industry is getting away with murder,"{'neg': 0.402, 'neu': 0.598, 'pos': 0.0, 'compound': -0.6908}",negative,0.5269580483436584
989391,989391,1001551.0,"Watching Weakness In Amgen,Biogen, Gilead, Mylan, Pfizer And Other Biotechs After Pres. Elect Trump Negative Statement On Drug Pricing",2017-01-11 11:25:00-05:00,PFE,watching weakness in amgen biogen gilead mylan pfizer and other biotechs after pres elect trump negative statement on drug pricing,"{'neg': 0.265, 'neu': 0.735, 'pos': 0.0, 'compound': -0.7579}",negative,0.9986708164215088
989392,989392,1001552.0,The Fentanyl Abuse Epidemic,2017-01-10 07:02:00-05:00,PFE,the fentanyl abuse epidemic,"{'neg': 0.583, 'neu': 0.417, 'pos': 0.0, 'compound': -0.6369}",neutral,0.9995620846748352
989393,989393,1001553.0,The Year's Biggest Healthcare Conference Commences This Week; Here's What You Need To Know,2017-01-09 06:33:00-05:00,PFE,the years biggest healthcare conference commences this week heres what you need to know,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998772144317627
989394,989394,1001554.0,Spark Gets A Check From Pfizer And A Downgrade From Vetr,2017-01-05 16:39:00-05:00,PFE,spark gets a check from pfizer and a downgrade from vetr,"{'neg': 0.0, 'neu': 0.84, 'pos': 0.16, 'compound': 0.2263}",positive,0.9925610423088074
989395,989395,1001555.0,ICU Medical Announces Terms To Acquire Hospira Infusion Systems From Pfizer Have Changed; Purchase Price Maximum Lowered From $1B To $900M,2017-01-05 16:13:00-05:00,PFE,icu medical announces terms to acquire hospira infusion systems from pfizer have changed purchase price maximum lowered from dollars b to dollars 00 million,"{'neg': 0.061, 'neu': 0.939, 'pos': 0.0, 'compound': -0.128}",neutral,0.9728384613990784
989396,989396,1001556.0,"ICU Medical, Inc. Provides Update on Hospira Infusion Systems Transaction, Says U.S. and Other Required Antitrust Clearances for Transaction Received, Deal To Close Feb. 2017",2017-01-05 16:06:00-05:00,PFE,icu medical inc provides update on hospira infusion systems transaction says u s and other required antitrust clearances for transaction received deal to close feb 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.99982088804245
989397,989397,1001557.0,"The Market In 5 Minutes: Jobless Claims Fall Again, Retailers Struggle",2017-01-05 09:13:00-05:00,PFE,the market in 5 minutes jobless claims fall again retailers struggle,"{'neg': 0.187, 'neu': 0.813, 'pos': 0.0, 'compound': -0.3182}",negative,0.9985150694847107
989398,989398,1001558.0,AbCellera Reports Multi-Target Research Collaboration with Pfizer,2017-01-05 09:02:00-05:00,PFE,abcellera reports multi target research collaboration with pfizer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999895453453064
989399,989399,1001559.0,Pfizer Reports Positive Top-Line Results from the Comparative REFLECTIONS B538-02 Study for PF-06410293,2017-01-05 08:31:00-05:00,PFE,pfizer reports positive top line results from the comparative reflections b538 to 02 study for pf 06410293,"{'neg': 0.0, 'neu': 0.735, 'pos': 0.265, 'compound': 0.6597}",positive,0.9996316432952881
989400,989400,1001560.0,Wall Street's M&A Chatter From January 4,2017-01-05 06:51:00-05:00,PFE,wall streets m and a chatter from january 4,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998862743377686
989401,989401,1001561.0,Spark Therapeutics Reports $15 Million Milestone Payment from Pfizer for Progress in Hemophilia B Gene Therapy Program,2017-01-04 07:32:00-05:00,PFE,spark therapeutics reports dollars 5 million milestone payment from pfizer for progress in hemophilia b gene therapy program,"{'neg': 0.0, 'neu': 0.773, 'pos': 0.227, 'compound': 0.5719}",positive,0.9986795783042908
989402,989402,1001562.0,Barron's Best Income Ideas For 2017,2017-01-02 17:26:00-05:00,PFE,barrons best income ideas for 2017,"{'neg': 0.0, 'neu': 0.543, 'pos': 0.457, 'compound': 0.6369}",neutral,0.999829888343811
989403,989403,1001563.0,"Standpoint Defends Opko Health, Thinks Bad News Will Reverse Within 3 Months",2016-12-30 12:45:00-05:00,PFE,standpoint defends opko health thinks bad news will reverse within 3 months,"{'neg': 0.241, 'neu': 0.759, 'pos': 0.0, 'compound': -0.5423}",positive,0.9988425970077515
989404,989404,1001564.0,Opko Health's Phase 3 Data Sends Stock Plunging,2016-12-30 10:12:00-05:00,PFE,opko healths phase 3 data sends stock plunging,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9984014630317688
989405,989405,1001565.0,"Pre-Market Prep Host Dennis Dick Tweets: Some huge sell imbalances this morning: $PG -151K, $VZ -242K, $XOM -183K, $WMT -127K, $CVX -117K, $GE -471K, $CAT -95K, $PFE -373K",2016-12-30 09:01:00-05:00,PFE,pre market prep host dennis dick tweets some huge sell imbalances this morning pg negative 151 thousand vz negative 242 thousand xom negative 183 thousand wmt negative 127 thousand cvx negative 117 thousand ge negative 471 thousand cat negative 95 thousand pfe negative 373 thousand,"{'neg': 0.469, 'neu': 0.499, 'pos': 0.033, 'compound': -0.9856}",negative,0.9970468878746033
989406,989406,1001566.0,"OPKO Announces Commencement Of Data Analysis In Phase 3 Study Of hGH-CTP, No Statistical Difference On Primary Endpoint Between hGH-CTP And Placebo",2016-12-30 08:26:00-05:00,PFE,opko announces commencement of data analysis in phase 3 study of hgh ctp no statistical difference on primary endpoint between hgh ctp and placebo,"{'neg': 0.087, 'neu': 0.913, 'pos': 0.0, 'compound': -0.296}",neutral,0.9998760223388672
989407,989407,1001567.0,Expensive Breakups In 2016 Surpass GDPs Of Dozens Of Developing Nations,2016-12-28 15:00:00-05:00,PFE,expensive breakups in 2016 surpass gdps of dozens of developing nations,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9993960857391357
989408,989408,1001568.0,6 Worst Biotech Stocks Of 2016,2016-12-23 11:50:00-05:00,PFE,6 worst biotech stocks of 2016,"{'neg': 0.451, 'neu': 0.549, 'pos': 0.0, 'compound': -0.6249}",negative,0.9659282565116882
989409,989409,1001569.0,"Meet The New Dogs: 2017's Dogs Of The Dow Include Coca-Cola, Boeing",2016-12-22 09:55:00-05:00,PFE,meet the new dogs 2017 dogs of the dow include coca cola boeing,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998903274536133
989410,989410,1001570.0,Breaking Down The Crowded Novel Ovarian Cancer Treatment Space,2016-12-21 09:19:00-05:00,PFE,breaking down the crowded novel ovarian cancer treatment space,"{'neg': 0.321, 'neu': 0.511, 'pos': 0.168, 'compound': -0.4767}",neutral,0.9998468160629272
989411,989411,1001571.0,Phizer Supplemental NDA for IBRANCE Accepted by FDA,2016-12-21 08:01:00-05:00,PFE,phizer supplemental nda for ibrance accepted by fda,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.2732}",neutral,0.9998751878738403
989412,989412,1001572.0,7 Companies That Could Be Acquired In 2017,2016-12-20 10:00:00-05:00,PFE,7 companies that could be acquired in 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998966455459595
989413,989413,1001573.0,Jefferies' 2017 Global Pharma Outlook,2016-12-19 10:56:00-05:00,PFE,jefferies 2017 global pharma outlook,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998619556427002
989414,989414,1001574.0,Portola Pharmaceuticals Enters into $50 Million Loan Agreement with Bristol-Myers Squibb and Pfizer for Continued Development of AndexXa,2016-12-19 08:00:00-05:00,PFE,portola pharmaceuticals enters into dollars 0 million loan agreement with bristol myers squibb and pfizer for continued development of andexxa,"{'neg': 0.0, 'neu': 0.856, 'pos': 0.144, 'compound': 0.4939}",positive,0.997183620929718
989415,989415,1001575.0,Pfizer Receives Approval in the European Union for Nimenrix in Infants Over 6 Months,2016-12-19 07:11:00-05:00,PFE,pfizer receives approval in the european union for nimenrix in infants over 6 months,"{'neg': 0.0, 'neu': 0.807, 'pos': 0.193, 'compound': 0.4767}",neutral,0.6985791325569153
989416,989416,1001576.0,Pfizer Reports FDA Approves Removal Of Boxed Warning Regarding Serious Neuropsychiatric Events From CHANTIX Labeling,2016-12-16 14:10:00-05:00,PFE,pfizer reports fda approves removal of boxed warning regarding serious neuropsychiatric events from chantix labeling,"{'neg': 0.201, 'neu': 0.652, 'pos': 0.147, 'compound': 0.0}",positive,0.9898926615715027
989417,989417,1001577.0,EMA Recommends Approval Of Pfizer's Lifmior For Treatment of Rheumatoid Arthritis,2016-12-16 07:33:00-05:00,PFE,ema recommends approval of pfizers lifmior for treatment of rheumatoid arthritis,"{'neg': 0.0, 'neu': 0.643, 'pos': 0.357, 'compound': 0.6124}",neutral,0.9703642725944519
989418,989418,1001578.0,Watch These 5 Huge Put Purchases In Thursday Trade,2016-12-15 04:25:00-05:00,PFE,watch these 5 huge put purchases in thursday trade,"{'neg': 0.0, 'neu': 0.777, 'pos': 0.223, 'compound': 0.3182}",neutral,0.9990532994270325
989419,989419,1001579.0,"UPDATE: Catalyst Biosciences Says Wyeth Has Granted Co. Exclusive License to Co.'s Proprietary Rights Applying to Factor CB 813a, CB 813d to Research, Develop, Manufacture, Commercialize Products",2016-12-14 16:37:00-05:00,PFE,update catalyst biosciences says wyeth has granted co exclusive license to co s proprietary rights applying to factor cb 813 a cb 81 3 dimensional to research develop manufacture commercialize products,"{'neg': 0.0, 'neu': 0.892, 'pos': 0.108, 'compound': 0.3612}",positive,0.9993724226951599
989420,989420,1001580.0,8-K from Catalyst Biosciences Shows Co. Entered Deal with Pfizer's Wyeth Related to Collaboration on Development of Novel Human Factor VIIa Products,2016-12-14 16:36:00-05:00,PFE,8 k from catalyst biosciences shows co entered deal with pfizers wyeth related to collaboration on development of novel human factor viia products,"{'neg': 0.0, 'neu': 0.905, 'pos': 0.095, 'compound': 0.3182}",positive,0.9991569519042969
989421,989421,1001581.0,"Pfizer, Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI, Did Not Meet Primary Endpoint In PFS",2016-12-14 16:17:00-05:00,PFE,pfizer astellas announce top line results from phase 4 plato trial of xtandi did not meet primary endpoint in pfs,"{'neg': 0.0, 'neu': 0.913, 'pos': 0.087, 'compound': 0.2023}",negative,0.6696704626083374
989422,989422,1001582.0,FDA Reports Approval of Pfizer's Eucrisa for Eczema,2016-12-14 13:08:00-05:00,PFE,fda reports approval of pfizers eucrisa for eczema,"{'neg': 0.0, 'neu': 0.693, 'pos': 0.307, 'compound': 0.4767}",positive,0.6949639916419983
989423,989423,1001583.0,Option Alert: PFE Feb $32 Put; 4000 @Bid @$0.86; Ref=$32.86,2016-12-14 11:59:00-05:00,PFE,option alert pfe feb dollars 2 put 4000 dollars .86 ref equals dollars 2.86,"{'neg': 0.0, 'neu': 0.855, 'pos': 0.145, 'compound': 0.296}",neutral,0.9998770952224731
989424,989424,1001584.0,Pfizer Reports Research & License Collaboration With Ab Initio To Discover GPCR Activating Antibodies,2016-12-13 13:05:00-05:00,PFE,pfizer reports research and license collaboration with ab initio to discover gpcr activating antibodies,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998575448989868
989425,989425,1001585.0,Technical Alert: Pfizer Pushes Higher For Second Day In A Row,2016-12-12 13:23:00-05:00,PFE,technical alert pfizer pushes higher for second day in a row,"{'neg': 0.0, 'neu': 0.82, 'pos': 0.18, 'compound': 0.296}",positive,0.9995500445365906
989426,989426,1001586.0,Pfizer Raises Qtr. Dividend from $0.30 to $0.32/Share,2016-12-12 11:54:00-05:00,PFE,pfizer raises qtr dividend from dollars .30 to dollars,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9989629983901978
989427,989427,1001587.0,"European Crohn's, Colitis Organisation Issues New Statement Support a Switch to Biosimilar from Reference Product in Inflammatory Bowel Disease",2016-12-09 10:18:00-05:00,PFE,european crohns colitis organisation issues new statement support a switch to biosimilar from reference product in inflammatory bowel disease,"{'neg': 0.0, 'neu': 0.87, 'pos': 0.13, 'compound': 0.4019}",neutral,0.8676596283912659
989428,989428,1001588.0,What If Trump Keeps Badmouthing Drug Pricing?,2016-12-07 13:38:00-05:00,PFE,what if trump keeps badmouthing drug pricing,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9993898868560791
989429,989429,1001589.0,"Pfizer, J&J, Other Big Pharma Names Dip Lower Just After the Open",2016-12-07 09:34:00-05:00,PFE,pfizer j and j other big pharma names dip lower just after the open,"{'neg': 0.145, 'neu': 0.855, 'pos': 0.0, 'compound': -0.296}",negative,0.9973522424697876
989430,989430,1001590.0,"Citi Global Healthcare Conf. Takes Place Today; Presenters Include Pfizer, Aerie Pharmaceuticals, Bristol-Myers, Alexion, Illumina, & Envision Healthcare",2016-12-07 08:38:00-05:00,PFE,citi global healthcare conf takes place today presenters include pfizer aerie pharmaceuticals bristol myers alexion illumina and envision healthcare,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998879432678223
989431,989431,1001591.0,Pfizer Fined $106 Million For Anti-Epilepsy Drug,2016-12-07 07:56:00-05:00,PFE,pfizer fined dollars 06 million for anti epilepsy drug,"{'neg': 0.223, 'neu': 0.777, 'pos': 0.0, 'compound': -0.3182}",negative,0.9299420118331909
989432,989432,1001592.0,CMA Fines Pfizer £84.2M for Drug Price Hike to NHS for Anti-epilepsy Drug,2016-12-07 04:54:00-05:00,PFE,cma fines pfizer £84.2 million for drug price hike to nhs for anti epilepsy drug,"{'neg': 0.141, 'neu': 0.859, 'pos': 0.0, 'compound': -0.3182}",negative,0.9916232228279114
989433,989433,1001593.0,8 Of The Biggest Biotech Announcements Out Of The 2016 ASH Meeting,2016-12-06 16:09:00-05:00,PFE,8 of the biggest biotech announcements out of the 2016 ash meeting,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999872088432312
989434,989434,1001594.0,Pressure Biosciences CEO On Biological Samples: It's All About How You Break Open A Cell,2016-12-05 15:55:00-05:00,PFE,pressure biosciences ceo on biological samples its all about how you break open a cell,"{'neg': 0.136, 'neu': 0.864, 'pos': 0.0, 'compound': -0.296}",neutral,0.9998934268951416
989435,989435,1001595.0,Allergan's Strength Lies In Its New Products And Robust Pipeline,2016-12-05 12:04:00-05:00,PFE,allergans strength lies in its new products and robust pipeline,"{'neg': 0.182, 'neu': 0.455, 'pos': 0.364, 'compound': 0.4215}",positive,0.99887615442276
989436,989436,1001596.0,The Medicines Company Is A Major Cardiovascular Player In The Making,2016-12-05 11:42:00-05:00,PFE,the medicines company is a major cardiovascular player in the making,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998887777328491
989437,989437,1001597.0,"Pfizer, Avillion Reports Phase 3 BFORE Study Of BOSULIF  Met Its Primary Endpoint",2016-12-05 08:01:00-05:00,PFE,pfizer avillion reports phase 3 bfore study of bosulif met its primary endpoint,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998778104782104
989438,989438,1001598.0,"Spark Therapeutics, Pfizer Present Updated Preliminary Data from Hemophilia B Phase 1/2 Trial Suggesting Consistent and Sustained Levels of Factor IX Activity at ASH 2016",2016-12-03 14:50:00-05:00,PFE,spark therapeutics pfizer present updated preliminary data from hemophilia b phase .5 trial suggesting consistent and sustained levels of factor ix activity at ash 2016,"{'neg': 0.0, 'neu': 0.927, 'pos': 0.073, 'compound': 0.2263}",positive,0.7634117603302002
989439,989439,1001599.0,Pfizer Announces New Phase 2 Results Show Investigational Compound Glasdegib Improved Overall Survival in AML and High-Risk MDS at ASH 2016,2016-12-03 14:38:00-05:00,PFE,pfizer announces new phase 2 results show investigational compound glasdegib improved overall survival in aml and high risk mds at ash 2016,"{'neg': 0.073, 'neu': 0.664, 'pos': 0.262, 'compound': 0.7506}",positive,0.9997076392173767
989440,989440,1001600.0,Benzinga's Top Initiations,2016-12-02 09:24:00-05:00,PFE,benzingas top initiations,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",neutral,0.9998692274093628
989441,989441,1001601.0,"The Market In 5 Minutes: Payrolls, Smith & Wesson Earnings And Starbucks' CEO Change",2016-12-02 09:03:00-05:00,PFE,the market in 5 minutes payrolls smith and wesson earnings and starbucks ceo change,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998856782913208
989442,989442,1001602.0,Guggenheim Initiates Coverage On Pfizer at Neutral,2016-12-02 07:18:00-05:00,PFE,guggenheim initiates coverage on pfizer at neutral,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998444318771362
989443,989443,1001603.0,"Pre-Market Prep Host Dennis Dick Tweets: Notable opening imbalances: $BAC +615K, $C +114K, $JPM +120K, $PFE +101K, $GE -143K, $PG -55K, $TWTR +35K",2016-12-01 09:22:00-05:00,PFE,pre market prep host dennis dick tweets notable opening imbalances bac positive 615 thousand c positive 114 thousand jpm positive 120 thousand pfe positive 101 thousand ge negative 143 thousand pg negative 55 thousand twtr positive 35 thousand,"{'neg': 0.173, 'neu': 0.468, 'pos': 0.359, 'compound': 0.91}",negative,0.9854494333267212
989444,989444,1001604.0,Pfizer's LYRICA Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint,2016-12-01 08:03:00-05:00,PFE,pfizers lyrica phase 3 trial in pediatric epilepsy meets primary endpoint,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996887445449829
989445,989445,1001605.0,"IBM, Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery",2016-12-01 08:00:00-05:00,PFE,ibm pfizer to accelerate immuno oncology research with watson for drug discovery,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9980734586715698
989446,989446,1001606.0,Pfizer Announces It Met Primary Endpoint For the Pivotal Comparative REFLECTIONS B3271002 Study for PF-05280014,2016-11-30 08:30:00-05:00,PFE,pfizer announces it met primary endpoint for the pivotal comparative reflections b3271002 study for pf 05280014,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9345142245292664
989447,989447,1001607.0,"Barclays Downgrades 5 Biopharma Stocks, Upgrades Pfizer And Alexion",2016-11-29 10:39:00-05:00,PFE,barclays downgrades 5 biopharma stocks upgrades pfizer and alexion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9872888326644897
989448,989448,1001608.0,Benzinga's Top Upgrades,2016-11-29 08:49:00-05:00,PFE,benzingas top upgrades,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",positive,0.7773524522781372
989449,989449,1001609.0,FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review,2016-11-29 08:18:00-05:00,PFE,fda accepts the biologics license application for avelumab for the treatment of metastatic merkel cell carcinoma for priority review,"{'neg': 0.0, 'neu': 0.887, 'pos': 0.113, 'compound': 0.3182}",neutral,0.9623819589614868
989450,989450,1001610.0,Barclays Upgrades Pfizer to Overweight,2016-11-29 05:56:00-05:00,PFE,barclays upgrades pfizer to overweight,"{'neg': 0.385, 'neu': 0.615, 'pos': 0.0, 'compound': -0.3612}",positive,0.9981163740158081
989451,989451,1001611.0,Can You Guess This Chart?,2016-11-23 07:36:00-05:00,PFE,can you guess this chart,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998624324798584
989452,989452,1001612.0,Stop The Presses: Xanax Sales Tend To Pick Up During The Holiday Season,2016-11-22 14:25:00-05:00,PFE,stop the presses xanax sales tend to pick up during the holiday season,"{'neg': 0.138, 'neu': 0.692, 'pos': 0.17, 'compound': 0.128}",positive,0.9996342658996582
989453,989453,1001613.0,"QuintilesIMS Forms New Collaboration with Bristol-Myers Squibb, Lilly, Merck KGaA, Darmstadt, Germany, and Pfizer to Generate Real World Insights On Usage of Anti-Cancer Therapies Across Europe",2016-11-22 08:04:00-05:00,PFE,quintilesims forms new collaboration with bristol myers squibb lilly merck kgaa darmstadt germany and pfizer to generate real world insights on usage of anti cancer therapies across europe,"{'neg': 0.205, 'neu': 0.795, 'pos': 0.0, 'compound': -0.7717}",neutral,0.9386434555053711
989454,989454,1001614.0,President-Elect Trump and Your Portfolio,2016-11-21 16:20:00-05:00,PFE,president elect trump and your portfolio,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999879002571106
989455,989455,1001615.0,"Pre-Market Prep Host Dennis Dick Tweets: Notable opening imbalances: $BABA +175K, $TWTR -90K, $BAC -236K, $MS -175K, $SQ -182K, $KR -109K, $PFE +109K",2016-11-17 09:25:00-05:00,PFE,pre market prep host dennis dick tweets notable opening imbalances baba positive 175 thousand twtr negative 90 thousand bac negative 236 thousand ms negative 175 thousand sq negative 182 thousand kr negative 109 thousand pfe positive 109 thousand,"{'neg': 0.415, 'neu': 0.468, 'pos': 0.116, 'compound': -0.9612}",negative,0.9369139075279236
989456,989456,1001616.0,PALOMA-2 Phase 3 Study Published In The New England Journal Of Medicine Demonstrates Clinical Benefit Of Pfizer's IBRANCE,2016-11-16 17:11:00-05:00,PFE,paloma 2 phase 3 study published in the new england journal of medicine demonstrates clinical benefit of pfizers ibrance,"{'neg': 0.0, 'neu': 0.857, 'pos': 0.143, 'compound': 0.4588}",positive,0.9986500144004822
989457,989457,1001617.0,"UPDATE: Pfizer Says OPAL Broaden, OPAL Beyond Met Primary Efficacy Endpoints Showing Statistically Significant Improvement with Tofacitinib 5 mg, 10 mg Twice Daily vs Placebo",2016-11-15 08:03:00-05:00,PFE,update pfizer says opal broaden opal beyond met primary efficacy endpoints showing statistically significant improvement with tofacitinib 5 mg 10 mg twice daily vs placebo,"{'neg': 0.0, 'neu': 0.827, 'pos': 0.173, 'compound': 0.5859}",positive,0.9996681213378906
989458,989458,1001618.0,Pfizer Reports Results from Phase 3 OPAL Development Program Investigating XELJANZ for Psoriatic Arthritis,2016-11-15 08:02:00-05:00,PFE,pfizer reports results from phase 3 opal development program investigating xeljanz for psoriatic arthritis,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999832272529602
989459,989459,1001619.0,"13F from Paulson & Co. Shows Increased Stake in Loxo Oncology, New Stake in Monster Worldwide, Steris, Talend, Tobira Therapeutics, Reduced Stakes in Pfizer, Puma Biotech, Synergy Pharma, Vanda, Liquidated Stake in Rite Aid",2016-11-14 17:54:00-05:00,PFE,13 f from paulson and co shows increased stake in loxo oncology new stake in monster worldwide steris talend tobira therapeutics reduced stakes in pfizer puma biotech synergy pharma vanda liquidated stake in rite aid,"{'neg': 0.0, 'neu': 0.942, 'pos': 0.058, 'compound': 0.2732}",positive,0.999413251876831
989460,989460,1001620.0,"UPDATE: Pfizer Says CRADA 'assesses OX40 agonist, utomilumab and avelumab immuno-oncology assets alone and in various combinations'",2016-11-14 08:14:00-05:00,PFE,update pfizer says crada assesses ox40 agonist utomilumab and avelumab immuno oncology assets alone and in various combinations,"{'neg': 0.102, 'neu': 0.812, 'pos': 0.086, 'compound': -0.0772}",neutral,0.9998892545700073
989461,989461,1001621.0,Pfizer Reports Collaboration with National Cancer Institute for Studying of Three Immunotherapy Agents Target Multiple Cancers,2016-11-14 08:14:00-05:00,PFE,pfizer reports collaboration with national cancer institute for studying of three immunotherapy agents target multiple cancers,"{'neg': 0.227, 'neu': 0.773, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9998558759689331
989462,989462,1001622.0,Landmark Study Demonstrates Pfizer's Celebrex has Similar Cardiovascular Risk vs Prescription Doses of Ibuprofen and Naproxen,2016-11-13 18:01:00-05:00,PFE,landmark study demonstrates pfizers celebrex has similar cardiovascular risk vs prescription doses of ibuprofen and naproxen,"{'neg': 0.121, 'neu': 0.805, 'pos': 0.075, 'compound': -0.2023}",neutral,0.8444145917892456
989463,989463,1001623.0,"Barron's Picks And Pans: Trump Stocks, Thermo Fisher, Discover And More",2016-11-13 14:59:00-05:00,PFE,barrons picks and pans trump stocks thermo fisher discover and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998682737350464
989464,989464,1001624.0,2 Big Medical Marijuana Stocks Riding High Post-Election,2016-11-10 10:45:00-05:00,PFE,2 big medical marijuana stocks riding high post election,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9945310950279236
989465,989465,1001625.0,The Market In 5 Minutes: Retail Earnings Come Into Focus,2016-11-10 09:01:00-05:00,PFE,the market in 5 minutes retail earnings come into focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998583793640137
989466,989466,1001626.0,Wall Street's M&A Chatter From November 10,2016-11-10 06:29:00-05:00,PFE,wall streets m and a chatter from november 10,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998823404312134
989467,989467,1001627.0,Pfizer Announces IBRANCE Receives EU Approval for Treatment of Women with HR+/HER2- Metastatic Breast Cancer,2016-11-10 04:11:00-05:00,PFE,pfizer announces ibrance receives eu approval for treatment of women with hr and her2 metastatic breast cancer,"{'neg': 0.196, 'neu': 0.667, 'pos': 0.138, 'compound': -0.3182}",positive,0.9987950325012207
989468,989468,1001628.0,"Pfizer Considering Sale, Spin-off of Consumer Health Unit, Including Advil, Chapstick Brands -Reuters",2016-11-09 19:27:00-05:00,PFE,pfizer considering sale spin off of consumer health unit including advil chapstick brands reuters,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998651742935181
989469,989469,1001629.0,Technical Alert: Pfizer Inc. Sharply Higher,2016-11-09 11:51:00-05:00,PFE,technical alert pfizer inc sharply higher,"{'neg': 0.0, 'neu': 0.694, 'pos': 0.306, 'compound': 0.296}",positive,0.9993358254432678
989470,989470,1001630.0,Last Night's Election - A Series Of Fortunate Events For Big Pharma,2016-11-09 11:06:00-05:00,PFE,last nights election to a series of fortunate events for big pharma,"{'neg': 0.0, 'neu': 0.791, 'pos': 0.209, 'compound': 0.4404}",neutral,0.9997673630714417
989471,989471,1001631.0,"Pharma Stocks Up Post Election: Ariad 16%, Infinity Up 13%, Allergan, Progenics, Endo 10%, Pfizer, Regeneron 8%, AbbVie 7%, Mylan, Medicines Co. 6%, Perrigo, Merck 5%, Bristol-Myers, Eli Lilly, Sanofi, Novartis 3.5%",2016-11-09 09:41:00-05:00,PFE,pharma stocks up post election ariad 16 percent infinity up 13 percent allergan progenics endo 10 percent pfizer regeneron 8 percent abbvie 7 percent mylan medicines co 6 percent perrigo merck 5 percent bristol myers eli lilly sanofi novartis 3.5 percent,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999679446220398
989472,989472,1001632.0,Biotech Is Getting A Big Boost Following Clinton's Loss,2016-11-09 08:38:00-05:00,PFE,biotech is getting a big boost following clintons loss,"{'neg': 0.192, 'neu': 0.583, 'pos': 0.225, 'compound': 0.1027}",positive,0.9996886253356934
989473,989473,1001633.0,Allergan Shares Spike ~$2 Over Last Few Mins as Hearing Unconfirmed Chatter Related to Pfizer Deal,2016-11-08 11:17:00-05:00,PFE,allergan shares spike dollars over last few mins as hearing unconfirmed chatter related to pfizer deal,"{'neg': 0.085, 'neu': 0.791, 'pos': 0.124, 'compound': 0.1779}",positive,0.9994884729385376
989474,989474,1001634.0,"Pfizer to Present Additional Research For XELJANZ® (Tofacitinib Citrate) In Rheumatologic Diseases, Including Rheumatoid Arthritis and Psoriatic Arthritis",2016-11-07 06:47:00-05:00,PFE,pfizer to present additional research for xeljanz® tofacitinib citrate in rheumatologic diseases including rheumatoid arthritis and psoriatic arthritis,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998395442962646
989475,989475,1001635.0,"Palatin's Female Arousal Drug Data Impresses, Investors React Positively",2016-11-03 09:06:00-04:00,PFE,palatins female arousal drug data impresses investors react positively,"{'neg': 0.0, 'neu': 0.519, 'pos': 0.481, 'compound': 0.7579}",positive,0.999382734298706
989476,989476,1001636.0,Spark Therapeutics and Pfizer Announce Updated Data from Hemophilia B Phase 1/2 Trial Suggesting Sustained Therapeutic Levels of Factor IX Activity,2016-11-03 09:05:00-04:00,PFE,spark therapeutics and pfizer announce updated data from hemophilia b phase .5 trial suggesting sustained therapeutic levels of factor ix activity,"{'neg': 0.0, 'neu': 0.913, 'pos': 0.087, 'compound': 0.2263}",positive,0.9974344372749329
989477,989477,1001637.0,Analysts Prescribe A Downgrade For Pfizer Stock,2016-11-02 12:24:00-04:00,PFE,analysts prescribe a downgrade for pfizer stock,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9976296424865723
989478,989478,1001638.0,Benzinga's Top Downgrades,2016-11-02 09:40:00-04:00,PFE,benzingas top downgrades,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",negative,0.9905633926391602
989479,989479,1001639.0,"The Market In 5 Minutes: Alibaba, Brocade And A Game 6",2016-11-02 09:05:00-04:00,PFE,the market in 5 minutes alibaba brocade and a game 6,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998906850814819
989480,989480,1001640.0,"A Peek Into The Markets: U.S. Stock Futures Mostly Lower Ahead of ADP Report, Fed Decision",2016-11-02 08:00:00-04:00,PFE,a peek into the markets u s stock futures mostly lower ahead of adp report fed decision,"{'neg': 0.121, 'neu': 0.879, 'pos': 0.0, 'compound': -0.296}",negative,0.9943102598190308
989481,989481,1001641.0,"Argus Downgrades Pfizer, Inc. Common Stock to Hold",2016-11-02 07:13:00-04:00,PFE,argus downgrades pfizer inc common stock to hold,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9968543648719788
989482,989482,1001642.0,"Pfizer Reports Prevenar 13 Received Approval for Use in Infants, Children in China",2016-11-02 06:50:00-04:00,PFE,pfizer reports prevenar 13 received approval for use in infants children in china,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.4767}",positive,0.9987161159515381
989483,989483,1001643.0,"BMO Capital Downgrades Pfizer, Inc. Common Stock to Market Perform",2016-11-02 06:05:00-04:00,PFE,bmo capital downgrades pfizer inc common stock to market perform,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.997658371925354
989484,989484,1001644.0,Mid-Afternoon Market Update: Dow Falls 150 Points; Pitney Bowes Shares Down On Earnings Miss,2016-11-01 15:06:00-04:00,PFE,mid afternoon market update dow falls 150 points pitney bowes shares down on earnings miss,"{'neg': 0.095, 'neu': 0.774, 'pos': 0.131, 'compound': 0.1531}",negative,0.9986503720283508
989485,989485,1001645.0,18 Biggest Mid-Day Losers For Tuesday,2016-11-01 14:17:00-04:00,PFE,18 biggest mid day losers for tuesday,"{'neg': 0.362, 'neu': 0.638, 'pos': 0.0, 'compound': -0.5267}",negative,0.9621010422706604
989486,989486,1001646.0,Mid-Day Market Update: InspireMD Jumps Following Positive CGuard Results; Neovasc Shares Drop,2016-11-01 12:11:00-04:00,PFE,mid day market update inspiremd jumps following positive cguard results neovasc shares drop,"{'neg': 0.117, 'neu': 0.559, 'pos': 0.324, 'compound': 0.5719}",positive,0.9993096590042114
989487,989487,1001647.0,Nerves Start To Fray Ahead Of Election As Investors Scramble For Protection,2016-11-01 11:37:00-04:00,PFE,nerves start to fray ahead of election as investors scramble for protection,"{'neg': 0.113, 'neu': 0.887, 'pos': 0.0, 'compound': -0.1027}",negative,0.5517354011535645
989488,989488,1001648.0,The Election Can't Come Soon Enough For Biotechs,2016-11-01 10:39:00-04:00,PFE,the election cant come soon enough for biotechs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999873161315918
989489,989489,1001649.0,Mid-Morning Market Update: Markets Edge Lower; Pfizer Profit Misses Views,2016-11-01 10:24:00-04:00,PFE,mid morning market update markets edge lower pfizer profit misses views,"{'neg': 0.273, 'neu': 0.533, 'pos': 0.193, 'compound': -0.0516}",negative,0.9985390901565552
989490,989490,1001650.0,"The Market In 5 Minutes: Pfizer's Earnings, Gannett Drops Tronc Bid",2016-11-01 09:00:00-04:00,PFE,the market in 5 minutes pfizers earnings gannett drops tronc bid,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9964659214019775
989491,989491,1001651.0,A Peek Into The Markets: U.S. Stock Futures Rise Following Strong Chinese Manufacturing Report,2016-11-01 07:57:00-04:00,PFE,a peek into the markets u s stock futures rise following strong chinese manufacturing report,"{'neg': 0.0, 'neu': 0.809, 'pos': 0.191, 'compound': 0.5106}",positive,0.9995514750480652
989492,989492,1001652.0,Investors Disappointed With Pfizer Q3 Earnings,2016-11-01 07:28:00-04:00,PFE,investors disappointed with pfizer third quarter earnings,"{'neg': 0.341, 'neu': 0.659, 'pos': 0.0, 'compound': -0.4767}",negative,0.9984095692634583
989493,989493,1001653.0,"Pfizer Sees FY 2016 EPS $2.38 to $2.43 vs $2.46 Est, Revenue $52B to $53B vs $53B Est",2016-11-01 06:46:00-04:00,PFE,pfizer sees fy 2016 eps dollars .38 to dollars .43 vs dollars .46 est revenue dollars 2 billion to dollars 3 billion vs dollars 3 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998550415039062
989494,989494,1001654.0,"Pfizer Q3 EPS $0.61 vs $0.62 Est, Revenue $13.05B vs $13.05B Est",2016-11-01 06:45:00-04:00,PFE,pfizer third quarter eps dollars .61 vs dollars .62 est revenue dollars 3.05 billion vs dollars 3.05 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998766183853149
989495,989495,1001655.0,"Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor",2016-11-01 06:32:00-04:00,PFE,pfizer discontinues global development of bococizumab its investigational pcsk9 inhibitor,"{'neg': 0.126, 'neu': 0.874, 'pos': 0.0, 'compound': -0.0772}",neutral,0.5058279633522034
989496,989496,1001656.0,"Earnings Scheduled For November 1, 2016",2016-11-01 04:52:00-04:00,PFE,earnings scheduled for november 1 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998763799667358
989497,989497,1001657.0,"Keep an Eye on These 10 Stocks for November 1, 2016",2016-11-01 04:27:00-04:00,PFE,keep an eye on these 10 stocks for november 1 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998639822006226
989498,989498,1001658.0,Watch These 7 Huge Call Purchases In Tuesday Trade,2016-11-01 01:27:00-04:00,PFE,watch these 7 huge call purchases in tuesday trade,"{'neg': 0.0, 'neu': 0.777, 'pos': 0.223, 'compound': 0.3182}",neutral,0.9986191987991333
989499,989499,1001659.0,Option Alert: PFE Dec16 34.0 Calls Sweep: 30300 @  Above Ask!  $0.18: 31k traded vs 7146 OI:  Earnings tmrrw Before Open  $31.66 Ref,2016-10-31 15:28:00-04:00,PFE,option alert pfe dec16 34.0 calls sweep 30300 above ask dollars .18 31 thousand traded vs 7146 oi earnings tmrrw before open dollars 1.66 ref,"{'neg': 0.0, 'neu': 0.916, 'pos': 0.084, 'compound': 0.296}",neutral,0.9998736381530762
989500,989500,1001660.0,October 2016 Sets Record For M&A At $251 Billion,2016-10-31 15:21:00-04:00,PFE,october 2016 sets record for m and a at dollars 51 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9078396558761597
989501,989501,1001661.0,Technical Alert: Pfizer Falls Under $32,2016-10-31 12:12:00-04:00,PFE,technical alert pfizer falls under dollars 2,"{'neg': 0.0, 'neu': 0.732, 'pos': 0.268, 'compound': 0.296}",negative,0.9946880340576172
989502,989502,1001662.0,"Trick Or Treat! Will Fed, Earnings, Jobs Report Offer Candy Or A Bag Of Rocks?",2016-10-31 11:41:00-04:00,PFE,trick or treat will fed earnings jobs report offer candy or a bag of rocks,"{'neg': 0.071, 'neu': 0.769, 'pos': 0.16, 'compound': 0.3612}",neutral,0.9998663663864136
989503,989503,1001663.0,"Merck KGaA, Pfizer IEMA Validates the Marketing Authorization Application for Avelumab for Treatment of Metastatic Merkel Cell Carcinoma",2016-10-31 04:06:00-04:00,PFE,merck kgaa pfizer iema validates the marketing authorization application for avelumab for treatment of metastatic merkel cell carcinoma,"{'neg': 0.0, 'neu': 0.876, 'pos': 0.124, 'compound': 0.34}",positive,0.9973230957984924
989504,989504,1001664.0,"Merck KGAA Said To Be Working With JP Morgan On Sale Of Biosimilar Drug Business; Watch Peers AbbVie, Pfizer, And Novartis",2016-10-28 14:31:00-04:00,PFE,merck kgaa said to be working with jp morgan on sale of biosimilar drug business watch peers abbvie pfizer and novartis,"{'neg': 0.0, 'neu': 0.917, 'pos': 0.083, 'compound': 0.2023}",neutral,0.999863862991333
989505,989505,1001665.0,6 Big Pharma Companies Left To Report September Quarterly Figures,2016-10-25 13:45:00-04:00,PFE,6 big pharma companies left to report september quarterly figures,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998661279678345
989506,989506,1001666.0,Pfizer's Medivation Receives FDA Approval For Prostate Cancer Drug XTANDI,2016-10-21 15:52:00-04:00,PFE,pfizers medivation receives fda approval for prostate cancer drug xtandi,"{'neg': 0.284, 'neu': 0.516, 'pos': 0.2, 'compound': -0.3182}",positive,0.994130551815033
989507,989507,1001667.0,"Bain, Advent, Torrent Capital Favorites to Buy Pfizer JV in Brazil -Reuters",2016-10-21 10:12:00-04:00,PFE,bain advent torrent capital favorites to buy pfizer jv in brazil reuters,"{'neg': 0.0, 'neu': 0.797, 'pos': 0.203, 'compound': 0.4215}",neutral,0.999271810054779
989508,989508,1001668.0,Medivation XTANDI Drug Has PDUFA Date Of Oct. 22 For Label Update With Earlier-Stage Use Data,2016-10-21 08:36:00-04:00,PFE,medivation xtandi drug has pdufa date of oct 22 for label update with earlier stage use data,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998712539672852
989509,989509,1001669.0,Pfizer Reports CDC Recommends Updated Guidance For Adminstering 2-3 Dose Series TRUMENBA,2016-10-19 18:04:00-04:00,PFE,pfizer reports cdc recommends updated guidance for adminstering 2 to 3 dose series trumenba,"{'neg': 0.0, 'neu': 0.872, 'pos': 0.128, 'compound': 0.2263}",neutral,0.9985294342041016
989510,989510,1001670.0,Johnson & Johnson's Robust Pipeline Supports Its Above-Average Valuation,2016-10-19 12:07:00-04:00,PFE,johnson and johnsons robust pipeline supports its above average valuation,"{'neg': 0.0, 'neu': 0.62, 'pos': 0.38, 'compound': 0.5994}",positive,0.9996411800384521
989511,989511,1001671.0,Pfizer Reports Winning of Grant to Evaluate Vaccine to Protect Newborns Against Group B Streptococcus,2016-10-19 08:01:00-04:00,PFE,pfizer reports winning of grant to evaluate vaccine to protect newborns against group b streptococcus,"{'neg': 0.0, 'neu': 0.585, 'pos': 0.415, 'compound': 0.8176}",positive,0.999599277973175
989512,989512,1001672.0,Pfizer Announces The U.S. Availability Of Biosimilar INFLECTRA,2016-10-17 16:06:00-04:00,PFE,pfizer announces the u s availability of biosimilar inflectra,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998513460159302
989513,989513,1001673.0,Pfizer to Present New Data on XELJANZ for Ulcerative Colitis at UEG Week 2016,2016-10-16 10:33:00-04:00,PFE,pfizer to present new data on xeljanz for ulcerative colitis at ueg week 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998341798782349
989514,989514,1001674.0,Benzinga's Top Downgrades,2016-10-13 09:20:00-04:00,PFE,benzingas top downgrades,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",negative,0.9905633926391602
989515,989515,1001675.0,"The Market In 5 Minutes: Stumpf Leaves Wells Fargo, More Trump Allegations",2016-10-13 08:48:00-04:00,PFE,the market in 5 minutes stumpf leaves wells fargo more trump allegations,"{'neg': 0.0, 'neu': 0.846, 'pos': 0.154, 'compound': 0.25}",neutral,0.9994090795516968
989516,989516,1001676.0,"Jefferies Downgrades Pfizer, Inc. to Hold",2016-10-13 06:47:00-04:00,PFE,jefferies downgrades pfizer inc to hold,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9982813596725464
989517,989517,1001677.0,Theravance Biopharma's Valuation Has Gotten A Little Carried Away,2016-10-12 13:21:00-04:00,PFE,theravance biopharmas valuation has gotten a little carried away,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9971925616264343
989518,989518,1001678.0,"Transgene Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate the Combination of TG4001 with Avelumab in HPV-Positive Head & Neck Cancer in a Phase 1/2 Study",2016-10-11 12:01:00-04:00,PFE,transgene announces collaboration with merck kgaa darmstadt germany and pfizer to evaluate the combination of tg4001 with avelumab in hpv positive head and neck cancer in a phase .5 study,"{'neg': 0.122, 'neu': 0.778, 'pos': 0.1, 'compound': -0.2023}",neutral,0.9995272159576416
989519,989519,1001679.0,Pfizer Announces First Positive Phase 3 Results in Adjuvant Setting for Renal Cell Carcinoma Show SUTENT Extended Disease Free Survival After Surgical Removal at ESMO 2016,2016-10-10 04:51:00-04:00,PFE,pfizer announces first positive phase 3 results in adjuvant setting for renal cell carcinoma show sutent extended disease free survival after surgical removal at esmo 2016,"{'neg': 0.0, 'neu': 0.777, 'pos': 0.223, 'compound': 0.7845}",positive,0.9995265007019043
989520,989520,1001680.0,Pfizer Announces Promising New Immunotherapy Combination Data With INLYTA in Advanced RCC,2016-10-09 11:26:00-04:00,PFE,pfizer announces promising new immunotherapy combination data with inlyta in advanced rcc,"{'neg': 0.0, 'neu': 0.68, 'pos': 0.32, 'compound': 0.5719}",positive,0.9854596257209778
989521,989521,1001681.0,Stocks Hitting 52-Week Highs,2016-10-07 10:20:00-04:00,PFE,stocks hitting 52 week highs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992315769195557
989522,989522,1001682.0,12 Biggest Mid-Day Gainers For Thursday,2016-10-06 12:55:00-04:00,PFE,12 biggest mid day gainers for thursday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996447563171387
989523,989523,1001683.0,Hearing Pfizer Will Sell Its NYC HQ by End of '16,2016-10-06 11:03:00-04:00,PFE,hearing pfizer will sell its nyc hq by end of 16,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998809099197388
989524,989524,1001684.0,Benzinga's Volume Movers,2016-10-06 10:37:00-04:00,PFE,benzingas volume movers,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998672008514404
989525,989525,1001685.0,Profit-Taking In ICU Medical Following Deal With Pfizer,2016-10-06 10:16:00-04:00,PFE,profit taking in icu medical following deal with pfizer,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.4404}",neutral,0.9998737573623657
989526,989526,1001686.0,"UPDATE: Pfizer Will Receive ~$400M in Newly-Issued Shares of ICUI, $600M in Cash from ICU Medical",2016-10-06 07:46:00-04:00,PFE,update pfizer will receive dollars 00 million in newly issued shares of icui dollars 00 million in cash from icu medical,"{'neg': 0.0, 'neu': 0.901, 'pos': 0.099, 'compound': 0.296}",neutral,0.9998728036880493
989527,989527,1001687.0,"ICU Medical Reports Will Buy Hospira Infusion Systems Unit from Pfizer for $1B in Cash, Stock",2016-10-06 07:45:00-04:00,PFE,icu medical reports will buy hospira infusion systems unit from pfizer for dollars b in cash stock,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998834133148193
989528,989528,1001688.0,Argus Slightly Disappointed With Pfizer's Decision Not To Split The Company,2016-10-03 10:37:00-04:00,PFE,argus slightly disappointed with pfizers decision not to split the company,"{'neg': 0.219, 'neu': 0.781, 'pos': 0.0, 'compound': -0.4228}",negative,0.9932618737220764
989529,989529,1001689.0,"Pre-Market Prep Host Dennis Dick Tweets: Notable opening imbalances: $TWTR +351K, $BABA +59K, $PFE -146K, $GE -288K, $PG -155K, $VZ -53K, $CAT -52K, $XOM -90K, $CVX -56K",2016-10-03 09:23:00-04:00,PFE,pre market prep host dennis dick tweets notable opening imbalances twtr positive 351 thousand baba positive 59 thousand pfe negative 146 thousand ge negative 288 thousand pg negative 155 thousand vz negative 53 thousand cat negative 52 thousand xom negative 90 thousand cvx negative 56 thousand,"{'neg': 0.403, 'neu': 0.497, 'pos': 0.099, 'compound': -0.9719}",negative,0.9865657687187195
989530,989530,1001690.0,iTeos Announces Initiation of Phase 1 Clinical Trial of IDO1 inhibitor being Conducted by Pfizer,2016-09-28 04:28:00-04:00,PFE,iteos announces initiation of phase 1 clinical trial of ido1 inhibitor being conducted by pfizer,"{'neg': 0.085, 'neu': 0.915, 'pos': 0.0, 'compound': -0.0772}",neutral,0.9998760223388672
989531,989531,1001691.0,Markets In Monotone Mode Despite Post-Debate Rally,2016-09-27 14:12:00-04:00,PFE,markets in monotone mode despite post debate rally,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998175501823425
989532,989532,1001692.0,Option Alert: PFE 9/30 33.5 Puts (Wkly) Sweep: 4999 @  ASK  $0.16: 5395 traded vs 331 OI:  Earnings 10/25  $33.79 Ref,2016-09-26 09:36:00-04:00,PFE,option alert pfe 33.5 puts wkly sweep 4999 ask dollars .16 5395 traded vs 331 oi earnings dollars 3.79 ref,"{'neg': 0.0, 'neu': 0.896, 'pos': 0.104, 'compound': 0.296}",neutral,0.9998786449432373
989533,989533,1001693.0,"The Market In 5 Minutes: Oil, Debates And Epidiolex",2016-09-26 09:04:00-04:00,PFE,the market in 5 minutes oil debates and epidiolex,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998807907104492
989534,989534,1001694.0,A Peek Into The Markets: U.S. Stock Futures Signal Lower Start On Wall Street,2016-09-26 07:50:00-04:00,PFE,a peek into the markets u s stock futures signal lower start on wall street,"{'neg': 0.136, 'neu': 0.864, 'pos': 0.0, 'compound': -0.296}",negative,0.9927940368652344
989535,989535,1001695.0,"Pfizer Decides Against Splitting Innovative And Essential Health, Will Remain One Company",2016-09-26 07:17:00-04:00,PFE,pfizer decides against splitting innovative and essential health will remain one company,"{'neg': 0.0, 'neu': 0.791, 'pos': 0.209, 'compound': 0.4404}",neutral,0.9998406171798706
989536,989536,1001696.0,UPDATE: Pfizer Says 2 Divisions Will Remain Separately Managed Within Single Company,2016-09-26 06:48:00-04:00,PFE,update pfizer says 2 divisions will remain separately managed within single company,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998905658721924
989537,989537,1001697.0,Pfizer Will Not Separate Into Two Publicly Traded Companies,2016-09-26 06:46:00-04:00,PFE,pfizer will not separate into two publicly traded companies,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998869895935059
989538,989538,1001698.0,Pfizer Reports Expiration of HSR Waiting Period for Proposed Deal of Medivation,2016-09-23 08:30:00-04:00,PFE,pfizer reports expiration of hsr waiting period for proposed deal of medivation,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994366765022278
989539,989539,1001699.0,The Market In 5 Minutes: No Interest Rate Hike...Yet,2016-09-22 09:04:00-04:00,PFE,the market in 5 minutes no interest rate hike yet,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.357}",neutral,0.9997932314872742
989540,989540,1001700.0,Can You Guess This Chart?,2016-09-22 07:31:00-04:00,PFE,can you guess this chart,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998624324798584
989541,989541,1001701.0,More Pharma Deals In The Pipeline?,2016-09-21 09:56:00-04:00,PFE,more pharma deals in the pipeline,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999841570854187
989542,989542,1001702.0,"Citi Research Reevaluates Bristol-Myers, Lowers Price Target",2016-09-20 09:13:00-04:00,PFE,citi research reevaluates bristol myers lowers price target,"{'neg': 0.176, 'neu': 0.824, 'pos': 0.0, 'compound': -0.128}",positive,0.9901572465896606
989543,989543,1001703.0,3 Pharma Companies Receive Positive EU Opinions,2016-09-16 10:07:00-04:00,PFE,3 pharma companies receive positive eu opinions,"{'neg': 0.0, 'neu': 0.625, 'pos': 0.375, 'compound': 0.5574}",positive,0.9882301092147827
989544,989544,1001704.0,"OncoImmune Announces Option and License Agreement with Pfizer Inc., Pfizer To Pay $250M Upfront and Potential Milestone Payments",2016-09-15 09:00:00-04:00,PFE,oncoimmune announces option and license agreement with pfizer inc pfizer to pay dollars 50 million upfront and potential milestone payments,"{'neg': 0.062, 'neu': 0.796, 'pos': 0.142, 'compound': 0.4215}",positive,0.9983868598937988
989545,989545,1001705.0,The Market In 5 Minutes: Apple Helps Lead Stocks Higher,2016-09-15 08:58:00-04:00,PFE,the market in 5 minutes apple helps lead stocks higher,"{'neg': 0.0, 'neu': 0.776, 'pos': 0.224, 'compound': 0.3818}",positive,0.9993938207626343
989546,989546,1001706.0,FDA Votes In Favor Of Removing Side-Effect Warning On Pfizer's Chantix,2016-09-15 08:57:00-04:00,PFE,fda votes in favor of removing side effect warning on pfizers chantix,"{'neg': 0.159, 'neu': 0.662, 'pos': 0.179, 'compound': 0.0772}",neutral,0.9961859583854675
989547,989547,1001707.0,"UPDATE: Pfizer, Merck's VERTIS SITA2 Also Achieved 4 Secondary Endpoints",2016-09-15 08:34:00-04:00,PFE,update pfizer mercks vertis sita2 also achieved 4 secondary endpoints,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9991388320922852
989548,989548,1001708.0,"Merck, Pfizer Reports Ertugliflozin Met Primary Endpoint of A1C Reduction",2016-09-15 08:32:00-04:00,PFE,merck pfizer reports ertugliflozin met primary endpoint of a1 calls reduction,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994900226593018
989549,989549,1001709.0,Can You Guess This Chart?,2016-09-15 07:22:00-04:00,PFE,can you guess this chart,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998624324798584
989550,989550,1001710.0,Five of 19 Panelists on FDA Panel Vote In Favor of Keeping Current Boxed Warning on Pfizer's Chantix,2016-09-14 16:24:00-04:00,PFE,five of 19 panelists on fda panel vote in favor of keeping current boxed warning on pfizers chantix,"{'neg': 0.114, 'neu': 0.758, 'pos': 0.128, 'compound': 0.0772}",neutral,0.9997219443321228
989551,989551,1001711.0,10 of 19 Panelists on FDA Panel Have Voted In Favor of Removing Boxed Warning of Serious Neuropsychatric Side Effects from Pfizer's Chantix,2016-09-14 16:24:00-04:00,PFE,10 of 19 panelists on fda panel have voted in favor of removing boxed warning of serious neuropsychatric side effects from pfizers chantix,"{'neg': 0.14, 'neu': 0.758, 'pos': 0.102, 'compound': 0.0}",neutral,0.9990115165710449
989552,989552,1001712.0,Four of 19 Panelists on FDA Panel In Favor of Modifying Language of Boxed Warning on Pfizer's Chantix,2016-09-14 16:23:00-04:00,PFE,four of 19 panelists on fda panel in favor of modifying language of boxed warning on pfizers chantix,"{'neg': 0.114, 'neu': 0.758, 'pos': 0.128, 'compound': 0.0772}",neutral,0.9998286962509155
989553,989553,1001713.0,Circle Pharma Enters into an Agreement with Pfizer to Build Screening Library of Macrocyclic Peptides,2016-09-12 08:00:00-04:00,PFE,circle pharma enters into an agreement with pfizer to build screening library of macrocyclic peptides,"{'neg': 0.0, 'neu': 0.814, 'pos': 0.186, 'compound': 0.4939}",positive,0.9930112957954407
989554,989554,1001714.0,"Reads For The Weed-Kend: Marijuana Roadside Testing, Pregnancy And Depression",2016-09-11 17:09:00-04:00,PFE,reads for the weed kend marijuana roadside testing pregnancy and depression,"{'neg': 0.27, 'neu': 0.73, 'pos': 0.0, 'compound': -0.5719}",neutral,0.9998657703399658
989555,989555,1001715.0,Another Election Year View On Healthcare ETFs,2016-09-08 11:12:00-04:00,PFE,another election year view on healthcare etfs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998784065246582
989556,989556,1001716.0,Pfizer Names Dr. Ole Isacson Chief Scientific Officer,2016-09-07 08:03:00-04:00,PFE,pfizer names dr ole isacson chief scientific officer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998741149902344
989557,989557,1001717.0,Retail Investors Loved Beat Up Stocks In August,2016-09-06 16:05:00-04:00,PFE,retail investors loved beat up stocks in august,"{'neg': 0.0, 'neu': 0.642, 'pos': 0.358, 'compound': 0.5994}",positive,0.9994490742683411
989558,989558,1001718.0,Investor Movement Index (IMX) for August 2016,2016-09-06 15:33:00-04:00,PFE,investor movement index imx for august 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998942613601685
989559,989559,1001719.0,"Out With The Old, In With The New: State Agencies Seem To Prefer Marijuana Over Opioids",2016-09-06 10:26:00-04:00,PFE,out with the old in with the new state agencies seem to prefer marijuana over opioids,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997089505195618
989560,989560,1001720.0,"Pfizer Gets European Approval For XALKORI, A Cell Lung Cancer Treatment",2016-08-31 08:10:00-04:00,PFE,pfizer gets european approval for xalkori a cell lung cancer treatment,"{'neg': 0.267, 'neu': 0.545, 'pos': 0.188, 'compound': -0.3182}",positive,0.9992863535881042
989561,989561,1001721.0,Pfizer Gets European Approval For XALKORI For Non-Small Cell Lung Cancer,2016-08-31 07:02:00-04:00,PFE,pfizer gets european approval for xalkori for non small cell lung cancer,"{'neg': 0.251, 'neu': 0.571, 'pos': 0.177, 'compound': -0.3182}",positive,0.999207079410553
989562,989562,1001722.0,Gemphire Therapeutics' Oral Cholesterol Drug Could Have $2.8 Billion Potential In U.S. Market,2016-08-30 13:23:00-04:00,PFE,gemphire therapeutics oral cholesterol drug could have dollars .8 billion potential in u s market,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9940966367721558
989563,989563,1001723.0,"Janney Initiates Galapagos At Buy, Sees Fair Value Of Shares At $64",2016-08-30 12:16:00-04:00,PFE,janney initiates galapagos at buy sees fair value of shares at dollars 4,"{'neg': 0.0, 'neu': 0.592, 'pos': 0.408, 'compound': 0.7096}",neutral,0.9997846484184265
989564,989564,1001724.0,"In Wake Of Medivation Deal, Argus Thinks Pfizer's Existing Business Is Underrated",2016-08-29 11:21:00-04:00,PFE,in wake of medivation deal argus thinks pfizers existing business is underrated,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9923105239868164
989565,989565,1001725.0,Novogen Names Gordon Hirsch as Chief Medical Officer,2016-08-29 07:05:00-04:00,PFE,novogen names gordon hirsch as chief medical officer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998834133148193
989566,989566,1001726.0,Here Are All The Big Biotech Mergers In 2016,2016-08-27 18:36:00-04:00,PFE,here are all the big biotech mergers in 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998871088027954
989567,989567,1001727.0,Pfizer's $1.5 Billion Antibiotics Buy: Strategic Long-Term Planning Or Pre-Split Prep?,2016-08-24 14:42:00-04:00,PFE,pfizers dollars .5 billion antibiotics buy strategic long term planning or pre split prep,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998571872711182
989568,989568,1001728.0,Risk Arbitrage Trading Strategies,2016-08-24 10:56:00-04:00,PFE,risk arbitrage trading strategies,"{'neg': 0.412, 'neu': 0.588, 'pos': 0.0, 'compound': -0.2732}",neutral,0.9998747110366821
989569,989569,1001729.0,Write A Prescription For More Pharma M&A With This ETF,2016-08-24 10:00:00-04:00,PFE,write a prescription for more pharma m and a with this etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998818635940552
989570,989570,1001730.0,The Market In 5 Minutes: Stocks Trading Higher As Earnings Season Quiets Down,2016-08-24 09:07:00-04:00,PFE,the market in 5 minutes stocks trading higher as earnings season quiets down,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992256164550781
989571,989571,1001731.0,Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca for Up to $1.575B,2016-08-24 04:19:00-04:00,PFE,pfizer to acquire small molecule anti infective business from astrazeneca for up to dollars .575 billion,"{'neg': 0.133, 'neu': 0.867, 'pos': 0.0, 'compound': -0.3182}",neutral,0.9997027516365051
989572,989572,1001732.0,Pfizer Has Had A Busy M&A Year...Or Has It?,2016-08-23 08:58:00-04:00,PFE,pfizer has had a busy m and a year or has it,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9988095760345459
989573,989573,1001733.0,"Pfizer, Target, JC Penney: Fast Money Picks For August 23",2016-08-23 06:52:00-04:00,PFE,pfizer target jc penney fast money picks for august 23,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996957778930664
989574,989574,1001734.0,"Benzinga's M&A Chatter for Monday August 22, 2016",2016-08-22 18:36:00-04:00,PFE,benzingas m and a chatter for monday august 22 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998840093612671
989575,989575,1001735.0,Monday's Market Wrap: Stocks Closed Mixed In Quiet Trade,2016-08-22 16:28:00-04:00,PFE,mondays market wrap stocks closed mixed in quiet trade,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9991350769996643
989576,989576,1001736.0,Mid-Afternoon Market Update: CIFC Rises Following Acquisition News; Marathon Oil Shares Slide,2016-08-22 15:02:00-04:00,PFE,mid afternoon market update cifc rises following acquisition news marathon oil shares slide,"{'neg': 0.0, 'neu': 0.845, 'pos': 0.155, 'compound': 0.296}",negative,0.9262973666191101
989577,989577,1001737.0,10 Biggest Mid-Day Gainers For Monday,2016-08-22 13:24:00-04:00,PFE,10 biggest mid day gainers for monday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995725750923157
989578,989578,1001738.0,Mid-Day Market Update: Crude Oil Down 2.8%; Intersil Shares Spike Higher,2016-08-22 12:45:00-04:00,PFE,mid day market update crude oil down 2.8 percent intersil shares spike higher,"{'neg': 0.219, 'neu': 0.651, 'pos': 0.13, 'compound': -0.3612}",negative,0.9976282715797424
989579,989579,1001739.0,Benzinga's Volume Movers,2016-08-22 11:22:00-04:00,PFE,benzingas volume movers,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998672008514404
989580,989580,1001740.0,Mid-Morning Market Update: Markets Mostly Lower; Pfizer To Buy Medivation For $14 Billion,2016-08-22 10:22:00-04:00,PFE,mid morning market update markets mostly lower pfizer to buy medivation for dollars 4 billion,"{'neg': 0.136, 'neu': 0.864, 'pos': 0.0, 'compound': -0.296}",neutral,0.999011754989624
989581,989581,1001741.0,Technical Alert: Pfizer Holds Support After Takeover Of Medivation Inc.,2016-08-22 10:22:00-04:00,PFE,technical alert pfizer holds support after takeover of medivation inc,"{'neg': 0.0, 'neu': 0.62, 'pos': 0.38, 'compound': 0.5994}",positive,0.9991084933280945
989582,989582,1001742.0,The Market In 5 Minutes: Indexes Remain In Tight Range As Rio Olympics Come To An End,2016-08-22 09:03:00-04:00,PFE,the market in 5 minutes indexes remain in tight range as rio olympics come to an end,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9753900170326233
989583,989583,1001743.0,5-Month Timeline: A Look Back At Medivation's Takeover Story,2016-08-22 08:46:00-04:00,PFE,5 month timeline a look back at medivations takeover story,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998428821563721
989584,989584,1001744.0,Goldman Sachs Talks Pfizer's Acquisition Deal Of Medivation,2016-08-22 08:17:00-04:00,PFE,goldman sachs talks pfizers acquisition deal of medivation,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9905672669410706
989585,989585,1001745.0,8 Stocks Moving In Monday's Pre-Market Session,2016-08-22 08:13:00-04:00,PFE,8 stocks moving in mondays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998704195022583
989586,989586,1001746.0,Pfizer Has Emerged The Victor In The Buyout Battle For Medivation,2016-08-22 08:09:00-04:00,PFE,pfizer has emerged the victor in the buyout battle for medivation,"{'neg': 0.206, 'neu': 0.794, 'pos': 0.0, 'compound': -0.3818}",positive,0.9963787198066711
989587,989587,1001747.0,A Peek Into The Markets: U.S. Stock Futures Down; Crude Oil Drops 2.7%,2016-08-22 07:51:00-04:00,PFE,a peek into the markets u s stock futures down crude oil drops 2.7 percent,"{'neg': 0.209, 'neu': 0.791, 'pos': 0.0, 'compound': -0.5719}",negative,0.9980157613754272
989588,989588,1001748.0,"Pfizer Buys Medivation For $14 Billion, Accelerating Its Pathway To Be A Leader In Oncology",2016-08-22 07:29:00-04:00,PFE,pfizer buys medivation for dollars 4 billion accelerating its pathway to be a leader in oncology,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999153733253479
989589,989589,1001749.0,Pfizer To Acquire Medivation For $81.50/Share Cash,2016-08-22 06:45:00-04:00,PFE,pfizer to acquire medivation for dollars 1. cash,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998857975006104
989590,989590,1001750.0,"Must Watch Stocks for August 22, 2016",2016-08-22 05:05:00-04:00,PFE,must watch stocks for august 22 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998829364776611
989591,989591,1001751.0,Medivation +20% Premarket @$81; FT Reported on Sunday Pfizer to Offer ~$80/Share,2016-08-22 04:22:00-04:00,PFE,medivation positive 20 percent premarket dollars 1 ft reported on sunday pfizer to offer dollars,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.5574}",positive,0.9995635151863098
989592,989592,1001752.0,Benzinga's Weekend M&A Chatter,2016-08-21 20:59:00-04:00,PFE,benzingas weekend m and a chatter,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998726844787598
989593,989593,1001753.0,Pfizer to Pay ~$80/Share For Medivation -Reuters,2016-08-21 18:27:00-04:00,PFE,pfizer to pay dollars for medivation reuters,"{'neg': 0.189, 'neu': 0.811, 'pos': 0.0, 'compound': -0.1027}",neutral,0.9993292093276978
989594,989594,1001754.0,Deutsche Takes A Look At Johnson & Johnson's Patent Woes,2016-08-18 14:53:00-04:00,PFE,deutsche takes a look at johnson and johnsons patent woes,"{'neg': 0.244, 'neu': 0.756, 'pos': 0.0, 'compound': -0.4404}",neutral,0.9990299940109253
989595,989595,1001755.0,Recent Patent Ruling A Positive For Pfizer,2016-08-18 14:26:00-04:00,PFE,recent patent ruling a positive for pfizer,"{'neg': 0.0, 'neu': 0.625, 'pos': 0.375, 'compound': 0.5574}",positive,0.9994921684265137
989596,989596,1001756.0,"UPDATE: Reuters Says Merck, Sanofi, Pfizer, Gilead, Celgene Have Each Submitted Expressions of Interest for Medivation",2016-08-17 12:55:00-04:00,PFE,update reuters says merck sanofi pfizer gilead celgene have each submitted expressions of interest for medivation,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.4588}",neutral,0.9998241066932678
989597,989597,1001757.0,The Least Popular Stocks This 13F Season,2016-08-16 12:08:00-04:00,PFE,the least popular stocks this 13 f season,"{'neg': 0.25, 'neu': 0.75, 'pos': 0.0, 'compound': -0.3252}",neutral,0.9996997117996216
989598,989598,1001758.0,ViiV Healthcare Launches Phase III Program Evaluating Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment - PRN,2016-08-16 08:59:00-04:00,PFE,viiv healthcare launches phase iii program evaluating two drug regimen combining dolutegravir and lamivudine for hiv 1 treatment to prn,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998660087585449
989599,989599,1001759.0,"13F from Paulson & Co. Shows Reduced AIG, Pfizer, T-Mobile Stakes",2016-08-15 17:27:00-04:00,PFE,13 f from paulson and co shows reduced aig pfizer t mobile stakes,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.7478022575378418
989600,989600,1001760.0,13F from Corvex Shows Liquidated ~17.5M Share Stake in Pfizer,2016-08-15 16:40:00-04:00,PFE,13 f from corvex shows liquidated 17.5 million share stake in pfizer,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.296}",neutral,0.999876856803894
989601,989601,1001761.0,13F from Elliott Shows Liquidated Nearly 4M Share Stake in Pfizer,2016-08-15 16:19:00-04:00,PFE,13 f from elliott shows liquidated nearly 4 million share stake in pfizer,"{'neg': 0.0, 'neu': 0.845, 'pos': 0.155, 'compound': 0.296}",neutral,0.9992640614509583
989602,989602,1001762.0,GlycoMimetics Initiated At Outperform By Cowen And Company,2016-08-15 12:01:00-04:00,PFE,glycomimetics initiated at outperform by cowen and company,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995280504226685
989603,989603,1001763.0,Jana Partners Dissolves Stake In Pfizer,2016-08-15 09:52:00-04:00,PFE,jana partners dissolves stake in pfizer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9980782270431519
989604,989604,1001764.0,"Appaloosa 13F Shows Dissolved Stake In Delta Air Lines, Valeant, Tenet Healthcare, United Rentals, Pfizer, Facebook, Bank Of America",2016-08-12 16:24:00-04:00,PFE,appaloosa 13 f shows dissolved stake in delta air lines valeant tenet healthcare united rentals pfizer facebook bank of america,"{'neg': 0.0, 'neu': 0.872, 'pos': 0.128, 'compound': 0.4215}",neutral,0.9998596906661987
989605,989605,1001765.0,"13F from David Tepper's Appaloosa Shows Liquidated Position in Facebook, Pfizer, United Rentals",2016-08-12 16:15:00-04:00,PFE,13 f from david teppers appaloosa shows liquidated position in facebook pfizer united rentals,"{'neg': 0.0, 'neu': 0.823, 'pos': 0.177, 'compound': 0.4215}",neutral,0.9542291164398193
989606,989606,1001766.0,Biogen Cancels Out Of Citigroup Conference Following Weeks Of Rumors,2016-08-11 15:02:00-04:00,PFE,biogen cancels out of citigroup conference following weeks of rumors,"{'neg': 0.174, 'neu': 0.826, 'pos': 0.0, 'compound': -0.2263}",negative,0.7684538960456848
989607,989607,1001767.0,"UPDATE: Pfizer, Sanofi, German Bidder Said to be Competing for Medivation",2016-08-11 10:18:00-04:00,PFE,update pfizer sanofi german bidder said to be competing for medivation,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999862790107727
989608,989608,1001768.0,Canada's Plan To Fight Opioid Addiction Might Hurt Its Weakest Patients,2016-08-08 16:59:00-04:00,PFE,canadas plan to fight opioid addiction might hurt its weakest patients,"{'neg': 0.538, 'neu': 0.462, 'pos': 0.0, 'compound': -0.8519}",negative,0.997748076915741
989609,989609,1001769.0,"Biogen Shares Unaffected Amid Dealreporter Report Suggesting Pfizer, J&J Could Also Be Looking at Co.",2016-08-08 11:28:00-04:00,PFE,biogen shares unaffected amid dealreporter report suggesting pfizer j and j could also be looking at co,"{'neg': 0.0, 'neu': 0.879, 'pos': 0.121, 'compound': 0.296}",negative,0.9920119643211365
989610,989610,1001770.0,Pfizer Reports Publication of New Analysis Demonstrating Long-Term Therapy with VYNDAQEL Slowed Progression of Rare Neurodegenerative Disease,2016-08-08 08:11:00-04:00,PFE,pfizer reports publication of new analysis demonstrating long term therapy with vyndaqel slowed progression of rare neurodegenerative disease,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9973912239074707
989611,989611,1001771.0,Terms Of The Trade: Dogs Of The Dow Investing Strategy,2016-08-03 14:38:00-04:00,PFE,terms of the trade dogs of the dow investing strategy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998886585235596
989612,989612,1001772.0,Mid-Afternoon Market Update: Crude Oil Down 1.5%; RetailMeNot Shares Gain On Strong Results,2016-08-02 14:31:00-04:00,PFE,mid afternoon market update crude oil down 1.5 percent retailmenot shares gain on strong results,"{'neg': 0.157, 'neu': 0.466, 'pos': 0.377, 'compound': 0.6369}",positive,0.9153649210929871
989613,989613,1001773.0,"Following Pfizer's Q2 Results, Citi Says Investors Remain Focused On Potential Breakup",2016-08-02 14:26:00-04:00,PFE,following pfizers second quarter results citi says investors remain focused on potential breakup,"{'neg': 0.0, 'neu': 0.822, 'pos': 0.178, 'compound': 0.3818}",neutral,0.9996390342712402
989614,989614,1001774.0,Mid-Day Market Update: Dow Drops Over 100 Points; Avon Shares Surge Following Earnings Beat,2016-08-02 12:14:00-04:00,PFE,mid day market update dow drops over 100 points avon shares surge following earnings beat,"{'neg': 0.0, 'neu': 0.864, 'pos': 0.136, 'compound': 0.296}",positive,0.9977478384971619
989615,989615,1001775.0,Hearing Evercore ISI Analyst Suggesting Medicines Co. Overhang May Have Been Removed as Pfizer Exec on Earnings Call Disclosed Co.'s PCSK9 Being Shelved,2016-08-02 11:20:00-04:00,PFE,hearing evercore isi analyst suggesting medicines co overhang may have been removed as pfizer exec on earnings call disclosed co s pcsk9 being shelved,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9527508020401001
989616,989616,1001776.0,"Barclay Reviews Pfizer's Second Quarter, Maintains $34 Target",2016-08-02 10:39:00-04:00,PFE,barclay reviews pfizers second quarter maintains dollars 4 target,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9869937300682068
989617,989617,1001777.0,Pfizer Says Plans to Decide by End of Year on Potential Company Split,2016-08-02 10:16:00-04:00,PFE,pfizer says plans to decide by end of year on potential company split,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998494386672974
989618,989618,1001778.0,Mid-Morning Market Update: Markets Open Lower; Pfizer Tops Q2 Views,2016-08-02 09:58:00-04:00,PFE,mid morning market update markets open lower pfizer tops second quarter views,"{'neg': 0.142, 'neu': 0.645, 'pos': 0.213, 'compound': 0.2732}",negative,0.9964447617530823
989619,989619,1001779.0,The Market In 5 Minutes: Futures Trending Lower For Seventh Session In A Row,2016-08-02 09:19:00-04:00,PFE,the market in 5 minutes futures trending lower for seventh session in a row,"{'neg': 0.145, 'neu': 0.855, 'pos': 0.0, 'compound': -0.296}",negative,0.9983755350112915
989620,989620,1001780.0,It's Normal For Pfizer To Trade Down After Beating Estimates,2016-08-02 09:08:00-04:00,PFE,its normal for pfizer to trade down after beating estimates,"{'neg': 0.25, 'neu': 0.75, 'pos': 0.0, 'compound': -0.4588}",negative,0.9987308382987976
989621,989621,1001781.0,"Pfizer Q2 EPS $0.64 vs $0.62 est, Revenue $13.1B vs $13.0B est",2016-08-02 06:46:00-04:00,PFE,pfizer second quarter eps dollars .64 vs dollars .62 est revenue dollars 3.1 billion vs dollars 3.0 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998716115951538
989622,989622,1001782.0,12 Stocks You Should Be Watching Today,2016-08-02 05:00:00-04:00,PFE,12 stocks you should be watching today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998550415039062
989623,989623,1001783.0,"Earnings Scheduled For August 2, 2016",2016-08-02 04:03:00-04:00,PFE,earnings scheduled for august 2 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998867511749268
989624,989624,1001784.0,"How Can Pfizer's Drugs, Trials, And Acquisitions Grow Sales?",2016-08-01 10:54:00-04:00,PFE,how can pfizers drugs trials and acquisitions grow sales,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994204044342041
989625,989625,1001785.0,"After GDP Surprise, Market Looks Ahead to More Earnings, July Jobs Report",2016-08-01 10:16:00-04:00,PFE,after gdp surprise market looks ahead to more earnings july jobs report,"{'neg': 0.0, 'neu': 0.84, 'pos': 0.16, 'compound': 0.2732}",positive,0.9982874989509583
989626,989626,1001786.0,Pfizer Acquires Bamboo Therapeutics For $150M Upfront And Potential Milestones Of $495M,2016-08-01 10:00:00-04:00,PFE,pfizer acquires bamboo therapeutics for dollars 50 million upfront and potential milestones of dollars 95 million,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998396635055542
989627,989627,1001787.0,Pfizer Reports Top-Line Results from Phase 3 Maintenance Trial of Oral XELJANZ in UC,2016-07-28 17:09:00-04:00,PFE,pfizer reports top line results from phase 3 maintenance trial of oral xeljanz in uc,"{'neg': 0.0, 'neu': 0.886, 'pos': 0.114, 'compound': 0.2023}",neutral,0.9857418537139893
989628,989628,1001788.0,Pfizer And Western Oncolytics Reach Immuno-Oncology Research Collaboration,2016-07-28 11:02:00-04:00,PFE,pfizer and western oncolytics reach immuno oncology research collaboration,"{'neg': 0.0, 'neu': 0.879, 'pos': 0.121, 'compound': 0.0258}",neutral,0.9998916387557983
989629,989629,1001789.0,Pfizer Reports Deal with Western Oncolytics for Research Collaboration Related to Investigation of Novel Oncolytic Virus Technology,2016-07-28 10:02:00-04:00,PFE,pfizer reports deal with western oncolytics for research collaboration related to investigation of novel oncolytic virus technology,"{'neg': 0.0, 'neu': 0.874, 'pos': 0.126, 'compound': 0.3182}",neutral,0.9997771382331848
989630,989630,1001790.0,18 Biggest Mid-Day Gainers For Wednesday,2016-07-27 12:10:00-04:00,PFE,18 biggest mid day gainers for wednesday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996297359466553
989631,989631,1001791.0,Option Alert: PFE Aug16 37.0 Puts Sweep: 3255 @  ASK  $0.86: 3255 traded vs 1906 OI:  Earnings 8/2 Before Open  $36.73 Ref,2016-07-27 10:13:00-04:00,PFE,option alert pfe aug16 37.0 puts sweep 3255 ask dollars .86 3255 traded vs 1906 oi earnings before open dollars 6.73 ref,"{'neg': 0.0, 'neu': 0.905, 'pos': 0.095, 'compound': 0.296}",neutral,0.9998703002929688
989632,989632,1001792.0,18 Stocks Moving In Wednesday's Pre-Market Session,2016-07-27 08:33:00-04:00,PFE,18 stocks moving in wednesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998733997344971
989633,989633,1001793.0,BIND Therapeutics Says Pfizer's $40M Bid is 'Highest and Best' in 363 Auction,2016-07-26 17:28:00-04:00,PFE,bind therapeutics says pfizers dollars 0 million bid is highest and best in 363 auction,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.6369}",positive,0.9973638653755188
989634,989634,1001794.0,"Teva, Mylan Said to have Interest in Pfizer's 40% Interest in Brazil JV -Reuters",2016-07-26 09:39:00-04:00,PFE,teva mylan said to have interest in pfizers 40 percent interest in brazil jv reuters,"{'neg': 0.0, 'neu': 0.684, 'pos': 0.316, 'compound': 0.7184}",neutral,0.9997683167457581
989635,989635,1001795.0,"Spark Therapeutics, Pfizer Announce Updated Data from First Cohort in Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels of Factor IX Activity",2016-07-25 08:30:00-04:00,PFE,spark therapeutics pfizer announce updated data from first cohort in hemophilia b phase .5 trial demonstrating consistent sustained therapeutic levels of factor ix activity,"{'neg': 0.0, 'neu': 0.924, 'pos': 0.076, 'compound': 0.2263}",positive,0.9878690838813782
989636,989636,1001796.0,The Market In 5 Minutes: The Dow's Win Streak Comes To An End,2016-07-22 08:55:00-04:00,PFE,the market in 5 minutes the dows win streak comes to an end,"{'neg': 0.0, 'neu': 0.759, 'pos': 0.241, 'compound': 0.5859}",neutral,0.5969291925430298
989637,989637,1001797.0,"Benzinga's M&A Chatter for Thursday July 21, 2016:",2016-07-21 16:46:00-04:00,PFE,benzingas m and a chatter for thursday july 21 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998881816864014
989638,989638,1001798.0,Medivation Spikes to High of $63.23 on Pfizer Takeover Rumor,2016-07-21 10:55:00-04:00,PFE,medivation spikes to high of dollars 3.23 on pfizer takeover rumor,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993334412574768
989639,989639,1001799.0,Traders Attributing Spike Higher in Medivation to Unconfirmed Chatter of Rival Bid from Pfizer,2016-07-21 10:48:00-04:00,PFE,traders attributing spike higher in medivation to unconfirmed chatter of rival bid from pfizer,"{'neg': 0.103, 'neu': 0.897, 'pos': 0.0, 'compound': -0.128}",positive,0.9995890259742737
989640,989640,1001800.0,"Opioid Addiction: What To Do When A Loved One Is Hooked, According To Science",2016-07-21 08:40:00-04:00,PFE,opioid addiction what to do when a loved one is hooked according to science,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.5994}",neutral,0.9998236298561096
989641,989641,1001801.0,"Spark Therapeutics, Pfizer Announce Receipt of FDA Breakthrough Therapy Designation for SPK-9001 for the Treatment of Hemophilia B",2016-07-21 07:34:00-04:00,PFE,spark therapeutics pfizer announce receipt of fda breakthrough therapy designation for spk 9001 for the treatment of hemophilia b,"{'neg': 0.0, 'neu': 0.905, 'pos': 0.095, 'compound': 0.2263}",positive,0.9994762539863586
989642,989642,1001802.0,Here Are The 14 Stocks Morgan Stanley Wants You To Focus On During Q2 Earnings,2016-07-19 08:30:00-04:00,PFE,here are the 14 stocks morgan stanley wants you to focus on during second quarter earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998778104782104
989643,989643,1001803.0,Pfizer Reports Received WHO Prequalification for Multi-Dose Vial Presentation of Prevenar 13,2016-07-19 08:04:00-04:00,PFE,pfizer reports received who prequalification for multi dose vial presentation of prevenar 13,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999870777130127
989644,989644,1001804.0,"Pfizer Reports Results from Two Pivotal Phase 3 Studies of Crisaborole Ointment: Achieved Statistically Significance on Primary, Secondary Endpoints",2016-07-13 08:06:00-04:00,PFE,pfizer reports results from two pivotal phase 3 studies of crisaborole ointment achieved statistically significance on primary secondary endpoints,"{'neg': 0.0, 'neu': 0.896, 'pos': 0.104, 'compound': 0.2732}",neutral,0.998874843120575
989645,989645,1001805.0,"Allergan, Teva Pharmaceutical Industries Entered into Amendment, Dated July 11, 2016 to Master Purchase Agreement; Amendment Reduced Cash Consideration to Be Paid By $221M;  Actonel; Carafate Added to List of Excluded Products -8K",2016-07-13 06:57:00-04:00,PFE,allergan teva pharmaceutical industries entered into amendment dated july 11 2016 to master purchase agreement amendment reduced cash consideration to be paid by dollars 21 million actonel carafate added to list of excluded products negative 8 thousand,"{'neg': 0.141, 'neu': 0.785, 'pos': 0.074, 'compound': -0.4404}",negative,0.9939171671867371
989646,989646,1001806.0,Watch These 7 Huge Put Purchases In Wednesday Trade,2016-07-13 03:35:00-04:00,PFE,watch these 7 huge put purchases in wednesday trade,"{'neg': 0.0, 'neu': 0.777, 'pos': 0.223, 'compound': 0.3182}",neutral,0.9998149275779724
989647,989647,1001807.0,Pfizer Reports Received FDA Approval for Prevnar 13 in Adults 18-49,2016-07-12 16:05:00-04:00,PFE,pfizer reports received fda approval for prevnar 13 in adults 18 to 49,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.4767}",positive,0.9805019497871399
989648,989648,1001808.0,Option Alert: PFE Jun17 30.0 Puts: 2500 @  ASK  $0.97: 2533 traded vs 928 OI:  Earnings 8/2 Before Open  $36.08 Ref,2016-07-12 11:10:00-04:00,PFE,option alert pfe jun17 30.0 puts 2500 ask dollars .97 2533 traded vs 928 oi earnings before open dollars 6.08 ref,"{'neg': 0.0, 'neu': 0.901, 'pos': 0.099, 'compound': 0.296}",neutral,0.9998728036880493
989649,989649,1001809.0,Pfizer's Phase 3 S-TRAC Trial Of SUTENT Meets Primary Endpoint,2016-07-08 10:34:00-04:00,PFE,pfizers phase 3 s trac trial of sutent meets primary endpoint,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998838901519775
989650,989650,1001810.0,Pfizer Reports Positive Top-Line Results From Phase 3 S-TRAC Trial of SUTENTas Adjuvant Therapy in Patients at High Risk of Recurrent Renal Cell Carcinoma,2016-07-08 08:00:00-04:00,PFE,pfizer reports positive top line results from phase 3 s trac trial of sutentas adjuvant therapy in patients at high risk of recurrent renal cell carcinoma,"{'neg': 0.069, 'neu': 0.754, 'pos': 0.177, 'compound': 0.5106}",positive,0.9996141195297241
989651,989651,1001811.0,Medivation Bidders Will Have To Price In Talazoparib; BMO Sees $68-$76 Takeout Price,2016-07-07 15:33:00-04:00,PFE,medivation bidders will have to price in talazoparib bmo sees dollars 8 dollars 6 takeout price,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998657703399658
989652,989652,1001812.0,Credit Suisse Says Medivation Market Value Is Approaching Its Target,2016-07-07 08:11:00-04:00,PFE,credit suisse says medivation market value is approaching its target,"{'neg': 0.0, 'neu': 0.615, 'pos': 0.385, 'compound': 0.6124}",positive,0.9989929795265198
989653,989653,1001813.0,Pfizer And Merck Germany Initiate Phase III Study To Assess Avelumab As First-line Treatment For Ovarian Cancer,2016-07-06 09:03:00-04:00,PFE,pfizer and merck germany initiate phase iii study to assess avelumab as first line treatment for ovarian cancer,"{'neg': 0.206, 'neu': 0.794, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9998729228973389
989654,989654,1001814.0,"Merck, Pfizer Report Initiation of Phase III Trial to Evaluate Avelumab as First-Line Treatment for Ovarian Cancer",2016-07-06 08:01:00-04:00,PFE,merck pfizer report initiation of phase iii trial to evaluate avelumab as first line treatment for ovarian cancer,"{'neg': 0.206, 'neu': 0.794, 'pos': 0.0, 'compound': -0.6597}",neutral,0.999735414981842
989655,989655,1001815.0,"Hearing Pfizer, Celgene Signed Medivation Confidentiality Deals",2016-07-05 17:45:00-04:00,PFE,hearing pfizer celgene signed medivation confidentiality deals,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9988189339637756
989656,989656,1001816.0,8 Biggest Mid-Day Gainers For Tuesday,2016-07-05 13:13:00-04:00,PFE,8 biggest mid day gainers for tuesday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996590614318848
989657,989657,1001817.0,12 Stocks Moving In Tuesday's Pre-Market Session,2016-07-05 08:21:00-04:00,PFE,12 stocks moving in tuesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998739957809448
989658,989658,1001818.0,Fast Money Traders Share Their Biotech Picks,2016-07-01 08:10:00-04:00,PFE,fast money traders share their biotech picks,"{'neg': 0.0, 'neu': 0.732, 'pos': 0.268, 'compound': 0.296}",neutral,0.9998687505722046
989659,989659,1001819.0,Guggenheim Introduces Equal-Weight S&P 100 ETF,2016-06-30 15:01:00-04:00,PFE,guggenheim introduces equal weight SP500 100 etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999893307685852
989660,989660,1001820.0,Pfizer Announces Two Phase 3 Bococizumab Trials Met Primary Endpoints,2016-06-28 08:34:00-04:00,PFE,pfizer announces two phase 3 bococizumab trials met primary endpoints,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998588562011719
989661,989661,1001821.0,Pfizer ro Invest $350M in Global Biotechnology Center in China,2016-06-28 04:07:00-04:00,PFE,pfizer ro invest dollars 50 million in global biotechnology center in china,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998683929443359
989662,989662,1001822.0,Could Chili Peppers Be The Answer To Opioid-Reliance For Chronic Pain?,2016-06-27 13:50:00-04:00,PFE,could chili peppers be the answer to opioid reliance for chronic pain,"{'neg': 0.231, 'neu': 0.769, 'pos': 0.0, 'compound': -0.5106}",neutral,0.9986791014671326
989663,989663,1001823.0,Chinese Expats Revolutionizing China's Homegrown Biopharma Sector,2016-06-27 09:41:00-04:00,PFE,chinese expats revolutionizing chinas homegrown biopharma sector,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9917185306549072
989664,989664,1001824.0,Pfizer Completes Anacor Acquisition,2016-06-24 13:21:00-04:00,PFE,pfizer completes anacor acquisition,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997658133506775
989665,989665,1001825.0,The Pros And Cons Of Pfizer Separating GEP,2016-06-20 14:25:00-04:00,PFE,the pros and cons of pfizer separating gep,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998593330383301
989666,989666,1001826.0,"Jefferies Maintains Buy on Pfizer, Lowers PT to $40.00",2016-06-20 08:37:00-04:00,PFE,jefferies maintains buy on pfizer lowers point to dollars 0.00,"{'neg': 0.143, 'neu': 0.857, 'pos': 0.0, 'compound': -0.128}",positive,0.9899369478225708
989667,989667,1001827.0,Merck KGAA to Apply for Marketing Authorization for Avelumab Against Merkel Cell Carcinoma in H2 2016,2016-06-20 06:29:00-04:00,PFE,merck kgaa to apply for marketing authorization for avelumab against merkel cell carcinoma in h2 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998012185096741
989668,989668,1001828.0,Jefferies Shares Pharma Stock Catalyst Outlook,2016-06-14 16:33:00-04:00,PFE,jefferies shares pharma stock catalyst outlook,"{'neg': 0.0, 'neu': 0.694, 'pos': 0.306, 'compound': 0.296}",neutral,0.9998517036437988
989669,989669,1001829.0,5 Pharmaceutical Price Target Raises From Jefferies,2016-06-14 15:13:00-04:00,PFE,5 pharmaceutical price target raises from jefferies,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995145797729492
989670,989670,1001830.0,February 27 Earnings Update,2016-06-14 11:28:00-04:00,PFE,february 27 earnings update,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998612403869629
989671,989671,1001831.0,Shire Will License PF-00547659 from Pfizer,2016-06-14 07:02:00-04:00,PFE,shire will license pf 00547659 from pfizer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998918771743774
989672,989672,1001832.0,"Has Cancer Research Become Cancerous? Same Cancer Strategy Targeted By 'Too Many Drugmakers,' Say Regulators",2016-06-13 09:37:00-04:00,PFE,has cancer research become cancerous same cancer strategy targeted by too many drugmakers say regulators,"{'neg': 0.404, 'neu': 0.596, 'pos': 0.0, 'compound': -0.8689}",neutral,0.9917730689048767
989673,989673,1001833.0,"Spark Therapeutics Announces Updated Data from First Cohort in Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels of Factor IX Activity",2016-06-13 07:15:00-04:00,PFE,spark therapeutics announces updated data from first cohort in hemophilia b phase .5 trial demonstrating consistent sustained therapeutic levels of factor ix activity,"{'neg': 0.0, 'neu': 0.921, 'pos': 0.079, 'compound': 0.2263}",positive,0.9912205338478088
989674,989674,1001834.0,Pfizer Announces INO-VATE ALL Study Met One Primary Endpoint; Did Not Meet Second,2016-06-12 08:54:00-04:00,PFE,pfizer announces ino vate all study met one primary endpoint did not meet second,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998582601547241
989675,989675,1001835.0,"Merck, Pfizer Announce Two Pivotal Phase 3 Studies for Ertugliflozin Met Primary Endpoints, Showing Significant A1C Reductions in Patients with Type 2 Diabetes at the American Diabetes Association's 76th Scientific Sessions",2016-06-12 08:29:00-04:00,PFE,merck pfizer announce two pivotal phase 3 studies for ertugliflozin met primary endpoints showing significant a1 calls reductions in patients with type 2 diabetes at the american diabetes associations 76 scientific sessions,"{'neg': 0.0, 'neu': 0.945, 'pos': 0.055, 'compound': 0.2023}",positive,0.9993845224380493
989676,989676,1001836.0,A Peek Into The Markets: U.S. Stock Futures Slide Ahead Of Consumer Sentiment Report,2016-06-10 07:54:00-04:00,PFE,a peek into the markets u s stock futures slide ahead of consumer sentiment report,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.8859424591064453
989677,989677,1001837.0,ICON Reveals Service Deal With Pfizer,2016-06-10 07:17:00-04:00,PFE,icon reveals service deal with pfizer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9972178936004639
989678,989678,1001838.0,"ICON Reports Service Deal with Pfizer, No Terms Disclosed",2016-06-10 06:02:00-04:00,PFE,icon reports service deal with pfizer no terms disclosed,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",neutral,0.9998880624771118
989679,989679,1001839.0,PAREXEL Announces Master Services Agreement with Pfizer,2016-06-10 04:18:00-04:00,PFE,parexel announces master services agreement with pfizer,"{'neg': 0.0, 'neu': 0.652, 'pos': 0.348, 'compound': 0.4939}",positive,0.9328121542930603
989680,989680,1001840.0,Takeover Talk A Help To Wide-Moat ETFs,2016-06-09 09:21:00-04:00,PFE,takeover talk a help to wide moat etfs,"{'neg': 0.0, 'neu': 0.722, 'pos': 0.278, 'compound': 0.4019}",neutral,0.997612714767456
989681,989681,1001841.0,UPDATE: FDA Panels Votes Saying Pfizer Troxyca ER Should Not Be Labeled 'Abuse-Deterrent' by oral Route Of Abuse,2016-06-08 15:32:00-04:00,PFE,update fda panels votes saying pfizer troxyca er should not be labeled abuse deterrent by oral route of abuse,"{'neg': 0.171, 'neu': 0.692, 'pos': 0.137, 'compound': -0.21}",neutral,0.9998127818107605
989682,989682,1001842.0,Pfizer To Present 23 Abstracts At European League Against Rheumatism Congress,2016-06-08 08:03:00-04:00,PFE,pfizer to present 23 abstracts at european league against rheumatism congress,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998705387115479
989683,989683,1001843.0,Pfizer Research Data For Tofacitinib Citrate  Providing Clinicians With Additional Information For The Treatment Of Moderate to Severe RA,2016-06-08 07:02:00-04:00,PFE,pfizer research data for tofacitinib citrate providing clinicians with additional information for the treatment of moderate to severe ra,"{'neg': 0.126, 'neu': 0.874, 'pos': 0.0, 'compound': -0.3818}",neutral,0.9998741149902344
989684,989684,1001844.0,Pfizer Reports Results from Second Phase 3 Trial of Oral XELJANZ in Adults with Psoriatic Arthritis: Met Primary Efficacy Endpoints,2016-06-07 07:02:00-04:00,PFE,pfizer reports results from second phase 3 trial of oral xeljanz in adults with psoriatic arthritis met primary efficacy endpoints,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9988089799880981
989685,989685,1001845.0,4 Key Takeaways From ASCO,2016-06-06 17:32:00-04:00,PFE,4 key takeaways from asco,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998791217803955
989686,989686,1001846.0,Pfizers Reports 7.1% Stake In Merus,2016-06-06 16:59:00-04:00,PFE,pfizers reports 7.1 percent stake in merus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998869895935059
989687,989687,1001847.0,Pfizer Reports 7.1% Passive Stake in Merus in 13G,2016-06-06 16:59:00-04:00,PFE,pfizer reports 7.1 percent passive stake in merus in 13 g,"{'neg': 0.0, 'neu': 0.847, 'pos': 0.153, 'compound': 0.2023}",neutral,0.9998829364776611
989688,989688,1001848.0,"Merck, Pfizer Offers Results from Pivotal Avelumab Study",2016-06-06 09:09:00-04:00,PFE,merck pfizer offers results from pivotal avelumab study,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998766183853149
989689,989689,1001849.0,"Pfizer Offers Data from Next-Gen ALK/ROS1 Inhibitor Trial, Results Presented at Oral Abstract at ASCO",2016-06-06 08:04:00-04:00,PFE,pfizer offers data from next gen alk and ros1 inhibitor trial results presented at oral abstract at asco,"{'neg': 0.071, 'neu': 0.929, 'pos': 0.0, 'compound': -0.0772}",neutral,0.9998860359191895
989690,989690,1001850.0,How Trade Imbalances Affect Stock Prices,2016-06-04 15:06:00-04:00,PFE,how trade imbalances affect stock prices,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9584681391716003
989691,989691,1001851.0,Pfizer Presents Data from Phase 1b Trial Investigating Utomilumab (a 4-1BB agonist) in Combination with a Checkpoint Inhibitor at #ASCO16,2016-06-04 09:40:00-04:00,PFE,pfizer presents data from phase 1 billion trial investigating utomilumab a 4 to 1 billion b agonist in combination with a checkpoint inhibitor at,"{'neg': 0.053, 'neu': 0.947, 'pos': 0.0, 'compound': -0.0772}",neutral,0.9998840093612671
989692,989692,1001852.0,"Ouch! Jobs Report Miss Sends Rate Hike Odds Down, Raises Questions",2016-06-03 13:49:00-04:00,PFE,ouch jobs report miss sends rate hike odds down raises questions,"{'neg': 0.138, 'neu': 0.862, 'pos': 0.0, 'compound': -0.1531}",negative,0.9979690909385681
989693,989693,1001853.0,Cantor Fitzgerald Sees 81% Upside In Spark Therapeutics; Initiating with A Buy,2016-06-03 09:18:00-04:00,PFE,cantor fitzgerald sees 81 percent upside in spark therapeutics initiating with a buy,"{'neg': 0.0, 'neu': 0.863, 'pos': 0.137, 'compound': 0.2263}",positive,0.9996176958084106
989694,989694,1001854.0,BioRap Technologies to Enter Strategic Collaboration With Pfizer Inc. to Research and Develop Novel Immunomodulators,2016-05-31 09:04:00-04:00,PFE,biorap technologies to enter strategic collaboration with pfizer inc to research and develop novel immunomodulators,"{'neg': 0.0, 'neu': 0.859, 'pos': 0.141, 'compound': 0.3182}",positive,0.9942057728767395
989695,989695,1001855.0,"Anacor Says Citi Reps Conveyed That Company Board Was Not Prepared To Accept May 6th Pfizer Proposal Because Company Received Third Party Offer; Pfizer Then Proposed ""Best And Final"" Offer Of $99.25/Share Cash May 16th",2016-05-26 14:20:00-04:00,PFE,anacor says citi reps conveyed that company board was not prepared to accept may 6 pfizer proposal because company received third party offer pfizer then proposed best and final offer of dollars 9. cash may 16,"{'neg': 0.09, 'neu': 0.749, 'pos': 0.161, 'compound': 0.6187}",neutral,0.9993209838867188
989696,989696,1001856.0,UPDATE: Filing Out Regarding Pfizer Tender Offer,2016-05-26 14:02:00-04:00,PFE,update filing out regarding pfizer tender offer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998606443405151
989697,989697,1001857.0,JPMorgan: Monsanto Shares Could Hit $180 Over The Next 5 Years,2016-05-24 15:32:00-04:00,PFE,jpmorgan monsanto shares could hit dollars 80 over the next 5 years,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.296}",neutral,0.8854662775993347
989698,989698,1001858.0,Pfizer Updates CHAMPIX To Add New Safety And Efficacy Data In European Union,2016-05-23 08:41:00-04:00,PFE,pfizer updates champix to add new safety and efficacy data in european union,"{'neg': 0.0, 'neu': 0.811, 'pos': 0.189, 'compound': 0.4215}",neutral,0.9987769722938538
989699,989699,1001859.0,Pfizer Reports EU Label For CHAMPIX Updated,2016-05-23 07:03:00-04:00,PFE,pfizer reports eu label for champix updated,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998738765716553
989700,989700,1001860.0,Pfizer Gets European Regulator Acceptance For Review Of Marketing For TRUMENBA,2016-05-20 09:03:00-04:00,PFE,pfizer gets european regulator acceptance for review of marketing for trumenba,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.4588}",positive,0.9984872341156006
989701,989701,1001861.0,Pfizer Announces European Medicines Agency Acceptance For Review Of Marketing Authorization Of Trumenba,2016-05-20 08:01:00-04:00,PFE,pfizer announces european medicines agency acceptance for review of marketing authorization of trumenba,"{'neg': 0.0, 'neu': 0.8, 'pos': 0.2, 'compound': 0.4588}",neutral,0.9239339828491211
989702,989702,1001862.0,JPMorgan's Take On Big Pharma's New ASCO Abstracts,2016-05-19 11:07:00-04:00,PFE,jpmorgans take on big pharmas new asco abstracts,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998806715011597
989703,989703,1001863.0,Pfizer's Hospira Unveils LifeCare PCA 7.0 Infusion System,2016-05-19 11:03:00-04:00,PFE,pfizers hospira unveils lifecare pca 7.0 infusion system,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998311996459961
989704,989704,1001864.0,Fitch Says Drug Approvals Are Driving Targeted Acquisitions In U.S. Pharma,2016-05-17 17:26:00-04:00,PFE,fitch says drug approvals are driving targeted acquisitions in u s pharma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.7661374807357788
989705,989705,1001865.0,Is Avoidance Of Morally Ambiguous Or Offensive Activities Justifiable In Corporate America?,2016-05-17 16:13:00-04:00,PFE,is avoidance of morally ambiguous or offensive activities justifiable in corporate america,"{'neg': 0.363, 'neu': 0.637, 'pos': 0.0, 'compound': -0.6908}",neutral,0.9998767375946045
989706,989706,1001866.0,A Look At All Of Pfizer's Acquisitions Over The Past 2 Years,2016-05-17 11:22:00-04:00,PFE,a look at all of pfizers acquisitions over the past 2 years,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998685121536255
989707,989707,1001867.0,Bull And Bear Takeaways From Pfizer's $5.2 Billion Deal,2016-05-17 07:26:00-04:00,PFE,bull and bear takeaways from pfizers dollars .2 billion deal,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998759031295776
989708,989708,1001868.0,"Benzinga's M&A Chatter for Monday May 16, 2016",2016-05-16 20:09:00-04:00,PFE,benzingas m and a chatter for monday may 16 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998844861984253
989709,989709,1001869.0,An ETF That Takes Investors To Dividend Growth,2016-05-16 15:53:00-04:00,PFE,an etf that takes investors to dividend growth,"{'neg': 0.0, 'neu': 0.729, 'pos': 0.271, 'compound': 0.3818}",positive,0.5227797627449036
989710,989710,1001870.0,Mid-Afternoon Market Update: Dow Jumps 200 Points; Aduro Biotech Shares Drop Following Announcement of Failed Phase 2b ECLIPSE Trial,2016-05-16 14:31:00-04:00,PFE,mid afternoon market update dow jumps 200 points aduro biotech shares drop following announcement of failed phase 2 billion eclipse trial,"{'neg': 0.211, 'neu': 0.703, 'pos': 0.086, 'compound': -0.4939}",negative,0.9980735778808594
989711,989711,1001871.0,8 Biggest Mid-Day Market Gainers,2016-05-16 12:32:00-04:00,PFE,8 biggest mid day market gainers,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995098114013672
989712,989712,1001872.0,Mid-Day Market Update: Nanosphere Jumps Following Luminex Deal; Breitburn Energy Partners Shares Drop,2016-05-16 12:06:00-04:00,PFE,mid day market update nanosphere jumps following luminex deal breitburn energy partners shares drop,"{'neg': 0.121, 'neu': 0.632, 'pos': 0.247, 'compound': 0.296}",negative,0.997855007648468
989713,989713,1001873.0,Benzinga's Volume Movers,2016-05-16 10:40:00-04:00,PFE,benzingas volume movers,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998672008514404
989714,989714,1001874.0,Omega Advisors Liquidates 1.29M Share Position In Pfizer,2016-05-16 10:28:00-04:00,PFE,omega advisors liquidates 1.29 million share position in pfizer,"{'neg': 0.0, 'neu': 0.784, 'pos': 0.216, 'compound': 0.296}",neutral,0.9998815059661865
989715,989715,1001875.0,Mid-Morning Market Update: Markets Open Higehr; Pfizer To Acquire Anacor Pharmaceuticals For $5.2B,2016-05-16 10:08:00-04:00,PFE,mid morning market update markets open higehr pfizer to acquire anacor pharmaceuticals for dollars .2 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998725652694702
989716,989716,1001876.0,The Market In 5 Minutes: Need A Hand?,2016-05-16 09:48:00-04:00,PFE,the market in 5 minutes need a hand,"{'neg': 0.0, 'neu': 0.686, 'pos': 0.314, 'compound': 0.4939}",neutral,0.9998708963394165
989717,989717,1001877.0,10 Stocks Moving In Monday's Pre-Market Session,2016-05-16 08:24:00-04:00,PFE,10 stocks moving in mondays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998624324798584
989718,989718,1001878.0,"Merger Monday: 6 Deals, Rumors And Bids You Might Have Missed",2016-05-16 08:13:00-04:00,PFE,merger monday 6 deals rumors and bids you might have missed,"{'neg': 0.18, 'neu': 0.82, 'pos': 0.0, 'compound': -0.296}",neutral,0.999816358089447
989719,989719,1001879.0,Pfizer To Buy Anacor For $5.2 Billion,2016-05-16 07:34:00-04:00,PFE,pfizer to buy anacor for dollars .2 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998801946640015
989720,989720,1001880.0,Pfizer Acquisition of Anacor Valued at $5.2B,2016-05-16 06:47:00-04:00,PFE,pfizer acquisition of anacor valued at dollars .2 billion,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.4404}",neutral,0.9998816251754761
989721,989721,1001881.0,Pfizer Announces Acquisition of Anacor for $99.25/Share Cash,2016-05-16 06:46:00-04:00,PFE,pfizer announces acquisition of anacor for dollars 9. cash,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998856782913208
989722,989722,1001882.0,Pfizer Blocks Drugs from Use in Lethal Injections - New York Times,2016-05-13 16:08:00-04:00,PFE,pfizer blocks drugs from use in lethal injections to new york times,"{'neg': 0.147, 'neu': 0.853, 'pos': 0.0, 'compound': -0.2263}",neutral,0.8626224994659424
989723,989723,1001883.0,13F Season: A Look Back At Q4 2015,2016-05-13 14:07:00-04:00,PFE,13 f season a look back at fourth quarter 2015,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999800980091095
989724,989724,1001884.0,Pfizer's Stage 3 Results On TRUMENBA Meet All Endpoints,2016-05-13 08:15:00-04:00,PFE,pfizers stage 3 results on trumenba meet all endpoints,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998867511749268
989725,989725,1001885.0,What To Expect This 13F Season (And Which Hedge Funds To Watch),2016-05-13 06:50:00-04:00,PFE,what to expect this 13 f season and which hedge funds to watch,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999858021736145
989726,989726,1001886.0,Pfizer Presents Results from Two Phase 3 TRUMENBA Studies at the European Society for Paediatric Infectious Diseases Meeting,2016-05-13 06:33:00-04:00,PFE,pfizer presents results from two phase 3 trumenba studies at the european society for paediatric infectious diseases meeting,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998853206634521
989727,989727,1001887.0,"Berenberg Unimpressed With Pfizer, Initiates Coverage At Hold",2016-05-12 17:59:00-04:00,PFE,berenberg unimpressed with pfizer initiates coverage at hold,"{'neg': 0.255, 'neu': 0.745, 'pos': 0.0, 'compound': -0.34}",negative,0.9956552982330322
989728,989728,1001888.0,Is This The Right Time To Do A Huge M&A Deal?,2016-05-12 13:46:00-04:00,PFE,is this the right time to do a huge m and a deal,"{'neg': 0.0, 'neu': 0.839, 'pos': 0.161, 'compound': 0.3182}",positive,0.949280858039856
989729,989729,1001889.0,The Market In 5 Minutes: Nothing's Impossible,2016-05-12 09:59:00-04:00,PFE,the market in 5 minutes nothings impossible,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998372793197632
989730,989730,1001890.0,Benzinga's Top Initiations,2016-05-12 09:00:00-04:00,PFE,benzingas top initiations,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",neutral,0.9998692274093628
989731,989731,1001891.0,Pfizer Reports 8% Passive Stake in Wave Life Sciences in 13G,2016-05-12 08:58:00-04:00,PFE,pfizer reports 8 percent passive stake in wave life sciences in 13 g,"{'neg': 0.0, 'neu': 0.87, 'pos': 0.13, 'compound': 0.2023}",neutral,0.9998877048492432
989732,989732,1001892.0,Pfizer Reports 8% Stake In Wave Life Sciences 13G Filing,2016-05-12 08:57:00-04:00,PFE,pfizer reports 8 percent stake in wave life sciences 13 g filing,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998846054077148
989733,989733,1001893.0,"Berenberg Initiates Coverage on Pfizer at Hold, Announces $38.00 PT, Expects Co To Deliver Mid-Single Digit Earnings Growth In Intermediate Term",2016-05-12 08:46:00-04:00,PFE,berenberg initiates coverage on pfizer at hold announces dollars 8.00 point expects co to deliver mid single digit earnings growth in intermediate term,"{'neg': 0.0, 'neu': 0.894, 'pos': 0.106, 'compound': 0.3818}",positive,0.9995855689048767
989734,989734,1001894.0,"Jefferies Updates Price Targets In Global Pharma, Sees 'Rich Catalyst Environment' Ahead",2016-05-11 13:05:00-04:00,PFE,jefferies updates price targets in global pharma sees rich catalyst environment ahead,"{'neg': 0.0, 'neu': 0.753, 'pos': 0.247, 'compound': 0.5574}",positive,0.9993461966514587
989735,989735,1001895.0,The Market In 5 Minutes: Don't Stop Me Now,2016-05-11 09:34:00-04:00,PFE,the market in 5 minutes dont stop me now,"{'neg': 0.0, 'neu': 0.809, 'pos': 0.191, 'compound': 0.2235}",neutral,0.9998656511306763
989736,989736,1001896.0,The Market In 5 Minutes: Better Late Than Never,2016-05-10 10:04:00-04:00,PFE,the market in 5 minutes better late than never,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.4404}",positive,0.9992712140083313
989737,989737,1001897.0,Report: Medivation Committed To Selling Itself,2016-05-10 08:42:00-04:00,PFE,report medivation committed to selling itself,"{'neg': 0.0, 'neu': 0.704, 'pos': 0.296, 'compound': 0.2732}",neutral,0.999693751335144
989738,989738,1001898.0,First Dosing of Pfizer DART Candidate in Phase 1 Study Triggers Milestone Payment to MacroGenics Of $2M,2016-05-10 07:33:00-04:00,PFE,first dosing of pfizer dart candidate in phase 1 study triggers milestone payment to macrogenics of dollars m,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9980844259262085
989739,989739,1001899.0,"Benzinga's M&A Chatter for Monday May 9, 2016",2016-05-09 20:40:00-04:00,PFE,benzingas m and a chatter for monday may 9 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998832941055298
989740,989740,1001900.0,Dealogic: 2016 Has Already Seen Failed U.S. Deals Worth $378 Billion,2016-05-09 15:51:00-04:00,PFE,dealogic 2016 has already seen failed u s deals worth dollars 78 billion,"{'neg': 0.204, 'neu': 0.679, 'pos': 0.117, 'compound': -0.34}",negative,0.996204674243927
989741,989741,1001901.0,Allergan Rallies Ahead Of Q1 Report,2016-05-09 15:50:00-04:00,PFE,allergan rallies ahead of first quarter report,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.973227858543396
989742,989742,1001902.0,"Medivation Spikes to High of $62.48 on Reuters Report of NDA's With Pfizer, Amgen",2016-05-09 13:05:00-04:00,PFE,medivation spikes to high of dollars 2.48 on reuters report of ndas with pfizer amgen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9473882913589478
989743,989743,1001903.0,"Benzinga's M&A Chatter for Thursday May 5, 2016",2016-05-05 20:02:00-04:00,PFE,benzingas m and a chatter for thursday may 5 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998888969421387
989744,989744,1001904.0,"Synergy Pharma Seen 'Weighing' Options, Sell-Side Forecasts Upside Regardless Of M&A Rumors",2016-05-05 12:29:00-04:00,PFE,synergy pharma seen weighing options sell side forecasts upside regardless of m and a rumors,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990441203117371
989745,989745,1001905.0,A Pfizer Split Is 'Clearly' On The Table,2016-05-05 10:59:00-04:00,PFE,a pfizer split is clearly on the table,"{'neg': 0.0, 'neu': 0.722, 'pos': 0.278, 'compound': 0.4019}",neutral,0.9998641014099121
989746,989746,1001906.0,"WAVE Life Sciences Enters Partnership with Pfizer to Develop Genetically Targeted Therapies for the Treatment of Metabolic Diseases, Pfizer To Pay $40M Upfront With $30 As Equity Inv. In Wave At $16/Share; Potential For $871M Through Milestones",2016-05-05 07:44:00-04:00,PFE,wave life sciences enters partnership with pfizer to develop genetically targeted therapies for the treatment of metabolic diseases pfizer to pay dollars 0 million upfront with dollars 0 as equity inv in wave at dollars potential for dollars 71 million through milestones,"{'neg': 0.033, 'neu': 0.967, 'pos': 0.0, 'compound': -0.1027}",neutral,0.9992048144340515
989747,989747,1001907.0,12 Stocks Moving In Wednesday's Pre-Market Session,2016-05-04 08:32:00-04:00,PFE,12 stocks moving in wednesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998750686645508
989748,989748,1001908.0,Pfizer Q1'16 Earnings Conference Call: Full Transcript,2016-05-03 19:08:00-04:00,PFE,pfizer first quarter 16 earnings conference call full transcript,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998300075531006
989749,989749,1001909.0,"Benzinga's M&A Chatter for Tuesday May 3, 2016",2016-05-03 18:52:00-04:00,PFE,benzingas m and a chatter for tuesday may 3 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998868703842163
989750,989750,1001910.0,Pfizer has Approached Medivation Regarding Potential Acquisition -Reuters,2016-05-03 18:01:00-04:00,PFE,pfizer has approached medivation regarding potential acquisition reuters,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997908473014832
989751,989751,1001911.0,Hearing Pfizer Has Approached Medivation,2016-05-03 18:01:00-04:00,PFE,hearing pfizer has approached medivation,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9985914826393127
989752,989752,1001912.0,Pfizer Rallies Off Q1 Report,2016-05-03 15:07:00-04:00,PFE,pfizer rallies off first quarter report,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994692206382751
989753,989753,1001913.0,Mid-Afternoon Market Update: On Deck Capital Drops Following Earnings Miss; Symmetry Surgical Shares Spike Higher,2016-05-03 14:31:00-04:00,PFE,mid afternoon market update on deck capital drops following earnings miss symmetry surgical shares spike higher,"{'neg': 0.09, 'neu': 0.787, 'pos': 0.124, 'compound': 0.1531}",negative,0.664311408996582
989754,989754,1001914.0,The Next Sector Rotation Will Be To Biotechs,2016-05-03 12:17:00-04:00,PFE,the next sector rotation will be to biotechs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998881816864014
989755,989755,1001915.0,Mid-Day Market Update: Dow Falls 1%; Cognex Shares Gain Following Earnings Beat,2016-05-03 12:08:00-04:00,PFE,mid day market update dow falls 1 percent cognex shares gain following earnings beat,"{'neg': 0.0, 'neu': 0.682, 'pos': 0.318, 'compound': 0.6808}",positive,0.989496648311615
989756,989756,1001916.0,"From Pfizer Q1 Earnings Conference Call: If Co. Decides to Split Up Co. This Year, Could Sell or Spin Off Its Established Products Unit by End of Next Year",2016-05-03 10:51:00-04:00,PFE,from pfizer first quarter earnings conference call if co decides to split up co this year could sell or spin off its established products unit by end of next year,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998655319213867
989757,989757,1001917.0,Mid-Morning Market Update: Markets Open Lower; Pfizer Beats Q1 Expectations,2016-05-03 09:55:00-04:00,PFE,mid morning market update markets open lower pfizer beats first quarter expectations,"{'neg': 0.167, 'neu': 0.833, 'pos': 0.0, 'compound': -0.296}",negative,0.9981645941734314
989758,989758,1001918.0,The Market In 5 Minutes: Do Or Die,2016-05-03 09:44:00-04:00,PFE,the market in 5 minutes do or die,"{'neg': 0.358, 'neu': 0.642, 'pos': 0.0, 'compound': -0.5994}",neutral,0.9998772144317627
989759,989759,1001919.0,12 Stocks Moving In Tuesday's Pre-Market Session,2016-05-03 08:25:00-04:00,PFE,12 stocks moving in tuesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998739957809448
989760,989760,1001920.0,"Pfizer Delivers Strong Q1 Numbers Helped By Hospira Acquisition, Boosts Guidance",2016-05-03 07:26:00-04:00,PFE,pfizer delivers strong first quarter numbers helped by hospira acquisition boosts guidance,"{'neg': 0.0, 'neu': 0.641, 'pos': 0.359, 'compound': 0.6808}",positive,0.9996533393859863
989761,989761,1001921.0,"Pfizer Raises FY 2016 Guidance; Sees EPS $2.38 to $2.48 vs $2.29 est, Revenue $51.0B to $53.0B vs $51.2B est",2016-05-03 06:48:00-04:00,PFE,pfizer raises fy 2016 guidance sees eps dollars .38 to dollars .48 vs dollars .29 est revenue dollars 1.0 billion to dollars 3.0 billion vs dollars 1.2 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995836615562439
989762,989762,1001922.0,"Pfizer Q1 EPS $0.67 vs $0.55 est, Revenue $13.0B vs $12.0B est",2016-05-03 06:47:00-04:00,PFE,pfizer first quarter eps dollars .67 vs dollars .55 est revenue dollars 3.0 billion vs dollars 2.0 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998689889907837
989763,989763,1001923.0,"Keep an Eye on These 12 Stocks for May 3, 2016",2016-05-03 04:38:00-04:00,PFE,keep an eye on these 12 stocks for may 3 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998618364334106
989764,989764,1001924.0,"Earnings Scheduled For May 3, 2016",2016-05-03 04:02:00-04:00,PFE,earnings scheduled for may 3 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998811483383179
989765,989765,1001925.0,GeoInvesting Says Anavex Life Sciences' Stock Has A Book Value Of Just $0.36,2016-05-02 12:25:00-04:00,PFE,geoinvesting says anavex life sciences stock has a book value of just dollars .36,"{'neg': 0.0, 'neu': 0.844, 'pos': 0.156, 'compound': 0.34}",neutral,0.9998706579208374
989766,989766,1001926.0,Earnings: Drug Makers Merck And Pfizer Report Q1 Results,2016-05-02 10:58:00-04:00,PFE,earnings drug makers merck and pfizer report first quarter results,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998562335968018
989767,989767,1001927.0,"The Market In 5 Minutes: May, She Will Stay",2016-05-02 09:49:00-04:00,PFE,the market in 5 minutes may she will stay,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998871088027954
989768,989768,1001928.0,Benzinga's Weekend M&A Chatter,2016-05-01 20:36:00-04:00,PFE,benzingas weekend m and a chatter,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998726844787598
989769,989769,1001929.0,Merck And Pfizer Earnings: Will They Beat Expectations Again?,2016-05-01 11:25:00-04:00,PFE,merck and pfizer earnings will they beat expectations again,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996457099914551
989770,989770,1001930.0,$45 Billion Thursday For M&A Shows There Are Still Plenty Of Buyers Out There,2016-04-29 16:14:00-04:00,PFE,dollars 5 billion thursday for m and a shows there are still plenty of buyers out there,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998483657836914
989771,989771,1001931.0,Pfizer Spokesperson Declines Comment Following Bloomberg Report Co. is One of Several Cos. Working with Advisors for Possible Medivation Bid,2016-04-29 13:42:00-04:00,PFE,pfizer spokesperson declines comment following bloomberg report co is one of several cos working with advisors for possible medivation bid,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998210072517395
989772,989772,1001932.0,"Hearing Medivation Seeking Bids of At Least $65/Share, AstraZeneca, Pfizer Mentioned as Weigh Bids",2016-04-29 12:32:00-04:00,PFE,hearing medivation seeking bids of at least dollars astrazeneca pfizer mentioned as weigh bids,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998778104782104
989773,989773,1001933.0,"Pfizer Shares Also Spiked Slightly Higher with Medivation, Novartis Moves",2016-04-29 12:31:00-04:00,PFE,pfizer shares also spiked slightly higher with medivation novartis moves,"{'neg': 0.0, 'neu': 0.804, 'pos': 0.196, 'compound': 0.296}",positive,0.9996651411056519
989774,989774,1001934.0,"Hearing DoJ Has Said Wyeth, Pfizer Have Agreed to Pay $784.6M to Resolve Suit Which Alleges Underpayment of Drug Rebates",2016-04-27 10:37:00-04:00,PFE,hearing doj has said wyeth pfizer have agreed to pay dollars 84.6 million to resolve suit which alleges underpayment of drug rebates,"{'neg': 0.056, 'neu': 0.757, 'pos': 0.187, 'compound': 0.5106}",positive,0.9994364380836487
989775,989775,1001935.0,Pfizer Reports SPIRE-2 CV Outcome Study for Bococizumab Full Enrolled,2016-04-26 08:31:00-04:00,PFE,pfizer reports spire 2 cv outcome study for bococizumab full enrolled,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998866319656372
989776,989776,1001936.0,Pharma Names Under Pressure Amid Perrigo Warning,2016-04-25 13:53:00-04:00,PFE,pharma names under pressure amid perrigo warning,"{'neg': 0.479, 'neu': 0.521, 'pos': 0.0, 'compound': -0.5574}",negative,0.9958502054214478
989777,989777,1001937.0,The Largest M&A Spreads On The Market,2016-04-25 13:11:00-04:00,PFE,the largest m and a spreads on the market,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999889612197876
989778,989778,1001938.0,Pfizer Partners With Rexall On OneStopMeds Service,2016-04-20 10:04:00-04:00,PFE,pfizer partners with rexall on onestopmeds service,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998780488967896
989779,989779,1001939.0,"Notable Imbalances: Coca-Cola, Oil Stocks Under Pressure",2016-04-20 09:56:00-04:00,PFE,notable imbalances coca cola oil stocks under pressure,"{'neg': 0.239, 'neu': 0.761, 'pos': 0.0, 'compound': -0.296}",negative,0.9980089068412781
989780,989780,1001940.0,Teva Strength Attributed By Traders To Comments Making Rounds Regarding Possible Pfizer Interest,2016-04-19 11:41:00-04:00,PFE,teva strength attributed by traders to comments making rounds regarding possible pfizer interest,"{'neg': 0.0, 'neu': 0.64, 'pos': 0.36, 'compound': 0.7351}",positive,0.9995012283325195
989781,989781,1001941.0,Pfizer Reveals Positive Results Of Phase 3 PALOMA-2 Clinical Trial Of IBRANCE,2016-04-19 10:14:00-04:00,PFE,pfizer reveals positive results of phase 3 paloma 2 clinical trial of ibrance,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.5574}",positive,0.9995808005332947
989782,989782,1001942.0,Pfizer Reports Phase 3 PALOMA-2 Trial Of IBRANCE Met Primary Endpoint For PFS,2016-04-19 08:09:00-04:00,PFE,pfizer reports phase 3 paloma 2 trial of ibrance met primary endpoint for pfs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9992652535438538
989783,989783,1001943.0,Cramer Gives His Opinion On Starwood And Time Warner Cable,2016-04-19 06:27:00-04:00,PFE,cramer gives his opinion on starwood and time warner cable,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998486042022705
989784,989784,1001944.0,Benzinga's Top Initiations,2016-04-18 09:47:00-04:00,PFE,benzingas top initiations,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",neutral,0.9998692274093628
989785,989785,1001945.0,"The Market In 5 Minutes: Brazil, Doha, And Earnings Season",2016-04-18 09:44:00-04:00,PFE,the market in 5 minutes brazil doha and earnings season,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998817443847656
989786,989786,1001946.0,Goldman Reinstates Coverage On Pfizer And Allergan Following Failed Merger,2016-04-18 08:06:00-04:00,PFE,goldman reinstates coverage on pfizer and allergan following failed merger,"{'neg': 0.268, 'neu': 0.732, 'pos': 0.0, 'compound': -0.5106}",neutral,0.9982752799987793
989787,989787,1001947.0,"Goldman Sachs Reinstates Neutral on Pfizer, Announces $35.00 PT",2016-04-18 07:05:00-04:00,PFE,goldman sachs reinstates neutral on pfizer announces dollars 5.00 point,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9825348258018494
989788,989788,1001948.0,"Barron's Picks And Pans: Ford, Intel, Sealed Air And More",2016-04-17 18:47:00-04:00,PFE,barrons picks and pans ford intel sealed air and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998921155929565
989789,989789,1001949.0,"Lachapelle: If Bayer Expands In Animal Healthcare, Zoetis Is Obvious Choice",2016-04-15 13:05:00-04:00,PFE,lachapelle if bayer expands in animal healthcare zoetis is obvious choice,"{'neg': 0.0, 'neu': 0.877, 'pos': 0.123, 'compound': 0.1027}",neutral,0.9924759268760681
989790,989790,1001950.0,Favus Gives 10 Reasons To Sell Allergan,2016-04-13 11:06:00-04:00,PFE,favus gives 10 reasons to sell allergan,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998230338096619
989791,989791,1001951.0,"Notable Imbalances Before Wednesday's Open: Investors Bullish On Financials, Selling Gold Stocks",2016-04-13 09:21:00-04:00,PFE,notable imbalances before wednesdays open investors bullish on financials selling gold stocks,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9974426031112671
989792,989792,1001952.0,"U.S. Appeals Court Revives Shareholder Lawsuit vs Pfizer Regarding Alleged Misrepresentations Concerning Celebrex, Bextra Safety -Reuters",2016-04-12 10:39:00-04:00,PFE,u s appeals court revives shareholder lawsuit vs pfizer regarding alleged misrepresentations concerning celebrex bextra safety reuters,"{'neg': 0.089, 'neu': 0.657, 'pos': 0.254, 'compound': 0.5423}",positive,0.8355932235717773
989793,989793,1001953.0,"Benzinga's M&A Chatter for Monday April 11, 2016",2016-04-11 20:38:00-04:00,PFE,benzingas m and a chatter for monday april 11 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998830556869507
989794,989794,1001954.0,The 10 Least Likely M&A Deals To Go Through,2016-04-11 10:06:00-04:00,PFE,the 10 least likely m and a deals to go through,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998688697814941
989795,989795,1001955.0,"Friday's After-Hours Movers: Energy, Pharmaceuticals Active",2016-04-08 16:41:00-04:00,PFE,fridays after hours movers energy pharmaceuticals active,"{'neg': 0.0, 'neu': 0.51, 'pos': 0.49, 'compound': 0.5859}",neutral,0.99988853931427
989796,989796,1001956.0,How One Analyst Is Playing The Biotech Rebound This Week,2016-04-07 15:45:00-04:00,PFE,how one analyst is playing the biotech rebound this week,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.2023}",neutral,0.9027059674263
989797,989797,1001957.0,"Street Struggles for Direction, Looking for Catalyst As Earnings Approach",2016-04-07 14:04:00-04:00,PFE,street struggles for direction looking for catalyst as earnings approach,"{'neg': 0.217, 'neu': 0.783, 'pos': 0.0, 'compound': -0.3612}",negative,0.9919694066047668
989798,989798,1001958.0,IBM Teams Up With Pfizer To Move Towards Parkinson's Cure,2016-04-07 13:47:00-04:00,PFE,ibm teams up with pfizer to move towards parkinsons cure,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997100234031677
989799,989799,1001959.0,White House Says Treasury Department Working on More Steps to Counter Tax Avoidance -Reuters,2016-04-07 13:25:00-04:00,PFE,white house says treasury department working on more steps to counter tax avoidance reuters,"{'neg': 0.164, 'neu': 0.727, 'pos': 0.109, 'compound': -0.2263}",neutral,0.9985095858573914
989800,989800,1001960.0,"The Market In 5 Minutes: Thursday, April 7, 2016",2016-04-07 10:36:00-04:00,PFE,the market in 5 minutes thursday april 7 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998838901519775
989801,989801,1001961.0,"Pfizer's Valuation Is Attractive, And JPMorgan Wouldn't Be Surprised To See A Breakup",2016-04-07 09:52:00-04:00,PFE,pfizers valuation is attractive and jpmorgan wouldnt be surprised to see a breakup,"{'neg': 0.107, 'neu': 0.707, 'pos': 0.186, 'compound': 0.3036}",positive,0.9995085000991821
989802,989802,1001962.0,Pfizer & IBM Report Collaboration To Experiment With Treatment Decision and Clinical Trial Design In Parkinson's,2016-04-07 08:32:00-04:00,PFE,pfizer and ibm report collaboration to experiment with treatment decision and clinical trial design in parkinsons,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998385906219482
989803,989803,1001963.0,"Morgan Stanley Assumes Pfizer at Equal-weight, Announces $35.00 PT",2016-04-07 08:25:00-04:00,PFE,morgan stanley assumes pfizer at equal weight announces dollars 5.00 point,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998831748962402
989804,989804,1001964.0,"JP Morgan Assumes Pfizer at Overweight, Announces $38.00 PT",2016-04-07 07:27:00-04:00,PFE,jp morgan assumes pfizer at overweight announces dollars 8.00 point,"{'neg': 0.203, 'neu': 0.65, 'pos': 0.146, 'compound': -0.1779}",neutral,0.9998807907104492
989805,989805,1001965.0,"Pfizer, Allergan: Fast Money Picks For April 7",2016-04-07 06:40:00-04:00,PFE,pfizer allergan fast money picks for april 7,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998465776443481
989806,989806,1001966.0,"JP Morgan Assumes Pfizer at Overweight, Announces $38.00 PT, Says Co Is 'well-positioned as a defensive business with healthy fundamentals'",2016-04-07 04:32:00-04:00,PFE,jp morgan assumes pfizer at overweight announces dollars 8.00 point says co is well positioned as a defensive business with healthy fundamentals,"{'neg': 0.092, 'neu': 0.625, 'pos': 0.283, 'compound': 0.4939}",positive,0.9995471835136414
989807,989807,1001967.0,"Benzinga's M&A Chatter for Wednesday April 6, 2016",2016-04-06 20:22:00-04:00,PFE,benzingas m and a chatter for wednesday april 6 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998881816864014
989808,989808,1001968.0,"After-Hours Recap: Bed Bath & Beyond, Apollo, Valeant, eBay & More",2016-04-06 18:36:00-04:00,PFE,after hours recap bed bath and beyond apollo valeant ebay and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999882698059082
989809,989809,1001969.0,6 Investment Banks Lost More Than $200 Million From Pfizer-Allergan Deal Collapse,2016-04-06 15:51:00-04:00,PFE,6 investment banks lost more than dollars 00 million from pfizer allergan deal collapse,"{'neg': 0.314, 'neu': 0.686, 'pos': 0.0, 'compound': -0.6705}",negative,0.9981422424316406
989810,989810,1001970.0,New Tax Inversions Rules: Threats To Healthcare ETFs?,2016-04-06 15:33:00-04:00,PFE,new tax inversions rules threats to healthcare etfs,"{'neg': 0.286, 'neu': 0.714, 'pos': 0.0, 'compound': -0.4215}",negative,0.8902066946029663
989811,989811,1001971.0,"PPH May Be Home To Hedge Fund Hotels, But This ETF Can Endure",2016-04-06 14:26:00-04:00,PFE,pph may be home to hedge fund hotels but this etf can endure,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998045563697815
989812,989812,1001972.0,SocGen Picks New Favorites In Big Pharma,2016-04-06 13:44:00-04:00,PFE,socgen picks new favorites in big pharma,"{'neg': 0.0, 'neu': 0.682, 'pos': 0.318, 'compound': 0.4215}",neutral,0.9989866614341736
989813,989813,1001973.0,Mylan Is 'Comfortable Moving Forward' With Acquisition Of Sweden-Based Meda,2016-04-06 13:23:00-04:00,PFE,mylan is comfortable moving forward with acquisition of sweden based meda,"{'neg': 0.0, 'neu': 0.752, 'pos': 0.248, 'compound': 0.5106}",positive,0.9986656904220581
989814,989814,1001974.0,Barron's: Allergan And Pfizer Still Buys Even After Deal Fell Through,2016-04-06 13:18:00-04:00,PFE,barrons allergan and pfizer still buys even after deal fell through,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9156624674797058
989815,989815,1001975.0,Pfizer Gets European Nod For Prevenar 13,2016-04-06 13:14:00-04:00,PFE,pfizer gets european nod for prevenar 13,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9813991189002991
989816,989816,1001976.0,Investors Applaud Ending Of Pfizer-Allergan Deal,2016-04-06 12:25:00-04:00,PFE,investors applaud ending of pfizer allergan deal,"{'neg': 0.0, 'neu': 0.667, 'pos': 0.333, 'compound': 0.4588}",positive,0.7752448916435242
989817,989817,1001977.0,Is Allergan Worth Over $300 Without Pfizer?,2016-04-06 11:57:00-04:00,PFE,is allergan worth over dollars 00 without pfizer,"{'neg': 0.0, 'neu': 0.787, 'pos': 0.213, 'compound': 0.2263}",neutral,0.9998831748962402
989818,989818,1001978.0,Societe Generale Initiates Coverage on Pfizer at Hold,2016-04-06 11:47:00-04:00,PFE,societe generale initiates coverage on pfizer at hold,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999881386756897
989819,989819,1001979.0,What Will Fed Minutes Mean To Markets?,2016-04-06 11:39:00-04:00,PFE,what will fed minutes mean to markets,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998424053192139
989820,989820,1001980.0,Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13,2016-04-06 11:01:00-04:00,PFE,pfizer receives european approval for new multi dose vial presentation of prevenar 13,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.4767}",positive,0.9978466033935547
989821,989821,1001981.0,Pfizer Receives FDA Approval For Cheaper Version Of Johnson & Johnson's Top Drug Remicade,2016-04-06 10:45:00-04:00,PFE,pfizer receives fda approval for cheaper version of johnson and johnsons top drug remicade,"{'neg': 0.0, 'neu': 0.71, 'pos': 0.29, 'compound': 0.5994}",positive,0.9993880987167358
989822,989822,1001982.0,"The Market In 5 Minutes: Wednesday, April 6, 2016",2016-04-06 10:33:00-04:00,PFE,the market in 5 minutes wednesday april 6 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998841285705566
989823,989823,1001983.0,Benzinga's Volume Movers,2016-04-06 10:16:00-04:00,PFE,benzingas volume movers,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998672008514404
989824,989824,1001984.0,10 Stocks Moving In Wednesday's Pre-Market Session,2016-04-06 08:19:00-04:00,PFE,10 stocks moving in wednesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998692274093628
989825,989825,1001985.0,Pfizer Announces Merger Termination With Allergan; Will Pay $150 Million Breakup Fee,2016-04-06 07:09:00-04:00,PFE,pfizer announces merger termination with allergan will pay dollars 50 million breakup fee,"{'neg': 0.104, 'neu': 0.896, 'pos': 0.0, 'compound': -0.1027}",neutral,0.9887533187866211
989826,989826,1001986.0,Allergan Release Says Company Still Has Strong Future Following Pfizer Merger Termination,2016-04-06 06:50:00-04:00,PFE,allergan release says company still has strong future following pfizer merger termination,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.5106}",positive,0.9994688630104065
989827,989827,1001987.0,Pfizer to Pay Allergan $150M Breakup Fee,2016-04-06 06:46:00-04:00,PFE,pfizer to pay allergan dollars 50 million breakup fee,"{'neg': 0.149, 'neu': 0.851, 'pos': 0.0, 'compound': -0.1027}",neutral,0.999845027923584
989828,989828,1001988.0,Pfizer Announces Termination of Merger with Allergan,2016-04-06 06:45:00-04:00,PFE,pfizer announces termination of merger with allergan,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9950902462005615
989829,989829,1001989.0,"Stocks To Watch For April 6, 2016",2016-04-06 04:29:00-04:00,PFE,stocks to watch for april 6 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998793601989746
989830,989830,1001990.0,"Benzinga's M&A Chatter for Tuesday April 5, 2016",2016-04-05 20:22:00-04:00,PFE,benzingas m and a chatter for tuesday april 5 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998867511749268
989831,989831,1001991.0,"If Pfizer Saves Allergan Deal, These Two Things Should Be Changed",2016-04-05 16:13:00-04:00,PFE,if pfizer saves allergan deal these two things should be changed,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999823272228241
989832,989832,1001992.0,Report: Pfizer May Abandon Allergan Deal,2016-04-05 15:11:00-04:00,PFE,report pfizer may abandon allergan deal,"{'neg': 0.367, 'neu': 0.633, 'pos': 0.0, 'compound': -0.4404}",negative,0.9381685853004456
989833,989833,1001993.0,Obama: Tax Inversions Are 'Wasteful',2016-04-05 13:50:00-04:00,PFE,obama tax inversions are wasteful,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.7565807700157166
989834,989834,1001994.0,"Hearing Pfizer is Leaning Towards Abandoning, Not Altering, Deal with Allergan",2016-04-05 13:39:00-04:00,PFE,hearing pfizer is leaning towards abandoning not altering deal with allergan,"{'neg': 0.206, 'neu': 0.794, 'pos': 0.0, 'compound': -0.3818}",neutral,0.7488861083984375
989835,989835,1001995.0,Pfizer Rallies Off Allergan News,2016-04-05 12:56:00-04:00,PFE,pfizer rallies off allergan news,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.99978107213974
989836,989836,1001996.0,Evidence Pfizer Could Revisit GlaxoSmithKline Or AstraZeneca Deals If Allergan Falls Through,2016-04-05 12:30:00-04:00,PFE,evidence pfizer could revisit glaxosmithkline or astrazeneca deals if allergan falls through,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.910123348236084
989837,989837,1001997.0,Allergan Now Trades Cheaper Than Its Standalone Value,2016-04-05 11:07:00-04:00,PFE,allergan now trades cheaper than its standalone value,"{'neg': 0.0, 'neu': 0.745, 'pos': 0.255, 'compound': 0.34}",positive,0.9994151592254639
989838,989838,1001998.0,Hearing Pres Obama Will Make Statement on Tax Inversions at 12:15 p.m. EDT,2016-04-05 11:06:00-04:00,PFE,hearing pres obama will make statement on tax inversions at 5 p m edt,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998800754547119
989839,989839,1001999.0,"The Market In 5 Minutes: Tuesday, April 5, 2016",2016-04-05 10:38:00-04:00,PFE,the market in 5 minutes tuesday april 5 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998812675476074
989840,989840,1002000.0,"Leerink: Treasury Notice Lowers Pfizer-Allergan Deal Chances, Ownership Test Changes A 'Surprise'",2016-04-05 08:49:00-04:00,PFE,leerink treasury notice lowers pfizer allergan deal chances ownership test changes a surprise,"{'neg': 0.093, 'neu': 0.556, 'pos': 0.352, 'compound': 0.4939}",negative,0.9386275410652161
989841,989841,1002001.0,"Merck KGaA, Pfizer Report First Patient Treated in Phase 3 Combo Study With Avelumab and INLYTA",2016-04-05 08:02:00-04:00,PFE,merck kgaa pfizer report first patient treated in phase 3 combo study with avelumab and inlyta,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998857975006104
989842,989842,1002002.0,"Pfizer, Allergan, Disney, Tesla: Fast Money Picks For April 5",2016-04-05 07:02:00-04:00,PFE,pfizer allergan disney tesla fast money picks for april 5,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998144507408142
989843,989843,1002003.0,"Pfizer Reports Top-Line Results From Phase 3 Tofacitinib Trial, Met Primary Endpoints Of Superior Treatment To Placebo",2016-04-05 07:01:00-04:00,PFE,pfizer reports top line results from phase 3 tofacitinib trial met primary endpoints of superior treatment to placebo,"{'neg': 0.0, 'neu': 0.751, 'pos': 0.249, 'compound': 0.6486}",positive,0.9993871450424194
989844,989844,1002004.0,"Pfizer Says Conducting Review of Treasury Action, Won't Speculate on Potential Impact -Reuters",2016-04-04 19:01:00-04:00,PFE,pfizer says conducting review of treasury action wont speculate on potential impact reuters,"{'neg': 0.0, 'neu': 0.87, 'pos': 0.13, 'compound': 0.2023}",neutral,0.9998047947883606
989845,989845,1002005.0,Betting On The Pfizer-Allergan Merger? You Now Have A 35% Arbitrage Opportunity After New Treasury Fears,2016-04-04 18:38:00-04:00,PFE,betting on the pfizer allergan merger you now have a 35 percent arbitrage opportunity after new treasury fears,"{'neg': 0.125, 'neu': 0.67, 'pos': 0.205, 'compound': 0.2023}",positive,0.9928643703460693
989846,989846,1002006.0,David Faber @davidfaber Tweet: 3 year look back provision on new inversion regs from Treasury is aimed at killing $PFE $AGN deal and may well succeed in doing just that.,2016-04-04 18:08:00-04:00,PFE,david faber tweet 3 year look back provision on new inversion regs from treasury is aimed at killing pfe agn deal and may well succeed in doing just that,"{'neg': 0.121, 'neu': 0.685, 'pos': 0.195, 'compound': 0.1779}",positive,0.9934825301170349
989847,989847,1002007.0,"PFE Trading Higher After Hours, Traders Attribute As Sympathy Move To AGN Selloff Following US Trsy. Tax Inversion Limitations",2016-04-04 17:25:00-04:00,PFE,pfe trading higher after hours traders attribute as sympathy move to agn selloff following us trsy tax inversion limitations,"{'neg': 0.0, 'neu': 0.878, 'pos': 0.122, 'compound': 0.3612}",positive,0.9982444047927856
989848,989848,1002008.0,"Allergan Shares Down From $277 To Low Of $228 After Hours On Tax Inversion Limitations By US Treasury, Now Trading At $235/Share",2016-04-04 17:25:00-04:00,PFE,allergan shares down from dollars 77 to low of dollars 28 after hours on tax inversion limitations by us treasury now trading at dollars,"{'neg': 0.077, 'neu': 0.775, 'pos': 0.148, 'compound': 0.2263}",negative,0.9955257773399353
989849,989849,1002009.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-04-04 16:52:00-04:00,PFE,the stocks that moved the SP500 dow and nasdaq today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998750686645508
989850,989850,1002010.0,Make A House Call With A Familiar Healthcare ETF,2016-04-04 08:28:00-04:00,PFE,make a house call with a familiar healthcare etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998750686645508
989851,989851,1002011.0,Cramer Gives His Opinion On Fitbit And Allergan,2016-04-03 16:48:00-04:00,PFE,cramer gives his opinion on fitbit and allergan,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998741149902344
989852,989852,1002012.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-04-01 16:43:00-04:00,PFE,the stocks that moved the SP500 dow and nasdaq today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998750686645508
989853,989853,1002013.0,Pfizer Offers Topline Results from Second Phase 3 Lipid-Lowering Study Evaluating Bococizumab,2016-04-01 08:00:00-04:00,PFE,pfizer offers topline results from second phase 3 lipid lowering study evaluating bococizumab,"{'neg': 0.143, 'neu': 0.857, 'pos': 0.0, 'compound': -0.25}",neutral,0.9998573064804077
989854,989854,1002014.0,Pfizer Releases Statement Stating A False PR was Linked To A Fake Web Site Anonymously Earlier Today and Was Erroneously Attributed To Pfizer,2016-03-31 16:30:00-04:00,PFE,pfizer releases statement stating a false pr was linked to a fake web site anonymously earlier today and was erroneously attributed to pfizer,"{'neg': 0.124, 'neu': 0.876, 'pos': 0.0, 'compound': -0.4767}",neutral,0.999824583530426
989855,989855,1002015.0,"Pfizer, Allergan Announce Received Added Info from FTC Related to Deal, Continue to Expect Deal to Close in 2H'16",2016-03-30 12:42:00-04:00,PFE,pfizer allergan announce received added info from ftc related to deal continue to expect deal to close in 2 hour 16,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.997200608253479
989856,989856,1002016.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-03-28 17:38:00-04:00,PFE,the stocks that moved the SP500 dow and nasdaq today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998750686645508
989857,989857,1002017.0,"Biopharma Names LLY, PFE, MRK, And More Popping Higher Following Reports China FDA To Investigate Improper Vaccine Trading",2016-03-28 11:29:00-04:00,PFE,biopharma names lly pfe mrk and more popping higher following reports china fda to investigate improper vaccine trading,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9949486255645752
989858,989858,1002018.0,Pfizer Reports EMA Acceptance for Review of MAA for XELJANZ for Treatment of Moderate to Severe Rheumatoid Arthritis,2016-03-23 16:17:00-04:00,PFE,pfizer reports ema acceptance for review of maa for xeljanz for treatment of moderate to severe rheumatoid arthritis,"{'neg': 0.12, 'neu': 0.741, 'pos': 0.139, 'compound': 0.1027}",neutral,0.978801429271698
989859,989859,1002019.0,Why Is The Allergan-Pfizer Spread Near All-Time Highs?,2016-03-21 10:25:00-04:00,PFE,why is the allergan pfizer spread near all time highs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9980974793434143
989860,989860,1002020.0,"UPDATE: Pfizer Expects 3 Phase-3 Stidies, LT Extension Trial Will FOrm Potential Submission Package To Regulatory Authorities For UC Indication",2016-03-18 11:04:00-04:00,PFE,update pfizer expects 3 phase 3 stidies lt extension trial will form potential submission package to regulatory authorities for uc indication,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998641014099121
989861,989861,1002021.0,Pfizer Announces Oral Tofacitinib Meets Primary/Key Secondary Endpoints In 2 Pivotal Phase 3 Ulcerative Colitis Trials,2016-03-18 11:02:00-04:00,PFE,pfizer announces oral tofacitinib meets primary and key secondary endpoints in 2 pivotal phase 3 ulcerative colitis trials,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.772842526435852
989862,989862,1002022.0,Pfizer Says CEO Total Comp For 2015 At $18M Vs Prior Year $23.3M; CFO Total Comp In 2015 $6.7M Vs Prior $8.5M,2016-03-15 16:40:00-04:00,PFE,pfizer says ceo total comp for 2015 at dollars 8 million vs prior year dollars 3.3 million cfo total comp in 2015 dollars .7 million vs prior dollars .5 million,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997308850288391
989863,989863,1002023.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-03-14 16:29:00-04:00,PFE,the stocks that moved the SP500 dow and nasdaq today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998750686645508
989864,989864,1002024.0,AstraZeneca Looks to Link Executive Compensation to $45B Revenue Target -Bloomberg,2016-03-13 17:17:00-04:00,PFE,astrazeneca looks to link executive compensation to dollars 5 billion revenue target bloomberg,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.5328932404518127
989865,989865,1002025.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-03-11 16:19:00-05:00,PFE,the stocks that moved the SP500 dow and nasdaq today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998750686645508
989866,989866,1002026.0,Pfizer Shares Quiet Following Co. Release XALKOR Has Been Approved by the FDA for Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer,2016-03-11 13:18:00-05:00,PFE,pfizer shares quiet following co release xalkor has been approved by the fda for treatment of patients with ros1 positive metastatic non small cell lung cancer,"{'neg': 0.126, 'neu': 0.629, 'pos': 0.246, 'compound': 0.4939}",positive,0.9851831793785095
989867,989867,1002027.0,XALKORI Approved by U.S. FDA for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer,2016-03-11 13:10:00-05:00,PFE,xalkori approved by u s fda for the treatment of patients with ros1 positive metastatic non small cell lung cancer,"{'neg': 0.158, 'neu': 0.612, 'pos': 0.23, 'compound': 0.25}",neutral,0.999841570854187
989868,989868,1002028.0,FDA Approves Generic Version of Viagra,2016-03-09 17:48:00-05:00,PFE,fda approves generic version of viagra,"{'neg': 0.0, 'neu': 0.649, 'pos': 0.351, 'compound': 0.4019}",neutral,0.9688859581947327
989869,989869,1002029.0,Pfizer Reports Commencement of $5B Accelerated Buyback Plan,2016-03-09 06:47:00-05:00,PFE,pfizer reports commencement of dollars b accelerated buyback plan,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9970644116401672
989870,989870,1002030.0,UPDATE: Pfizer Says Phase 3 Study Showed Prophylaxis with BeneFIX Significantly Reduced Annualized Bleeding Rate Compared to On-Demand Therapy,2016-03-08 17:01:00-05:00,PFE,update pfizer says phase 3 study showed prophylaxis with benefix significantly reduced annualized bleeding rate compared to on demand therapy,"{'neg': 0.073, 'neu': 0.927, 'pos': 0.0, 'compound': -0.128}",positive,0.9996022582054138
989871,989871,1002031.0,Pfizer Reports Publication of Study Results for BeneFIX Coagulation Factor IX Once-Weekly Prophylaxis for Hemophilia B,2016-03-08 17:00:00-05:00,PFE,pfizer reports publication of study results for benefix coagulation factor ix once weekly prophylaxis for hemophilia b,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998749494552612
989872,989872,1002032.0,"UBS Maintains Buy On Pfizer & PT $36, Says Allergan Deal Makes Strategic Sense And Believes Consensus Fails To Give Sufficient Credit To Allergan Pipeline",2016-03-08 06:51:00-05:00,PFE,ubs maintains buy on pfizer and point dollars 6 says allergan deal makes strategic sense and believes consensus fails to give sufficient credit to allergan pipeline,"{'neg': 0.095, 'neu': 0.816, 'pos': 0.088, 'compound': -0.0516}",positive,0.9989882111549377
989873,989873,1002033.0,"Jefferies Maintains Buy On Pfizer, Lowers PT From $45 To $42",2016-03-08 06:00:00-05:00,PFE,jefferies maintains buy on pfizer lowers point from dollars 5 to dollars 2,"{'neg': 0.111, 'neu': 0.889, 'pos': 0.0, 'compound': -0.128}",positive,0.7548614740371704
989874,989874,1002034.0,The Other Sector ETF Player,2016-03-07 14:26:00-05:00,PFE,the other sector etf player,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998953342437744
989875,989875,1002035.0,Allergan Files Form S-4 for Offering of Securities Related to Merger With Pfizer,2016-03-07 06:25:00-05:00,PFE,allergan files form s 4 for offering of securities related to merger with pfizer,"{'neg': 0.0, 'neu': 0.855, 'pos': 0.145, 'compound': 0.296}",neutral,0.9998883008956909
989876,989876,1002036.0,"UPDATE: Merck, Pfizer, and Verastem Combination Trial Of Avelumab and VS-6063 Expected To Begin In 2nd Half 2016",2016-03-03 07:16:00-05:00,PFE,update merck pfizer and verastem combination trial of avelumab and vs 6063 expected to begin in 2 half 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998904466629028
989877,989877,1002037.0,"Merck KGaA, Darmstadt, Germany, Pfizer and Verastem Report Combination Trial of Avelumab and VS-6063 in Ovarian Cancer",2016-03-03 07:10:00-05:00,PFE,merck kgaa darmstadt germany pfizer and verastem report combination trial of avelumab and vs 6063 in ovarian cancer,"{'neg': 0.206, 'neu': 0.794, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9998713731765747
989878,989878,1002038.0,Stocks To Watch During Cowen's 36th Annual Healthcare Conference,2016-03-01 13:21:00-05:00,PFE,stocks to watch during cowens 36 annual healthcare conference,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998830556869507
989879,989879,1002039.0,Bernie Sanders  ‏@SenSanders Tweet: Enough is enough. Pfizer and other pharmaceutical companies can no longer be allowed to rip off American patients.,2016-02-25 14:12:00-05:00,PFE,bernie sanders ‏ tweet enough is enough pfizer and other pharmaceutical companies can no longer be allowed to rip off american patients,"{'neg': 0.095, 'neu': 0.905, 'pos': 0.0, 'compound': -0.296}",neutral,0.9950710535049438
989880,989880,1002040.0,Pfizer ReportsFDA Approval of XELJANZ Extended-Release Tablets Treatment for Rheumatoid Arthritis,2016-02-24 11:16:00-05:00,PFE,pfizer reportsfda approval of xeljanz extended release tablets treatment for rheumatoid arthritis,"{'neg': 0.0, 'neu': 0.78, 'pos': 0.22, 'compound': 0.4767}",positive,0.9989120960235596
989881,989881,1002041.0,"Viiv Healthcare Phase II Study, Says Comparable Viral Suppression Rates Btwn Injectable Regiment & 3 Drug Oral Regimen",2016-02-23 14:57:00-05:00,PFE,viiv healthcare phase ii study says comparable viral suppression rates btwn injectable regiment and 3 drug oral regimen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998786449432373
989882,989882,1002042.0,"Allergan Gains 1.50% Following Q4 Beat, Company Updates On M&A Activity",2016-02-22 08:51:00-05:00,PFE,allergan gains 1.50 percent following fourth quarter beat company updates on m and a activity,"{'neg': 0.0, 'neu': 0.854, 'pos': 0.146, 'compound': 0.34}",positive,0.999718964099884
989883,989883,1002043.0,Slump Could Be Healthcare ETF Buying Opportunity,2016-02-22 07:44:00-05:00,PFE,slump could be healthcare etf buying opportunity,"{'neg': 0.0, 'neu': 0.682, 'pos': 0.318, 'compound': 0.4215}",positive,0.9993953704833984
989884,989884,1002044.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-02-17 16:32:00-05:00,PFE,the stocks that moved the SP500 dow and nasdaq today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998750686645508
989885,989885,1002045.0,Everything You Might Have Missed This 13F Season: Part 2,2016-02-17 15:58:00-05:00,PFE,everything you might have missed this 13 f season part 2,"{'neg': 0.18, 'neu': 0.82, 'pos': 0.0, 'compound': -0.296}",neutral,0.9998238682746887
989886,989886,1002046.0,Paulson & Co Reports New Stake In Pfizer,2016-02-16 17:09:00-05:00,PFE,paulson and co reports new stake in pfizer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996528625488281
989887,989887,1002047.0,10 M&A Deals The Market Thinks Might Not Happen,2016-02-16 14:53:00-05:00,PFE,10 m and a deals the market thinks might not happen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998470544815063
989888,989888,1002048.0,"13F from Cooperman's Omega Shows Reduced Stakes in Anadarko, Facebook, Motorola Solutions, Pfizer, Time Warner",2016-02-16 09:49:00-05:00,PFE,13 f from coopermans omega shows reduced stakes in anadarko facebook motorola solutions pfizer time warner,"{'neg': 0.0, 'neu': 0.898, 'pos': 0.102, 'compound': 0.1779}",positive,0.9945026636123657
989889,989889,1002049.0,13F from JANA Shows New ~9.17M Share Stake in Pfizer,2016-02-16 08:20:00-05:00,PFE,13 f from jana shows new 9.17 million share stake in pfizer,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.296}",neutral,0.9997687935829163
989890,989890,1002050.0,"Pfizer Reaches Agreement to Resolve Medicaid Protonix Claims, Wyeth to Make ~785M Payment",2016-02-16 06:48:00-05:00,PFE,pfizer reaches agreement to resolve medicaid protonix claims wyeth to make 785 million payment,"{'neg': 0.0, 'neu': 0.611, 'pos': 0.389, 'compound': 0.7184}",positive,0.9993434548377991
989891,989891,1002052.0,Schroer: Biotech Will Turn Around,2016-02-13 22:12:00-05:00,PFE,schroer biotech will turn around,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9966733455657959
989892,989892,1002053.0,"13F from Appaloosa Shows New Stakes in Southwestern Energy, Kinder Morgan, Pfizer",2016-02-12 16:34:00-05:00,PFE,13 f from appaloosa shows new stakes in southwestern energy kinder morgan pfizer,"{'neg': 0.0, 'neu': 0.675, 'pos': 0.325, 'compound': 0.6486}",neutral,0.5071440935134888
989893,989893,1002054.0,The Generic Drug Battle,2016-02-10 09:13:00-05:00,PFE,the generic drug battle,"{'neg': 0.464, 'neu': 0.536, 'pos': 0.0, 'compound': -0.3818}",neutral,0.9998735189437866
989894,989894,1002055.0,BoA Adds Pfizer To US 1 List; It 'Won't Keep You Up At Night',2016-02-09 09:52:00-05:00,PFE,boa adds pfizer to us 1 list it wont keep you up at night,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998220801353455
989895,989895,1002056.0,Most Of Credit Suisse's Top Investment Ideas For 2016...In One Place,2016-02-08 15:56:00-05:00,PFE,most of credit suisses top investment ideas for 2016 in one place,"{'neg': 0.0, 'neu': 0.681, 'pos': 0.319, 'compound': 0.5688}",neutral,0.9998818635940552
989896,989896,1002057.0,"Schoenebaum: Biotech P/Es Show 'Buying Signal' With Caveat; Amgen, Biogen, Celgene & Gilead Have Catalysts",2016-02-08 15:27:00-05:00,PFE,schoenebaum biotech pe ratio s show buying signal with caveat amgen biogen celgene and gilead have catalysts,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999256432056427
989897,989897,1002058.0,How To Invest In An Aging World With The 'Live Long & Prosper' ETF,2016-02-08 10:53:00-05:00,PFE,how to invest in an aging world with the live long and prosper etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994180202484131
989898,989898,1002059.0,RBC Analyst Says 'Buy The Spread' On Allergan-Pfizer Deal,2016-02-08 09:12:00-05:00,PFE,rbc analyst says buy the spread on allergan pfizer deal,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.5798773765563965
989899,989899,1002060.0,Pharmaceuticals Turn To Politics To Protect Prices,2016-02-08 08:17:00-05:00,PFE,pharmaceuticals turn to politics to protect prices,"{'neg': 0.0, 'neu': 0.698, 'pos': 0.302, 'compound': 0.3818}",neutral,0.9995563626289368
989900,989900,1002061.0,"RBC Capital Positive On AGN, Would Use Co To Be Long On PFE/AGN Spread, Expects Deal To Close In H2 2016, Maintains Outperform And $354 PT",2016-02-08 07:57:00-05:00,PFE,rbc capital positive on agn would use co to be long on pfe and agn spread expects deal to close in h2 2016 maintains outperform and dollars 54 point,"{'neg': 0.0, 'neu': 0.886, 'pos': 0.114, 'compound': 0.5574}",positive,0.9996813535690308
989901,989901,1002062.0,A Checkup On A Big Healthcare ETF,2016-02-05 13:19:00-05:00,PFE,a checkup on a big healthcare etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998867511749268
989902,989902,1002063.0,How To Build A Defensive Portfolio,2016-02-04 15:13:00-05:00,PFE,how to build a defensive portfolio,"{'neg': 0.0, 'neu': 0.82, 'pos': 0.18, 'compound': 0.0258}",neutral,0.9998394250869751
989903,989903,1002064.0,25 Companies That Could Still Buy Back Mountains Of Stock,2016-02-04 12:39:00-05:00,PFE,25 companies that could still buy back mountains of stock,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998527765274048
989904,989904,1002065.0,Is Big Pharma Hinting At A SMID-Cap Biotech Rally?,2016-02-03 13:16:00-05:00,PFE,is big pharma hinting at a smid cap biotech rally,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9963681697845459
989905,989905,1002066.0,Joe McCann: Here's How To Play Biotech Market In Earnings Season,2016-02-03 11:48:00-05:00,PFE,joe mccann heres how to play biotech market in earnings season,"{'neg': 0.0, 'neu': 0.806, 'pos': 0.194, 'compound': 0.34}",neutral,0.9998607635498047
989906,989906,1002067.0,Earnings Recap For February 2,2016-02-02 16:45:00-05:00,PFE,earnings recap for february 2,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998847246170044
989907,989907,1002068.0,Pfizer Holds Steady After Q4 Report,2016-02-02 13:42:00-05:00,PFE,pfizer holds steady after fourth quarter report,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999249279499054
989908,989908,1002069.0,From Conf Call: Pfizer CEO Feels Planned Tax-Inversion Merger With Allergan Is Fully Within U.S. Law,2016-02-02 10:47:00-05:00,PFE,from conf call pfizer ceo feels planned tax inversion merger with allergan is fully within u s law,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997981190681458
989909,989909,1002070.0,"Hearing Intercept Pharma hires JPM to Handle Interest from Pfizer, Gilead, BristolMyers -Daily Mail",2016-02-02 09:43:00-05:00,PFE,hearing intercept pharma hires jpm to handle interest from pfizer gilead bristolmyers daily mail,"{'neg': 0.0, 'neu': 0.812, 'pos': 0.188, 'compound': 0.4588}",neutral,0.9998323917388916
989910,989910,1002071.0,"Pfizer Reports Better-Than-Expected Q4, Shares Dip Lower",2016-02-02 07:23:00-05:00,PFE,pfizer reports better than expected fourth quarter shares dip lower,"{'neg': 0.154, 'neu': 0.49, 'pos': 0.357, 'compound': 0.4404}",negative,0.9986065030097961
989911,989911,1002072.0,Pfizer Sees FY Rennue $49B to $51B vs $52.5B est,2016-02-02 06:49:00-05:00,PFE,pfizer sees fy rennue dollars 9 billion to dollars 1 billion vs dollars 2.5 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998181462287903
989912,989912,1002073.0,Pfizer Sees FY EPS $2.20 to $2.30 vs $2.36 est,2016-02-02 06:48:00-05:00,PFE,pfizer sees fy eps dollars .20 to dollars .30 vs dollars .36 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998238682746887
989913,989913,1002074.0,"Pfizer Q4 EPS $0.53 vs $0.52 est, Revenue $14.05B vs $13.56B est",2016-02-02 06:46:00-05:00,PFE,pfizer fourth quarter eps dollars .53 vs dollars .52 est revenue dollars 4.05 billion vs dollars 3.56 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998689889907837
989914,989914,1002075.0,Must Watch Stocks for Today,2016-02-02 04:23:00-05:00,PFE,must watch stocks for today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998546838760376
989915,989915,1002076.0,"Earnings Scheduled For February 2, 2016",2016-02-02 04:01:00-05:00,PFE,earnings scheduled for february 2 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999879002571106
989916,989916,1002077.0,"Earnings: Pharma Tends to Top Street Estimate—Can PFE, MRK Repeat?",2016-02-01 10:38:00-05:00,PFE,earnings pharma tends to top street estimate—can pfe mrk repeat,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.2023}",neutral,0.9986340403556824
989917,989917,1002078.0,"Stock Marquee is Crowded in Week Ahead: Oil, Earnings, Labor Data",2016-02-01 10:28:00-05:00,PFE,stock marquee is crowded in week ahead oil earnings labor data,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9992639422416687
989918,989918,1002079.0,UPDATE: Portola Pharma Licensing Deals for Andexanet Alfa in Japan Valued at Up to $120M,2016-02-01 07:04:00-05:00,PFE,update portola pharma licensing deals for andexanet alfa in japan valued at up to dollars 20 million,"{'neg': 0.0, 'neu': 0.847, 'pos': 0.153, 'compound': 0.4404}",neutral,0.9990266561508179
989919,989919,1002080.0,Bristol-Myers and Pfizer Announce Collaboration with Portoloa Pharma,2016-02-01 06:56:00-05:00,PFE,bristol myers and pfizer announce collaboration with portoloa pharma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9836719632148743
989920,989920,1002081.0,Mixed Earnings Expectations For Merck And Pfizer,2016-01-31 19:21:00-05:00,PFE,mixed earnings expectations for merck and pfizer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9972623586654663
989921,989921,1002082.0,Large Johnson & Johnson Shareholder Just Revealed 8 Major Concerns,2016-01-28 15:27:00-05:00,PFE,large johnson and johnson shareholder just revealed 8 major concerns,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9905486702919006
989922,989922,1002083.0,"JNJ Kicks Off Health Care Earnings—What About Deals, Buybacks?",2016-01-25 11:43:00-05:00,PFE,jnj kicks off health care earnings—what about deals buybacks,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.4939}",neutral,0.9993902444839478
989923,989923,1002084.0,US Big Pharma: What To Watch For In Q4 Results,2016-01-25 11:16:00-05:00,PFE,us big pharma what to watch for in fourth quarter results,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998005032539368
989924,989924,1002085.0,The FDA Just Crushed Sarepta Therapeutics' Hopes Of Releasing A Muscular Dystrophy Drug,2016-01-21 11:23:00-05:00,PFE,the fda just crushed sarepta therapeutics hopes of releasing a muscular dystrophy drug,"{'neg': 0.169, 'neu': 0.663, 'pos': 0.169, 'compound': 0.0}",positive,0.9994851350784302
989925,989925,1002086.0,"Philogen Announces Pfizer Exercised Options Granted Under Deal Established in Dec. '14 for Potential Development, Commercialization of Multiple ADCs",2016-01-21 09:06:00-05:00,PFE,philogen announces pfizer exercised options granted under deal established in dec 14 for potential development commercialization of multiple adcs,"{'neg': 0.0, 'neu': 0.9, 'pos': 0.1, 'compound': 0.25}",positive,0.9877983927726746
989926,989926,1002087.0,Write A Prescription For This Healthcare ETF,2016-01-15 08:24:00-05:00,PFE,write a prescription for this healthcare etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998854398727417
989927,989927,1002088.0,"Pfizer Announces Acquisition Of Top Chinese Healthcare Brand, Considering Sale Of Hospira Pump Unit",2016-01-14 10:10:00-05:00,PFE,pfizer announces acquisition of top chinese healthcare brand considering sale of hospira pump unit,"{'neg': 0.0, 'neu': 0.878, 'pos': 0.122, 'compound': 0.2023}",neutral,0.9991143345832825
989928,989928,1002089.0,Pfizer Considers Sale of Hospira Pump Unit -Bloomberg,2016-01-14 04:33:00-05:00,PFE,pfizer considers sale of hospira pump unit bloomberg,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997743964195251
989929,989929,1002090.0,Pfizer Acquires Treerly Healthfrom Sirio Pharma; Terms Not Disclosed,2016-01-14 04:28:00-05:00,PFE,pfizer acquires treerly healthfrom sirio pharma terms not disclosed,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9980472326278687
